key: cord-0046789-3f9yhi09
authors: Rabinowitz, Peter M.; Conti, Lisa A.
title: Zoonoses
date: 2010-12-27
journal: Human-Animal Medicine
DOI: 10.1016/b978-1-4160-6837-2.00009-9
sha: 4b3f22cd1333182761241cb6812aed252a1c96bb
doc_id: 46789
cord_uid: 3f9yhi09

nan

• Establish or refresh lines of communication among the human health and veterinary clinicians within the community (e.g., provide continuing education, update distribution list information). • Routinely disseminate information about reportable diseases to the human health and veterinary community. • Consider providing emerging disease exercises that involve the human health and veterinary community.

• Consider zoonotic diseases in the differential diagnosis of a wide range of medical complaints, and counsel clients about risk. • Reassure owners about non-zoonoses in terms of human risk. • Consider inviting veterinary clinicians and veterinary professionals in the community to a joint continuing education meeting regarding zoonoses.

• Consider the zoonotic potential of animal infectious diseases and whether an infection in an animal indicates environmental risk shared by humans as well. • Consider inviting human health clinicians and veterinary professionals in the community to a joint continuing education meeting regarding zoonoses.

The history of contact between animals and humans has always involved infectious diseases, and today more than half of the infectious diseases of humans are zoonotic in origin. In fact, the majority of "emerging" infectious diseases in the past three decades are zoonotic. Therefore the control and prevention of these diseases can be accomplished only through improving approaches to reducing disease transmission among humans and other animals. Despite the great deal of attention that has been focused on emerging infectious zoonotic diseases, including severe acute respiratory syndrome (SARS), West Nile virus, monkeypox, and avian influenza, there has been less discussion and effort targeted at the environmental "drivers" of such diseases. One possible reason is that the traditional approach of the human health community to zoonotic disease has been an "us versus them" approach. The problem is viewed as an infectious animal reservoir that then poses an infectious risk to humans-either through direct contact with infected animals and their excretions, meat, milk, or other tissues, or via a vector transmission bringing the pathogen from the animal population into human hosts. The control of such "us versus them" diseases has traditionally involved measures such as control of the animal reservoir (through culling, quarantine, or vaccination) or vector control (through pesticides and personal protection). For many zoonotic diseases, however, such approaches are limited because the ultimate causes of infection in the animals may not be addressed sufficiently. For example, Nipah virus emerged as a deadly pathogen in Malaysia when pig farms were built close to forest areas frequented by fruit bats (Figure 9 -1 and Color Plate 9-1). These fruit bats, natural Zoonoses Peter M. Rabinowitz 

hosts for Nipah and other henipaviruses, had sufficient contact with the pig farms to allow the virus pathogen to "spill over" from the wildlife reservoir into the domestic pig population, causing mortality for pigs and humans (and cats) in contact with them. 1 Therefore, for many infectious diseases that cross between animals and humans, it is advisable for human health professionals to move beyond an "us versus them" view of animals and infections and to instead join veterinarians and public health professionals to examine the environmental forces driving disease emergence that constitute a "shared risk" of infection for both humans and animals. 2 Figure 9 -2 outlines these relationships.

This chapter presents this shared risk approach for a number of zoonotic diseases. For each disease, environmental risk factors (drivers) of infectious risk are discussed, as well as practical steps that public health, human health, and animal health professionals can take to prevent, control, diagnose, and treat such infections. A key step with each disease is providing accurate information about risk to clients and other members of the health professions.

Infection in animals can be a warning signal of infectious disease risk to humans, and sometimes the converse is true. At the same time, many animal diseases currently are not believed to pose a threat to humans, and many human infectious diseases do not appear to infect pets and other animals.

Experience has shown that this situation may change as organisms continue to adapt to new environments and acquire mutations that allow them to cross species barriers. Nonetheless, human health clinicians should (1) be aware of animal diseases that, based on current knowledge, do not appear to cause disease in humans and (2) be able to reassure patients who express such concerns. Similarly, clinicians can correct misinformation regarding species-specific human diseases that patients may believe come from animal contact. For example, human pinworm infection is not a zoonotic disease. Table 9 -1 lists some of these non-zoonoses. As this list shows, many of these agents, while currently not considered zoonotic to any significant degree, bear some relation to human pathogens.

The sections in this chapter present individual descriptions of zoonotic diseases that human health and veterinary clinicians and public health professionals in the United States may encounter in their clinical work. It has been estimated, however, that there are more than 1600 known zoonotic pathogens, some of which are considered to be "emerging" in terms of expanding their geographical range or pathogenicity to other species. Our knowledge of the zoonotic potential of many infectious pathogens is continually changing as new evidence, some based on improved techniques of molecular diagnosis, appears. Table 9 -2 presents a number of pathogens and diseases for which clinicians and public health professionals should maintain an awareness of possibly increasing zoonotic disease risk. Table 9 -3 lists a number of currently recognized zoonotic pathogens and some of the species for which the pathogen has been reported. 

• Characterize the risk in the community, including whether cases have been reported in livestock or wildlife and whether there is a possibility of environmental contamination. • Work with veterinary authorities to control disease in animals. • Conduct immediate investigation of human cases to determine whether they are related to zoonotic transmission or deliberate toxin release. • Ensure that potentially exposed individuals receive postexposure prophylaxis (PEP). • Counsel people who contact spores to wash hands with soap and water, followed by an organic iodine solution immersion. Clothing should be washed and boiled. • Recommend that imported animal hides be disinfected before use. The U.S. Department of Agriculture (USDA) Animal and Plant Health Inspection Service (APHIS) regulates importation of all animal hides but does not mandate screening of imported hides for B. anthracis.

In addition, some hides may be imported illegally. 2 • Reduce environmental exposure risk through disinfection where possible. • Provide guidance for environmental sampling and environmental cleanup. 3, 4 Human Health Clinicians

• Consider the diagnosis in all patients with livestock contact or travel to endemic countries. • Report suspicion of disease immediately to public health authorities.

• Counsel travelers to endemic areas about risk reduction and monitoring for symptoms. • If providing occupational health services to workers at risk, ensure that they are educated about symptoms of the disease, use adequate protective equipment, and that efforts are taken to reduce potential of infection (such as disinfection of animal hides with formalin). • Consider vaccine for high-risk groups, 5 including laboratory workers and persons who handle potentially infected animals and animal products in high-incidence areas where safety standards are insufficient to prevent exposure to anthrax spores. 6 Military personnel 7 deployed to areas with high risk for biological warfare may require vaccination.

• Do not perform a necropsy on suspected animal cases.

• Annually vaccinate cattle, sheep, horses, goats, and swine in endemic areas using the Sterne strain vaccine. 8 Treat infected and potentially infected animals. During quarantine these animals should not be used as food. • Report suspected cases to agricultural health authorities who can quarantine premises to prevent spread of disease. • Veterinarians who work with potentially infected animals in high-incidence areas should consider vaccination. • Avoid contact with blood and bloody discharges. Keep flies and scavengers from carcasses. Infected carcasses should be burned (preferred) to destroy spores or buried in quick lime. To kill spores use 2% glutaraldehyde or 5% formalin for several hours. Heat sterilization at 121° C for 30 minutes can also be used. • Notify health department immediately if cases are diagnosed in animals. Such cases could both pose a risk to humans and be a sentinel warning of deliberate release of toxin.

The bacterium B. anthracis is a spore-forming, nonmotile, gram-positive bacillus 3 to 5 microns long. When the vegetative form is exposed to air, it sporulates to form infectious spores. The spores may survive for decades in soil (Figure 9 -3).

National disease control programs have reduced the global incidence of anthrax. It remains common in some Mediterranean countries, localized areas of Canada and the United States, parts of Central and South America, central Asia, parts of sub-Saharan Africa, and western China. 9 An epizootic among cattle in South Dakota in 2000 resulted in 157 cattle deaths and one human case of cutaneous anthrax. 10 Human anthrax resulting from exposure to infected livestock remains rare in the United States but occurs more commonly in less-developed countries. In many regions, the true incidence is not known because many cases in animals and humans probably go unreported.

Anthrax can be an occupational disease of workers who process carcasses and hides of infected animals, including farmers, abattoir workers, butchers, and workers in factories that process hides. Veterinarians who handle sick animals are also at risk, as are laboratory workers who routinely work with B. anthracis. Cases of both inhalation and cutaneous anthrax have developed in travelers and drum makers who have bought drums or hides originating from infected animals. In 2007, two cases of cutaneous anthrax in Connecticut were tied to importation of infected goat hides for drum-making ( Figure 9 -4). 2 In the 2001 intentional use of anthrax in mail, postal workers were an occupational risk group. No animals were affected in these attacks.

The reservoir for anthrax is the environment, where the spores can survive for years in alkaline calcium-rich soil. Anthrax is principally a disease of livestock, including cattle, sheep, goats, and camels. Wild ruminants such as antelope and bison can also be infected and pose a risk to livestock. 11 However, all mammals are susceptible, 12 and horses, pigs, dogs, cats, and humans can be incidentally infected. Because of their higher body temperatures birds are normally resistant, but ostriches are susceptible. In some settings, biting flies may serve as vectors for anthrax transmission. 9 In the 1979 accidental release of aerosolized anthrax in Sverdslovsk, Russia, cattle and sheep died as far as 50 km downwind from the release site, while human cases of inhalation anthrax occurred only up to 4 km downwind from the release. 13 The fact that animals became sickened over a wider geographical area than did humans may reflect their increased susceptibility and increased exposure risk, making animal cases sentinels for human risk.

Infected animals release vegetative bacteria into the environment. As the bacteria are exposed to air, they sporulate and the spores can survive for years. Ruminant animals grazing on areas contaminated by spores can ingest the spores and become infected. This can lead to further contamination of the environment and additional animal cases (Figure 9 -5). Biting flies appear to play a role in large outbreaks by facilitating animal-animal transmission, sometimes over significant distances (5 to 15 km). Direct animal-animal transmission among herbivores is considered insignificant, 9 but if carnivores eat the flesh of infected animals, they can become infected.

Transmission from animal to human usually involves direct contact with spores because the vegetative form of the microbe is not as infectious. Spores may be present on an infected animal's hide, in meat that has been in contact with air and has developed spores, or as an aerosol from infected animal hide or tissues or from the environment.

Most human infection occurs through direct contact with animals or animal products. Such transmission is more likely when there are breaks in the skin and leads to the cutaneous form of the disease (Figure 9-6 ).

Airborne transmission from animals to humans can occur when spores are aerosolized during the processing or handling of contaminated animal hair, wool, hides, and bones. Improvements in working conditions have reduced this risk. Airborne transmission can also occur during the deliberate release of the agent.

Humans can also become infected through ingestion of tissue from an infected animal, leading to development of gastrointestinal or oropharyngeal anthrax. Human-tohuman transmission is considered rare and has been reported only with cutaneous anthrax. 

The persistence of spores in the environment depends on a number of factors, including temperature, humidity, soil pH, calcium and other cations in soil, and the abundance of soil bacteria that could break down spores. 14 Outbreaks in wild-life species have been linked to climate factors such as hot, dry weather following spring flooding. 11 Heavy rainfall may increase the population of biting flies that can amplify animal outbreaks and may lead to spores being brought to the soil surface. 9, 12 Anthrax spores can contaminate indoor environments. One of the recent cases in Connecticut tied to imported drum hides was the child of the drum maker, who became infected through contamination of the household environment. 2

There are three main forms of the disease: cutaneous, inhalational, and gastrointestinal. In naturally occurring human disease, more than 95% of cases are the cutaneous form. Inhalational anthrax is the next most common form. Gastrointestinal anthrax has never been reported in the United States. Table 9 -4 shows the comparative clinical presentations of anthrax in humans and animals.

Cutaneous anthrax begins 1 to 7 days after inoculation with a small, painless, pruritic papule that is often asymptomatic and does not lead to an infected individual seeking medical care. Over a period of days, vesicles develop with surrounding edema, which then rupture to form an ulcer covered by a black eschar. A significant degree of edema develops around the eschar and can be severe. Most cutaneous lesions are on the hands and arms. If the head and neck are involved, breathing may be compromised by the swelling. Bacteremia can develop, leading to systemic complications. Without antibiotic treatment the mortality rate is approximately 20%. 15 Figure 9 -6 shows cutaneous anthrax in a child.

Inhalational anthrax often begins with nonspecific malaise, mild fever, and nonproductive cough 1 to 6 days after exposure. After several days, a second phase of the disease begins abruptly with high fever, dyspnea, cyanosis, and stridor. A hemorrhagic lymphadenitis can develop with mediastinal widening (Figure 9-7) . Without treatment, respiratory decompensation soon occurs. In up to half of cases, anthrax meningitis may also be present, with meningeal signs and altered consciousness. 15 Mortality rate is high even with antibiotic treatment.

Gastrointestinal anthrax is characterized by fever, abdominal pain, and bloody diarrhea that develop 2 to 5 days after ingestion of contaminated meat (to date, it has not been reported in the United States). Oropharyngeal involvement can produce swelling with respiratory compromise. The mortality rate can be 25% to 75%. 16 

Cattle and sheep develop an acute form of anthrax that is usually rapidly fatal. Clinical signs include fever, depression, staggering, difficulty breathing, and collapse. Subcutaneous edema may be present. Pregnant animals may abort before dying. Infected horses can also develop acute disease with fever, colic, diarrhea, weakness, and swelling of the neck, sternum, belly, and genitalia. The disease is also rapidly fatal.

Pigs are considered to be more resistant to the disease compared with ruminants. Although pigs may develop an acute septicemia with sudden death and/or oropharyngitis with throat swelling and suffocation, a chronic form of disease is more common, with mild systemic signs and cervical lymphadenopathy.

Dogs, cats, nonhuman primates, and wild carnivores can develop disease resembling that in pigs (Figure 9-8) . 15 

The differential diagnosis of cutaneous anthrax in humans includes boils, cellulitis, spider bite, rickettsial disease, ulceroglandular tularemia, rat-bite fever, leishmaniasis, and human orf. A history of exposure to livestock or livestock products, the presence of extensive edema, and the lack of pus and pain can provide clues to the diagnosis.

Inhalational anthrax can present with nonspecific symptoms and may be confused with other causes of pneumonitis, including community-acquired pneumonia and influenza. In the second, severe stage of illness, possible considerations include aortic dissection, pneumonic plague, and hantavirus pulmonary syndrome. A screening protocol for inhalation anthrax has been proposed by a consensus report . This protocol is based on history of exposure and the presence of clinical signs.

Gastrointestinal anthrax, though rare, typically presents as a cluster of cases of acute abdominal pain and diarrhea following ingestion of food from a common source. It can therefore be confused with other causes of food-borne illness.

The differential diagnosis of oropharyngeal anthrax includes streptococcal pharyngitis and Ludwig's angina. 9 The laboratory diagnosis of anthrax involves identification of the capsulated organism in blood or tissues using methylene blue (M'Fadyean)-stained smears or through bacterial culture of blood or other specimens. 16 Rapid tests that are increasingly available include polymerase chain reaction (PCR), enzyme-linked immunosorbent assay (ELISA), and immunohistochemical staining. Diagnostic testing for suspected inhalation anthrax in humans should include chest radiography and/or chest computed tomographic (CT) scanning to look for mediastinal widening. 1

In cattle, anthrax can be confused with other causes of sudden death, including lightning strikes, poisonings, leptospirosis, anaplasmosis, and clostridial infections. In pigs, other diagnoses to consider include classical or African swine fever and pharyngeal malignant edema. In dogs, other systemic infections or causes of pharyngeal edema should be considered.

Diagnostic testing can be performed on a swab of blood that is allowed to air-dry, resulting in sporulation of the bacteria and death of other bacteria and contaminants. In pigs, lymph tissue should be sent for studies. Bacterial culture, PCR, and fluorescent antibody stains can demonstrate the organism in blood and tissues. 17 

Treatment of anthrax in humans involves treatment with antibiotics as soon as the disease is suspected or as PEP. Table 9 -5 shows the recommended initial treatment regimens. Although quinolones or doxycycline are first-line agents, if the infecting strain is found to be susceptible to penicillin, penicillin can be substituted.

Control of anthrax in animals may involve a combination of vaccination, quarantine, PEP of subclinically exposed animals, antibiotic treatment, or euthanization of sick animals and disposal of carcasses by burning. Cattle at risk should receive a full course of antibiotics, followed by vaccination 7 to 10 days later. Vaccination and antibiotics should not be given concurrently. Animals under treatment should be moved to a new pasture that is free from possible con tamination.

Carcasses of animals that have died of anthrax should not be necropsied or otherwise opened to prevent sporulation of the bacteria and further cycles of infection. 

• Be alert to diagnosis in persons with unexplained lymphadenopathy or fever of unknown origin. • Counsel immunocompromised patients to avoid cat scratches, thoroughly clean wounds after a scratch or bite, and to not allow cats to lick a person's skin or open wounds. • Consider risk of infection in any patient bitten or scratched by a cat or with flea or tick bites. • Counsel occupationally exposed workers (e.g., zookeepers) and persons owning cats to avoid and seek care for bites and scratches and to be alert to signs and symptoms of infection. • Report cases to health department if required in state.

• No human vaccine is currently available.

• Ensure flea control for cats. • Counsel cat owners, especially immunocompromised patients, about avoiding cat scratches and bites, thorough cleaning of cat infected wounds, and not allowing cats to lick a person's skin or open wound. Although declawing has not been associated with preventing infection, some recommend trimming cats' nails routinely. Some suggest keeping cats indoors. • A vaccine has been developed (though not currently marketed).

B. henselae is a gram-negative bacillus in the family Bartonellaceae. This family shares some features with rickettsial organisms but has been removed from the order Rickettsiales. 

B. henselae is found worldwide.

CSD can be an occupational disease of veterinarians and others providing care to cats. Studies of zookeepers have revealed seroprevalence rates for past Bartonella infection as high as 65%, 4 while a convenience survey of veterinarians and veterinary workers found Bartonella species seroprevalence of only 7%.

Bartonella species have been found in a wide range of subclinically infected mammals, including rodents, rabbits, deer, elk, bighorn sheep, cattle, foxes, dogs, and coyotes. 5 Domestic cats are considered the principal reservoir for B. henselae. 6 Seroprevalence studies have shown rates of antibody positivity in cats in the range of 40%. 7 However, infection in cats is considered either subclinical or subtle, even in the setting of chronic bacteremia. B. henselae has also been isolated from cat fleas, dog fleas, and a number of other vectors. 8 Dogs may also be infected with B. henselae. Recent data show that ticks may play a role in transmission to humans. 9 B. quintana at present is known to have only a human reservoir and is spread by the human body louse. B. vinsonii and B. elizabethae have been found in asymptomatic rodent reservoirs, including rural mice (B. vinsonii) 10 and urban rats (B. elizabethae). 11 Infection to humans may occur through vectors or direct contact.

Despite the fact that B. henselae can occur in vectors, transmission to humans is thought to be mainly mechanical through a scratch or bite or licking of an open wound or rubbing the eyes with contaminated hands (Figure 9 -10). The role of fleas in transmission is not well understood.

Flea infestation is a definite risk factor for both feline and zoonotic infection because cats infested with fleas have higher seroprevalence of Bartonella infection.

Cat scratch infection produces an inoculation at the point of injury, with inflammation of nearby lymph nodes several weeks later (Color Plate 9-2). The lymph swelling often is selflimited over a period of months in immunocompetent hosts . In up to one sixth of cases the lymph nodes suppurate. Other symptoms can include malaise, fatigue, fever, and rash. 3 Atypical presentations of B. henselae infection include Parinaud's oculoglandular syndrome (granulomatous conjunctivitis accompanied by pretragal lymphadenopathy). 3 Even in immunocompetent patients, serious complications of B. henselae infection can occur, such as central nervous system (CNS) involvement (including encephalopathy and myelitis) 12 and hepatic abscesses. In many but not all cases, CSD precedes the development of more serious complications. In the elderly, B. henselae endocarditis may be found more frequently (a common cause of culture-negative endocarditis), whereas CSD is less frequent than in younger individuals. 12 In immunocompromised individuals, complications of infection can include bacillary angiomatosis (Color Plate 9-3). Peliosis hepatis, a condition characterized by fever, chills, hepatosplenomegaly, and gastrointestinal symptoms, can develop in immunocompromised patients. Like B. henselae, B. quintana causes a number of conditions, including trench fever, endocarditis, bacillary angiomatosis, and peliosis hepatitis. 11 At present. case reports of bacteremia and endocarditis in humans resulting from infection with B. vinsonii 10 and B. elizabethae are limited. 13 Antibodies to B. elizabethae have been found in urban homeless and drug users, 14 but the clinical significance remains poorly understood.

B. henselae causes subclinical infection in cats, including chronic bacteremia. Between 5% and 60% of cats may be seropositive depending on the geographical area. There is a case report of B. henselae infection in a Golden Retriever causing pelosis hepatitis (Figure 9-12 and Color Plate 9-4). 15 Table 9 -7 provides comparative clinical manifestations in humans and other animals.

Diagnosis in humans is based on the clinical picture of local lymphadenopathy, especially in the setting of a history of cat contact. Bartonella species are difficult to grow in culture; therefore other diagnostic techniques such as PCR and serology are often required (e.g., immunofluorescent antibody [IFA] titer ≥1:64 to B. henselae). 19 Cross-reactions can occur among Bartonella species and Chlamydia and • Educate the public (especially travelers to endemic countries) on risk of infection from unpasteurized dairy products. • Encourage public health measures to avoid consumption of unpasteurized dairy products. • Educate hunters of feral swine and other potentially infected wildlife (e.g., elk, bison) about infection control precautions, including gloves and protective clothing while preparing carcasses and burying of all remains to avoid scavenging. • If disease is present in livestock population, educate farmers and livestock workers regarding personal protection when handling strain 19 vaccine, potentially infected tissue, and adequate ventilation in abattoir environments. • Sentinel human cases may indicate problems with food safety, infection in local livestock, or inadequate safety controls for workers and require public health follow-up. • Educate local veterinary and human health clinicians about groups at risk, signs of disease, and to consider the possibility of intentional exposure activity.

• Screen for exposure risk factors: ingestion of unpasteurized dairy products, contact with potentially infected animals, recent travel to endemic areas, and animal contact during travel. • Human cases should immediately be reported to local health officials. • When treating human cases, while rarely transmitted person to person, counsel about safe sex precautions to prevent secondary transmission. • Ensure that workers in high-risk occupations (including veterinarians and laboratory workers) are using appropriate biosafety procedures.

• Consider brucellosis in workup of fever of unknown origin. • Offer PEP and management to exposed laboratory workers and veterinary workers with vaccine exposure. • Counsel patients to avoid consuming unpasteurized dairy products and to use protective clothing (rubber boots, gloves, goggles) if they must come in contact with infected livestock, wild ruminants, or wild dogs. • Consider a 3-to 6-week prophylactic antibiotic course for a needlestick injury with a veterinary vaccine, laboratory, or bioterrorism exposure. 3 • No human vaccine is available.

• Isolate and screen herd replacements. • Quarantine infected herds, test and slaughter to eradicate infection, and disinfect facility where infected animals have been housed. • Report animals with positive screenings to agriculture officials. • Vaccinate cattle, sheep, and goats against Brucella.* • Ensure proper biosafety procedures are followed in veterinary facility and that staff are aware of symptoms of infection. • If diagnosing animal case, discuss zoonotic risk with owner; offer direct communication with human health clinician caring for family. • Disinfect with 1% sodium hypochlorite, 70% ethanol, or iodine solutions. Brucella can also be inactivated by several hours of direct sunlight. 3 Replacement swine herds can be placed on ground that has been free of pigs for a minimum of 30 days.

Brucellosis is caused by Brucella species, which are gramnegative coccobacilli. A number of species in the genus have affinities for particular animal hosts. These species have been further subdivided into biologically distinct strains (biovars). 6 At least four species of Brucella are found in animals and man; these include Brucella abortus (cattle), B. melitensis (goats), B. suis (swine),* and B. canis (dogs). There have been several reported isolations of bacteria from marine mammals, including seals, whales, and dolphins that are currently classified in the genus Brucella. However, the human zoonotic potential of these new agents remains to be established. 7

Brucellosis is found worldwide, but its prevalence depends largely on the state of control in domestic animals. In the United States, bovine brucellosis control programs have reduced the frequency of infection in both cattle and humans.

Between 1986 and 2007, fewer than 150 human cases were reported annually in the United States. 8, 9 As a result, many human health clinicians in the United States have never seen a case. In the United States, the highest incidence rates are in states bordering Mexico, including California and Texas. The most common Brucella species for human infections in the United States are B. abortus and B. melitensis. 10 The occurrence of human brucellosis is higher in other countries where livestock infection is not as well controlled, including Mexico, other Latin American countries, the Mediterranean basin, Eastern Europe, Asia, Africa, and the Middle East. The United Nations' Food and Agriculture Organization has set a goal for worldwide eradication of brucellosis.

Worldwide, brucellosis is considered largely an occupational disease of workers exposed to cattle and other large animals through animal husbandry, dairy, and slaughter operations. Such workers include herdsmen, slaughterhouse workers, and veterinarians. Handling of infected aborted fetuses and newborn animals is considered a particularly high-risk activity. Another risk is sharing living spaces with potentially infected animals; high rates of brucellosis infection have been reported among goat-herding families that bring goats into family bedrooms during the winter. 11 A rare occurrence among veterinarians is the self-inoculation (needlestick, splash or spray to mucous membranes, or broken skin) of vaccine strains of Brucella (RB51 or B. abortus strain 19, or B. melitensis Rev-1) during animal vaccination; this represents one of the rare reported occupational risks of animal vaccination. 12 Outbreaks have occurred in laboratory workers who handled Brucella cultures outside biological safety cabinets, 9 and dog handlers are considered to be at risk from B. canis. However, analysis of recent cases in the United States indicates that brucellosis is increasingly a foodborne disease associated with ingestion of unpasteurized dairy products from infected animals. 10 

The species and biovars of Brucella are adapted to particular animals that serve as definitive hosts. However, as shown in Tables 9-9 and 9-10, cross-species infections can occur, with humans and dogs particularly susceptible to infection by a number of different Brucella species. 13 bison, water buffalo, 14 goats, 4 horses, 15 dogs, 4 

Brucella melitensis Goats, sheep, cows, dogs 4 Brucella suis Pigs, feral swine and wild boar, horses, cattle, 4 

Brucella canis Dogs *A number of vaccines are available for different animal species. In cattle, vaccination with B. abortus strain 19 or RB51 increases resistance to infection. 4 The same vaccines have been used to attempt to control outbreaks in wildlife species, including coyotes, elk, and bison. 5 Goats can be vaccinated with the Revl strain of B. melitensis. There is no vaccine for Brucellosis in swine. In dogs, brucellosis vaccine has not been found to be effective. 4

Brucellosis is transmitted by direct contact with infected tissues or secretions and enters the body by breaks in the skin or contact with mucous membranes (Figure 9 -13). It can also be acquired by ingestion of contaminated foods. Aerosol transmission can easily occur. It is thought that a small number of inhaled organisms can lead to human infection, as seen in outbreaks of infection among laboratory workers. Brucella consequently requires biosafety level 3 containment in laboratories.

Transmission in cattle occurs through ingestion of contaminated pasture forage or water, as well as through licking and other direct contact of infected calves, fetuses, and afterbirths. Transmission in dogs is due to ingestion of or other contact with contaminated tissue, including sexual contact. The risk of transmission of brucellosis from dogs to humans is considered low and related to frequent close contact with blood, birth tissues, or other infected secretions. 17 In humans, person-to-person infection has been reported through breastfeeding, childbirth, bone marrow transplants, sexual contact, and transfusions, but these modes of transmission are considered exceptional. 6 

Brucella may survive for months in the environment in water and other media that are not exposed to direct sunlight or heat. Pastures can become contaminated by feces, products of conception, and vaginal discharges of infected animals, leading to spread of infection in herds of grazing animals. Brucella organisms have been recovered from cow manure that has remained in a cool environment for longer than 2 months. 4

Five to 60 days after infection, Brucella can cause a febrile illness that may be abrupt or gradual. Symptoms are often nonspecific and include fever, headache, night sweats, fatigue, arthralgia, myalgia, joint pain, anorexia, abdominal pain, diarrhea, vomiting, and weight loss. Depression may be a prominent feature. The fever may be "undulant" in patients who remain untreated. Clinical findings may be unremarkable, but in 20% to 30% of patients hepatosplenomegaly and/or lymphadenopathy may develop. Osteoarticular involvement of the spine and large weightbearing joints (Figure 9 -14) is common. 18 Rarely, more severe infection can lead to epididymitis, orchitis, uveitis, endocarditis, and meningitis. A review of human cases found B. melitensis was more likely than B. abortus to cause abdominal pain and tenderness, hepatomegaly, splenomegaly, thrombocytopenia, pancytopenia, and hepatic dysfunction. 10 Laboratory findings are usually mild or absent but may include elevation of liver function test results, thrombocytopenia, and other hematologic abnormalities.

In most animals, spontaneous abortion is the most common manifestation of Brucella infection. Infection may be chronic and poorly responsive to treatment.

In pregnant cows, B. abortus causes placental infection leading to abortion in the second half of gestation. It also causes reduced milk yield, testicular abscesses and epididymitis in bulls, and (rarely) joint involvement with longstanding infection. 4 Infection in goats, sheep, and pigs is similar to that in cattle.

In sheep, B. ovis causes epididymitis in rams but abortions and stillbirths in ewes (Color Plate 9-5). 4 Horses develop a rare bursitis condition known as poll evil or fistulous withers that may be caused by B. abortus or occasionally B. suis (Figure 9-15 ). 4 In dogs, the most common recognized sign and symptom are abortion and infertility. Females may have a prolonged vaginal discharge following abortion. Lymphadenitis may be seen. In males, orchitis, epididymitis, and prostatitis may occur. Spondylitis resulting in back pain and weakness, and uveitis are reported complications (Color Plate 9-6). 4 Cats are apparently resistant to Brucella infection. 19

The differential diagnosis of brucellosis in humans is extensive and includes other causes of fever, including influenza, mononucleosis, human immunodeficiency virus (HIV), and malaria. A history of contact with animals, laboratory exposure, or consumption of unpasteurized dairy products should make clinicians suspect brucellosis. Diagnosis in humans is based on culturing the organism from blood, bone marrow, or other tissue, and/or serology. Cultures may be slow to grow and require caution in handling. Elevated immunoglobulin G (IgG) antibodies titers by ELISA or other tests including serum agglutination (SAT) are often key to the diagnosis, as active infection titers often exceed 1:160. Infection with B. canis may produce antibodies that do not react with standard Brucella test antigens; therefore specific B. canis serology must be requested if this infection is suspected. PCR techniques have shown promising results but are still in development. 21 In dogs, cultures of blood and tissue are also used. There are several serological tests. The RSAT test has a high sensitivity but low specificity. The mercaptoethanol test also has low specificity; positive results must be confirmed by other tests such as the agar-gel immunodiffusion (AGID) test. 4 Possible herd infection in cattle is diagnosed using the Brucella milk ring test, which is sensitive but not specific (Color Plate 9-7). 4 Blood samples are collected from slaughtered animals. Further tests are used to confirm positive results.

Following laboratory or vaccine exposure to Brucella species, 100 mg of doxycycline twice daily and rifampin 600 mg/ day should be taken for 21 days. Trimethoprin sulfamethoxazole is an alternative for those with a contraindication to doxycycline. Doxycycline alone should be given if the exposure was to Brucella abortus strain RB51, which is resistant to rifampin. 9 Baseline serum drawn for Brucella serology with repeat serology at 2, 4, 6, and 24 weeks can be used to monitor for evidence of infection. Such monitoring is not recommended for exposures to vaccine RB51, which does not elicit an antibody response on available assays. Exposed pregnant women should consult their obstetric care provider regarding PEP. Exposed persons should be monitored on a regular basis for the development of fever and other clinical signs of infection. 9

Antibiotic therapy for brucellosis infection in humans and other animals is outlined in Table 9 -11 below. In humans, relapse and prolonged convalescence may occur after antibiotic treatment. Patients with focal complications including spinal or neurological involvement may require a more prolonged course of treatment.

In animals, treatment can be unsuccessful even after prolonged administration of antibiotics. Therefore euthanasia and culling are often used as a means of brucellosis control. Animals may still be infectious to other animals (and humans) despite treatment, and this should be considered before attempting treatment of a pet dog. Neutering of infected dogs is sometimes performed to achieve infection control.

In cattle, antibiotic treatment is considered practical. 4 

Campylobacter enteritis (ICD-10 A 04.5)

Campylobacter species (C. jejuni and C. coli) are now considered the leading cause of bacterial enteritis in humans (Campylobacter enteritis). 1 They are also found in a large number of animal species. Collaborative research between human health and veterinary researchers led to the relatively recent discovery of Campylobacter species as significant human pathogens. Improving diagnostic methods continue to shed light on the prevalence and clinical importance of Campylobacter species, including the high zoonotic potential of these agents.

Campylobacter fetus is associated with less common, but severe, infections in immunocompromised persons. Cattle, sheep, and goats are generally infected by contact with reproductive discharges and feces. C. fetus also is a sexually transmitted disease among cattle. Traditional culture methods for other Campylobacter may not detect C. fetus; therefore its true clinical importance remains poorly understood and probably underestimated.

• Educate public (especially travelers to endemic countries) on the risk of infection from untreated drinking water, unpasteurized dairy products, and uncooked poultry, including handwashing and food preparation precautions.

• Educate food handlers to avoid cross-contamination of foods-use separate cutting boards. • Pursue public health measures to control local consumption of unpasteurized dairy products. • Prevent infected health care workers from providing direct patient care. • Educate local human health and veterinary clinicians and public about risk of infection in puppies and kittens. Stress the need for handwashing and other hygiene after contact with pets and poultry. Prevent children from handling sick animals. • Work with agricultural agencies and local farms to reduce incidence of Campylobacter in poultry at all phases of rearing and production. • Educate local veterinary and human health clinicians about groups at risk and symptoms of disease and importance of handwashing for people with diarrhea. • Coordinate with agriculture officials and veterinarians to receive information about outbreaks of C. fetus in local livestock herds so that agricultural workers can be educated about disease and need for biosafety on farms.

• Report cases to health department if required in state.

• Interview infected individuals about exposure risk factors, such as recent travel to developing country; ingestion of unpasteurized dairy products or undercooked meat; and contact with poultry or poultry products, dogs and cats (especially kittens and puppies), or other potentially infected animals. Notify public health authorities of ongoing risk to other humans. • Counsel immunocompromised patients to avoid contact with puppies, kittens, dogs, and cats with diarrhea; poultry; unpasteurized dairy products; or undercooked meat. 

Campylobacter species are spiral, S-shaped, or curved, gramnegative rods (9) (10) (11) (12) (13) (14) (15) (16) (17) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . More than 20 strains have been described, including C. jejuni, C. coli, C. upsaliensis, C. larii, C. fetus, and C. helveticus. 5 Most cases of Campylobacter enteritis in humans are believed to be due to C. jejuni or C. coli. However, when more sensitive isolation techniques are used, some cases have been found to be 

Campylobacter jejuni was diagnosed in a child by her physician. The child was exposed to a puppy that was mildly ill a few weeks previously and recovered fine. No specific diagnostic tests were performed on the puppy; it was treated symptomatically and recovered. The physician is concerned about the possibility of the puppy being the source of the Campylobacter. The puppy has had all routine dewormers and vaccinations and is in good health now. Question/concern: The puppy is part of a much larger group of dogs and puppies (~100) that are currently being rehabilitated in foster homes. All were mixed together when they were removed from a common source environment several months ago. There have been no reports of diarrhea in other puppies or human household members among children or parents caring for the puppies over the past several months. Would a fecal culture now reveal Campylobacter? Would there be any value in screening other puppies, or should we just have Campylobacter on the differential and perform appropriate diagnostics should any other puppies become ill in the future?

Response: There have been several studies demonstrating the link of Campylobacter and illness in children. The population attributable risk is in the range of 5% to 7%. Campylobacter shedding is more frequent in kittens and puppies versus adult animals. At least in kittens, an average carriage of about 4 to 6 weeks was observed (unknown in dogs). Treatment for animals with diarrhea is appropriate because it likely decreases the days of shedding and the number of organisms shed. Appropriate hand hygiene is critical in households with foster puppies. Treatment for asymptomatic dogs would probably not be appropriate (because of antibiotic resistance issues) even though a fair number of puppies and kittens shed Campylobacter when they are asymptomatic. Likely the quantity of organisms is less, and studies seem to support contact with dogs with diarrhea as a source. 23 caused by C. larii and C. fetus. Fluoroquinolone-resistant Campylobacter infections are more likely to be severe with bloody diarrhea.

C. fetus is a gram-negative, motile bacteria. Based on current knowledge, it has distinctive epidemiological and clinical features. C. fetus has a tendency to invade the vascular endothelium 6 in humans and is an opportunistic pathogen causing mainly systemic infection. In animals, Campylobacter fetus subspecies fetus (intestinalis) is thought to be primarily an intestinal pathogen (although it has been associated with infertility 4 ), whereas C. fetus venerealis infects the genital tract. Selective media used to culture other Campylobacter species use antibiotics that may inhibit C. fetus. 7 C. fetus also grows at a lower incubation temperature (25° C vs. 42° C) than other Campylobacter species. 8 Normal isolation techniques may not detect C. fetus, and as diagnostic methods improve, our understanding of Campylobacter infections will continue to evolve.

C. jejuni, C. coli, and C. fetus are found worldwide. In the developing world, C. jejuni and C. coli infections are considered to be mostly diseases of young people. The incidence of C. fetus in humans is uncommon but believed to be much higher than recorded. 8

Because poultry flocks have high rates of colonization with Campylobacter, persons engaged in poultry raising and processing are at increased risk of infection. 10 Other risk factors identified have been drinking unpasteurized milk, contact with farm animals, and eating poultry in restaurants. 11 Campylobacter is an important cause of travelers' diarrhea in travelers to countries with poor sanitation (Color Plate 9-8).

Ownership of cats and dogs (especially puppies and kittens) is considered a risk factor for infection, although the extent of pet-to-human transmission remains unknown. 12 Most human cases of C. fetus to date have occurred in immunocompromised persons, although cases in healthy individuals have been recorded. 13 Risk factors include hepatic cirrhosis, HIV infection, diabetes, and systemic lupus erythematosus.

C. jejuni and C. coli occur across a range of species and particular strains appear able to cross species barriers. Surveys of poultry, such as chickens and turkeys, have found colonization rates up to 100%, and contaminated chicken meat is considered a major source of infection for humans.

A survey of dogs and cats in Switzerland found colonization rates of 41% in dogs and 42% in cats. 14 A Taiwan survey reported higher rates in stray dogs versus nonstrays. 15 C. fetus is widespread in cattle and sheep. It also occurs in reptiles. Unlike C. jejuni, it is not commonly recognized in poultry, and therefore poultry may not be a major source of human infection. 16 

C. jejuni and C. coli are transmitted by consumption of contaminated food, such as undercooked poultry or unpasteurized dairy products. It can also be transmitted by fecal-oral contact (Figure 9-19 ). Waterborne transmission is also possible.

The source of many human C. fetus infections is unknown, and the mechanism of transmission from animals to humans remains unclear. 8 In cattle, C. fetus venerealis is a sexually transmitted disease. However, cows and ewes may be chronically infected and may have colonization of the gallbladder, leading to fecal elimination. In sheep transmission is fecal-oral, with sexual transmission apparently not playing a role. 8

Environments contaminated by poultry manure, such as occurs in backyard poultry rearing, could propagate C. jejuni and C. coli infection. Because Campylobacter organisms can survive in water, the bacteria circulate in wild bird populations such as waterfowl and shorebirds. 17 Surface water can become contaminated with infected feces of wild and domestic birds; therefore pollution of water bodies is a potential source of infection.

Transmission of C. fetus in sheep and cows is thought to involve environmental contamination of grazing areas by infected tissues and feces. 8

Campylobacter enteritis in humans is an acute but usually self-limited diarrheal illness characterized by abdominal cramping, diarrhea, and fever. The incidence is higher among infants and young adults ages 15 to 44 years. . Fecal smear shows numerous Campylobacter species organisms (lighter-staining smaller bacteria), a mixed population of bacterial rods, and two degenerating neutrophils. The characteristic "gull wing" formations (visible on the surface of the neutrophil) are chains of three to five of these slender, gram-negative, comma-shaped, or curved motile rods. The organisms have the same morphologic characteristics in all species of animals. Campylobacter are often overlooked because of their small size. Animals can be carriers, in which case usually only very low numbers are seen. These organisms can be either the primary cause of diarrhea or act as secondary pathogens in conjunction with other enteric bacteria. Campylobacter species are difficult to culture. Neutrophils are not seen in normal stool and indicate an active infection. ( In many cases, blood or mucus is noted in the feces, indicating colorectal inflammation. 18 The abdominal pain may mimic appendicitis. Usually the diarrhea resolves after several days without specific treatment, but other symptoms may persist longer.

Bacteremia and other extraintestinal manifestations are rare, but complications of infection may include erythema nodosum, uveitis, meningitis, and reactive arthritis. Guillain-Barré syndrome occurs in approximately 1 of 1000 cases of C. jejuni infection. 19 C. fetus is an opportunistic pathogen in humans typically presenting as an acute or chronic bacteremia or thrombophlebitis. Complications include myocarditis, endocarditis, meningitis, and abortion .

Campylobacter may be present in animals without signs or it may cause diarrhea. Adult animals and poultry older than 1 week are usually subclinical carriers. 3, 18, 19 The diarrhea is usually most severe in young animals (e.g., in puppies and kittens from birth to 6 months) or in debilitated animals. 4, 20 The diarrhea can range from watery to mucus with blood or bile streaking. Affected animals may have reduced appetite and, rarely, vomiting. Tenesmus is common. Diarrhea also occurs after infection in cattle (especially calves), primates, ferrets, and mink. 4 In sheep, C. jejuni infection is associated with abortion (Color Plate 9-9). 21 C. fetus is an important cause of infertility and abortions in cattle and sheep. In cattle, bovine genital campylobacteriosis presents with early fetal death, infertility, and abortion. 4 Table 9 -12 shows comparative clinical presentations of campylobacteriosis in humans and other animals.

Diagnosis in humans is based on culturing the organism from feces, blood, bone marrow, or other tissue using correct media and incubation procedures. It should be recognized that the selective media may inhibit the growth of certain Campylobacter species such as C. fetus, leading to false-negative results. Identification of organisms in feces using phase-contrast or dark-field microscopy can be used to make a presumptive diagnosis. 5 PCR techniques have recently been developed and may play a greater role in diagnosis in the future.

In animals, cultures and microscopic examination of feces or reproductive discharges are also used. Agglutination and ELISA tests are used on vaginal mucus of cows suspected to be infected. 

Most human enteritis cases are self-limited and resolve with only supportive therapy such as replacement of fluid and electrolytes, lactose-free diet, and avoidance of caffeine. Antibiotic treatment is reserved for more severe cases, including six or more unformed stools per day, and/or temperature of 101.5° F or more, and significant persistent tenesmus, stool blood, and leukocytes. Immunocompromised patients (e.g., individuals who are HIV positive) should be treated with antibiotics to prevent systemic complications 18 Treatment in humans is outlined in Table 9 -13. Although in the past ciprofloxacin has been used as a primary therapeutic agent, high rates of resistance to fluoroquinolones have been observed in certain settings. 22

As in humans, many enteritis cases in dogs and cats are selflimited. When signs are severe (e.g., high fever or dehydration), persist beyond 5 days, or are present in immunocompromised patients, treatment with antibiotics is recommended. Chlamydophila (formerly Chlamydia) psittaci infection from exposure to birds causes disease in humans ranging from mild flulike signs to severe pneumonia and sepsis. Although fewer than 50 human cases of psittacosis are reported yearly in the United States, 1 it is likely that many cases go undetected. C. psittaci commonly infects psittacine (parrot family) birds that are used as pets, but domestic poultry flocks, especially turkeys and ducks, can develop widespread infection with significant flock mortality and occupational risk to poultry workers. Human disease with mammalian chlamydiae (i.e., C. abortus, C. felis, and C. pneumoniae) is rarely reported. The diagnosis of chlamydiosis can be challenging in humans and other animals.

New molecular evidence is broadening our understanding of the host range and clinical spectrum of Chlamydophila infections. 2 Therefore clinicians should maintain a high index of suspicion in the appropriate settings where infection can occur.

• Characterize the risk in the community related to pet shops, aviaries, bird ownership, and poultry production. • Coordinate with agriculture officials to control the disease in bird populations. • Ensure that poultry workers with occupational risk for C. psittaci infection are informed about the disease and its prevention through exposure controls and protective equipment.

• Consider the diagnosis in all patients with bird contact (avian chlamydiosis) who present with respiratory symptoms or fever, as well as patients with keratoconjunctivitis (or rarely endocarditis and glomerulonephritis) and cat contact (mammalian chlamydiosis). • Report suspected cases to public health authorities. See CDC case definition: http://www.cdc.gov/ncphi/disss/ nndss/casedef/psittacosiscurrent.htm. • Counsel patients with psittacine birds to take steps to protect their birds from exposure to C. psittaci and to seek veterinary care for ill birds, especially if owners are immunocompromized. Other risk reduction measures include avoiding mouth-to-beak contact and appropriate personal protective equipment (PPE) when cleaning cages or handling dead birds (see Box 9-2). • If caring for workers with occupational exposure to birds (e.g., pet shop workers, poultry workers), ensure that they immediately report symptoms of fever, myalgias, and cough, and that the workplace is adopting preventive practices (see Box 9-2), including respiratory protection for workers who are working with ill or potentially exposed birds. • Counsel pregnant patients to avoid contact with pregnant or aborting sheep and goats.

• Counsel bird owners on the signs of psittacosis, how to protect their birds from exposure, and how to reduce risks to humans, especially if owners are immunocompromised. • Consider the diagnosis of chlamydiosis in any sick bird with lethargy and nonspecific signs, especially if recently purchased or stressed (e.g., transported). • Follow local and state reporting regulations; contact local health department or Department of Agriculture. • Train veterinary personnel in biosafety measures, such as wearing masks and gloves when working with potentially infected birds, and use of strict personal hygiene (e.g., handwashing and cleaning/disinfecting footwear) to prevent spreading the organism to other animals. • If a case is diagnosed in a cat, immunize cats in the household or cattery using C. psittaci vaccine. A live C. abortus vaccine may reduce shedding in sheep.

C. psittaci is an intracellular bacterium closely related to the human pathogen Chlamydia trachomatis (causes venereal infection in humans) and other zoonotic Chlamydiae (Table 9- 14) . A number of different strains (serovars) of C. psittaci have been described; the majority are avian pathogens. The strains vary in virulence and zoonotic potential; for example, the turkey strain may be more virulent than serovars that affect pigeons and ducks. 5 (formerly Chlamydia psittaci, feline strain, causes conjunctivitis in cats), C. abortus (formerly Chlamydia psittaci, mammalian abortion strain or serotype 1, causes abortion in ruminants, especially sheep and goats), and C. pneumoniae (formerly Chlamydia pneumoniae, previously considered a human pathogen, but has been isolated from horses, reptiles, and amphibians). 6 The CDC considers C. psittaci a category B biological warfare agent because of its ability to be produced and disseminated in quantities sufficient to affect large populations. 7

Worldwide.

Groups at increased risk for C. psittaci infection include owners of birds, pet store workers, veterinarians, zookeepers, live poultry and poultry processing workers, and diagnostic laboratorians. Recent studies have found seroprevalence rates as high as 15% in workers at pet bird breeding facilities. 8 Seroprevalence rates of 15% have been reported in livestock farmers. 9 Pregnant women have developed severe infection with C. abortus, including sepsis, stillbirth, and abortion after contact with birth products of sheep and goats, but such cases are considered rare. 10

C. psittaci occurs in most birds. One serovar is found in a wide range of psittacine birds, including parrots, parakeets, and cockatiels (Color Plate 9-10). Another infects turkeys and ducks and, rarely, chickens. Certain Chlamydiae infect mammals, and a high rate of subclinical carriage has been reported in rodents. 11 Prevalence rates of 5% to 10% in cats have been reported, and exposure to infected cats has been linked to human infection. 12 Many animals shed the organisms in the absence of clinical signs. Crowding and other stressors appear to increase the rate of fulminant diseases in birds. Wildlife may serve as a reservoir and pose an infectious threat to domestic poultry. 5

Chlamydiae exists in two forms, an infectious but metabolically inactive elementary body that is relatively stable in the environment, and the metabolically active but noninfectious reticulate body (Figure 9 -21). 5 Infection is initiated by the elementary body attaching to susceptible cell membranes, primarily in the respiratory and later gastrointestinal tracts. 13 Transformation of the elementary body to the reticulate body occurs within several hours, after which the reticulate body creates progeny that differentiate into elementary bodies and are released from infected cells. The bacteria can be shed in the feces, leading to fecal-oral transmission 5 ; in addition, nasal, ocular, and uterine discharges can lead to direct inoculation into mucous membranes or aerosol transmission.

Bird species implicated in zoonotic aerosol transmission include psittacine birds, poultry, shorebirds, and raptors. 3 Direct handling of an infected bird or cat followed by selfinoculation of conjunctiva or other mucous membranes is another potential route of animal-human transmission, as is beak-to-mouth contact (kissing a pet bird). Person-toperson transmission has been reported in close contacts of infected persons. 14

Under certain conditions, the bacterial elementary body can persist for prolonged periods in the environment. This can lead to reinfection of poultry flocks or pet birds through both oral and respiratory routes.

C. psittaci can cause an acute febrile syndrome with headache, myalgias, cough, and photophobia. Respiratory symptoms may be mild in relation to the chest x-ray findings, which may appear worse than the patient's condi-tion appears (Figure 9 -22). Sputum production is often scant. Hepatomegaly and pharyngeal erythema often occur. The pulse may be paradoxically slow in relation to the degree of fever. Skin signs include Horder's spots, a pink, blanching maculopapular rash. 15 Keratoconjunctivitis has been reported in cases of contact with infected cats. 15 Complications of infection include hepatitis, splenomegaly, hemolytic anemia, disseminated intravascular coagulation (DIC), endocarditis, myocarditis, pericarditis, and glomerulonephritis. Neurological complications including hearing loss, cranial nerve palsy, cerebellar symptoms, and confusion can also occur.

In more severe cases, progressive pneumonia and acute respiratory distress syndrome (ARDS) develop with multiorgan failure. Infection in pregnancy can cause severe complications including DIC and fetal death. Past infection does not appear to confer subsequent immunity. 15 Many aspects of the disease remain incompletely understood, including an association with ocular adnexal lymphoma, and indolent lymphoma from chronic avian chlamydiosis. 10, 16, 17 These associations, if true, may lead to preventive therapies for these lymphomas.

Severe complications including sepsis, stillbirth, and miscarriage can develop in pregnant women infected with C. abortus from contact with pregnant sheep and goats. 18 The role of other Chlamydiae and Chlamydia-like organisms in obstetrical pathology is emerging. 19

Many birds and mammals shed Chlamydiae without any signs. However, C. psittaci can cause morbidity and mortality in psittacine birds, with malaise, weight loss, diarrhea, and conjunctivitis. Stress and crowding appear to increase the prevalence of clinical disease. 5 As in humans, previously infected animals may become reinfected.

Cats typically develop conjunctivitis and mild upper respiratory disease. Conjunctivitis may also be seen in other species (Figures 9-23 and 9-24). Kittens 2 to 6 months old are more likely to be infected. C. abortus is a major cause of reproductive failure and abortion in sheep and goats. Chlamydial infection has been associated with horses with recurrent airway obstruction. 20 Table 9 -15 provides clinical presentations of chlamydiae infections in humans and other animals.

The differential diagnosis in humans includes other causes of atypical pneumonia, including Legionella, Mycoplasma, C. pneumoniae, Coxiella, and influenza. The clinical presentation of an atypical pneumonia in the setting of a history of exposure to birds should lead clinicians to strongly consider the diagnosis of psittacosis.

Confirmation of the diagnosis is usually by serology, using either complement fixation or microimmunofluorescence (MIF). Serology specimens should be obtained acutely and Culture of the organism is difficult and poses a risk to laboratory personnel and therefore should be performed only in qualified laboratories. A PCR test is available through the CDC.

In birds, the diagnosis can be challenging, especially in asymptomatic cases. A combination of culture, antibody testing, and antigen detection is recommended.

For necropsy diagnosis, tissue specimens from the liver and spleen are preferred. In live birds, conjunctival, choanal, and cloacal swab specimens or liver biopsy specimens can be used. Fecal specimens can be collected over several days and pooled for increased sensitivity. As with diagnosis of human disease, the culture of C. psittaci requires specialized laboratory facilities to minimize risk to laboratory personnel. Conjunctival scrapings of various animals may reveal elementary bodies in epithelial cells (Figure 9-25) .

Serological tests available include elementary body agglutination (EBA) for detection of IgM antibodies, and indirect fluorescent antibody test (IFA) to detect IgG antibodies.

Complement fixation (CF) is more sensitive than agglutination methods. Antigen tests include ELISA tests that were originally developed for identification of Chlamydia trachomatis in humans and IFAs to detect antigen. PCR is available in a number of diagnostic laboratories to detect C. psittaci DNA in samples. Care is necessary in the preparation of samples for PCR testing to prevent environmental contamination. 3

Treatment in humans depends on whether the diagnosis is suspected or confirmed. If the diagnosis is not certain, the patient should receive antibiotics to cover the spectrum of organisms causing community-acquired pneumonia, with the regimen adjusted to the severity of disease and existing comorbid conditions such as alcoholism or chronic obstructive lung disease. Once the diagnosis is confirmed, more specific therapy can be given as outlined in Table 9 -16. Doxycyline and tetracycline are the mainstay of treatment in humans but are contraindicated in children younger than 8 years and pregnant women, for whom a macrolide antibiotic such as erythromycin may be considered. However, erythromycin may be less efficacious in severe cases and it may not protect the fetus of a pregnant patient. 15 Treatment in animals also relies on antibiotics of the tetracycline class. Euthanasia may be considered as a control measure during outbreaks. In cats, a vaccine is available that does not prevent disease but may reduce the severity and duration of illness 

Like Giardia, Cryptosporidium species are a common parasitic cause of infectious diarrhea in humans and are found in many vertebrate species. Many episodes of infection are mild enough that they do not come to medical attention. Yet because of its capability to cause massive human outbreaks through waterborne exposure, it is considered a category B bioterrorism agent. In immunocompromised patients, cryptosporidiosis can cause serious and even fatal disease. A growing body of knowledge supports the importance of cross-species transmission between animals, especially calves, and humans.

Public Health Professionals Remove reservoirs (recently infected people) from contact with susceptible populations. Exclude children with diarrhea from school or child care centers, water parks, swimming pools, and so on. • Support policies to keep public areas free of animal feces. • Consider efficacy of local water treatment procedures with regard to removal of oocysts (i.e., chlorination lacks efficacy; therefore alternative disinfection procedures such as filtration or ozonation may be required).

• Report cases to public health authorities: http://www. cdc.gov/mmwr/preview/mmwrhtml/00047449.htm. • Include questions about animal contact for every patient presenting with diarrhea. • Consider occupational exposure of cattle workers and animal shelter workers. • Person-to-person transmission is possible; counsel infected persons about hand hygiene and avoiding fecal exposure during sexual activity.

• Counsel owners and any others in contact with infected animals about the zoonotic risk, need for hand hygiene after handling pet, feces, pet toys, and other objects that are potentially infected with cysts.

• Decontaminate infected animal's coat with shampoo and kennels or other environments with an 18-hour exposure to 5% ammonia, 10% formol saline, or 3% hydrogen peroxide. 2 • Counsel persons who work with young ruminants or animal shelters of the increased potential for exposure and provide a clean birthing environment. Neonates should receive colostrum, segregate calves from other calves for the first 2 weeks of life, and maintain hygienic husbandry practices including fly and rodent control. • Counsel immunosuppressed persons regarding the risks of animal exposures.

Cryptosporidia are protozoan parasites of the coccidia group in the phylum Apicomplexa (Figure 9 -26). At least 30 species of Cryptosporidium and multiple genotype variations have been described in a wide number of animal species ( Table  9 -17). The two species believed to cause most cases of human infections are C. hominis (formerly known as C. parvum anthroponotic genotype or genotype 1) and C. parvum. C. hominis is a human pathogen, although infection has been found in lambs, cattle, and other mammals. C. parvum infects humans, cattle, and other ruminants. Other species reported in humans include C. canis (dogs), C. felis (cats), and C. meleagridis (birds). Cryptosporidia colonize the intestinal and biliary tracts but can also be found in the lungs. The organism reproduces in the intestinal tract to produce oocysts. Oocysts are immediately infectious as shed in feces. The oocysts measure 2.5 to 5 microns in diameter and can survive in moist environments, including water supplies, for several months. They are resistant to chlorination but are inactivated by boiling water or ozonation.

C. parvum occurs worldwide in animals and humans. Human prevalence is greater in developing countries with poor sanitation practices. Reported rates of infection in human populations range from 20% in developing countries to 1% to 4% in developed countries. 3

Children younger than 2 years, their caregivers, and immunocompromised persons have an increased risk of infection. Other risk groups include animal handlers, travelers, contacts of infected persons, and men who have sex with men. 

Humans are the reservoir for C. hominis, whereas humans, cattle, and other ruminants (e.g., goats, sheep, deer, elk) appear to be major reservoirs for C. parvum. 4 C. muris infects mice and cattle gastric glands, and chickens are the reservoir for C. baileyi. In many individuals and species, asymptomatic carriage may occur with the ability to transmit the infection to others and the environment. The zoonotic potential of avian Cryptosporidia has not been fully elucidated.

Each oocyst contains four sporozoites that are the infective phase of the parasite (Figure 9 -27). When shed in feces, the oocysts are immediately infective. Upon ingestion by a host, the sporozoites are released and invade the mucosa of the intestinal tract. Sporozoites mature into trophozoites that multiply asexually first. Then these trophozoites undergo sexual reproduction (meronts) to produce sporozoites, most of which acquire a protective cover to form an oocyst. These oocysts are passed in the feces, where they are immediately infective. Sporozoites that remain in the intestine without developing a cyst wall are able to reinfect the host, perpetuating infection. 5 The infectious dose is about 130 organisms to initiate a C. parvum infection in 50% of healthy volunteers. 6 Cattle can shed up to 1 million organisms per gram of feces. Most transmission appears to occur through ingestion of oocysts. Vehicles of transmission include drinking water, direct fecal-oral contamination, foodborne exposure, or contact with contaminated objects leading to ingestion ( Figure  9 -28). Infected drinking water and freshwater bathing areas have been the sources of large human outbreaks, such as the sickening of more than 400,000 people in Milwaukee, Wis., due to improperly treated municipal water supply in 1993. 7 A secondary means of transmission is by inhalation of aerosolized oocysts.

Calves are accepted as a source for human infection. A study in Wisconsin using PCR analysis of human isolates concluded that most sporadic cases of cryptosporidiosis in that state were zoonotic in origin, with cattle and other ruminants the main source. 8 The types of zoonotic transmission that occur appear to differ by geographical area, with less zoonotic transmission occurring in urban areas. The risk of human infection by dogs and cats is believed to be small in industrialized countries. C. canis, C. felis, and C. meleagridis are responsible for as much as 20% of human infection in some developing countries, but some evidence indicates that although diseases originates in animals, these strains are being transmitted person to person. 4 Data from the Milwaukee outbreak and others suggest two thirds of water-source human outbreaks are not of animal origin. Transmission in animals, as in humans, occurs through ingestion and possibly inhalation of oocysts.

Cryptosporidium cysts, like Giardia, can contaminate water supplies and other moist environments for months. Environments where manure is spread have been associated with increased risk of human infection. 9

The majority of the North American population has been exposed to the infection at some time. Cryptosporidium infection in immunocompetent humans can be asymptomatic.

The major symptom is diarrhea-often explosive, profuse, and watery with mucus-accompanied by abdominal pain and cramping, vomiting, and weight loss. 3 Low-grade fever may occur. The diarrhea is self-limiting in healthy people, lasting 8 to 20 days. In patients infected with HIV and in other immunodeficient patients, symptoms can be more severe and chronic and include massive diarrhea and involvement of the respiratory and biliary tracts. 5

In dogs and cats, the disease is often subclinical. Puppies and kittens are more likely than adults to show intestinal signs of infection. In cats and dogs, most clinical cases are associated with immunosuppression, such as with feline leukemia virus, canine distemper virus, canine parvovirus, and intestinal lymphosarcoma, and can manifest as intestinal, hepatic, pancreatic, or respiratory disease. 10 Calves may exhibit diarrhea, anorexia, and weight loss. Adults are often asymptomatic. Cryptosporidiosis commonly causes vomiting in snakes (Color Plate 9-11). Table 9 -18 provides a comparison of clinical manifestations in humans and other animals. 

In human beings, cases are diagnosed by IFA visualization of oocysts in feces. An ELISA test is also available. Many laboratories do not routinely test for Cryptosporidium, so a special request may be necessary.

Animal diagnosis involves testing for oocysts in feces with sucrose or zinc sulfate solution with visualization after modified acid-fast staining, a procedure typically performed by a veterinary laboratory rather than by the private practitioner (Color Plate 9-12). Routine in-house flotation tests often fail because cysts are small (4 to 5 microns in diameter). To inactivate potential cysts and submit fecal samples to an appropriate laboratory, mix one part 100% formalin with nine parts feces. Oocysts are not shed continuously; therefore repeat samples may be necessary.

Acute cryptosporidiosis is treated with supportive care including rehydration. Antibiotics are indicated for symptomatic patients. In patients with HIV infection, adequate antiretroviral therapy is essential to reducing the morbidity of cryptosporidiosis infection (Table 9- 19) .

In immunocompetent animals the disease is usually self-limiting and may include oral glucose-electrolyte solution. Severe diarrhea warrants parenteral fluids. If there are zoonotic concerns, a trial of antibiotics may be warranted. No antibiotics are registered for treatment of Cryptosporidium in animals. Monitor fecal oocyst shedding 14 days after treatment. Dermatophytosis is a skin infection caused by members of three genera of fungi: Epidermophyton, Microsporum, and Trichophyton. Because all domestic animals are susceptible to dermatophytosis and many dermatophytes can pass between species, dermatophytosis is probably one of the most common pet-associated and occupational zoonoses. It has been estimated that approximately 2 million people in the United States are infected each year as a result of contact with animals. 1 The true prevalence is probably greater than recognized; the signs of disease may be mild, so infected individuals may not seek medical care and the condition is often not reported to local health authorities.

• Provide descriptive epidemiology about the disease.

• Educate the public on modes of transmission and risk factors for infection. • Raise awareness of the disease among high-risk groups such as animal workers and in school settings. • Make recommendations for environmental cleanup of contaminated surfaces and fomites with dilute bleach solution (1:10).

• When taking a history on a patient with a rash for which dermatophytosis is suspected, inquire about pet and other animal exposures. • Teach patients to always wash their hands after contact with pets and other animals. 2 • Encourage infected patients with dogs and cats to seek veterinary evaluation of their pets. • No human vaccine is available.

• Ensure that owners bring affected animals for prompt treatment; be aware that there are inapparent carriers and that use of corticosteroids may prolong infection. • Counsel clients and veterinary care staff about handwashing and other measures to avoid zoonotic transmission.

• Counsel pet owners and clinic employees to disinfect contaminated equipment, bedding, and the environment with dilute bleach solution (1:10). • Consider the possibility of rodents spreading the disease to pets and other animals. • If dermatophytosis is diagnosed in a pet, treat the animal and advise the owner and family members of the zoonotic risk and to seek medical care if symptoms are noticed. • Isolation may be advisable for an animal that is under treatment due to the zoonotic nature of the disease. • An attenuated vaccine for cattle is available in Europe, where it has been reported to reduce the incidence of zoonotic disease in animal care workers 3 ; it is not currently available in the United States. • Therapy cats should be tested biannually. 4

Fungi that cause dermatophytosis are spore-producing pathogens that may be classified according to mode of transmission as anthropophilic (preferring humans), zoophilic (preferring animals), or geophilic (preferring soil environments). Although zoophilic species often can pass from animals to humans, they tend to not be readily transmissible from human to human. Table  9 -20 lists the main species and their type. 5

These pathogenic fungi are found worldwide and the incidence is generally higher in hot and humid climates. Trichophyton tonsurans is commonly found in urban areas in the eastern United States, Puerto Rico, Mexico, the United Kingdom, and Australia. T. verrucosum and T. mentagrophytes are common in rural areas 2 as is Microsporum canis. M. audonii is more common in West Africa.

Dermatophytoses from animals are an occupational risk for veterinary health care workers and other animal workers. Pet owners, children, and immunocompromised individuals are at increased risk of infection, 2 as are humans living in close quarters (such as military personnel, athletes, school children, and inner-city residents) who are at risk for human-tohuman transmission. Table 9 -20 lists the principal animal reservoir species for the T. mentagrophytes zoophilic dermatophytoses. The different species of fungi tend to vary in their host specificity. M. nanum, an infection of pigs, tends not to infect other species, 4 whereas T. mentagrophytes has a much wider host range, infecting rodents, dogs, cats, rabbits, horses, humans, hedgehogs, 6 and other animals. Mechanical vectors include furniture, animal bedding, hair care articles (scissors, combs, and brushes), clothing, and hats.

Transmission occurs through direct skin-to-skin and skinto-hair contact with infected animals or humans and indirect contact with the infectious arthrospores in the environment or on fomites (Figure 9-29 ). An infected human or animal can generate an aerosol of infectious arthrospores. 2 The infectious spores germinate in the keratinized layers of skin, hair, and nails. 7 The mode of transmission also helps determine the severity of clinical disease. In general, animal-to-human transmission produces some of the most severe clinical syndromes, as shown in Table 9 -21.

The fungi and infectious spores can survive on surfaces and in desquamated skin for months. 2 Therefore environmental contamination can play an important role in transmission. In general, moist, warm environmental conditions favor the growth of fungi and persistence of spores on surfaces and articles. Environmental samples such as soil and clothing associated with human and other animal cases have spore positivity rates as high as 100%. 8 Contamination with multiple dermatophyte species has been found on veterinary clinic floors, producing an environmental risk of infection for both animals, clients, and the veterinary staff. 2 

The incubation period in humans is 10 to 14 days. Infection in humans usually begins with a small area of erythema that develops into a patch of annular scaling skin with a raised border that then slowly spreads peripherally. Infections are usually accompanied by pruritus, which can lead to excoriation and secondary bacterial infections. As shown in Table 9 -21, zoophilic fungi are more likely than anthropophilic or geophilic fungi to produce severe inflammatory changes in humans, often with pustular lesions (kerion). 9 The location of the infection determines the name of the dermatophytosis.

Tinea capitis is an infection of the scalp that occurs most commonly in children. It is caused by only two genera: Trichophyton and Microsporum. In the United States, T. tonsurans is the most common cause and M. canis is the second most common. 9 Tinea capitis can produce localized hair loss, pustules, and scarring ( Figure 9 -30).

Tinea corporis is an infection of the trunk and extremities that does not involve the hair, palms, soles, or groin. Worldwide, it is most commonly caused by T. rubrum followed by T. mentagrophytes. 9 It can present in a variety of ways dependent in part on the mode of transmission, but classically causes a circular annular lesion with scaling (Color Plate 9-13).

Tinea pedis is an infection of the toes and feet caused T. rubrum, T mentagrophytes, Epidermophyton floccosum, and T. tonsurans. 9 Other dermatophyte infections include tinea barbae, an infection of the beard area; tinea cruris, an infection of the groin and perianal area; and tinea manum, an infection of the hand.

In immunocompromised individuals, T. mentagrophytes and M. canis can cause disseminated skin infection.

The incubation period in animals is generally 1 to 2 weeks. The infection in dogs may begin as alopecia (Figure 9-31) . Erythema, scaling, and pruritus may develop around the lesions. In some dogs clinical signs do not develop yet the dogs are capable of shedding spores into the environment. In immunocompromised animals, these infections can be severe (Color .

Up to 90% of infected cats show no clinical signs of disease. Clinical infections are more common in kittens and long-haired breeds of cats. Clinical signs include a poor hair coat or circular skin lesions, usually on the face or paws (Color Plate 9-15).

Infections are more common when cattle are stabled indoors. Lesions often begin as gray-white areas that thicken, scab, and slough, leaving an area of alopecia. Infection is often self-limited over several months (Color Plate 9-16). 3 Horses tend to become infected at areas of contact with a harness. The disease manifests as areas of localized alopecia with skin thickening ( Rodents such as mice may show no evidence of disease or may have white scabbing lesions on the head and trunk (Color Plate 9-18). Table 9 -22 shows the comparative clinical presentations in humans and animals.

In humans the diagnosis can be made clinically based on the typical appearance of lesions and a history of contact with an infected person or animal. The differential diagnosis may include eczema, impetigo, and conditions causing localized alopecia, such as cutaneous lupus. The sensitivity and specificity of the Wood's lamp test is limited because only some dermatophytes will fluoresce; therefore this test should be used only as part of a screening process. Wood's lamp-positive areas can be used to guide scrapings for microscopic examination and/or culture. Samples of skin and hair should be taken from the periphery of lesions where infection is active.

Scrapings or clippings can be placed in 10% to 20% potassium hydroxide solution and examined microscopically. Hyphae can appear as chains (Figure 9 -33). Conidae (spores) can also be recognized by microscopy .

In addition to microscopy, fungal culture is often worthwhile to confirm the diagnosis and the fungal species (Color Plate 9-19). Similar diagnostic tests are used in other animals. Table 9 -23 outlines treatment guidelines in humans and other animals. Many human cases of dermatophytosis are selflimited and do not require treatment. However, treatment may shorten the duration of infection and reduce the possibility of further transmission. Companion animals with positive culture findings should be treated because of the zoonotic disease risk. 11 However, eradicating the disease may be a challenge if multiple animals are housed together. Response to therapy is monitored by dermatophyte culture as many animals will remain culture positive while improving clinically.

For mild skin infections, topical medication may be sufficient. More extensive infections may require systemic treatments. In food-producing animals, treatment options may be limited because of food safety concerns. Human infection is apparently a rare event that occurs when children ingest fleas containing tapeworm eggs. 2 Although infection in both humans and other animals is usually asymptomatic, the white, seedlike, motile proglottids are passed in the stool, causing concern.

• Educate the public about the need for routine flea control. • Ensure policies are in place for proper disposal of animal feces.

• The veterinarian caring for the family pets should be contacted to ensure that pets receive treatment. • The appearance of proglottids in the stool of a child may be a sentinel event indicating probable flea infestation in the house as well as infection of a household pet. Human health clinicians should counsel adult patients or parents of pediatric patients to seek veterinary advice and preventive services to ensure that the house and pets of a patient are treated for fleas. • Children should wash their hands after playing with pets. Children with pica behavior require careful supervision when playing in environments with pets.

• Counsel pet owners to practice flea control.

• Deworm all dogs and cats in the household when infection is identified in one animal (typically because of passage of tapeworm segments in stool). • Counsel owners of pets that have been diagnosed with tapeworms or fleas to watch for signs of infection in children in the household.

The double-pored dog tapeworm (D. caninum) is a Cestode that is the most common tapeworm of dogs and cats. 3 The adult worms may be as long as 70 cm and can live in the small intestine for up to 3 months. The adult worms consist of a head (scolex), neck, and chain of segments known as proglottids (Figure 9 -36). New segments form at the neck and older segments are pushed back. 4 Each proglottid contains both male and female elements and can become full of eggs (gravid) and break off from the rest of the worm, to be shed in the feces. Fleas play an important role in the life cycle of the worm as intermediate hosts.

Worldwide.

Young children appear to represent most human cases because of their close contact with pets and greater likelihood DiPYLiDiASiS of ingesting fleas directly or in food. A case in a 5-week-old infant has been reported. 5

Dogs and cats are the principal reservoirs, although wild carnivores have also been found to be infected. Humans are accidental hosts.

The adult worms live in the intestine of the reservoir host ( Figure  9 -37). Gravid proglottids are released in the feces (Figure 9 -38).

In the environment the proglottids break down, releasing the eggs. If the eggs are ingested by a larval cat or dog flea, the eggs hatch and turn into cysticercoids as the flea develops. Dogs and cats may ingest a flea as a defensive behavior. Children may ingest a flea accidentally when playing with or handling a dog or cat or by ingesting food containing a flea (Figure 9 -39). Once the flea is ingested, cysticercoids are released into the small intestine, where they develop into adult worms within 20 days. 6 

The key environmental risk is flea infestation of a house or other living environment.

Based on existing case reports, human infection with dipylidiasis is usually asymptomatic. The proglottids appear in the stool as white, rice-like motile objects and may be shed over a number of months. In one report, dipylidiasis was misdiagnosed as recurrent pinworm (Enterobius vermicularis) infection and therefore incorrectly treated. 7 Abdominal discomfort may occur, as well as abdominal distension, appetite disturbances, and insomnia. 6 Accompanying neurological symptoms including vertigo and light-headedness have been described. 8

The infection in dogs and cats is considered to cause few clinical signs. Perianal pruritus may be present. Infected dogs may therefore "scoot," dragging their anus along the ground to relieve the itching. The most significant finding is the sight of proglottids in the feces, emerging from the anus or stuck to perianal hairs. These appear as white, crawling rice-like segments on the fur or in feces or on the perianal area.

The diagnosis is usually made clinically by identifying the motile proglottids and obtaining a history of contact with fleas or a dog or cat. In animals, visualizing the proglottids of D. caninum is diagnostic. Table 9 -24 shows the manifestation of disease in humans and other animals.

The goal of treatment in humans and other animals is the elimination of the cestodes. Table 9 -25 summarizes recommended treatment regimens for dipylidiasis in different species. Flea control is also important for dogs and cats. This can be accomplished with monthly treatments of selamectin, lufenuron, imadacloprid, fipronil, 10 or spinosad. 

• Provide descriptive epidemiology regarding the risk in the community. • Prevent dogs, cats, and foxes from contaminating playgrounds and other public areas with feces. • Educate the public to thoroughly wash all fruits and vegetables before consuming them. • Educate pet owners to not allow dogs and cats to roam outside or feed on raw carcasses. • Ensure that workers with occupational risk for Echinococcus infection (e.g., sheep ranchers, wildlife rehabilitators) receive adequate surveillance and reduction of exposure risk through exposure controls and protective equipment.

• Disease is reportable in some states.

• Counsel dog owners to wash hands after handling pet and to avoid contact with animal feces. • Counsel all patients to thoroughly wash vegetables and fruits before consumption. • Ensure that high-risk groups (e.g., veterinarians, laboratory workers, and wildlife rehabilitators) frequently exposed to foxes and wild animals use protective measures (gloves and handwashing).

• Counsel clients to avoid feeding raw meat to dogs and cats and to not allow pets to hunt. • Train veterinary personnel in biosafety measures to reduce risk from infected dogs and wild animals.

• Regularly examine and treat high-risk dogs and cats (e.g., sheep dogs). • An experimental recombinant vaccine is available for sheep in high-risk areas.

The causative agent of echinococcosis in humans is the larval (hydatid) phase of Cestodes ( 

Echinococcosis tends to occur in well-defined groups who have contact with dogs that ingest the raw viscera of infected animals. These include sheepherders who use dogs and persons in Alaska who allow dogs to feed on entrails of wild caribou and moose. Many of the cases diagnosed in the United States are in immigrants from countries where contacts between dogs and sheep and cattle are common. 4 Children may be at greater risk of infection because of close contact with dogs. 

Reported risk factors for E. multilocularis infection include owning dogs that kill game or roam outdoors, living in a farmhouse or near a field, growing vegetables, owning outdoor cats, or eating unwashed fruit. 5

Dogs and wild canids are the definitive hosts for E. granulosus. The adult tapeworms reproduce in the dog intestine and shed gravid proglottids or eggs in the feces. These eggs can remain viable in moist conditions with moderate temperatures for months. Intermediate hosts include a wide variety of herbivores as well as mongooses, non-human primates, and humans.

The growing urban populations of red and arctic foxes, the primary definitive host for E. multilocularis, increase concern for human risk of infection. 6 The intermediate hosts for E. multilocularis are usually rodents, including mice, shrews, lemmings, and voles. 7 In addition to foxes, dogs and cats that hunt such animals can subsequently infect humans. 8

The adult tapeworms living in the intestine of a dog or other carnivore release eggs that are shed in the feces ( Figure  9 -42). Human infection occurs by ingesting these eggs, either through contamination of food or by direct contact with dogs or other definitive hosts. Children are often infected because of more intimate contact with dogs and frequent hand-tomouth contact. Once ingested, the eggs hatch into larvae (oncospheres) in the small intestine. Migrating through the intestinal wall, they lodge in the liver, lung, or other tissues. There they form cysts containing protoscolices. E. granulosus tends to form large, slowly growing unilocular cysts with a well-defined limiting membrane. By contrast, E. multilocularis form multilocular cysts, also known as "alveolar" cysts, without a limiting membrane and grow more aggressively. 4 This results in the potential for E. multilocularis to cause more serious complications. When dogs feed on the carcass of an intermediate host containing cysts, the protoscolices develop into adult worms in the dog intestine (Color Plate 9-20).

Contamination of the environment by egg-containing feces of infected canids is an important factor in transmission of Echinococcus. Feces containing eggs can contaminate grazing areas of sheep and other ruminants, leading to infection of these animals. 8 Echinococcus eggs can survive in the environment for weeks to months under optimal conditions. 9 Dogs that defecate near vegetable gardens or otherwise contaminate sources of food and water can be a source of infection for humans. Factors that increase the abundance of foxes and rodents (potentially infected with E. multilocularis) around dwellings can increase the risk of infection to humans and domestic animals; these can include the presence of food sources including pet food and bird seed from bird feeders. Table 9 -26 shows the clinical features of Echinococcus infection in humans and other animals.

The cysts tend to be slow growing, unilocular, and often asymptomatic for many years. The size may reach 15 cm or larger. Many cysts are discovered only during imaging performed for other reasons (Figure 9 -43). The severity of disease depends largely on the organ involved and cyst size and number. Most hydatid cysts are found in the liver (50% to 70%) and lungs (20% to 30%) but more rarely can involve spleen, muscles, heart, kidney, and even the brain. Symptoms develop if a cyst becomes large enough to affect organ function or cause pain or if cysts rupture or become superinfected. Liver cysts can cause abdominal pain, whereas lung cysts can cause chest pain, cough, hemoptysis, and embolism. 7 Cyst rupture or leak suddenly, producing anaphylactic reactions, release of protoscolices, eosinophilia, and secondary infectious complications. 8

Cysts tend to grow more aggressively than those of E. granulosus, almost always involving the liver, but capable of forming metastases in other organs (Figure 9 -44). Symptoms can include pain, jaundice, weight loss, and hepatic obstruction, with sometimes fatal complications. The clinical picture can thus resemble hepatic carcinoma. The World Health These are comparatively rare infections that usually involve the liver or lungs and are characterized by the development of multiple microcysts.

Adult Cestode worms in the intestine of dogs, cats, and other definitive hosts rarely cause serious disease, 11 although large parasite burdens can result in signs of enteritis.

Intermediate hosts for E. granulosus, including sheep, goats, and horses, develop cystic disease that is generally subclinical, although jaundice, ascites, bronchopneumonia, decreased growth, and lameness have been reported ( Figure  9 -45 and Color Plate 9-21). 12 Rodents may develop clinical cystic disease from E. multilocularis. 1 Nonhuman primate deaths have been reported from zoologic institutions.

The initial diagnosis is often made using ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI). The differential diagnosis in human beings includes tumors, abscesses, and tuberculosis. When echinococcosis is suspected, serologic testing is performed using immunoblot or ELISA but is not 100% sensitive. Fine-needle aspiration of cyst contents can help make the diagnosis in equivocal cases by demonstrating protoscolices in the cyst fluid but carries a risk of cyst rupture and leakage.

In definitive host animals, arecoline purgatives can result in finding adult parasites or proglottids. In an experienced laboratory, fecal examination can reveal tapeworm eggs. A stool-based PCR test (copro-PCR) is also available. 13 In intermediate hosts, diagnosis can be made on histologic samples.

Treatment of hydatid cyst disease in humans depends on the location of the cyst. While treatment is often surgical, the technique of puncture-aspiration-injection-reaspiration (PAIR) with the adjunctive use of an antihelminthic appears promising as an alternative for the treatment of uncomplicated cysts. 14 Albendazole is given before the procedure; then the cyst is aspirated and injected with hypertonic saline solution or alcohol and is then reaspirated with final irrigation. Albendazole treatment is then continued for 28 days. Such treatment produces cure in more than 90% of cases. 15 The treatment for alveolar echinococcosis is wide surgical excision, although albendazole can be tried in similar doses to that used in E. granulosus infection.

In the definitive animal host, tapeworms are treated with antihelminthics. Table 9 -27 provides treatment information for humans and other animals. 

Some actions to consider in an integrated pest management approach include: • Keep grass mowed.

• Remove leaf litter, brush, and weeds at the edge of the lawn.

• Restrict the use of groundcover, such as pachysandra, in areas frequented by family and pets. • Remove brush and leaves around stone walls and wood piles. • Discourage rodent activity. Clean up and seal stone walls and small openings around the home. • Move firewood piles and bird feeders away from the house. • Use veterinary-approved tick prevention products on pets;

perform daily tick checks on pets and safely remove and dispose of ticks. • Use plantings that do not attract deer, or exclude deer through various types of fencing. • Move children's swing sets and sand boxes away from the woodland edge and place them on a wood chip or mulch-type foundation. • Trim tree branches and shrubs around the lawn edge to let in more sunlight. • Adopt hardscape and xeriscape (dryer or less waterdemanding) landscaping techniques with gravel pathways and mulches. Create a 3-foot or wider wood chip, mulch, or gravel border between lawn and woods or stone walls. • Consider areas with decking, tile, gravel, and border or container plantings in areas by the house or frequently traveled. • Widen woodland trails.

• Consider a least-toxic pesticide application to tick-infested areas of high human exposure. human health professionals to work together since they were recognized as animal pathogens several decades before being described in human infection. 1 As with several other zoonotic diseases, recent advances in molecular diagnostics are shedding new light on the true prevalence of infection and the degree of overlap between human and animal ehrlichioses. Discoveries using animal models of infection with these agents also may further our understanding of diagnostic and treatment options in humans.

• Provide epidemiologic analysis of these reportable diseases and assessment of local ehrlichiosis and anaplasmosis disease risk for the health district. • Educate the public to:  Avoid tick-infested areas, but if this is not possible, wear appropriate clothing (long sleeves, long pants, tuck pants legs into socks, and wear light-colored clothing to visualize ticks). Wash clothes with hot water. 2  Use CDC-recommended tick repellents such as DEET or permethrin (apply to clothes, not skin) where ticks are abundant. Be sure to follow label instructions before using any repellent.  Do frequent tick checks to remove even tiny immature-stage ticks.  Encourage adults to inspect children at least once daily for ticks. When in heavily infested areas, inspect children every 3 to 4 hours.

Use appropriate technique to remove ticks. Wear gloves or grasp tick with tweezers as close to the skin as possible and pull gently, or use a tick-removal spoon. Follow-up by cleaning the area, applying antibiotic topical on tick bite site, and washing hands. 3  Discourage the use of matches, petroleum products, or nail polish as tick removal methods. 3  Implement integrated pest management techniques including landscape management (Box 9-3). Counsel pet owners to discuss tickborne disease prevention strategies with their veterinarian. • Work with local planning agencies on smart growth to avoid fractionating forested areas (see Chapter 6, Built Environment).

• E. chaffeensis affects monocytic phagocytes, and the disease it causes in humans was formerly termed human monocytic ehrlichiosis (HME) but is now most commonly referred to as ehrlichiosis. E. chaffeensis is mainly a human pathogen but also causes diseases in dogs. E. ewingii is found in neutrophils, especially in immunocompromised patients. 4 It was formerly in the disease category "human ehrlichiosis, unspecified" and now is described as E. ewingii ehrlichiosis when it causes disease in humans; it has also been found to cause canine infections. The organism A. phagocytophilum (which now includes the agent formerly called E. equi) also infects neutrophils. The disease in humans was formerly termed human granulocytic ehrlichiosis (HGE); it is now referred to as human granulocytic anaplasmosis (HGA) or, most commonly, simply anaplasmosis. Strains of A. phagocytophilum also cause disease in dogs, horses, ruminants and, rarely, cats. 5 A. platys is a canine pathogen that infects platelets and causes a disease known as infectious canine cyclic thrombocytopenia; it is not thought to be a significant human pathogen. Another canine pathogen, E. canis, causes ehrlichiosis in dogs; although it is not considered a highly likely zoonotic agent, at least one case of human infection with E. canis has been reported. 6 Neorickettsia sennetsu causes a febrile syndrome (sennetsu fever) that is rare outside Asia. 7

The distribution of both human and domestic animal cases of the various ehrlichioses and anaplasmosis varies largely depending on the distribution of tick vector and reservoir species ( 

As in other tickborne diseases, the risk of ehrlichioses and anaplasmosis varies between and within regions and is generally related to the abundance of host ticks that can carry the disease. Individuals living in areas of high tick abundance are at increased risk. Immunocompromised individuals are at risk of infection with severe disease.

Infected animals are not believed to pose a substantial direct zoonotic risk to humans. In general, animal infections serve as a means of sustaining infections in tick vectors, and humans and other animals acquire infection from tick bites. White-tailed deer (O. virginianus) are considered a likely major reservoir for E. chaffeensis and E. ewingii, 4 and dogs may also play a role. The primary reservoir for A. phagocytophilum consists of small mammals, including deer mice (Peromyscus) and wood rats (Neotoma), although deer may also play a role. 9 Vectors of A. phagocytophilum are ticks of the genus Ixodes, including I. scapularis, I. ricinus, I. pacificus, I. triangulaceps, I. spinipalpis, and I. persulcatus (Color Plate 9-23). 4 These hard ticks are also the vector for Borrelia burgdorferi, Babesia microti, and tickborne encephalitis; therefore coinfection is common. The vector for E. chaffeensis and E. ewingii is the Lone Star tick (A. americanum). In dogs, the brown dog tick (R. sanguineus) is the principal vector for A. platys and E. canis. 10 Dermacentor variabilis, the American dog tick, can also be a vector of E. canis infection. 11 Accidental hosts for these agents include humans, dogs, cats, and ruminant animals.

Most ehrlichioses are tickborne infections. The larval, nymphal, and adult forms of the tick vectors are capable of transmitting infections. Figure 9 -48 shows the life cycle of infection for E. chaffeensis. Most infections in the United States occur between May and August, coincident with periods of peak tick feeding activity. 9 Direct transmission between humans and other mammals has not been reported.

The relation of environmental factors to the risk of anaplasmosis and ehrlichiosis may resemble that for Lyme disease, with landscape modification in the United States related to suburbanization of the human population playing a significant role. These suburban developments encroach into land that was previously forest habitat and result in "fragmentation" of forests (see Chapter 6) . This provides habitat for deer and small mammals that can serve as reservoirs for certain Ehrlichia and Anaplasma and also increases tick abundance and infection rates. Climate change with warmer winters may also be leading to increased tick abundance during the following spring and summer. 12 Wild birds may play a role in dispersing the Ixodes tick vectors that can transmit A. phagocytophilum. 13 

Human ehrlichioses caused by E. chaffeensis, E. ewingii, or E. canis and anaplasmosis (HGA) caused by A. phagocytophilum can present as clinical syndromes that share a number of common features, including fever, headache, and myalgias, with laboratory findings of thrombocytopenia, leukopenia, and elevated liver function test results.

Rash is not a common feature of all ehrlichioses and anaplasmosis, although it may occur in up to 30% of children with E. chaffeensis infections. When present, it is maculopapular, not petechial. 14 E. chaffeensis may cause more severe disease than the other pathogens, and CNS involvement may occur in up to 20% of cases, including meningitis and meningoencephalitis. Septic shock and respiratory distress syndrome can also develop in patients with E. chaffeensis. Severe complications and even death are more common among immunocompromised patients. The overall mortality rate of E. chaffeensis disease is approximately 3%. 9 Coinfections with other agents sharing the same tick vector are not uncommon; therefore Lyme disease, babesiosis, or tickborne encephalitis may be seen in up to 10% of E. chaffeensis cases. 9 Peripheral neuropathy may develop in patients with A. phagocytophilum, but severe complications and fatalities are less common (case fatality rate approximately 0.7%) than with E. chaffeensis.

Canine ehrlichiosis is a multisystemic disorder that can cause a variety of clinical signs, including fever, anorexia, CNS signs, hemorrhagic conjunctivitis, vasculitis, spleno megaly, and lymphadenopathy (Color Plates 9-24 to 9-27). The course of the infection may be subclinical, acute, or chronic. 15 Although cases of canine ehrlichiosis confirmed via cytology or serology have been attributed to E. canis, it is now thought that some cases may have been related to infections with E. chaffeensis, E. ewingii, or A. phagocytophilum. 16 Doberman pinschers and German shepherd dogs are considered by some to be more likely than other breeds to have severe chronic E. canis infection. 15 E. ewingii causes polyarthritis with fever and hepatosplenomegaly in dogs. 15 Concurrent infection with other Ehrlichia, Anaplasma, Babesia, Haemobartonella, or Hepatozoon organisms can worsen the clinical course of ehrlichiosis in dogs.

Canine anaplasmosis caused by A. phagocytophilum is thought to produce a milder clinical syndrome with fever, lethargy, and thrombocytopenia. A. platys causes a moderate to severe cyclic thrombocytopenia in dogs; however, bleeding complications are rare. 15 Clinical ehrlichiosis has also been described in cats. Although the species of Ehrlichia that naturally infects cats has not been fully determined, clinical illness with signs including fever, anorexia, pale mucous membranes, and weight loss has been described. 16 A few cases of feline A. phagocytophilum infections, also known as feline granulocytotropic anaplasmosis, have been described in cats. Clinical signs associated with these infections include fever, anorexia, and lethargy.

A. phagocytophilum causes tickborne fever (also known as pasture fever) in cattle, sheep, and other ruminants, predominantly in Europe (Figure 9 -49). The clinical signs are listed in Table 9 -28. Equine anaplasmosis (formerly equine ehrlichiosis) is also caused by A. phagocytophilum (formerly E. equi) and consists of a febrile disease resembling human anaplasmosis. Table 9 -28 shows the comparative clinical presentations in humans and other animals.

Ehrlichial infections in humans can resemble other tickborne febrile syndromes. A history of a tick bite and thrombocytopenia, leukopenia, and elevated liver function test results favor the diagnosis. Unlike Rocky Mountain spotted fever (RMSF), vasculitis is not present in ehrlichial infections. 14 In HME, rapid laboratory diagnosis is possible when cellular stippling of intracytoplasmic inclusions (morulae) in monocytes are seen, although this is uncommon (see Figure 9 -49), while in HGA, morulae in neutrophils and bands can be seen more commonly (in up to 20% to 80% of cases 14 ; Color Plate 9-28 and Figure 9 -50). A PCR test using ethylenediamine tetraacetic acid (EDTA) or citrate-anticoagulated blood is becoming the standard method of diagnostic confirmation for both conditions. 14 The organisms can also be grown in cell cultures but this may take several weeks. Serologic tests using a fluorescent antibody reaction can be used to compare acute and convalescent titers, and demonstration of a fourfold change in titers is considered the most sensitive method of detecting infection, although the test may cross-react with other diseases, including Lyme disease and RMSF. 9 PCR testing may help resolve problems of cross-reactivity between species that can occur with serology testing.

In dogs, serology using IFA is commonly used with titers is more reliable 3 weeks after infection. Although IFA is sensitive, the test may not be very specific because of cross-reactivity between E. ewingii and E. canis, as well as E. canis and A. phagocytophilum. Standardized serologic tests for feline patients are needed. Depending on the ehrlichial species, cytology may be a useful tool for detecting the presence of morulae in blood or tissue smears. Depending on the type of animal and ehrlichial species, any one or a combination of other testing such as PCR, serology, immunoblotting, and organism cultivation may be useful in confirming the diagnosis.

Antibiotic treatment of ehrlichial infection in humans and other animals is shown in Table 9 -29.

Because of the serious nature of Ehrlichia and Anaplasma infections, early initiation of antibiotic treatment is recommended when the diagnosis is suspected. Doxycycline is considered the first line of treatment (see Table 9 -29). In pregnancy, rifampin has been recommended by some authorities. 

Antibiotics and supportive care are the mainstay of clinical disease in dogs and horses. Antibiotics commonly used in small animals include doxycycline, chloramphenicol, and imidocarb dipropionate. Oxytetracycline can be very effective in reducing the severity of illness in cattle. 18 Adjunctive steroid treatment is sometimes used when thrombocytopenia is life threatening. The prognosis is excellent with acute disease and prompt treatment. Prognosis is poor for dogs with E. canis infection that progresses to hypoplastic marrow; anabolic steroids may be needed to stimulate bone marrow production. In ruminants, administration of oxytetracycline early in the course of the disease may be beneficial. Tick and infection control strategies are considered effective herd health strategies to prevent clinical cases. 18 3 and cases of edema in pigs tied to toxinproducing strains resembling those occurring in humans. 4 Urinary tract infections in humans have been linked with E. coli from food sources. 5 It is likely that additional patterns of interspecies transmission of E. coli infection will be recognized in the future 6 ; however, this chapter emphasizes current knowledge regarding enterohemorrhagic strains, such as O157:H7. Pathogenic E. coli strains, particularly those that are antibiotic resistant, from the food supply are a public health and economic concern.

• Ensure that health professionals know how to report cases to the local health authorities. • Exclude infectious patients from child care or patient care facilities and food production facilities. • Educate the public on modes of transmission and the preventive measures that they can use, including the following:

 Discourage consumption of undercooked ground meat and unpasteurized dairy products or juices. The organism can be maintained in the environment for months in feces and soil. Disinfection agents include 1% sodium hypochlorite, 70% ethanol, and iodine-based solutions. 7 • Ensure that local petting zoos and other areas where the public has contact with animals have policies and procedures in place to reduce the risk of infection. This includes providing access to handwashing stations, proper manure disposal, and separation of animals from food areas. • Provide descriptive epidemiology of disease in local human and animal populations. • Coordinate with agriculture officials to ensure that food safety and farm safety measures are in place.

• Ensure adequate hydration and consider hospitalization to reduce the risk of hemolytic uremic syndrome. 1 • Report cases immediately to local health authorities. • Institute enteric precautions for patients.

• Educate patients about personal hygiene and proper handwashing techniques. • Avoid the use of antibiotics in patients with Shiga toxin-producing E. coli infections.

• Counsel animal handlers about hygiene, handwashing, and avoiding direct contact with feces. • Prevent infection in puppies and kittens by cleaning and disinfecting the parturition environment (1:32 dilution of bleach), ensuring adequate colostrum intake, ensuing that the bitch/queen is in good health, and washing hands/changing clothes and shoes before handling neonates. • Counsel pet owners to avoid feeding raw or undercooked meat to dogs and cats.

E. coli is a gram-negative bacillus that is a lactose fermenter and a normal inhabitant of the intestinal tract of most mammals ( Figure 9 -51). The classification into different serogroups is based on the O polysaccharide antigen. Further differentiation into serotypes is based on the H (flagellar) antigen. 8 The most common serotype of EHEC in human infections is O157:H7. This serotype does not ferment sorbitol, so this aids in the identification of the organism. EHEC organisms are capable of producing potent cytotoxins known as Shiga toxins 1 and 2 (also known as verocytotoxins). Shiga toxin 1 is also produced by Shigella dysenteriae (see Chapter 11) .

EHEC strains have been identified in North America and South America, Europe, Japan, and southern Africa. The distribution of these strains in other parts of the world is unknown. 1

Although E. coli infections can occur in persons of all ages, children younger than 5 years are at increased risk of developing serious complications from EHEC infections, including hemolytic uremic syndrome (HUS). In the elderly, thrombocytopenic purpura may develop.

Cattle are the principal reservoir for EHEC. Other ruminants may also be reservoirs. EHEC strains have been identified in sheep, goats, turkeys, chickens, cats, deer, swine, horses, and dogs. 9,10 Contaminated meat and other food are major vehicles for human infection. Human-to-human transmission is common. When a subclinically infected cat was found to have the same strain of O145:H-EHEC as a child with bloody diarrhea, it was not possible to determine the direction of the transmission, so human-to-animal transmission may be possible as well. 11

Transmission occurs through direct contact with feces or through the ingestion of meat, dairy products, produce, or water that is contaminated with feces ( Figure 9 -52). The infective dose is estimated to be fewer than 10 organisms. 12 Subclinically infected animals may shed organisms in their feces for prolonged periods. Significant outbreaks have been linked to contaminated beef, vegetables and fruit, and unpasteurized juice and dairy products. Contaminated dust settling into drinks has been suspected in outbreaks associated with fairs and petting zoos. Contaminated swimming pools and drinking water supplies have been associated with waterborne transmission of the bacterium. 13 After the organisms have been ingested, they reproduce in the intestinal tract. The incubation period to clinical illness is between 2 to 10 days. 1 Infected humans may then shed organisms in their feces for several weeks.

Shiga toxin-producing E. coli result in cytotoxic effects on intestinal epithelia that cause characteristic bloody diarrhea. Shiga toxins systemically cause renal endothelial damage and possible HUS.

E. coli has been shown to persist in contaminated environments for prolonged periods. 14 The organism may persist for longer periods in the soil in cold climates.

Forty-two weeks after an outbreak of human illness at a fair in Ohio, E. coli O157:H7 was able to be recovered from the sawdust in the implicated barn. 15 Campers have become infected by camping and contacting mud and soil in pastures where livestock such as sheep have grazed in the past. 12

E. coli O157:H7 and other EHEC strains of E. coli cause varying infections that can range from asymptomatic to fatal. Common symptoms include watery diarrhea, often (in more than half of cases 16 ) followed by large amounts of blood, abdominal cramping, and colitis (Color Plate 9-29). Fever is either low grade or absent. In most cases, the disease can resolve in 5 to 10 days without antibiotics. 17 Severe complications are more common in children and the elderly and include HUS in approximately 10% of cases, acute renal failure, coagulopathies, and anemia. 18 E. coli O157:H7 is the major cause of HUS in the United States and the most common cause of acute renal failure in children.

Cattle are typically subclinical carriers for E. coli O157:H7 (Figure 9 -53). Herd prevalence rates in excess of 40% have been reported. Studies of calves have shown EHEC prevalence rates of almost 70%. 19 Sheep (rates in excess of 30%), dogs, deer, swine, and other animals may also subclinically carry EHEC.

ETC, EPEC, uropathogenic E. coli, and cytotoxic necrotizing factor E. coli have been recovered from dogs, while EPEC, VTEC, and uropathogenic E. coli organisms have been recovered from cats. Many of the E. coli strains that have been recovered from dogs and cats are hemolytic.

Neonates that have not had adequate amounts of colostrum are more susceptible to enteritis or septicemia caused by β-hemolytic E. coli. Sporadic cases of E. coli enteritis, cystitis, endometritis, pyelonephritis, prostatitis, or mastitis have also been reported in puppies and kittens, as well as adult dogs and cats. 

Fecal samples should be cultured on sorbitol/MacConkey's media. All EHEC strains should be sent to a public health laboratory for serotyping to characterize the strain and detect possible outbreaks. There are also commercial assays for Shiga toxins and DNA probe for specific genes. 1 Subtyping of E. coli O157:H7 can be done using pulsed gel electrophoresis to further detect outbreaks.

Many human cases of EHEC infection are self-limiting and do not require medical intervention. Even in more serious cases, it is believed that antibiotic treatment and antimotility agents may increase the release of toxins and increase the risk of HUS. 16 Supportive measures include fluid and electrolyte replacement and monitoring of hematologic and renal function for the development of HUS. HUS often requires transfusion, dialysis, and intensive care. 20 In adult animals the disease may be self-limiting; however, animals with clinical signs may need intensive supportive care. Antibiotic therapy protocols should be based on culture results and sensitivity testing. Trimethoprim-sulfa can be used at 30 mg/kg orally every 12 to 24 hours or amoxicillin can be used at 10 to 20 mg/kg orally every 8 to 12 hours. The prognosis for neonates with clinical signs is often poor.

• Diagnosis and Management of Foodborne Illnesses: http:// www.cdc.gov/mmwr/preview/mmwrhtml/rr5304a1.htm • E. coli Resources for Clinicians: http://www.cdc.gov/ecoli/ clinicians.htm 

Giardiasis (ICD-10 A07.1)

Giardia intestinalis (also known as Giardia lamblia, Lamblia intestinalis, Giardia duodenalis) 1 is a common parasitic cause of infectious diarrhea in humans. Human cases are thought to be a result of person-to-person transmission, either directly or through contaminated water supplies. The importance of animals, including dogs and cats, as disease reservoirs and sources of zoonotic transmission of the disease remains incompletely understood and potentially overlooked by human health clinicians and public health authorities. Recent advances in molecular genotyping hold promise for clarifying the risk of Giardia infection related to human-animal contact.

• Disease is reportable to public health authorities in some states.

• Ensure public water supplies are not contaminated with human or other animal waste and that water treatment includes filtration. • In the event of a case report, determine risk factors for infection and whether others are at risk. • Consider zoonotic sources of infection (e.g., pets, farm animals/petting zoos, water supplies with animal contact). • Educate the public, veterinarians, and human health clinicians about risk factors for transmission, including not drinking untreated surface water. • Support policies to clean up dog feces and other animal waste in public areas. • Ensure that day care center staff have proper training to avoid outbreaks.

• Check with your state health office to determine whether the disease is reportable to public health authorities using the case definition; see http://www. cdc.gov/mmwr/preview/mmwrhtml/ss5607a2.htm. • Include questions about animal contact in every patient presenting with diarrhea. If pets are in the house, suggest a consultation with the family veterinarian. Human Giardia may be able to infect pets. • Person-to-person transmission is possible. Counsel infected persons about handwashing, avoiding swimming for 2 weeks after symptoms end, and avoiding fecal exposure during sexual activity.

• Counsel owners and any others in contact with infected animals about the zoonotic risk, need for handwashing after handling pet, feces, pet toys, and other objects that are potentially infected or contaminated with cysts. • Decontaminate infected animal's coat with shampoo; also decontaminate kennels or other environments with quaternary ammonium disinfectants that are effective in inactivating Giardia cysts. • Consider vaccinating puppies and kittens at 7 weeks, with booster 3 weeks later, against Giardia trophozoites 1 (controversial). • Decontaminate hard surfaces with 1% sodium hypochlorite, 2% glutaraldehyde, or quaternary ammonium solutions. 1 • Keep pets indoors to reduce their exposure to the organism.

Giardia is a genus of flagellated protozoan parasite that lives principally in the upper intestine of vertebrates ( Figure 9 -54).

Recent classification identifies Giardia intestinalis as the major species responsible for human infection. Giardia species are found in most mammals, and while different strains appear to have adapted to specific host species, molecular tools for typing particular isolates are now allowing an examination of how much zoonotic transmission is taking place. The current classification includes at least seven distinct assemblages (genotypes) of G. intestinalis: A and B are found in humans and a number of other animals, and C through G appear to be more host specific. 2,3 Giardia organisms exist in two forms, a vegetative trophozoite form capable of causing illness in the host, and a transmissible cyst form that is shed in feces ( Figure 9 -55). The cysts measure 7 to 10 microns by 8 to 13 microns and can survive up to 2 months in water, where they are resistant to routine chlorination. Upon ingestion by a host, the cysts develop into pathogenic trophozoites that cling to the brush border surface of the intestinal mucosa and reproduce by fission.

G. intestinalis occurs worldwide in humans and other animals, with greater human prevalence in regions with poor sanitation practices and crowding. Reported prevalence in human populations ranges from 2% to 4% in developed countries to more than 15% in children from developing countries.

Children appear to become infected more frequently than adults. Particular risk groups include children in day care facilities, day care workers, parents of infected children, individuals living in areas without adequate sanitation or who drink from shallow wells, wilderness travelers who drink unfiltered or untreated water, swimmers who swallow water from lakes or ponds, international travelers, and men who have sex with men. 4

In many host species, Giardia infection can produce humoral immunity after 100 days that may result in self-limiting infection. 5 In the United States, the prevalence of Giardia in canine kennels has been reported up to 100%. 6 Humans and a wide range of other animals are reservoirs. In many individuals and species, asymptomatic carriage may occur with the ability to transmit the infection to others. Studies of infection prevalence in animals vary greatly: 20% to 35% in puppies, 10% to 15% in kittens, 5% to 90% in calves, 60% to 80% in lambs, 17% to 32% in foals, and 7% to 44% in young pigs. 7

Cysts develop in the intestine and are shed into the environment in feces, where they are immediately infective (Figure 9 -56). Transmission occurs when cysts are ingested through drinking water, direct fecal-oral contamination, foodborne exposure, or contact with contaminated objects leading to ingestion. Infected drinking water is thought to be the major form of transmission. The infective dose is low, with a median infective dose (ID 50 ) of 10 cysts. Fecal excretion is high-an infected human can secrete 900 million cysts per day. 8 Once the cysts are ingested, they develop into trophozoites in the small intestine. The trophozoites remain there and, if they cause disease, they do so without invading the mucosa. They have a sucking disk by which they attach to the entero-cytes and are thus not shed continuously. Reproduction takes place by binary fission and cysts are produced to continue the life cycle.

Circumstantial evidence, such as finding similar genotypes in both children and household dogs, suggests that transmission between pets and people takes place. 9,10 Case control studies have shown increased odds for infection among pet owners and people reporting contact with farm animals. 11 Transmission in animals, as in humans, occurs through ingestion of cysts. Both cysts and trophozoites can be found in the feces (diagnostic stages). 1, The cysts are hardy and can survive several months in cold water. Infection occurs by the ingestion of cysts in contaminated water, food, or by the fecal-oral route (hands or fomites). 2, In the small intestine, excystation releases trophozoites (each cyst produces two trophozoites). 3, Trophozoites multiply by longitudinal binary fission, remaining in the lumen of the proximal small bowel where they can be free or attached to the mucosa by a ventral sucking disk. 4, Encystation occurs as the parasites transit toward the colon. The cyst is the stage found most commonly in nondiarrheal feces. 5, Because the cysts are infectious when passed in the feces or shortly afterward, person-to-person transmission is possible. While animals are infected with Giardia, their importance as a reservoir is unclear. (From Centers for Disease Control and Prevention: Giardiasis. http://www.dpd.cdc.gov/dpdx/HTML/Giardiasis.htm. Accessed September 13, 2008.) 

Because the Giardia cyst can persist for months in the environment, the status of water supplies is a critical environmental factor in sporadic and epidemic outbreaks of giardiasis in both humans and animals. Inadequate filtration of drinking water supplies has been associated with major outbreaks. The degree of contamination of municipal water supplies and shallow wells with animal and human feces is also important. On farms, contamination of water sources could spread infection among animals.

Dogs shedding cysts in feces can contaminate environments such as a lawn or public park for months, [12] [13] [14] leading to risks to children who play around soil. Similarly, livestock housing facilities and grazing areas can become contaminated with Giardia cysts, leading to infection risk for animals and farmers. Even marine shellfish are capable of being contaminated with Giardia cysts, suggesting a foodborne infection risk to humans. 15

Giardia infection in humans is usually asymptomatic or mild enough to escape diagnosis. Most cases are self-limited, yet significant acute and chronic infection can occur. Acute infection can produce bloating, abdominal pain, explosive diarrhea, with pale, frothy, steatorrheic feces often mixed with mucus, but not blood. Symptoms may be continuous or intermittent (with bouts of constipation).

In chronic infections, there can be bloating, abdominal pain, flatulence, steatorrhea, lactose intolerance, and weight loss. In children this can lead to failure to thrive and developmental delays. 16 Rarely, infection can lead to reactive arthritis.

In dogs and cats, the disease is often subclinical. Young animals are more likely to show signs of infection and present with frothy diarrhea that may be foul smelling. Calves, lambs, foals, and caged birds (cockatiels, parrots) may also develop diarrhea due to Giardia. Table 9 -31 provides a comparison of clinical manifestations of giardiasis.

In humans, the differential diagnosis includes other causes of chronic diarrhea, including bacteria such as Campylobacter and Salmonella, viral gastroenteritis, and other protozoa including Cryptosporidium and Cyclospora, and underlying disease such as celiac sprue. Diagnosis is typically by direct microscopic visualization of trophozoites or Giardia cysts in the feces. Repeated fecal analysis may be necessary. ELISA and IFA tests for antigen are also commercially available. It should be noted that demonstration of cysts alone in feces does not prove Giardia is the cause of a diarrheal episode because many Giardia infections are asymptomatic. In questionable cases, a duodenal aspirate, string test, or biopsy may be performed to detect trophozoites. 18 Animal diagnosis involves testing for Giardia trophozoites in direct unstained fecal smears to look for motile trophozoites or using Lugol's iodine to help distinguish the cysts and trophozoites (Figure 9 -57). 19 A zinc sulfur concentration test (ZCST) is a fecal flotation method for cysts and is considered a more sensitive test than a newer, fecal ELISA. A direct IFA test may be more sensitive for detecting low numbers of cysts. 20

Acute giardiasis is treated with supportive care including rehydration. Antibiotics are indicated for symptomatic patients. Table 9 -32 provides treatment information for giardiasis in humans and other animals.

All drugs for Giardia treatment are extralabel in animals. However, a number of drugs are effective. In addition to antibiotic treatment, an animal's coat should be washed with an antiseptic shampoo solution to eliminate cysts. Vaccines 19 have been developed for dogs and cats, but their use is controversial. 

Clinical syndromes of hantavirus infection, including hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with nephropathy, are thought at present to be principally human diseases. However, the presence of domestic animals in, and wildlife around, a household can increase the risk for rodent infestation or contact that can result in hantavirus risk to humans. Limiting contact between humans and rodents (including wild species and laboratory animals) can reduce the risk of infection. However, these interventions are unlikely to prevent sporadic transmission with serious fatal outcomes.

• Provide descriptive epidemiology of cases in the health district. • Educate the public about measures to reduce risk, including the following: 

• Report disease to public health authorities using the case definition (All About Hantaviruses): http://www. cdc.gov/ncidod/diseases/hanta/hps/noframes/phys/ casedefn.htm. • Ensure that workers in affected areas who are frequently exposed to rodents or who are involved in cleanup of rodent-infested areas are informed of their occupational risk and have a baseline medical screening, including respirator fit testing. They should use protective equipment-including either half-face or supplied air respirators with N100 or P100 filters (Color Plate 9-30)-and gloves while handling rodents or traps containing rodents; they also should disinfect gloves after use. 2,3 • If fever or respiratory symptoms develop in a worker within 45 days of the last potential exposure, he or she should immediately seek medical attention and inform the health care provider of the potential occupational risk of hantavirus infection. The provider should contact local public health authorities promptly if hantavirus-associated illness is suspected. A blood sample should be submitted to the state health department for hantavirus antibody testing. 4

• Counsel clients about pet-feeding practices that reduce the risk of rodent infestation. • Dogs and cats are not known to be infected with hantaviruses, but these pets may bring infected rodents into contact with people. • Train veterinary personnel in biosafety measures to reduce risk from infected rodents.

Hantaviruses are trisegmented, negative-sense RNA viruses in the Bunyaviridae family. Unlike other bunyaviruses, which are arthropod borne, hantaviruses are rodent borne. A number of species cause human disease, and new hantaviruses and their rodent hosts continue to be described. Like other segmented RNA viruses, hantaviruses appear capable of reassortment when dual infections of target cells occurs, which could lead to the emergence of novel strains. 5

In the New World, hantaviruses are found from Canada to Argentina. In North America, Sin Nombre, New York-1, Bayou, and Black Creek Canal hantaviruses have been associated with HPS. 6 In South America, HPS caused by Andes virus may be particularly pathogenic for humans, and rare occurrence of human-human transmission of infection has been linked to this virus in Argentina. 7 Hantaan virus is the major pathogen in Asia and has also been detected in Africa.

In the United States, groups at increased risk for hantavirus infection are those with rodent contact, including persons living in endemic areas such as the Southwest, forestry workers, farm workers, construction workers engaged in renovation, wildlife biologists and zoologists, and laboratory animal handlers. Although the risk to such groups is low overall, it may be higher in areas of endemic foci. 2

Rodents and, in a few instances, insectivores (shrews) are the reservoir host of hantaviruses, and each hantavirus species is associated primarily with a single rodent or insectivore species. 10 Hantavirus infection within individual rodents of a reservoir species is believed to occur horizontally, with males frequently infected at higher prevalence than females. 4 Lifelong persistence of infection with sporadic shedding of virus has been demonstrated for multiple species. HPS is associated with rodents of the subfamily Sigmodontinae.

• Seal rodent entry holes or gaps with steel wool, lath metal, or caulk. • Trap rats and mice using appropriate snap trap.

• Clean up rodent food sources and nesting sites. • Keep woodpiles and compost heaps away from house. • Take precautions when cleaning rodent-infected areas:  Use cross-ventilation when entering a previously unventilated enclosed room or dwelling before cleanup. From "Prevent Rodent Infestations" at http://www.cdc.gov/rodents/prevent_rodents/ index.htm.

The principal reservoir for hantavirus in the United States is the deer mouse (Peromyscus maniculatus, Color Plate 9-31); other rodents carriers are the cotton rat (Sigmodon hispidus), the rice rat (Oryzomys palustris), and the white-footed mouse (Peromyscus leucopus). Seoul viruses are carried by rats (Rattus species). 11 Although most of these reservoir species are usually found in more rural areas, they are capable of infesting buildings in periurban zones near forested areas. 12

The spread of virus to humans is believed to occur primarily through inhalation of aerosol of dried feces, saliva, or urine from infected rodents (Figure 9 -58). Bites from infected rodents or contact with their feces, saliva, or urine with broken skin, mucous membranes, or through ingestion are other possible transmission pathways. Person-to-person transmission has been reported only for Andes virus, which has been isolated from human saliva 13 ; this transmission required close personal contact in an enclosed space (bus). 8

Contamination of the environment by urine, saliva, and feces of infected rodents is the principal driver of transmission. Under certain conditions, the virus can persist for prolonged periods (several months) in the environment. 14 Environmental factors that increase the density of rodents around human habitation are critical to human risk. These factors include abundance of food sources (unsecured food in kitchens, seeds from bird feeders, pet/livestock food). A combination of mild winters and increased rainfall related to El Niño cycles has also been associated with increased rodent abundance. 15 Spatial risk mapping in the American Southwest has identified areas of increased hantaviral transmission related to elevation and precipitation. 16 

HPS is a life-threatening disease that begins with a nonspecific prodrome of fever, chills, and myalgia, leading to hypotension and pulmonary edema with accompanying respiratory distress and shock. The incubation period is 1 to 4 weeks.

Radiographs may reveal diffuse alveolar infiltrates ( Figure 9 -59). Mechanical ventilation is often necessary. Complications may include disseminated intravascular coagulation, myocardial dysfunction, and cardiac arrhythmias. The case fatality rate may reach 40%. In parts of South America, however, milder forms of the disease may occur. 17

This is a disease of variable severity, with a number of different clinical stages. 1. The febrile or toxic stage is characterized by the abrupt onset of fever, chills, and headache that may be accompanied by photophobia and other symptoms. 2. The hypotensive phase may involve clinical shock and death. 3. The oliguric (renal) phase follows the hypotensive phase and includes declining renal function and urine output. Hemorrhagic complications may occur. 4. The diuretic phase is characterized by improved urine output and clinical condition. 5. The convalescent phase may include long-term abnormalities of renal function, including renal acidosis and renal insufficiency.

Rodents appear to have subclinical infection with hantaviruses. Serological studies in the United States have failed to demonstrate significant rates of subclinical infection in dogs or cats. 18

The differential diagnosis includes legionella, plague, tularemia, Q fever, leptospirosis, Goodpasture's syndrome (antiglomerular basement antibody disease), and drug-induced noncardiac edema. Typical hematologic findings of hantavirus infection include immature neutrophils (bandemia), atypical lymphocytosis, and thrombocytopenia. 19 An ELISA IgM test is available, and immunohistochemistry can be used for retrospective diagnosis.

There is no specific treatment for HPS. Treatment is supportive. Clinicians need to have a high suspicion for the disease because patients require early transfer to an intensive care unit. Mechanical ventilation and support of blood pressure with pressor agents may be necessary. Extracorporeal membrane oxygenation has reportedly provided clinical benefit in some cases.

Hantavirus hemorrhagic fever with nephropathy is also treated with supportive measures, including dialysis if necessary. Ribavirin has been used in some cases. 17

Cutaneous larva migrans (ICD-10 B76.9) Disease due to Ancylostoma caninum or Ancylostoma braziliense (B76.0)

Hookworms of the genus Ancylostoma are common parasites that can cause serious infections in dogs and cats and usually milder illness in humans. The classic manifestation of A. caninum and A. braziliense infection in humans is a dermatitis resulting from the larvae burrowing under the skin, known as creeping eruption or cutaneous larva migrans. Preventive veterinary care and healthy public policies about pet sanitation can reduce the risk of human disease.

• Restrict dogs and cats from beaches and other recreational areas or require cleanup of all animal feces. • Promote strategic deworming of all pets.

• Educate the public about risk of unprotected contact with sand and soil (e.g., need to wear shoes while walking on beach, using a waterproof barrier to damp soils when working under a house). • Recommend rodent control as rodents are paratenic hosts (intermediate hosts are not needed for parasite development).

• Counsel patients in endemic areas and travelers to endemic areas about the risks of unprotected skin contact to soil and sand. • Counsel patients about handwashing after handling potentially contaminated soil, washing vegetables and fruit.

• Provide strategic deworming to dogs and cats.

• Counsel clients to keep dogs on leash and properly dispose of feces, discourage contact with wildlife, keep cats indoors. • Treat pregnant bitches prophylactically. • Decontaminate soil and lawns with sodium borate.

Hookworms are nematode worms (Color Plate 9-32). Although a number of hookworm species occur in humans and other animals, A. canium (dog hookworm) and A. braziliense are the species associated with human disease in the United States. A. braziliense is considered the most common cause of cutaneous larva migrans. 1 A related species, A. ceylanicum, has historically been confused with A. braziliense. 2 The adult A. caninum worms are 12 to 15 cm in length; the other species are somewhat smaller.

Because the larvae prefer warm, humid environmental conditions, hookworm infection is more common worldwide in tropical and subtropical regions. A. caninum is more widely distributed than A. braziliense or A. ceylanicum. In the United States, infection with A. caninum and A. braziliense occurs mostly in the southeast states along the Gulf of Mexico. A. ceylanicum is found in tropical regions.

Exposure to contaminated soil and sand is a major risk factor; therefore human cases occur among bathers who walk barefoot on contaminated beaches or soils. Other risk groups include gardeners, workers who have to crawl into contaminated crawl spaces under buildings, and travelers to tropical regions.

Dogs are the principal reservoir for A. caninum. A. braziliense occurs in cats and dogs. A survey of feral cats in Florida found 33% infected with A. braziliense. A. braziliense also is found in wild felids. It is thought that infection in rodents (paratenic hosts) may also play a role in disease transmission. 2

Dogs and cats become infected through ingestion of larvae, skin penetration of larvae or from transmission in milk or colostrum of infected bitches (dogs) (Figure 9 -60). In puppies and kittens, the larvae migrate through the bloodstream and lymphatics to the lungs, where they are coughed up and swallowed and mature in the small intestine. Approximately 15 to 20 days after infection, the mature worms produce eggs. 3 In older cats and dogs, the life cycle is arrested in the larval stage, but such larvae may become reactivated if adult worms are removed from the intestine or during pregnancy.

After an infected animal sheds eggs into the environment in feces, the eggs complete embryonation, hatch, and larvae begin to develop through a series of stages. The process of developing into infective larvae takes 7 to 10 days in moist, warm soil. 4 Larvae infect humans through contact with skin, usually of the foot. This produces a characteristic dermatitis (ground itch). The larvae of A. caninum and A. braziliense burrow under the skin but eventually die. In the process they produce the lesions of cutaneous larva migrans. Larvae of A. ceylanicum, however, pass through the lymphatics and bloodstream into the lungs, ascend up the trachea where they are swallowed (similar to infection in dogs and cats), and reach the small intestine, where they attach to the wall and develop to maturity in 3 to 4 weeks. 4

Temperature, humidity, and soil type are important factors determining how well the hookworm eggs hatch and develop into infective larvae. In general, these organisms prefer moist, warm climates and moist, sandy soils. In moist, warm conditions the third-stage (infective) larvae can survive up to 3 weeks. 3 Pet sanitation policies in beaches, parks, and other public places can affect the risk of human infection.

Human infection with A. caninum or A. braziliense causes a linear dermatitis that appears within days to weeks after infection (Color Plate 9-33). The rash is usually accom-panied by intense itching, erythema, and edema. Vesicles may appear. Secondary infection may occur. The infection may last weeks or months. Laboratory findings can include eosinophilia and increased IgE levels.

Rarely, cases of intestinal infection with A. caninum have occurred. In such cases, larvae migrate deeper and may reach the intestines causing eosinophilic enteritis. Loeffler's syndrome (eosinophilia, asthma, migratory pulmonary infiltrates, fever, and urticaria) has been described. 5

In young animals, hookworm infection can be an acute disease process with significant blood loss and sudden death. Black, tarry stools may occur. Laboratory tests show anemia that may be accompanied by eosinophilia. The fourth larval stage and adult worms cause a chronic anemia and enteritis. The lung migration phase of the life cycle can rarely cause a dry cough. 6 Because animals may repopulate the bowel with larvae dormant in tissues, infection may continue for months or years. Dogs previously sensitized to Ancylostoma may manifest "hookworm dermatitis" at sites of percutaneous larval penetration (Color Plate 9-34). Table 9 -33 shows the comparative clinical presentation of hookworm infection in humans and other animals.

Cutaneous larva migrans in humans is diagnosed clinically by the characteristic linear, slow-moving rash and a history of exposure to potentially contaminated soils. Biopsy may show an eosinophilic infiltrate but usually does not reveal the organism and therefore is not generally indicated to establish the diagnosis. 7 In animals, eggs can be identified in feces by fecal flotation (Figure 9 -61). 6 

Many human cases of cutaneous larva migrans are self-limited and do not require medical intervention. However, in symptomatic and persistent infection, anthelmintic therapy is warranted. Topical thiabendazole cream may be effective. 7 Table 9 -34 lists choices of oral anthelmintic agents, which are associated with a high cure rate.

Acute illness in dogs and cats is treated with an antihelmintic, as well as supportive care such as blood transfusions. In dogs, adult larvae treatment is sometimes given during the third trimester of pregnancy to reduce transmission to offspring. Pups should be treated at 2 weeks, then every 2 weeks until weaned.

In cats, the queen is given a dewormer before breeding and after littering. Kittens can begin treatment with an adulticide dewormer by 4 weeks of age. 7 Table 9 -34 outlines antihelmintic therapy for hookworm infection. Influenza pandemics can occur when a new influenza virus emerges to which the overall population lacks immunity, typically to a new hemagglutinin subtype (Figure 9-62) . The emergence of a pandemic influenza strain has been associated with reassortment of gene segments between human and animal strains. Characteristic traits of pandemics include concurrent, widespread outbreaks of influenza throughout the world, sometimes outside the usual influenza season, with high attack rates in all age groups. 1 Pandemics are usually associated with substantial increases in mortality.

Influenza viruses affect a number of different species, including birds, swine, horses, and dogs, but animal-tohuman transmission has been documented only for birds and swine. Humans may transmit human influenza virus to pet ferrets and swine. 3 The epizootic of H5N1 high pathogenicity avian influenza in domestic and wild birds in Asia, Europe, and Africa has focused increased attention on the potential of influenza viruses to cross species barriers and cause human disease, although this is still considered a rare event and the H5N1 epizootic has not, to date, produced a pandemic virus. Dogs and cats have become naturally and experimentally infected with avian influenza viruses but have not as yet been shown to transmit the infection to humans. A swine influenza A H1N1 virus that emerged in Mexico in the spring of 2009 has further underscored the zoonotic nature of this disease. Human cases were identified worldwide within 1 week after the cause of the outbreak had been identified. As of October 25, 2009, the World Health Organization had confirmed more than 440,000 humans infected with the pandemic H1N1 virus and 5700 deaths worldwide (http://www. who.int/csr/don/2009_10_30/en/index.html). Human-toanimal transmission of the virus has also caused outbreaks in swine and turkeys (http://www.fao.org/news/story/en/ item/29532/icode/). 4 H1N1 influenza infection has also been documented in ferrets and a cat (http://www.usda. gov/documents/FINAL_RESULTS_2009_PANDEMIC_ H1NI_INFLUENZA_CHT.pdf). influenza outbreaks in the growth/early finishing animals. Breeding herds are often vaccinated as well. • All horses in contact with other equines should be vaccinated against equine influenza. Three types of equine influenza virus vaccines are available. 8 Inactivated vaccines and canary pox vector vaccines are administered intramuscularly. The initial series consists of 2 doses of vaccines given 3 to 6 weeks apart followed by boosters every 6 months. Annual influenza vaccine boosters may be sufficient for horses at low risk of exposure once they have been primed with 3 doses of vaccine over a 7-month period. The third vaccine type, modified live cold-adapted vaccines, is administered intranasally. One priming dose is recommended followed by boosters every 6 months. 

Influenza viruses (Family Orthomyxoviridae) are enveloped, segmented, negative-stranded RNA viruses covered with two surface glycoproteins (Figure 9 -64). 1 They are divided into three distinct types (A, B, and C) on the basis of their M and nucleocapsid proteins. 9 Influenza A viruses are further divided into subtypes based on the antigenic characteristics of their hemagglutinin (H) and neuraminidase (N) surface glycoproteins. Each virus carries one H and one N glycoprotein type (see Figure 9 -63). Sixteen hemagglutinin subtypes (H1 through H16) and 9 neuraminidase (N1 through N9) have been identified from avian hosts. 10 Seasonal human influenza A viruses recognized to date have possessed H1, H2, or H3 and N1 or N2 glycoproteins. Influenza A (H1N1) and A (H3N2) have been circulating worldwide in human populations since 1977. Influenza B, which occurs only in humans and seals, is also responsible for significant human morbidity globally each year. 5 Influenza C is rarely recognized in comparison to A and B viruses but can cause focal human epidemics. New seasonal influenza viruses evolve from point mutations (antigenic drift) in the surface glycoproteins, particularly the H, which frequently happens during viral replication. Gene segment reassortment among influenza A viruses can also occur. If these reassortments involve human and animal influenza viruses, they may lead to significant antigenic changes (antigenic shifts) that can result in the emergence of a novel virus subtype (Figure 9 -65). Influenza viruses exhibit various degrees of host adaptation with easy transmission between individuals within the same species, and greater difficulty of infection and unsustainable transmission to unrelated host species. 11, 12 The basis of this host or species adaptation is unclear, but the presence of the proper constellation of gene segments is critical and may include specific hemagglutinin binding to receptors on host cells, especially respiratory cells, and their differential distribution; cleavability of hemagglutinin protein; presence or absence of glycosylation sites on the hemagglutinin; length of neuraminidase protein and its affinity for the sialic acids; and ability of polymerase complex to function within the host cell. 13 Strains of avian influenza virus are classified as low pathogenic (LP) or high pathogenic (HP) based on their lethality in chickens. 14 Currently HPAI H5N1 is circulating in Asia, Europe, and Africa. However, other highly pathogenic strains have caused outbreaks in the recent past, including H7N7, H7N3, and H5N2. All HPAI viruses have been H5 and H7, but most H5 and H7 viruses are of low pathogenicity.

Worldwide.

Several population groups are at high risk for complications of seasonal influenza, including people who are 50 years old or older and people with chronic health problems, such as cardiovascular disease, renal and metabolic disorders (including diabetes), and respiratory disorders (including asthma). Other high-risk groups include women who are pregnant during the flu season, children and adolescents who are receiving long-term aspirin therapy, and children younger than 5 years. 15 Severe influenza disease is also often seen in individuals with immunosuppressive disorders such as cancer or HIV/AIDS. 5 Individuals performing activities involving close contact with animals, such as slaughtering animals and defeathering birds, have been reported to be at increased risk for avian and swine influenza. [16] [17] [18] 

Avian influenza viruses are maintained in nature by wild birds. The viruses have been isolated from more than 100 bird species in 13 genera; however, the most important avian influenza reservoir hosts belong to the Anseriformes (ducks, geese, and swans) and the Charadriiformes (gulls, terns, and shorebirds) groups. 19 More virus isolations have been reported from Mallards (Anas platyrhynchos) than any other bird species. Certain influenza virus strains have adapted to genetically distinct horse, swine, poultry, dog, and human viruses and are self-sustaining in those species. [19] [20] [21] Incidental hosts or sporadic infections have been reported in mink, ferrets ( Figure 9 -66), stone marten, domestic cats, large felids (tigers and leopards), and sea mammals. 19, 22 Swine are susceptible to both human and avian virus strains and are hypothesized to be able to serve as viral mixing vessels where human and avian gene segments may reassort. 1 The 2009 H1N1 swine influenza virus is a novel reassortant of two (parent) swine influenza viruses. It also contains genes of avian and human influenza virus origin incorporated into one of the parent viruses at an earlier time. 23 However, reassortment in swine may not be a requirement for emergence of a pandemic strain if the avian strain can produce infection in a human host.

Human influenza is usually spread from person to person in close contact through large-particle respiratory droplet and short-distance small-particle aerosol transmission (coughs, sneezing) (Figure 9 -67). Indirect spread via contact with surfaces contaminated with respiratory droplets is also a possible transmission mode, and there is evidence that the virus can persist for 1 to 2 days on some surfaces. 5 In swine, the virus is found in respiratory secretions and spreads by aerosolization and by direct pig-to-pig contact. 24 Birds can shed high concentrations of influenza virus in feces, and fecal/oral spread is believed to be an important route of virus transmission in wild birds. 19 Infected birds can also shed influenza virus in their saliva and nasal secretions. Poultry can become infected when they have direct contact with infected birds or indirectly through contact with contaminated surfaces (such as equipment or cages) or feed or water. Aerosol transmission may also be possible over short distances. 25 Touching surfaces contaminated with avian influenza virus in respiratory droplets and handling infected birds or bird manure are hypothesized risk factors for human infection with avian influenza, possibly through contaminated-hand-to-mucous membrane contact or inhalation of contaminated dust particles or aerosols generated during cleaning, slaughtering, defeathering, and other activities. 16, 18 Swine influenza transmission appears to occur during close direct or indirect human contact with infected swine. 17

As stated previously, it is believed that contaminated environments such as surfaces, aerosols, and water may play a role in animal-to-animal influenza transmission and may also be important in human-to-human and animal-to-human transmission, although the significance of such environmental spread in each circumstance is not well understood.

Human crowding, such as in nursing homes, is associated with an increased rate of human outbreaks. As in animals, a high density of birds or swine in a production facility or a live animal market, as well as mixing of waterfowl, poultry, and other animal species including swine in a single facility, may facilitate the spread of virus between animals. Farms that have ponds or other water bodies where wild waterfowl can come in contact with domestic animals may also constitute an environmental risk. Whether the seasonal pattern of influenza is related to other environmental variables such as temperature and humidity remains unclear.

Influenza virus infections can affect all age groups, although the highest infection rates are seen among infants and children. Upper and lower respiratory tract complications occur across age groups, but hospitalizations and deaths from infection are more common in people older than 65 years.

Uncomplicated influenza typically has a quick onset of fever, myalgia, headache, malaise, sore throat, and nonproductive cough. Rhinitis may also be present. Otitis media, nausea, and vomiting are other common influenza manifestations among children. Young children may be less likely than other influenza cases to present with fever and cough. 5 The incubation period is short (1 to 4 days) and the morbidity period generally lasts 3 to 7 days. Lassitude and cough may persist for 2 weeks or more. 26 Adults may be infectious the day before through day 5 after disease onset. Young children may shed virus several days before and after symptom onset. 5 Complications of influenza are common. Patients may develop primary viral pneumonia, viral or secondary bacterial sinusitis and otitis, or pneumonia and experience exacerbations of underlying medical conditions such as pulmonary or cardiac disease. Influenza virus infection also has been uncommonly associated with encephalopathy, transverse myelitis, myositis, myocarditis, pericarditis, and Reye syndrome. 5 Humans can on rare occasions become infected with avian 27 or swine 19,28 influenza viruses. Symptoms range from a mild conjunctivitis or upper respiratory tract disease to pneumonia, acute respiratory distress, and death. Further human-to-human transmission of these animal influenza viruses has been reported but is uncommon.

Avian influenza (AI) viruses are classified into low pathogenicity (LP) and high pathogenicity (HP) based on specific criteria related to their ability to produce high mortality rate in chickens or have a hemagglutinin protein cleavage site sequence compatible with previous HPAI virus. 29 Most AI strains are LP and generally cause no or few clinical signs in poultry. Typical clinical signs associated with LPAI reflect an upper respiratory tract disease or reproductive disease in hens (i.e., drops in egg production with abnormal eggs). However, some H5 and H7 LPAI viruses have mutated into HPAI viruses in the field. Signs of HPAI include high mortality rate; sudden death without premonitory clinical signs; lethargy; severe decrease in egg production; facial edema with swollen eyelids, comb, wattles, and hocks; purple discoloration of the wattles, combs, and legs; upper respiratory tract signs; incoordination; and diarrhea. 30 Turkeys are susceptible to certain strains of H1 and H3 swine influenza viruses. 31, 32 Swine influenza A H1N1 and H3N2 viruses are endemic in swine populations in the United States. 33 Clinical signs of influenza in pigs include fever, coughing, nasal and/or ocular discharge, dyspnea, and depression. Reproductive problems are seen in both males and females. Milk production may also be reduced. The morbidity period is usually 5 to 7 days. Morbidity can reach 100%. Mortality rates are low, usually between 1% and 3%; however, secondary bacterial infections may develop and increase mortality. 25 Influenza A viruses H3N8 and H7N7 cause equine influenza in horses and other equids. The incubation period is generally 1 to 3 days. Incubation periods as long as 7 days have been reported. Clinical signs include fever; a harsh, dry cough; and serous to mucopurulent nasal discharge. In partially immune or vaccinated animals, one or more of these signs may be absent. Other typical signs include depression, muscle Potential transmission route soreness, anorexia, and enlarged submandibular lymph nodes. Young foals lacking maternal antibody protection are susceptible to a fatal viral pneumonia. Horses can also develop a potentially fatal secondary bacterial pneumonia, pleuropneumonia, and myocarditis. 8, 34 Infected horses may shed virus over an extended period starting during the incubation period and ending a week or more after apparent recovery. Peak viral shedding is thought to occur during the first 24 to 48 hours when the animal is febrile. 8 The virus is spread via aerosolized respiratory droplets and fomites with an attack rate that can approach 100% in susceptible populations.

Canine influenza was first recognized in 2004. An equine influenza virus A H3N8 strain has apparently adapted to dogs and causes outbreaks of respiratory disease. Most animals develop a mild cough, purulent nasal discharge, and low-grade fever. 21 Dogs can also develop a more severe disease with high fever and pneumonia. Between 5% and 10% of ill dogs die from the illness. 21, 35 Avian influenza can cause fatal infection in domestic and large cats. Reported signs of HPAI H5N1 in felids include fever, panting, nervousness, and depression. 36 Table 9 -35 shows comparative clinical presentations in humans and other animals. 

The differential diagnosis for human influenza includes other respiratory pathogens, including Mycoplasma pneumoniae, adenovirus, respiratory syncytial virus, rhinovirus, parainfluenza viruses, and Legionella species infection. 26 Studies have estimated that 80% to 90% of healthy adults presenting with an acute onset of fever and a cough, the most common presentation of influenza, in areas with confirmed influenza activity have the disease. Young children and older adults are less likely to present with these symptoms. Infants may present with high fevers. A septicemia-like disease, cough, and fever are seen in 64% of children younger than 5 years, and fewer than one in three nonhospitalized patients 60 years or older present with typical influenza signs. 5 Laboratory confirmation of disease is important. Specimens should be collected the first few days after onset of symptoms or no more than a week after disease onset in young children. The most common diagnostic tests currently used in clinics, doctors' offices, and hospitals are rapid influenza tests using immunochromatography. These tests require no reagent additions or wash steps, usually detect both influenza A and B, and use respiratory tract specimens specified in the manufacturers' instructions. 38 Results are available within 30 minutes. The accuracy of these tests depends on the sensitivity and specificity of the assay, the amount of virus in the sample, and the specimen type used. Infants and young children shed the highest viral titers, and these tests perform best in this patient group. The rapid tests typically have greater than 90% specificity and an average 70% sensitivity for detecting influenza. False-positive results are more common when the prevalence of influenza is low; false-negative results are more likely to occur when disease prevalence is high.

Additional diagnostic tests available in hospital and other clinical laboratories include viral cultures, direct immunofluorescence antibody (DFA) on clinical specimens, reverse transcriptase polymerase chain reaction (RT-PCR), and enzyme immunoassay (EIA). The ideal specimen depends on the test used but may include nasopharyngeal and nasal swabs or aspirates, nasal and bronchial washes, throat swabs, or sputum collected within the first 4 days of illness. Results from antigen tests such as DFA or EIA should be available within a few hours of arrival at the laboratory. Conventional viral cultures can take between 2 and 10 days, whereas rapid centrifugation cultures followed by IFA staining are reported at 1 and 2 days. RT-PCR assays are currently confined to reference laboratories and some large tertiary care hospitals, and where available are performed no more than once a day. Influenza virus infection can be confirmed by serology as well. Paired acute and convalescent sera taken 2 to 4 weeks apart are needed. 5 Serological and rapid tests for human influenza A may not recognize avian influenza viruses (such as influenza A H5N1).

Animal influenza is diagnosed based on clinical signs and laboratory test results. Antigen can be recovered from respi-ratory secretions in horses, swine, and dogs the first few days after disease onset. Optimal specimens include nasal secretions and lung tissue from swine, nasopharyngeal swabs from horses, nasal swabs from dogs, and oropharyngeal swabs from birds. Serological testing is another valuable diagnostic tool in animals. Acute and convalescent samples taken 2 weeks apart are needed.

In poultry, samples of oropharyngeal and cloacal swabs are preferred for diagnosis. In the United States, matrix gene real-time reverse transcriptase polymerase chain reaction (RRT-PCR) is used to identify influenza A virus and all positives are further tested by H5 and H7 specific RRT-PCR. The hemagglutinin proteolytic cleavage site is sequenced for all H5 or H7 RRT-PCR+ samples to determine LP or HP. The avian influenza virus detection is confirmed by virus isolation in 9-to 11-day embryonating chicken eggs. All influenza A viruses are subtyped by hemagglutination-inhibition (HI) and neuraminidase-inhibition (NI) tests and pathotyped by in vivo chicken pathogenicity testing. Serological monitoring of poultry is done using commercial ELISA and agar gel immunodiffusion (AGID) tests for influenza A, and positives are subtyped by HI and NI tests.

Four antiviral medications-amantadine, rimantadine, oseltamivir (Tamiflu), and zanamivir (Relenza)-are approved by FDA for influenza treatment. 39 The first two are not currently recommended because of the widespread presence of antiviral resistance in influenza A (H3N2) viruses and lack of activity against influenza B. The latter two drugs are neuraminidase inhibitors with activity against both influenza A and B viruses. Early treatment reduces illness severity and risk of complications leading to antibiotic use. In hospitalized adults, oseltamivir treatment appears to reduce the likelihood of influenza-related mortality. Antiviral resistance also occurs to the neuraminidase inhibitors, and during the 2007-08 Northern Hemisphere season, community circulation of oseltamivir-resistant H1N1 viruses was noted for the first time.

Treatment should be started as soon as possible after disease onset. Oseltamivir is approved for treatment of people 1 year of age and older. Zanamivir is approved for treatment of people 7 years of age and older. Both drugs can also be used as chemoprophylaxis with a disease prevention efficacy ranging from 70% to 90%. Zanamivir is not recommended for persons with underlying airways disease (e.g., asthma or chronic obstructive pulmonary disease). Table  9 -36 outlines treatment guidelines for symptomatic disease in humans.

Treatment of influenza in horses, dogs, and pigs is generally supportive. Antivirals as listed above for humans are not approved for treatment of animal infections, in part due to concern about development of drug resistance. 

Leishmaniasis caused by infection with protozoans in the genus Leishmania causes millions of infections each year around the world. The infection takes two basic forms: cutaneous and visceral, but disease syndromes may overlap. The severity of human infection ranges from mild skin lesions to severe disfiguring facial involvement or systemic disease with organ failure and death. This zoonotic disease is transmitted by insect vectors, usually of the phlebotomine sand fly family. Leishmaniasis has been transmitted directly from dog to dog in the United States. Worldwide risk of leishmaniasis is increasing in both humans and animals. Factors responsible may include the transboundary movement of humans and animals, global climate change affecting the distribution of vectors, the HIV epidemic, 1 and increasing contact of humans with wilderness areas where the disease is endemic. In addition to being a disease of travelers returning to the United States, there is an expanding focus of human cases of leishmaniasis in Texas, as well as an ongoing outbreak of canine visceral leishmaniasis in foxhounds in the eastern United States. The complex interrelationships of leishmaniasis infection in animals and humans demand ongoing cooperation between animal and human health professionals to detect new cases and better control this challenging disease.

• Characterize the risk in the community, including whether the sand fly vector is present and if there is evidence of transmission to humans or domestic animals. • Educate human health providers that infection could be spread through shared needles.

• Conduct an immediate investigation of a human or veterinary case to determine whether it is related to travel or local transmission. • In endemic areas, develop a strategy with vector specialists for vector control based on local ecology and transmission patterns. Interventions may include targeted spraying in suspected sand fly habitat, including around doorways of dwellings (if residential transmission suspected), stone walls, animal houses, and garbage dumps. • In endemic areas where dogs are serving as a reservoir, work with animal control authorities on effective strategies including use of insecticide-impregnated collars.

Culling of dog populations has not been proven effective in some areas. 2 • Ensure that travelers to endemic areas take steps to avoid sand fly bites. Use insect repellent and permethrinimpregnated bed nets and protective clothing. 2

• Consider the diagnosis in all patients with a history of recent travel or residence in an endemic area. • Immediately report disease to public health authorities. • Counsel travelers to endemic areas about risk reduction in terms of avoiding sand fly bites (see above).

• 

Leishmaniasis occurs in 88 countries, mainly in the tropics and subtropics, with varying patterns of disease and ecological relationships (the disease has not been reported in Australia and Oceania). In the United States, most cases are seen in travelers and their pets returning from endemic regions. There is a small focus of cases of cutaneous leishmaniasis in Texas that appears to be extending northward. 6 Cutaneous leishmaniasis due to L. braziliensis and L. mexicana complexes occurs in Latin American countries with the exception of Chile and Uruguay. In the Eastern Hemisphere, cutaneous leishmaniasis is caused by L. tropica, L. major, and L. aethiopica; hotspots include the Indian subcontinent, China, southwestern Asia including Afghanistan and Iran, the Mediterranean region, and sub-Saharan Africa including Sudan.

In the New World, visceral leishmaniasis in humans is due to infection with L. infantum and L. chagasi and is found across Central and South America. In the Old World, L. donovani is the principal cause of visceral leishmaniasis, which occurs in mostly rural areas of India, Bangladesh, China, Nepal, Pakistan, southern regions of the former Soviet Union, the Middle East and Mediterranean, and sub-Saharan and East Africa. 2 In the United States, L. infantum seroprevalence studies of dog kennels have identified positive results in 21 states.

Groups at increased risk for leishmaniasis include individuals who encounter the sand fly vector, including forest workers and rural residents. In areas where visceral leishmaniasis is endemic and the sand fly vector is found, dog ownership can be a risk factor for infection. 7

The vectors and reservoir hosts of leishmaniasis are diverse and vary in part by geographical region and agent. Phlebotomine sand flies are most active dusk through dawn and difficult to see as they are about one third of the size of a mosquito.

In the Americas, New World cutaneous leishmaniasis has zoonotic transmission through bites of a number of sand fly species; mammalian hosts include small rodents and larger mammals. In Texas, the burrowing wood rat (Neotoma micropus) is the apparent reservoir for cutaneous leishmaniasis. Zoonotic Old World cutaneous leishmaniasis caused by L. major is spread by bites of the sand fly Phlebotomus papatasis. 5 A major reservoir is gerbils (Meriones unguiculatus). Hyraxes (Procavia capensis) are another mammalian host. Although dogs can be infected, they do not always serve as a competent reservoir for cutaneous leishmaniasis. A human-to-human transmission cycle of cutaneous leishmaniasis in the Old World due to L. tropica is spread by P. sergenti.

Lutzomyia species sand flies spread visceral leishmaniasis in the New World, whereas L. donovani is spread person to person in the Indian subcontinent and Eastern Africa by a number of sand fly species. Dogs and wild canids (foxes and jackals) are the principal animal reservoir for visceral leishmaniasis. 5

Transmission is largely vector-borne through bites of the female phlebotomine sand fly injecting the infective, flagellated promastigote forms into the skin of a vertebrate host (Figure 9 -68). The parasite then transforms into the nonflagellated amastigote (Color Plate 9-35) and multiplies within macrophages throughout the host's reticuloendothelial system. The vector cycle is complete with sand fly infection from the vertebrate host, where the organisms multiply extracellularly in the sand fly gut over 8 to 20 days to produce infectious promastigotes (see Figure 9 -68). 5 Once infected, a mammalian host appears to retain the ability to be infectious to others even after treatment. The agent may remain dormant in the host animal for years, and then infection can recur when immune status declines, such as in HIV infection, malnutrition, or administration of immunosuppressive drugs for organ transplants or other conditions. Chronically infected individuals, even after receiving treatment, can serve as a reservoir for further infection of sand fly vectors. In addition to vector-borne transmission, person-to-person transmission has been reported through blood transfusions and the sharing of needles between IV drug users.

In an outbreak of canine visceral leishmaniasis among U.S. foxhounds, transmission occurred dog to dog (but not dog to person) through direct contact with blood and secretions and transplacentally from an infected bitch to her pups. There is no evidence of vector transmission to dogs in the United States, and sand flies are not found in many of the regions where dogs are infected. 8 However, in areas where both visceral leishmaniais in dogs and sand flies occur, there is a potential risk of future episodes of vector-borne transmission from dogs to humans.

Key environmental factors include the population of reservoir hosts and the population of vectors. Sand fly populations may increase with availability of breeding sites and humid areas around ponds or in tree holes. Factors that increase contact between humans and vectors and reservoirs have been tied to outbreaks, including deforestation and encroachment of human habitation into forested areas. Climate change appears to be playing a role in the extension of the ranges of some vectors and animal reservoirs. Table 9 -37 provides clinical presentations of leishmaniasis.

Each year cutaneous leishmaniasis occurs in approximately 1.5 million people worldwide. Cutaneous involvement of leishmaniasis infection can take a number of forms, depending on the species involved and the immune status of the host.

Simple cutaneous leishmaniasis often begins with a small macule at the site of the fly bite that progresses to a papule. The papule enlarges over time and may ulcerate. 9 In many cases, the lesions resolve spontaneously over a period of months or years (Color Plate 9-36).

Diffuse cutaneous leishmaniasis tends not to ulcerate but instead spreads gradually through the skin, causing chronic nodular lesions especially on the face and extremities. It may be a lifelong infection.

Atypical cutaneous leishmaniasis in Central America caused by L. infantum or L. chagasi is characterized by che loid-type lesions without ulceration. 2 Leishmaniasis recidivans caused by L. tropica occurs in Iran and other parts of central Asia. The tuberculoid lesions tend to involve the face, spreading outward and often relapsing. It also tends to be a chronic infection lasting for decades. 9 Mucocutaneous leishmaniasis due to L. braziliensis or related species can develop in individuals years after the lesions of cutaneous leishmaniasis have healed. The symptoms may begin with nasal stuffiness but progress to respiratory and swallowing difficulties as tissue destruction involves the nose, mouth, and laryngopharyngeal regions (Color Plate 9-37).

Visceral leishmaniasis (kala-azar), occurring in about a half million people each year, is usually due to infection with either L. donovani or L. infantum. This disease is characterized by systemic signs such as fever and weight loss. Hepatosplenomegaly, pancytopenia, and increased gammaglobulins can occur. Lymphadenopathy and abnormal liver function test results are common. In India, hyperpigmentation is part of the clinical syndrome. Although many cases resolve spontaneously, malnutrition and immunocompromised condition predispose patients to more severe disease and the risk of fatal complications. A post-kala-azar cutaneous leishmaniasis can occur in recovered individuals. These lesions can be a reservoir for continued transmission through sand fly bites.

Dogs tend to develop systemic, visceral, and cutaneous involvement (Figures 9-69 and 9-70). Weight loss, anorexia and fever are common. Splenomegaly and lymphadenopathy occur in up to a third of affected dogs. Epistaxis, muscle atrophy, and seizures can also occur (Color Plate 9-38). The skin lesions tend to present as hyperkeratosis and chapping over the head, muzzle, and footpads. These lesions can ulcerate. Renal failure is the most common cause of death and is preceded by nausea and vomiting. Laboratory findings include hyperproteinemia, proteinuria, and elevated liver function test results. 10 Infection in cats and horses is less common than in dogs and principally involves the skin, typically presenting with nodules on the ears (Color Plate 9-39 and Figure 9 -71). 10 

The differential diagnosis of cutaneous leishmaniasis in humans can be broad and includes sporotrichosis, cutaneous tuberculosis or atypical mycobacterial infection, blastomycosis, sarcoidosis, syphilis, and neoplasia. The presence of suggestive lesions in the setting of a potential contact such as history of travel to an endemic area should lead one to consider the diagnosis. Definitive diagnosis is often accomplished by a biopsy of the lesion with tissue identification of amastigotes or culture of promastigotes. 9 The leishmanin skin test result is often positive in simple cutaneous leishmaniasis. PCR techniques are in development. 11 Visceral leishmaniasis in endemic areas can be confused with other causes of fever, chronic weight loss, and splenomegaly such as malaria and schistosomiasis. The diagnosis can be made by isolating amastigotes from macrophages in a bone marrow biopsy or a splenic biopsy. The latter is considered more sensitive but involves a risk of hemorrhage. 9 In animals, a skin biopsy can reveal the presence of intracellular organisms. Serology with IFA or ELISA is available but cross-reactions with Trypanosoma cruzi can occur. Biopsies of skin, spleen, bone marrow, or lymph nodes can be cultured; smears of these samples may reveal the organism. 10 A PCR test is available at some academic institutions. 12 

Treatment in humans may involve an often prolonged course of treatment with a variety of agents. The medical management of leishmaniasis is complicated and drug resistance varies by region; therefore infectious disease consultation is advisable. Table 9 -38 outlines some currently recommended therapeutic regimens. 14 In dogs, no drug has been consistently curative. Relapses and the repeated need for treatment are common, although maintenance therapy can reduce parasitemia and reduce the likelihood of transmission. 10

Other names in humans: Weil's disease, mud fever, swamp fever, rice field fever, swineherd disease

Although leptospirosis is considered a rare disease in the United States, it is one of the most prevalent and important zoonotic diseases worldwide. 1 The epidemiology of this emerging infection appears to be changing due to climate and manmade alterations in the environment. Contamination of water supplies by infected animals is a major source of human exposure, underscoring the importance of waterborne infectious disease risks. The occurrence of leptospirosis in dogs and wildlife living near human habitation and the fact that it is capable of causing both serious disease and outbreaks among groups with high-risk exposure argue for greater awareness of this disease among human and animal health professionals.

• Provide descriptive epidemiology of the disease in animal and human populations.

• Educate the public on modes of transmissions (e.g., do not allow animals to drink from contaminated water bodies, maintain good hygiene at kennels and in livestock birthing areas, control rodents). • Support rodent control efforts in the community. • Educate local veterinary and human health clinicians in endemic areas about prevention strategies targeted to groups at risk. • Educate occupational health providers regarding risk groups and how to recognize signs and symptoms of disease. • Ensure that workers at risk are using appropriate PPE. • Disinfect with 1% sodium hypochlorite, 70% ethanol, glutaraldehyde, detergents and acid. The organism is killed by pasteurization and moist heat (121° C for 15 minutes). 2

• Screen patients for occupational, recreational, housing, and animal (pet and livestock) exposures. • Treat and report cases to health department if reportable in state. • Counsel patients on measures to reduce risk of transmission to other humans (direct transmission is rare but possible; e.g., during sexual intercourse and breastfeeding) and from animals (e.g., hygiene regarding urine, reduce rodent exposure). • Ask patients/family members about any observed illness in pets or other nearby animals; communicate with veterinary professionals animal cases are suspected. • Counsel immunocompromised patients about risks from animal and environmental contact.

• No human vaccine is available in the United States.

• Exposure prophylaxis: In evaluating an individual who has been exposed to leptospirosis through occupational or environmental contact, consider antibiotics for prophylaxis. A systematic review concluded that prophylactic treatment with doxycycline 200 mg PO weekly for individuals at high risk of exposure (such as individuals training in jungle conditions during the rainy season) was superior to placebo in preventing cases of infection.

(evidence-based recommendation: strength B). 3

• Segregate and treat infected animals. 

Leptospirosis is caused by gram-negative spirochete bacteria in the genus Leptospira. Based on molecular analysis, there are believed to be at least 13 different species of Leptospira and more than 250 serovars. 5 These species and serovars vary widely in pathogenicity. Leptospires can be cultured in polysorbate-albumin media (Figure 9 -72). 5

Leptospirosis is considered an emerging infectious disease and one of the most common global zoonoses 1 ; it is found worldwide except in the polar regions. It is highly prevalent in tropical countries with areas of high rainfall and alkaline soils. 6 The CDC has removed leptospirosis from the list of nationally reportable diseases, and estimates that 1 to 200 cases are identified yearly in the United States (50% of cases occur in Hawaii). 7 However, recent outbreaks and sporadic cases in the United States suggest that leptospirosis remains underdiagnosed and underreported in animals and humans, and that many U.S. health care providers are unfamiliar with the epidemiology and clinical presentation of this disease, which is capable of causing severe morbidity and (rarely) death.

Leptospirosis is an important occupational disease risk for farmers, dairy and abattoir (slaughterhouse) workers, butchers, hunters, dog handlers, veterinarians, and other veterinary health providers who have direct contact with animals. Workers with exposure to contaminated water, such as military personnel, rice farmers, fishing industry workers, plumbers, and sewer workers, are also at risk. Recreational exposure to contaminated water leads to infection in campers, sportsmen, freshwater bathers, and travelers returning from highly endemic countries. Urban slum dwellers with rodent exposure are another risk group and infection has been reported in children who handled infected puppies. 5 In the United States, recent reported cases have occurred among cleanup workers at a Hawaiian university campus where a stream had flooded, 8 a returning traveler who had explored caves in Malaysia, 9 an inner-city hospital patient who had recently swum in a creek, 10 and triathletes and community dwellers who had swum in and ingested water from a contaminated lake. 11 HIV-infected and other immunocompromised patients are at risk of severe disease. 12

Hosts who exhibit clinical infection with leptospirosis include humans, dogs (where the incidence is reported to be increasing), 13 horses, cattle, 14 sheep, and swine. Leptospira species appear to exist subclinically in a large number of wildlife species, including rats and other rodents, raccoons, opossums, reptiles, and frogs. However, in some wildlife species, such as sea lions, periodic epidemics of clinical disease can occur. 15 In the northeastern United States and Canada increasing rates of infection among reservoir hosts, such as skunks, raccoons, and squirrels, that are common in suburban settings has been reported. 16 

Leptospira enter the body through breaks in the skin or contact with mucous membranes (Figure 9-73) . Humans are commonly infected by exposure to water, moist soil, or food contaminated by urine or secretions, or by direct contact with infected animals. Venereal transmission occurs in swine and has been suspected in humans. 17 Eating infected rodents or other animals can result in infection through mucous membrane contact. Direct person-to-person transmission has been reported between soldiers working in close proximity in swampy areas, and in relation to breastfeeding. 6

Outbreaks in humans and animals have been linked to heavy rains resulting in flooding, moist soils, and standing water. Other environmental risk factors include alkaline soils and alkaline freshwater, rodent infestation, and suburban encroachment on wildlife habitat. A case control study of dogs found that seropositive dogs were more likely to live in periurban environments. 18 Inner-city households with cats have been associated with a decreased risk of leptospirosis, possibly through a reduction in rodent exposure. 19

Leptospirosis in humans has protean manifestations, depending in part on the infecting serovar. Infection leads to a systemic vasculitis. The majority of human infections are mild and self-limited; however, in approximately 10% of cases, severe and even fatal illness can develop. The two main severe forms of the disease are Weil's disease (a triad of jaundice, acute renal failure, and bleeding) and severe pulmonary hemorrhagic syndrome (SPHS) ( Table 9 -39).

After the bacteria enter the body, there is an incubation period of approximately 10 days, followed by the abrupt onset of the leptospiremic phase or febrile phase, which can last 4 to 9 days. In addition to fever, conjunctival suffusion, uveitis, myalgias, and a pretibial rash can be seen. A convalescent (leptospiruric or immune) phase follows. During this period, which often lasts several weeks or longer, secondary transmission may occur through excretion of the leptospires in urine. Aseptic meningitis is a common occurrence during this phase of illness. 5 Figure 9 -74 shows the biphasic nature of the illness.

Weil's disease may develop during the immune phase or progress directly from the acute phase of infection. Prominent features include renal failure caused by nephritis, hepatic dysfunction, and thrombocytopenia with hemorrhagic complications.

In some cases, hemorrhagic pneumonitis and severe respiratory distress leading to circulatory collapse can occur without hepatic or renal failure. Mortality is high in severe cases of Weil's disease and SPHS (Color Plate 9-40). 

Although many cases of leptospirosis in dogs are subclinical and chronic, dogs can develop acute disease with fever, anorexia, jaundice, vomiting, and hematuria. Other features of infection can include injected mucous membranes, uveitis, and cough. 20 The most common serious complications in dogs appear to be acute renal failure, vasculitis, and hepatic dysfunction. 21 The disease is much rarer in cats, but similar clinical features to dog leptospirosis may be seen. 20 Cattle and other livestock including sheep, pigs, and horses can develop either acute or chronic forms of infection. The acute form is more common in young animals and can include fever or respiratory involvement. Adult livestock are more likely to develop the chronic form of the disease and manifest infection as abortion or stillbirth.

The disease is often subclinical in wild animals including rodents. Seals and sea lions may have depression, fever, and abortion.

The differential diagnosis in humans includes acute causes of fever and jaundice such as hepatitis and malaria. Leptospirosis should be suspected in a patient who presents with exposure risk factors and fever, uveitis/conjunctival suffusion, and abnormal liver and renal function test results. Leptospires can be cultured from blood and cerebrospinal fluid (CSF) during the acute phase of illness and in urine after the first week of illness. Most laboratory diagnosis of human leptospirosis is currently based on serology using the microagglutination test (MAT) or ELISAs. Antibodies develop after about 1 week of illness. The MAT has a high specificity for specific serovars. However, it may lead to underdiagnosis if a person is infected with an unusual serovar not well covered by the standard test. Serial serology titers are required to document seroconversion-a fourfold increase in titer is considered evidence of recent infection. 6 The use of PCR techniques for diagnosing human leptospirosis has been reported. 23 In animals, the MAT and ELISA are also used; paired sera are preferred. Diagnosis can be affected by a history of immunization, and the results of serology must be interpreted with caution in vaccinated animals. A milk ELISA can be used on a single cow or for bulk tank sampling.

A study of antibiotic prophylaxis for soldiers during jungle military training showed a protective benefit of doxycycline, 200 mg/week, in preventing infection with leptospirosis. 24 Therefore individuals with high-risk exposures for short periods can consider such prophylaxis. However, the efficacy of prophylaxis in other situations, such as after exposure, remains unclear.

Antibiotic treatment in people and animals is not always curative but should be started as early in the course of disease 

• Provide descriptive epidemiologic analysis of this reportable disease and assessment of local Lyme disease risk for the health district. • Educate the public to:  Avoid tick-infested areas, but if not possible, wear appropriate clothing (long sleeves, long pants, tuck pants legs into socks, and light-colored clothing to visualize ticks). Wash clothes with hot water. 4  Use CDC-recommended tick repellents such as DEET, picaridin, or alternatives on clothes or bare skin following label instructions.  Do frequent tick checks to remove even tiny immature-stage ticks ("seed" ticks). Inspect children at least once daily for ticks. When in heavily infested areas inspect children every 3 to 4 hours.  Use appropriate technique to remove ticks. Wear gloves or grasp tick with tweezers as close to the skin as possible and pull gently (do not use a match, petroleum products, or nail polish). Follow up by cleaning the area, applying antibiotic topical on tick bite site, and washing hands. 5  Implement integrated pest management techniques including landscape management (see Box 9-3). Counsel pet owners to discuss Lyme disease prevention strategies with their veterinarian.

• Work with local agencies to control deer and rodent populations. • Work with local planning agencies on smart growth to avoid fractionating forested areas.

• Report Lyme disease cases to public health authorities using the case definition; see http://www.cdc.gov/ ncphi/disss/nndss/casedef/lyme_disease_2008.htm.

• 

Lyme disease is caused by a number of species of gram-negative, spirochete bacteria belonging to the genus Borrelia ( Figure  9 -75). Borrelia species that cause Lyme disease are grouped under the name Borrelia burgdorferi sensu lato. In the United States, the predominant genotype associated with Lyme disease is Borrelia burgdorferi sensu stricto. This genotype also causes Lyme disease in Eurasia, as do B. afzelii, B. garinii, and B. japonica (Japan). Among these genotypes, there is considerable genetic diversity. 7 Borrelia are slow-growing bacteria (Figure 9 -76) that require special culture medium and generally are difficult to culture from blood and tissue biopsies. 8 The organisms are sensitive to heat and ultraviolet light and do not survive long outside the body. Effective disinfectants include 1% sodium hypochlorite and 70% ethanol. 9

Initially recognized in the Northeastern United States, specifically in Lyme, Connecticut, in 1975, Lyme disease has now been reported in almost every state and in Canada, although the tick vectors have a more restricted distribution. The distribution of Lyme disease in the United States is concentrated, with 12 states accounting for about 95% of reported human cases. 10 Clinical illness from B. burgdorferi was first documented in dogs in 1984. 11, 12 Geographical foci of higher infection risk are found along the East Coast, Wisconsin, Minnesota, and parts of California and Oregon (Figure 9 -77), particularly in peridomestic areas. Areas of endemic Lyme disease activity have been reported in Europe, Russia, China, and Japan. 8 

The risk of Lyme disease varies among regions and is generally correlated to the abundance of host ticks that can carry the disease agent. Individuals at most risk for infection are those living in endemic areas of high vector tick density, with a large proportion of the ticks infected, and that are engaged in activities with increased time and exposure to vector ticks. 13 Behavioral factors including frequent outdoor activities such as hunting, camping, and hiking most likely play an important role in disease susceptibility. 14 (Figure 9-80) , and the dusky-footed wood rat (Neotoma fuscipes) and kangaroo rats (Dipodomys californicus) in the West, serve as disease reservoirs for Lyme disease, remaining persistently infected and capable of infecting naïve ticks. In the West, the life cycle is more complex; the spirochete is maintained in an independent enzootic cycle involving I. spinipalpis as the arthropod vector. 13 Lizards may function as reservoirs in some parts of the United States or be a "dilution host," reducing the vector infection prevalence in other areas. 16 In the United States, the white-tailed deer (Odocoileus virginianus) is the preferred host for I. scapularis and helps maintain adult tick populations by serving as hosts for the adult ticks. Birds may introduce I. scapularis into previously nonendemic areas. 13 Adult male ticks tend to remain on deer, whereas adult females will engorge after mating to drop off and lay about 2000 eggs in the spring.

Humans and domestic animals are accidental hosts for B. burgdorferi. Dogs have an increased risk of Lyme disease exposure in endemic areas relative to humans, and this risk can be highly focal with seroprevalence rates as high as 50% to 90% in endemic areas, providing sentinel information for humans. 10 Cats appear to have significant exposure risks as well; a seroprevalence study in Connecticut found more than 45% of cats showed evidence of infection with B. burgdorferi, as well as a significant amount of coinfection with Anaplasma phagocytophilum; yet most cats did not show clinical signs. 17

The life cycle of B. burgdorferi is related to the 2-year life cycle of the hard Ixodes tick vector. Ixodes ticks pass through larval, nymphal, and adult forms (Figure 9-81) . To mature from one form to another, they must consume a blood meal. Eggs are laid in the spring and the larvae hatch in the summer. As they feed on the blood of vertebrates, the larvae can become infected with B. burgdorferi. After feeding, the larvae become less active and mature into nymphs by the following spring. 18 The majority of human cases occur in the spring and summer as a result of bites by nymphs that are active and seeking a blood meal to allow them to develop into adults. 8 Once they have fed, the nymphs develop into adults. The adult female lays eggs the following spring to continue the cycle. With every feeding, it is possible for a tick to become reinfected with B. burgdorferi and also coinfected with other pathogens such as Babesia and Anaplasma.

When an infected nymphal or adult tick initially bites an animal, it appears that it must remain attached and feed for about 24 hours for upregulation of spirochete outer surface protein C (OSP C) and transmission of organisms to take place. Peak transmission occurs after about 48 hours. 3,19 

The relation of environmental factors to the risk of Lyme disease is complex but it appears that landscape modification in the United States related to suburbanization of the human population is playing a significant role. As suburban developments and other human built environments encroach into land that was previously forest habitat, they produce "fragmentation" of forests (Figure 9 -82). This breaking up of forested area into patches interspersed with human residential development has caused an increase in deer populations by providing ideal vegetative habitat (including ornamental shrubs for deer to eat) and reduced pressure of being hunted and predators. It also appears to favor increases in populations of peridomestic Peromyscus, which are important hosts for Ixodes ticks and for B. burgdorferi. Such forest fragmentation has been shown to be related to tick abundance and infection rates. 20 However, individual human behavior appears to play an important role in determining human risk, including time spent outdoors and use of protective repellents and clothing. Another environmental factor is climate and climate change. Warmer winters may result in increased tick abundance during the following spring and summer. 21 Because the environment appears to play a role in Lyme disease risk, studies have examined whether environmental modifications can reduce such risk. Area-wide acaricide use reduces tick populations, but many communities are reluctant to use wide-scale pesticides. However, targeting small areas of high human exposure, such as residential yards, has been highly effective in reducing nymphal tick density. 22 Treating host animals with acaricides, such as the "four poster" method of treating deer with acaricide at feeding stations, has reduced tick populations, but the distribution of bait designed to reduce tick feeding on rodents is less effective. By eliminating the deer population, the maintenance host of ticks, the risk of Lyme disease has been nearly eliminated in an island setting. 23, 24 Integrated pest management can be effective to aid in tick control, including landscape modification around dwellings (see "Key Points for Clinicians and Public Health Professionals").

In many of the reported cases, the disease begins with early localized infection, consisting of fever and a characteristic skin rash (erythema migrans [EM] ) that often starts with a red macule or papule at the site of the tick bite that expands into a circular rash. The rash may develop central clearing, producing a bull's-eye appearance (Color Plate 9-41). The bacterium is sometimes cultured from the leading edge of the rash. Accompanying symptoms may include fatigue, fever, headache, anorexia, arthralgias, myalgias, and lymphadenopathy. Southern tick-associated rash illness (STARI), a differential in the early diagnosis of Lyme disease, manifests with a similar EM rash (Color Plate 9-42), mild clinical signs, and absence of antibodies to B. burgdorferi. STARI may be associated with B. lonestari rather than B. burgdorferi and transmitted by the lone star tick, A. americanum (see http:// www.cdc.gov/ncidod/dvbid/stari/index.htm).

Days to weeks after the onset of the rash, early disseminated infection may develop, with more severe systemic symptoms. Multiple EM lesions may appear during this phase, as well as borrelial lymphocytomas-blue-red nodules on the earlobes or nipples. Early disseminated infection can involve the nervous system with the development of chronic symptoms including seventh nerve (Bell's) palsy or facial paralysis, meningitis, motor or sensory peripheral neuropathy, and encephalopathy. Cardiac involvement may occur with atrioventricular block. If infection remains untreated, late-stage disease can develop months to years after initial infection, with arthritis of the knees or other weight-bearing joints (Figure 9 -83). In late-stage disease, the skin can develop acrodermatitis chronica atrophicans, erythematous plaques and nodules on the extremities. Other complications include encephalopathy and keratitis (Figure 9-84) . 25 Previous infection does not confer immunity.

Most dogs do not manifest clinical signs after exposure to B. burgdorferi or have vague signs that go unnoticed by the owner. Dogs have not been reported to have the bull's-eye rash. Approximately 5% of seropositive dogs develop clinical Lyme disease. 6, 26 Clinical signs may not appear for 2 to 6 months after infection and may include lameness, fever, anorexia, myalgia, lethargy, lymphadenopathy, cardiac arrhythmias (rarely), neurological signs, and ocular manifestations (Color Plates 9-43 and 9-44). 3, 6 Dogs have also been reported with Lyme arthropathy, a recurrent arthritis with lameness particularly in the tarsal and carpal joints (Figure 9-85) . Lyme nephropathy, a chronic protein-losing nephropathy that may be related in part to immune complex deposition, can progress to a fatal acute oliguric or anuric renal failure. 6, 26 Some have questioned whether the nephropathy could be related to coinfections with other agents. Coinfection with other tickborne diseases is common, either transmitted by the same tick vector (A. phagocytophilum, Babesia microti, or Bartonella species) or other tick vectors (Ehrlichia species and Rickettsia rickettsii). 3, 6 Previous infection with B. burgdorferi does not appear to confer immunity. Cats appear to be largely asymptomatic but can rarely develop arthritis. 27 Serosurveys using ELISA antibody screening have reported seroprevalence rates in horses greater than 80% in endemic areas. 28 Although a wide range of clinical conditions have been associated with Lyme infection in horses, clinical infection is considered to be extremely rare and poorly understood. 29 EM lesions have been experimentally caused by infecting rabbits with B. burgdorferi. Table 9 -41 provides a comparison of Lyme disease clinical presentations in humans and other animals.

In humans who present with a classic EM rash (described as 5 cm or greater to differentiate it from a hypersensitivity reaction) and a history of a tick bite or tick exposure in a Lymeendemic area, serological confirmation may not be necessary. However, a search should be performed for possible coinfection with agents such as Anaplasma and Babesia. When the rash is not present but Lyme disease is suspected and pretest probability is 20% or greater, serological testing using a two-step method is recommended. This consists of a screening ELISA test followed by a confirmatory Western blot if the ELISA is indeterminate or positive. If less than 4 weeks has elapsed since the onset of infection, both IgG and IgM should be tested; if more than 4 weeks have elapsed, only IgG should be tested. The two-step method is considered to have high specificity and a low risk of false-positive diagnosis. 31, 32 In animals, a rapid antibody test has been developed to detect antibodies against the C6 B. burgdorferi protein and correlates well with the Western blot immunoassay. 33 This test detects only antibodies against antigen acquired through natural exposures, and therefore will not yield positive results in vaccinated animals. 6 In dogs, testing validates exposure to the B. burgdorferi organism but not clinical illness. Supporting evidence for a diagnosis of Lyme disease is based on history of exposure to B. burgdorferi through exposure to Ixodes ticks in an endemic area, clinical signs, positive C6 peptide and/or Western blot antibody test results, ruling out other differential diagnoses, and response to antibiotics. 6 Controversy exists in the veterinary literature about whether healthy dogs should be routinely screened for B. burgdorferi antibodies. 6 Limitations to serological testing include a long incubation period, presence of subclinical infections, cross- Prophylaxis with oral doxycycline may be offered to adults or children if a tick bite is due to an adult or nymphal I. scapularis tick that has been attached for at least 24 hours, less than 72 hours has elapsed since removal of the tick, and the use of doxycycline is not contraindicated (doxycycline 200 mg PO for 1 dose; children 8 and older, 4 mg/kg). 1 Following a tick bite, regardless of whether prophylaxis is given, individuals should be monitored for any signs of disease such as development of a fever or an EM rash. The use of antibiotics for disease treatment depends on the stage of disease. Table 9 -42 outlines recommended antibiotics regimens outlined by the Infectious Diseases Society of America (IDSA). The use of macrolides should be reserved for persons who are unable to tolerate tetracyclines, penicillins, or cephalosporins because their efficacy may be lower.

Recommended antibiotic regimens for animals with clinical manifestations of Lyme disease are also shown in Table 9 -42. More specific supportive and symptomatic medical treatment should be directed toward the affected organ system. Dogs do not appear to develop natural immunity to infection nor do they develop long-term immunity after vaccination. Therefore after the full course of antibiotic treatment, subsequent exposure to B. burgdorferi can result in reinfection.

In the United States there are currently four vaccines for dogs that stimulate antibody production against a single outer surface protein A (OSP A) located on the bacterium when it is attached to the tick's gut. 6 This prevents infection because the vaccinated dog's OSP A antibodies move with the blood to the tick's gut and bind to the bacteria, thus preventing the bacteria from upregulating OSP C and moving to the saliva to infect the dog. 34 

Lynda U. Odofin 

Lymphocytic choriomeningitis (LCM) is a rodent-borne viral infection that may cause substantial neurological disease, 1,2 especially in immunocompromised individuals. Like other members of the Arenadiviridae family, the causative agent, lymphocytic choriomeningitis virus (LCMV), uses rodents as reservoirs. 3 Although the common house mouse, Mus musculus, is the natural host and principal reservoir of LCMV, 4 wild, pet, and laboratory rodents (rats, guinea pigs, hamsters) can be infected also. Infected mice can shed the virus throughout their lives 4 ; infected females transmit the virus to their offspring, which may become asymptomatic persistent viral shedders. 5 Human infection is through contact with infected pet rodents or infected wild mice or their droppings. Infected rodents often do not show any signs of illness. 6 LCMV is an emerging neuroteratogen, known to cause diverse congenital defects in children. In addition, because of recent outbreaks in organ transplant patients, 7-9 LCM is a reportable disease in some U.S. states; such states require physicians to report the disease to local health authorities.

Public Health Professionals  Wash hands thoroughly with soap and water after cleaning up pet droppings. Closely supervise young children, especially those younger than 5 years, when cleaning cages, and make sure they wash their hands immediately after handling rodents and rodent caging or bedding.

Do not kiss pet rodents or hold them close to the face. • Recommend that testing for LCMV should be included in the screening protocols for potential organ donors.

• Ensure that potentially exposed immunocompromised persons and pregnant women are given immediate medical attention, and advise such individuals to avoid contact with rodents and rodent droppings and to rodent-proof their homes. • As part of the history, patients with aseptic meningitis and encephalitis should be asked about contact with rodents or rodent droppings. 10 

• Advise clients to consult their physicians if an infected rodent is seen or if they are considering acquiring a rodent as a pet. • Although the length of LCMV infection in pets varies, it has been shown that hamsters (subfamily Cricetinae) can transmit the virus for at least 8 months. Thus it is advisable to euthanize infected rodents. • Although LCMV is not reported in animals, it is advisable to report increased incidence of cases to the local health authorities. Disease in animals may serve as an early warning of environmental exposure risk and possible human outbreaks. • Screening pet rodents is not recommended as serological testing on rodents can be inaccurate and results misleading; however, hygienic practices (handwashing, cage sanitation) should be followed. 12

LCMV is an enveloped single-stranded RNA virus belonging to the family Arenaviridae. The virus is serologically related to Lassa, Machupo, Junin, Guaranito, and Sabia viruses 5 and has been referred to as the prototypic member of the family. Along with Lassa and Lassa-related viruses, LCMV forms the Old World group of the Arenaviridae. 13 Because of its unique properties, the LCMV model has been used to make important contributions to the fields of virology and immunology 14 and further understanding of viralimmune interactions. For instance, a specific glycoprotein (GP1), which is expressed on the envelope of LCMV, 15 mediates attachment of the virus, thereby initiating infection; thus mutations in this protein have the potential to alter viral targeting and influence the course of disease. 14 The immune system plays a major role in the outcome of human LCMV infection, ranging from no disease in healthy individuals to severe neurological disease in immunocompromised individuals.

LCMV is found worldwide and is endemic in wild mice. The virus has the greatest geographical range potential of any arenavirus and may occur on all land masses where the genus Mus has been introduced, including all continents except Antarctica. 7, 16 The CDC estimates 5% of the U.S. wild mouse population is infected with LCMV, although epidemiological studies have documented a prevalence ranging from 3% to 21% in various U.S. locations. 11 An overall prevalence rate of 9% (43/468) was determined in wild mice captured in various sites, including residential and park locations in Baltimore, Maryland. 13 In general, human infection, with the exception of those associated with hamsters, 13 tends to reflect the distribution of house mice. [17] [18] [19] Several serological studies conducted in urban areas have shown that the prevalence of LCMV infection among humans ranges from 2% to 5%. 11 In Baltimore, LCMV antibodies were found in 4.7% of 1149 inner-city residents tested, 6,20 and 49% of these reported house mice within their residence. 21 The true incidence of LCM is unknown because many cases go unreported owing to the self-limiting effect in healthy individuals and lack of recognition by physicians.

In general, people who are in contact with rodents are at risk from LCMV infection; these include laboratory workers who routinely work with LCMV and laboratory mice and other rodents, farmers who are in frequent contact with wild mice, homeowners with mouse infestations, veterinarians who handle sick hamsters and other rodents, pet-store keepers, and pet rodent owners. Immunocompromised individuals, children younger than 5 years, and fetuses are particularly vulnerable to LCMV, which usually lead to severe infection in these subpopulations.

Recently LCMV infection has been associated with organ transplants. 8, 9 Transmissions of virus between donors and recipients have been documented in the United States and other parts of the world. In one of these cases, the donor had recently acquired a pet hamster. 22

LCMV has a highly restrictive host range; the house mouse (M. musculus) is the natural host and reservoir. Once infected, house mice often become lifelong shedders of the virus. Infection has also been reported in other rodents such as wood mice (Apodemus sylvaticus) and yellow-necked field mice (A. flavicollis). 23 Pet hamsters and guinea pigs are not known to be natural reservoirs for LCM, but pet rodents can become infected if they have contact with wild house mice in a breeding facility, pet store, or home. The golden hamster (Mesocricetus auratus) has become an important linkage host for LCMV transmission in humans and has been the source of recent outbreaks in the United States and abroad. [24] [25] [26] [27] 

Infected house mice play a major role in maintaining the life cycle of LCMV, thereby ensuring its persistence in nature (Figure 9 -86). Wild mice are usually infected in utero, thereby becoming chronically or persistently infected. The virus is usually excreted in urine, saliva, and feces of infected mice; transmission to humans occurs through the oral and respiratory contact with virus-contaminated excreta, food, or dust or through the contamination of skin lesions and cuts. Fomites such as bedding materials and other articles contaminated by infected rodents can put nearby humans at infection risk.

Human-to-human transmission occurs vertically between infected mother and fetus and horizontally from organ transplant between infected donors and recipients. Many of the women who gave birth to children with congenital LCM had a known exposure to wild mice or sick hamsters during pregnancy. 28

Most of the human LCMV infection is usually associated with contact with infected rodents (wild and pet rodents); thus the virus persistence in the environment is dependent on the infection rate of mice and frequency of contact between infected rodents and humans. For instance, during the fall there appear to be more mice in residential areas and even commercial areas such as restaurants because the mice look for warmer places to spend the winter. This enables more contact with nearby pet rodents (hamsters, guinea pigs) and even humans.

The immune response plays a major role in determining the manifestation and progression of clinical symptoms following LCMV infection. Thus infection in healthy people usually goes unnoticed and the virus is readily cleared. The onset of symptoms in ill individuals occur 8 to 15 days after exposure and is characterized by a biphasic febrile illness. The initial phase, which may last as long as a week, typically begins with any or all of the following flulike symptoms: fever, malaise, lack of appetite, muscle aches, retroorbital headache, nausea, and vomiting. Other symptoms that appear less frequently include sore throat; cough; arthritis; pain in the chest, testicles, and parotid gland; and rarely a rash. Most people recover after this phase. However, some may proceed to the second phase of the disease consisting of symptoms of meningitis or characteristics of encephalitis. The course of the disease is usually short, rarely fatal (about 1% mortality rate), and the prognosis is usually good, although convalescence with fatigue and vasomotor instability may be prolonged. An association between LCMV infection and myocarditis has been suggested.

Immunosuppressed patients such as organ recipients may develop fatal hemorrhagic fever; of 11 organ recipients described in three LCM clusters, 10 died of multisystem organ failure, with LCMV-associated hepatitis the prominent feature. 10 Congenital LCMV infection first was recognized in Europe half a century ago. 24, [29] [30] [31] The first U.S. cases were reported in 1993 30,31 and were characterized by severe brain and retinal injury. 15, [32] [33] [34] [35] Infection of the fetus during the early stages of pregnancy may lead to developmental deficits that are permanent; congenital LCM can be manifested in a variety of neurological signs such as microcephaly, chorioretinitis, hydrocephalus, seizures, and hypertonia (Figure 9 -87). These signs are usually evident within 48 hours of birth. Diverse clinical signs have been recorded among 20 children diagnosed with congenital LCMV infection. 36 LCMV was diagnosed in these children at birth with follow-up of 11 years. Clinical signs covered a wide spectrum of neurological disease, but chorioretinitis was the only common presenting sign. In addition, the study suggested that the variability of the disease was related to the gestational timing of infection.

The most common laboratory abnormalities are leukopenia and thrombocytopenia in the first phase of disease with a mild elevation in liver enzymes in the serum. After the onset of neurological disease, an increase in protein levels and the number of white blood cells or a decrease in the glucose levels in the CSF is usually observed. No chronic state has been reported in humans, who usually clear the virus after the acute phase of the disease. 

Wild mice infected with LCMV in utero or at an early age develop a persistent subclinical infection and likely shed the virus for life. In naturally infected colonies of wild mice, the proportion of mice with persistent infection increases over time and at 4 years almost all the animals will be shedding virus. 37 Although most rodents with LCMV infection are subclinical, there have been reports of illness in infected hamsters characterized by a wasting disease that may run a long course (ranging from several weeks to months). Early signs include loss of activity, loss of appetite, and rough coat. Later the animal may show signs of weight loss, hunched posture, inflammation of the eye lids (blepharitis), clonic convulsions, and eventually death. The effects of LCMV have been studied in laboratory mice and mimic the disease in humans. Mice exposed to the virus at an older age are more likely to develop clinical disease. Gross lesions include necrosis of the liver and lymphoid tissue. LCMV infection has been documented in other animals such as dogs and monkeys; however, this is rare and has been consistently associated with contact to infected rodents.

In humans, the early stage of disease could be confused with the flu, and at latter stages it must be differentiated from other aseptic meningitides and viral encephalitides, such as those caused by enteroviruses, the arthropod-borne togaviruses, or herpes simplex virus. Drug-induced meningitis is also a differential. In the case of congenital LCM, valid differential diagnoses include TORCH infections (toxoplasmosis, rubella, cytomegalovirus, herpes, and syphilis), parvovirus, and enterovirus. Confirmatory diagnosis usually is by virus isolation in blood or CSF, by PCR, or identification of anti-LCMV IgM and IgG by ELISA or complement fixation. Detection of rising antibody titers in paired sera by IFA, and LCMV antigens by immunohistochemistry in liver biopsy or at autopsy also are considered diagnostic.

In rodents, confirmatory diagnosis is by viral isolation via inoculation in guinea pigs or LCM-free mice, complement fixation, and fluorescent antibody ( Table 9 -43).

Early diagnosis is the key to successful treatment of LCM. Treatment is mainly supportive and involves use of antiinflammatory drugs. As for other cases of aseptic meningitis, suggested treatment regimens include intravenous fluids and analgesics. 38 Treatment in animals is normally not advocated because they could develop a chronic state and continue to shed the virus, thereby posing a risk for other animals and humans. In general, by the time clinical signs are seen the prognosis is poor. 

In recent years, methicillin-resistant Staphylococcus aureus (MRSA), long considered a nosocomial infection of hospitalized patients, has emerged as a significant pathogen in the community setting. Although S. aureus most commonly causes skin and soft tissue infections, invasive strains of MRSA have been associated with necrotizing pneumonia, sepsis, and necrotizing fasciitis, even in previously healthy persons. 1 This community-acquired MRSA (CA-MRSA) has also been found in companion animals [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] and livestock, [14] [15] [16] [17] and there is evidence of transmission between animals and humans. 4, 8, 12, 15, [18] [19] [20] [21] [22] [23] [24] [25] [26] Concern has been expressed in the media about the emergence of a new "superbug" in people and animals. The picture is complex and evolving, reinforcing the need for close cooperation and communication between human and veterinary health professionals.

Public Health Professionals 30 Recommend testing of pets only in situations where the entire household is being tested. All animal testing should be directed by the attending veterinarian, with results reported to the physician with pet owner consent.

• Ensure that the clinical laboratory processing bacterial cultures is able to identify S. aureus and MRSA in clinical specimens.

• Isolate and screen all suspected cases. Isolate confirmed cases. • Consider the role of household pets and other animal contacts in situations where MRSA transmission appears to be ongoing in a household. Recommend testing of pets in situations where the entire household is being tested. Animal results should be reported to the physician with pet owner consent. • Ensure that adequate hand hygiene procedures and a high standard of environmental cleaning and disinfection are in place for staff in veterinary hospitals, and isolation procedures are used for suspected MRSA cases. • Consider screening of veterinary personnel 32 during extreme circumstances (i.e., when there is epidemiological evidence of personnel-borne transmission and transmission persists after improvement in infection control practices are made). Note: The prevalence of MRSA colonization is higher in general among veterinary personnel than the general population 4,20,23,33 and veterinary staff can be exposed at any time. A negative screening result does not ensure that the person's test result will be negative the following day. A positive result also does not mean the person is involved in transmission, and there is no indication to restrict the duties of a veterinary worker in whom MRSA has been colonized.

The S. aureus bacterium is a gram-positive coccus that is coagulase positive and exists as a commensal organism in humans and many animal species, typically carried in the nasopharynx. The resistance of S. aureus to β-lactam antibiotics (penicillins and cephalosporins) including methicillin is due to the production of a penicillin-binding protein (PBP2a) encoded by the mecA gene, which is carried on a transposable genetic element called the staphylococcal cassette chromosome mec (SCCmec). There are at least five different SCCmec types (I-V) and several subtypes. 34 The PBP2a protein is expressed in the cell wall and has a low affinity for β-lactam antibiotic binding. Some MRSA also have membrane-bound protein pumps to remove antibiotics. Although strains of S. aureus that are resistant to methicillin have been identified for many years, some recent clones circulating in humans since 2000 include genes coding for Panton-Valentine leukocidin (PVL), a membrane toxin that appears to be related to virulence (Figure 9 -88). 29 The bacteria are stable in the environment for 17 hours in sunlight, 46 hours on glass, less than 7 days on floors, 42 days in carcasses and organs, and 60 days in meat products. 35

S. aureus is a major human pathogen that is found worldwide. It appears to have a predominantly human reservoir and can be isolated from the nares of about 30% of healthy adults. 36 MRSA has emerged in developing countries, where it remains common. 37 In some parts of the United States, the majority of community isolates of S. aureus from ill patients are now MRSA. 38

The major risk factor for MRSA infection continues to be contact with the health care system, such as a recent hospitalization, nursing home stay, or surgery. 39 Studies of hospital personnel have found MRSA in nasal carriages in 6% of persons sampled. 1 For cases that arise in the community, reported risk factors include age younger than 2 years, low socioeconomic status, participation in contact sports, injection drug use, men who have sex with men, military personnel, inmates of correctional facilities, veterinarians, pet owners, and pig farmers. 40

Although humans are considered the primary host for S. aureus infection, S. aureus is clearly a commensal of many other species. In addition to skin and soft tissue infection, pneumonia, and other pathologic conditions, asymptomatic nasal carriage rates of 30% or greater have been reported. Previous surveys have indicated that human nasal carriage rates of MRSA are much lower than for S. aureus in general, but this may be changing. 41 In animals, S. aureus is not as common a pathogen as other Staphylococcus species such as S. pseudintermedius (previously referred to as S. intermedius). 7 However, recent studies have found significant carriage rates of MRSA in dogs and cats from almost all body sites tested (wounds, abscesses, and chronic pyodermas). Other animals that carry MRSA include horses, pigs, elephants, rabbits, cattle, and birds. 4, 12, [14] [15] 17, 21, 42, 43 Strain-typed MRSA infections found in dogs and cats are typically indistinguishable from predominant human strains. 3, 6, 8, 44, 45 To date, studies have shown transmission of MRSA from people to animals and animals to people, but it is not clear whether animals are a significant reservoir for people. However, evidence suggests that several new MRSA strains may have entered human populations from pigs and cattle. 4 A study in a small animal hospital found 9% of the dogs were MRSA carriers, whereas almost 18% of the staff was infected. 5 Among S. aureus isolates from sick animals in veterinary teaching hospitals, 14% were MRSA. 46 Among healthy dogs and cats in the general population, MRSA prevalence has been reported at 1% to 3%, although there was a high rate of infection with methicillin-resistant coagulase-negative Staphylococcus (MRCoNS). 14 The epidemiology in pigs may be different. A relatively high prevalence of nasal carriage of MRSA has been reported 47 in agreement with previous studies showing transmission between pigs and farmers. 14 MRSA infections associated with pigs and calves have emerged as a significant concern in Europe. Studies have identified pig or calf contact as significant risk factors for both colonization or infection with a specific MRSA strain, called ST398, which has been found in pigs in Europe, Asia, and North America. [15] [16] [17] 42 Astoundingly high rates of colonization have been identified in pig and cattle farmers. 15, 16, 25 There is concern that this strain is now causing infections beyond direct human contacts and that farm animals may be an important reservoir of this strain for human infections. 25, 48, 49 

The risk of transmission between humans and other animals may vary by species and type of MRSA (Figure 9 -89). One study found evidence of MRSA transmission between dogs and veterinary workers. 50 Equine-human zoonotic transmission has been fairly clearly established. 12 The mode of transmission in the community is thought to be primarily by hands that become contaminated by contact with colonized or infected body sites of other individuals or fomites contaminated with body fluids containing MRSA. Other factors contributing to transmission include skin-toskin contact, crowded conditions, and poor hygiene. 51 Risk factors for acquisition of MRSA are likely to include certain antimicrobial use in veterinary medicine.

MRSA can persist on environmental surfaces and has been cultured from surfaces in veterinary hospitals. 4 Despite finding MRSA on various environmental surfaces, evidence of surfaces as a source of infection is weak; direct contact with humans or animals is a much more likely route of transmission. 

S. aureus typically causes skin and soft tissue infection, including furunculosis, folliculitis, and cellulitis. The more invasive strains of MRSA have been associated with necrotizing pneumonia and necrotizing fasciitis (Color Plate 9-45). Sepsis can occur with any strain. Often the first sign of infection is a small pustule or area of redness. This can rapidly progress to a localized abscess or a more generalized infection (Color Plate 9-46).

Infection in animals, while often subclinical, can be associated with a wide range of opportunistic infections, ranging from skin and soft tissue infections to pneumonia and sepsis (Color Plate 9-47). S. aureus causes mastitis in cows, and milk is a recognized source of S. aureus infection (but not MRSA). Surveys of dairy products have detected MRSA in milk and cheese. 52 Table 9 -44 provides comparative clinical presentations in humans and other animals.

In humans and animals, the cornerstone of diagnosis is culture with appropriate sensitivities. Genotyping can provide information about strain type but does not provide any guidance regarding clinical management. For rapid diagnosis in human patients, a Gram stain showing gram-positive cocci in clusters is suggestive of S. aureus infection. This does not apply in animals where other Staphylococcus organisms are common.

Some veterinary laboratories may not perform the studies necessary to identify a case of staphylococcal infection as S. aureus or MRSA because traditionally S. pseudintermedius has been a more important pathogen. Table 9 -45 outlines treatment guidelines in humans and other animals. Since clindamycin resistance occurs in some cases, a test for inducible resistance "double D" (double disk diffusion) or D-test should be performed before using this agent. 53 Antimicrobial therapy should be based on antibiogram as well as patient (e.g., age, renal function) and infection factors (e.g., location, organic debris, drug penetration). In most cases, MRSA isolates are susceptible to a variety of antimicrobials, and commonly used antimicrobials such as chloramphenicol may be used. Trimethoprim-sulfamethoxazole is often useful; however, adverse effects (keratoconjunctivitis sicca, arthropathy) must be considered. Aminoglycosides are often effective but must be administered parenterally. Some isolates may appear susceptible to fluoroquinolones in vitro, but this class of drugs should not be used because in vivo response is typically poor and resistance develops quickly.

There is currently controversy about the use of drugs in a veterinary setting that are important in human medicine (i.e., vancomycin, linezolid). Although veterinarians have the ability to use such drugs in an extra-label fashion, ethical issues about the use of these critically important human drugs should be considered, and if used, they should only be used in extreme circumstances when no other options exist and the infection cannot be treated topically or in some other manner. 44 

Infection with orf virus is primarily a disease of sheep and goats that can significantly affect husbandry operations. Transmission of the disease to humans was first recognized in the 1930s 1-3 and remains an occupational risk to those who handle these animals, particularly immunocompromised individuals. It is also a hazard in public settings such as petting zoos and county fairs. Recent outbreaks in the United States have underscored the importance of differentiating orf virus infection from life-threatening or other rare diseases in humans and from other economically significant diseases in animals such as foot and mouth disease (FMD).

• Provide descriptive epidemiology for the community. • Encourage barrier protection such as the use of nonporous gloves when handling infected or recently vaccinated animals in addition to handwashing. • Encourage animal owners and exhibitors to carefully monitor their animals and promptly quarantine those that present lesions or were recently vaccinated. 5

• Consider the diagnosis in humans compared with other life-threatening conditions such as cutaneous anthrax. • Counsel at-risk workers regarding the importance of protecting open wounds, using nonporous gloves, and handwashing when caring for infected or recently vaccinated sheep and goats [5] [6] [7] and to use caution when handling the animal vaccine. • Counsel immunocompromised individuals or those with chronic skin disorders to avoid contact with potentially infected animals. • No human vaccine is available.

• Consider orf in the differential diagnosis of vesicular lesions, including foot and mouth disease. • Counsel farmers to remove thistle and harsh brush from grazing areas, which can reduce skin trauma to the mouth and muzzle area necessary for transmission of the virus. 6 • Counsel animal owners to refrain from bringing infected or recently vaccinated animals to public events or shows. • Advise PPE and sharps injury prevention for veterinary staff and farm workers during vaccination and care of infected animals. • Ensure that veterinarians and veterinary staff can recognize signs of occupational infection and seek care. • Report disease to veterinary/agriculture and public health authorities as well as occupational health care providers caring for at-risk workers. • Live, nonattenuated orf virus vaccines are commercially available. 5 Preparations can also be made from scabs of previously infected animals. Both types are potentially infectious to humans who handle the vaccine, experience a sharps injury during vaccine administration, or have contact with the vaccine site or recently vaccinated animals. 5 Orf virus vaccines are intended to produce controlled infection in flocks and will ultimately seed the environment with virus-containing scabs. 6 Thus vaccination should be used only in previously infected flocks. 8, 9 The immunity conferred by current vaccines is not lifelong and failures have been reported. 5 The 2001 USDA National Animal Health Monitoring System (NAHMS) sheep survey reported that 5% of sheep operations vaccinated replacement or breeding ewes and 14% vaccinated nursing lambs. 10 In counseling animal owners who are considering vaccinating their livestock, veterinary clinicians should:

 Encourage the vaccination of lambs at ≈1 month of age and a second vaccination at 2 to 3 months for at-risk lambs. 11

Provide proper precaution to prevent outbreaks and transmission to humans associated with vaccine use.

Discourage the use of vaccines in flocks that have not previously been infected.

Orf is caused by Parapoxvirus ovis, also known as orf virus (Figure 9 -90). It is a highly epitheliotropic poxvirus of the family Poxviridae with a double-stranded DNA genome of approximately 140 kb. 12 It can be visualized by electron microscopy of negatively stained samples and appears as a cylinder of roughly 260 × 160 nm with a crisscross pattern characteristic of poxviruses. 7,13 Several other related parapox viruses cause zoonotic infections. Paravaccinia virus (also known as pseudo-cowpox) infect the teats of cattle and cause nodular lesions on the hands of dairy workers (milker's nodule). 12 Other zoonotic parapox virus infections include bovine papular stomatitis and seal pox. 14

Orf virus is found worldwide with a higher prevalence in countries with extensive sheep and goat populations. [6] [7] [8] According to the 2001 national USDA NAHMS survey, 40% of U.S. sheep operations reported cases of orf infection within the past 3 years. 10 Human cases in recent years have been reported in Illinois, Tennessee, Missouri, New York, and California. 5, 6 The incidence of human cases reflects the prevalence of infection in sheep and goat populations. However, cases in humans are probably underreported because those at risk are often familiar with the disease, recognize that it is self-limiting, and choose not to seek medical attention. 1, 2, 16, 17 The fact that many laboratories lack the diagnostic capability for orf virus testing may further contribute to underreporting of the disease. 6

Orf virus is an occupational risk to those who handle sheep and goats, including farmers, shepherds, veterinarians, butchers, and abattoir workers. 2, 16 Wildlife researchers with contact with wild sheep and goat species are also at risk. These groups are especially at risk during the primary lambing season (spring and summer) because young animals are more susceptible to infection. 1,5,12 Those handling orf vaccines or recently vaccinated flocks are at greater risk of developing an infection. 1, 5, 6 Children may be at greater risk in both occupational (e.g., family farm) or recreational (e.g., petting zoo 4 ) settings because common childhood behaviors such as nuzzling animals can lead to significant skin contact or bites. 5 Furthermore, children may be less likely to wash their hands or use gloves than adults. 5 Orf has been reported in conjunction with religious holidays during which families customarily slaughter a sheep or cow. 12, 16, 17 Contact with wildlife such as deer can also result in transmission to humans. 18 Patients with chronic skin disorders such as eczema are at increased risk for contracting orf infection. 5 Immunocompromised individuals are at risk for more severe disease. 6

Small ruminants including sheep and goats are the predominant species affected, although infection has been reported in gazelles, musk oxen, alpacas, camels, deer, reindeer, and dogs. 7, 19, 20 Wild bighorn sheep (Ovis canadensis) and other wild sheep and goats can be infected. Certain breeds such as Boer goats are particularly susceptible to infection. 8, 19 Humans are accidental hosts. 

Orf virus is transmitted via direct contact with broken skin or mucous membranes (Figure 9 -91). Skin trauma is considered a predisposing factor in both animals 9,19,21 and humans. 5, 6, 9 Modes of transmission between animals include contact with infected animals or fomites such as bedding, feed, stalls fences, and trailers. 7, 8 Because young animals are particularly susceptible due to their developing immune systems, outbreaks often occur during the principal lambing season. 1, 5 Suckling can lead to lesions on the mother's teats and cause her to withhold feeding, leading to the spread of the disease to non-mother adults or to humans via tube-or bottle-feeding practices. 5 Transmission from animals to humans can be facilitated by either minor (thistle pricks, torn cuticle) or severe (animal bite) skin trauma. 5, 6 Other human activities that can lead to infection include shearing, petting, and handling infected equipment. 8 Orf virus can persist in wool and hides for over a month after the resolution of lesions, putting butchers, abattoir workers, and shearers at risk. 7, 22 Orf virus vaccine is a live, nonattenuated preparation that has been known to cause outbreaks among sheep and human handlers. 6, 7 Human-to-human transmission of orf infection has yet to be reported.

Infected animals can shed virus-containing scabs that persist in animal housing and other inanimate objects such as harnesses, and pastures. 7, 8, 12 This environmental contamination can lead to indirect infection of other animals and humans. Although the virus is susceptible to ultraviolet rays, it is resistant to desiccation, temperature drops, and other environmental stressors and can survive in the soil and on surfaces for months. 7, 13, 22 

Initial signs of infection appear at the site of skin penetration after a 2-to 3-day incubation period. Lesions can reach 3 cm in diameter and typically occur on the hands or forearms, although infection of the face has also been reported. 2 Symptoms of infection progress through several stages, each lasting approximately a week. 2 The maculopapular stage begins with isolated or multiple erythematous macules and papules appearing at the site of contact that may be pruritic. The target stage features the development of vesiculonodules characterized by a white ring enclosing a red center (Color Plate 9-48). This is followed by an acute stage with an erythematous nodule with weeping, bleeding, and eventual crusting.

In immunocompetent patients, the infection is usually self-limited with full healing without scarring over a 6-week period. 5, 6, 13, 16 Bacterial superinfection of the lesions may occur. 7, 13 Other reported complications include pain, fever, malaise, erythema multiforme, blindness from ocular involvement, lymphangitis, and autoimmune pemphigus with bullous eruptions. 1, 13, 17, [22] [23] [24] Immunocompromised patients are at greater risk for these complications, in addition to progressive or recurring "giant" lesions. 5, 6, 8, 13 Infection with orf confers immunity, but reinfection has been reported, although it is typically less severe. 1

Although animals of any age are susceptible, the disease is seen primary in animals younger than 1 year because adult animals are typically immune as a result of previous contact. 5 Outbreaks among livestock tend to occur in spring and summer.

Lesions occur primarily on the muzzle, nostrils, ears, lips, eyelids, lower legs, buccal mucosa, or teats, especially when nursing. 2 Boer goats may develop suppurative arthritis, chronic fibrinous pneumonia, and premature thymic involution. 19 No loss of appetite or difficulty in nursing was reported in lambs infected with buccal cavity lesions. 21 Recovery occurs within a month. Some animals may require feeding assistance. Animals can be infected more than once during their lifetime, but infections occur far apart and young animals present with the most severe cases. 8 Table  9 -46 shows comparative clinical presentations in humans and other animals.

The diagnosis of orf in humans can be made clinically based on a history of exposure to sheep or goats and the presence of characteristic skin lesions. The differential diagnosis includes a number of potentially life-threatening infections, including cutaneous anthrax, 5 tularemia, and erysipeloid. 5, 6 Other similar conditions include milker's nodule, cowpox, pyogenic granuloma, and skin cancer. 3, 17 Clues to the clinical diagnosis include a history of exposure to sheep, goats, deer, and alpacas in petting zoos, farms, or other settings such as fairs, especially if animals were recently vaccinated or have skin lesions. Laboratory diagnostic techniques include PCR, electron microscopic histopathological analysis, and viral isolation, but these tests are not widely available. 

Lesions in animals can resemble foot and mouth disease because both diseases can present as erythematous, ulcerated papules. 6, 9, 21 The main clinical sign differentiating orf from foot and mouth disease is the proliferative nature of the lesions. 21 As with humans, the diagnosis can be confirmed with PCR or viral isolation.

Orf infections in immunocompetent persons typically resolve spontaneously over 3 to 6 weeks. 2 Some treatments, including 40% topical idoxuridine, 2,5 imiquimod, 12 or cidofovir cream, accelerate the resolution of lesions. 24 Cleaning and antiseptically dressing the lesion can reduce the risk of secondary infection. 2 Surgical treatment may be used in severe cases but can occasionally result in the formation of satellite lesions. 2 The course of treatment usually depends on the location of the lesion. 13 In animals, repellent should be applied to avoid development of myiasis caused by larvae from the fly Cochliomyia hominivorax. 7 Cases of bacterial superinfection can be treated with antibiotics. 

• Consider the diagnosis in any sick cat from an enzootic area with fever, lymphadenopathy, and abscesses on the head and neck or progressive respiratory signs

• Seal rodent entry holes or gaps with steel wool, lath metal, or caulk. • Trap rats and mice using appropriate snap trap.

• Clean up rodent food sources and nesting sites. • Keep wood piles and compost heaps away from the house. • Take precautions when cleaning rodent-infected areas:  Use cross-ventilation when entering a previously unventilated enclosed room or dwelling before to cleanup. PLAGUe accompanied by other systemic signs. The submandibular lymph node is the most common site of lymphadenopathy due to the inoculation of the oral mucosa from ingestion of plague-infected rodents. • Train veterinary personnel in biosafety measures such as masks and gloves when working with potentially infected animals. N-95 respirators are recommended. 3 • Treat animals at the veterinary hospital for 48 to 72 hours and observe clinical improvement (including defervescence) before allowing animal to be treated at home. This will ensure that owners will not be exposed to infectious saliva and other secretions when handling or treating their pet. • Isolate and control fleas on suspected cases while treating with antibiotics. • Follow local and state reporting regulations; contact local health department immediately regarding suspected animal cases. • Recommend keeping cats indoors. • Counsel clients not to let cats and dogs roam outside or otherwise come in contact with wildlife in endemic areas, and to treat monthly to control and prevent flea infestations. • Store animal food in rodent-proof containers.

• A plague vaccine for use in endangered black-footed ferrets has been developed and used. 4

Y. pestis is a gram-negative, bipolar staining, nonmotile bacillus that is a member of the family of Enterobacteraciae. 5 The CDC classifies Y. pestis to be a category A biological warfare agent due to its ability to be produced and disseminated in quantities sufficient to affect large populations and its high case fatality rate among untreated persons. It is believed that deliberate use of the agent would be in an aerosol form. 6

Plague occurs in localized areas on most continents, with most cases being reported in less-industrialized countries (Color Plate 9-49). Some cases in developing countries are related to rats and their fleas in urban areas (urban plague). In the United States, most cases occur in rural areas west of the Mississippi, where the disease exists in wild (ground-dwelling) rodent reservoirs (sylvatic plague)-New Mexico, Idaho, Colorado, Nevada, Oregon, Texas, Arizona, California, Utah, Washington, and Wyoming. Mapping of rodent habitat in the Southwestern United States has successfully identified areas of increased human risk related to conifer forests and amount of precipitation. Much of the area of increased plague risk in the Southwest overlaps with risk areas for hantaviral infection, another rodent-borne disease. 7

Groups at increased risk for Y. pestis infection include hunters, veterinarians, mammalogists, campers, hikers, Native Americans, owners of cats allowed to roam free, and rural residents in enzootic areas. A significant number of cat-associated human cases have occurred among veterinarians and veterinary assistants. 3, 8 Most U.S. cases occur between May and October, when temperatures favor transmission from the fleas and potential human and rodent interactions are higher. 5

Worldwide, an important reservoir for Y. pestis is domestic rats (R. rattus and R. norvegicus), especially in urban settings. In the United States, however, wild rodents are the principal reservoir species, including ground squirrels, rock squirrels, and prairie dogs. 9 In many of these species, susceptible individuals develop the disease and significant die-offs among colonies of some species of prairie dogs are well documented (Color Plate 9-50). 10 Black-footed ferrets, an endangered species, can become infected from preying on prairie dogs. 4 Risk of exposure to fleas infected by Y. pestis is elevated in areas adjacent to rodent colonies experiencing widespread mortality, and these die-offs provide a warning of infection risk to humans and domestic animals. Fleas are the principal vector of plague. Urban plague has been linked to exposure to the oriental rat flea Xenopsylla cheopis (Color Plate 9-51), which commonly infests Rattus species. Fleas, once infected, may remain infectious for a year or longer. 11 Both male and female fleas can transmit the infection. Wild rodent fleas vary by species in their ability to be effective vectors. Cat fleas (Ctenocephalides felis) are considered poor vectors for plague. 3, 11 The human flea (Pulex irritans) may spread the infection between humans in situations of crowding and poor sanitation. 11

Plague is spread through flea bites, direct contact with an infected animal, and by inhalation of infectious aerosols (Figure 9 -92). 12, 13 Fleas that have ingested a blood meal from an infected host can then infect another animal through a bite. The usual source of human infection is a bite from an infected flea or direct handling of an infected animal carcass. Dogs and cats may bring fleas into a home where they can bite humans. Infected cats with pneumonic plague are a source of respiratory spread to humans. Person-to-person transmission through infectious aerosols occurs when there is respiratory involvement but has not been documented in the United States since 1924.

The bacterium does not appear to survive long outside a mammal host. It can be destroyed by sunlight and drying. 14 Environmental factors influencing the risk of plague include those driving increases in rodent populations. Human habitation encroachment into wildlife habitat is an environmental driver of infection risk, because it leads to contact between wild rodent reservoirs of the infection and their fleas and peridomestic rodents. Dogs and cats may contribute to this wildlife-human contact by bringing fleas into dwellings.

There are several forms of human plague infection:

• Bubonic plague usually results from a flea bite or direct contact with an infected animal. There can be a local reaction at the site of the bite. After 2 to 6 days, fever, weakness, and malaise develop with lymphadenopathy. The swollen, extremely tender lymph nodes (buboes) typically occur most commonly in the groin, neck (rarely), or axilla and are often unilateral (Color Plate 9-52). Bacteremia is common. Without treatment, bubonic plague can progress to sepsis, shock, and death. • Primary septicemic plague may develop without buboes. This form has a higher fatality rate than bubonic plague, possibly because of delays in diagnosis. Hypotension and disseminated intravascular coagulation can occur with shock and organ failure (Color Plate 9-53). • Pneumonic plague may result from secondary spread to the lungs of bubonic plague or from primary infection caused by contact with a human or cat with respiratory involvement. Most cases of primary pneumonic plague in the United States are currently related to exposure to infected cats. 8 Pneumonic plague is highly fatal and can lead to further horizontal transmission to close contacts through respiratory spread. • Pharyngeal plague also results from respiratory infection and is characterized by sore throat, pharyngitis, and local lymphadenopathy. • Meningeal plague is rare but may be a complication of bubonic plague. 5

Although certain subpopulations of the rodent hosts of the disease are apparently resistant to developing clinical infection, other individuals are susceptible, so that high mortality rates can occur. In these latter groups, such as prairie dogs, monitoring acute mortality can help predict plague activity in an area.

Cats are known to be susceptible to plague and can exhibit bubonic, pneumonic, or septicemic forms of the disease. Bubonic plague of the head and neck is the most common form in cats following bites from infected flea or consumption of infected rodents (Color Plate 9-54). 15 Secondary septicemic or pneumonic plague can also develop in cats; this form has led to primary pneumonic plague infection of humans in close contact with such cats (Figure 9-93) . Signs in cats include fever, malaise, cough, and buboes. Without treatment, feline plague can be fatal in a substantial proportion of cases. Wild felids such as bobcats and mountain lions are also susceptible to plague.

Although dogs are less likely to develop clinical illness than cats, signs of infection have been documented in three naturally infected dogs in New Mexico (Color Plate 9-55). 16 Clinical signs included fever, lethargy, submandibular lymphadenitis, a purulent intermandibular lesion, oral cavity lesions, and cough. In dogs, antibodies to plague appear by day 8, peak by day 21, and decline by day 100 after exposure. This characteristic, combined with their relative resistance to clinical illness, makes dogs potentially useful as sentinels for plague risk in enzootic areas. Table 9 -47 summarizes the clinical presentations of plague in humans and other animals.

The differential diagnosis of bubonic plague in humans includes other causes of acute lymphadenopathy, including bartonellosis (cat-scratch disease), staphylococcal abscess, tuberculosis, and lymphogranuloma venereum. The rapid onset and associated symptoms should help the clinician make the diagnosis. Pneumonic plague can resemble other rapidly progressive pneumonias. A history of exposure to fleas, rodents, sick cats, or wild carnivores can be helpful, as well as any information of recent outbreaks among animals or humans where the person lives or has recently traveled.

Samples of blood and wound drainage should be sent for culture and chest x-rays films should be obtained. A national network of laboratories has been established for rapid diagnosis of plague, and consultation should be obtained regarding the appropriate testing facility to process specimens. In bubonic plague, the bubo can be aspirated and sent for Gram stain, Wayson stain, DFA, and culture. 5 PCR tests may be available. Diagnosis can be confirmed by serology obtained acutely and after several weeks showing a fourfold rise in titer, a single titer greater than 1:128, 18 or by positive bacteriophage testing from a culture isolate.

In animals, culture and DFA of tissues antibody serology testing are the mainstays of diagnosis. Diagnostic samples can include wound drainage, lymph node aspirates, blood, and necropsy specimens biopsy of liver, lung, spleen, or bone marrow. If there is evidence of respiratory involvement, a pharyngeal swab can be performed. Specimens should be kept chilled. 3

Treatment in human beings with antibiotics should be begun as soon as the diagnosis is suspected. Patients should be hospitalized in an intensive care unit with wound drainage and droplet precautions until 48 hours of appropriate antibiotics with clinical improvement (including defervescence). Although streptomycin has the greatest proven efficacy, it is not widely available in the United States, and gentamicin or doxycycline may be used (Table 9 -48). 19 If buboes become large and fluctuant they may require incision and drainage. Supportive care with intravenous fluids and close hemodynamic monitoring is necessary for most patients.

Persons with close contact with a patient or animal with pneumonic plague or other potential exposures (bite from a cat with potentially infectious saliva, bubo drainage in an open wound, and so on) should receive antibiotic prophylaxis and surveillance for symptoms for 7 days after exposure ceases.

Infected cats should be hospitalized, isolated, and have immediate flea treatment with imidacloprid or pyrethrin. Antibiotics should be begun immediately and intravenous fluids and other supportive measures used aggressively. Cats with the pneumonic form of the disease should be considered for euthanasia if adequate infection control is not available in a veterinary hospital because of the infectious nature of the respiratory droplets and the high fatality rate of primary pneumonic plague. 17 Table 9 -48 lists recommendations for antibiotic treatment of plague in humans and animals. 

Q fever is a disease caused by Coxiella burnetii that has a reservoir in a number of animal species. It is spread to humans by direct contact, most commonly through inhalation of organisms but also possibly through ingestion or other intake routes. It causes potentially serious disease in a proportion of people infected, and because of its high infectiveness and environmental persistence has been considered a potential bioterrorism agent. The true impact of Q fever as a zoonotic disease is probably underrecognized because of the nonspecific nature of the illness in many cases.

• Human disease is reportable to public health authorities. • In the event of a case report, determine whether others are at risk and whether there is an ongoing risk of exposure (consider bioterrorism potential of this agent).

• Recommend cleaning sources of contaminated soils and dusts from the environment (understanding that the organism is highly resistant to chemical and physical agents) and disinfection with 0.05% hypochlorite, 5% peroxide, or 1:100 Lysol solution. 2 • Educate the public, veterinarians, and human health clinicians about risk factors for transmission; organisms localize in reproductive and mammary tissues and can be also be shed in urine and feces and spread by ticks (viable organisms have been recovered from tick feces after 19 months and after 42 months in milk at 4° to 6°C). 2 • Support the maintenance of milk pasteurization to prevent infection in the general population.

• Report human disease to public health authorities. http://www.cdc.gov/ncphi/disss/nndss/casedef/q_ fever_2008.htm. • Consider diagnosis in high-risk individuals such as persons with occupational exposure. • Consider in the differential diagnosis of patients presenting with culture-negative endocarditis. • Provide occupational preventive services to high-risk individuals, including counseling on PPE and biosafety, as well as consideration of vaccine. Persons with valvular heart disease should not work in laboratory settings with C. burnetii. • Vaccine: a vaccine has been developed for high-risk individuals in Australia but is limited to those at high risk of exposure and who have no demonstrated sensitivity to Q fever antigen. 3 The vaccine is not currently available in the United States either commercially or through an investigational new drug permit. • Person-to-person transmission is rare but has been reported through sexual contact and to health care staff during obstetrical procedures on infected patients.

• Instruct owners and any others in contact with infected animals to immediately seek medical advice. • Segregate parturient animals and destroy (burn or bury) placentas and other reproductive discharges to reduce transmission. • Ensure veterinary staff follow proper biosafety procedures, including around parturient animals. • Isolate infected animals and implement airborne transmission precautions for staff. • Ensure that ruminants used for research purposes are free of C. burnetii through serological testing. • A vaccine for livestock has been developed and shown to reduce infection in calves and reduce shedding in previously infected animals. However, the vaccine is not currently commercially available in the United States.

Q fever is caused by Coxiella burnetii, a gram-negative obligate intracellular, coccobacillus organism in the gamma subdivision of Protobacteria (along with Legionella, Francisella, and Rickettsiella) (Figure 9 -94). The organism is highly infectious, with an infective dose of 1 to 10 organisms. 3 It exists in two different antigenic phases, and the human antibody response generated to each antigen phase can be used to assess progression of infection. Phase II antibodies are more predominant in humans experiencing acute infection, whereas phase I antibodies are proportionately more common in chronic disease states, such as endocarditis. 4 There are also at least two different morphologic forms of the bacteria; one is large and bacilliform, another is small and coccoid. The small, high-density form (small cell variant [SCV]) has some resemblance to a spore in terms of its hardiness; it is highly resistant to environmental degradation and therefore plays an important role in transmission.

C. burnetii occurs worldwide. It is probably more prevalent than recognized owing to the often subclinical nature of disease in humans and animals and the difficulty with laboratory diagnosis. In 2000, cases were reported in California, Colorado, Idaho, Kansas, Minnesota, Nebraska, Nevada, Oregon, and Utah.

Q fever often occurs as an occupational disease. Workers at risk include slaughterhouse workers; veterinarians and veterinary staff; farmers; researchers working with pregnant animals, especially sheep; and workers in diagnostic laboratories where the organism may be cultured. However, even casual contact with farm environments or farm animals can lead to infection. Also, because the agent may be spread on dust, persons living near high-risk areas may be at risk for infection through windborne spread.

Although it is less commonly reported among children than adults, Q fever does occur in children, especially among those exposed to farm animals and farm environments for even brief amounts of time. 5 Children can also be infected by drinking raw milk, although they are typically asymptomatic. Exposure to parturient cats has caused outbreaks in humans in the past among pet owners and their families. 6

Animals are the natural reservoir for C. burnetii. It is found worldwide in sheep (Figure 9-95) , cattle, goats, birds, dogs, and cats. Serological evidence of past exposure has also been shown in a variety of wild mammals. In the United States, seroprevalence studies have shown antibodies in more than 40% of sheep, 16% of goats, and 3% of cattle. 7 A study in Colorado found that more than 8% of female cats studied had evidence of C. burnetii in uterine tissue, raising the issue of risk to owners during birthing. A study in Asian cats found seroprevalence rates of up to 41% in stray cats and 14% in pet cats. 8 However, the risk of pet-to-human transmission may be low, as an Austrian seroprevalence study did not find that pet ownership was a risk factor for seropositivity to C. burnetii. 9

Animals infected with C. burnetii shed high concentrations of the organism in birth products and milk, as well as lower concentrations in feces and urine (Figure 9-96) . The organism can be tickborne in animal-to-animal transmission, but transmission from animals to humans is thought to result mostly from inhalation of droplets and/or aerosols containing organisms from infected placental tissue, other parturient tissues, and dusts containing dried body fluids. The organism is found commonly in raw milk with reported prevalence of >94%. 10 Milk pasteurization has been designed specifically to destroy this heat-resistant organism. Foodborne transmission to humans may occur rarely through unpasteurized milk. Transmission in domestic animals is thought, as in humans, to occur mostly through inhalation of infectious aerosols or ingestion of contaminated tissue.

The agent can be found in a number of species of ticks, but tickborne transmission is believed to be more important in wildlife populations than in domestic animal or human infection. 1 However, the patterns of C. burnetii infection in wildlife remain poorly understood.

Coxiella can persist for months in the environment. The SCV form of the bacteria that is shed in feces and other body fluids is similar in some ways to a spore and quite resistant to disinfectants and temperature extremes. Therefore infectious particles can persist in fomites and dusts, and aerosol transmission has occurred over long distances through windborne spread. 1 Proximity to farms is a risk factor for infection, as wind patterns appear to play a role in environmental transmission by dispersing infectious aerosols over wide areas. 11 Although the role of wildlife is not well understood, living near forested areas has been found to be a risk factor for suburban dwellers. 12 

Q fever can present with acute or chronic symptoms (Table  9 -49). Some cases in humans are asymptomatic or consist of sufficiently nonspecific symptoms, which results in missed diagnoses. After an incubation period of several weeks, the disease in its acute form often presents with fever, malaise, chills, weakness, headache, and sweats. Pneumonia is a predominant feature, although pulmonary symptoms may be absent even though pneumonitis may be seen on radiographs ( Figure  9 -97). 4 Chronic symptoms may develop over months to years. Chronic infection may include granulomatous hepatitis, meningitis, and osteomyelitis. The most serious form of chronic infection is bacterial endocarditis, which occurs particularly in persons with underlying valvular disease (Color Plate 9-56). Infection in children can often be asymptomatic but can also present acutely, with encephalitis and neurological symptoms. 13 In convalescent individuals, a postinfectious fatigue syndrome (fever fatigue syndrome) has been described. 4

Animals typically do not manifest clinical signs with the exception of reproductive disease, especially abortion, infertility, and retained placenta (see Table 9 -49; Color Plate 9-57). Because infection often goes unrecognized in animals human illness may serve as sentinel events, indicating the presence of infection in a domestic animal population. 14

The diagnosis in humans is usually made by serology. A rise in titers is seen in acute infection. Because the prevalence of antibody positivity in certain populations is relatively high, it is necessary to examine paired serological titers. Laboratories interpreting serological results need to use caution; misdiagnosis has resulted from improper interpretation. 15 IgM levels greater than 1:128 suggest acute infection. 11 A PCR test has been developed to aid in diagnosis. 14 In chronic infection, high levels of phase I antibody titers (IgG >1:800) are seen, and phase I antibody titers are usually greater than phase II titers. Blood cultures appear sterile because of the need for intracellular cultivation. Although cell culture and embryonated egg methods exist to culture the organism from blood, laboratory workers are at risk of infection through such procedures, which should not be attempted outside a specialized laboratory experienced in handling the C. burnetii organism. The CDC can provide assistance in isolation. C. burnetii is considered a "select agent," so handling of live organisms in a laboratory setting is restricted. On biopsy tissue, immunostains and electron microscopy can be diagnostic for the C. burnetii organism. 4 Serological testing is also used in animals. A fourfold increase in IgG over a 4-week period is diagnostic. 16 Tissue (aborted fetus, placenta) can be submitted for immunohistochemical testing. The organism can be isolated from blood in specialized test laboratories (New Mexico Department of Agriculture, Veterinary Diagnostic Services). 16 

Acute Q fever is treated with doxycycline as a first-line agent. Chronic infection, including infective endocarditis in humans resulting from Q fever, is treated with a combination of antibiotics for an extended time (18 months to 3 years).

Although information on the efficacy of treatment in animals is limited, prophylactic treatment of endemic herds (or asymptomatic pets) with tetracyclines may reduce the zoonotic potential (rather than eliminate infection). 17 Other control measures include segregating pregnant animals indoors and burying or burning infected reproductive tissue wastes. 7 Table 9 -50 provides antibiotic treatment information for Q fever infection in humans and other animals. This is intended to be an annual event.

Human rabies is relatively rare in North America, but exposure to potentially rabid wild or feral animals occurs frequently. Owner noncompliance with rabies vaccination protocols of their pets, especially cats, can be a source of exposure as well. Managing and preventing such exposures requires an understanding by human health and animal health professionals of the status of rabies infection in local wildlife and domestic animal populations, the judicious use of vaccination strategies, and animal control measures.

Rabies can therefore serve as a model for improved communication and cooperation among public health, animal health, and human health professionals. Appropriate exclusion of bats from buildings • Analyze and report trends from compulsory reports of animal and human rabies. • Advise the public that any bite wound or potential exposure to rabies should be thoroughly washed with soap and water, and the bite reported to local health authorities.

• Work with local human and veterinary medical providers and animals control officials in the management of potential rabies exposures. • Support the preexposure vaccination of high-risk individuals. • Explore methods of control of viral transmission in wildlife population (such as oral vaccine). • Discourage ownership of pet wildlife or wild/domestic hybrids. • Support appropriate vaccination requirements and policies to reduce translocation and importation of potentially rabid animals. • Support scientific research on which to base public health policy. • Provide access to appropriately trained laboratorians to diagnose the disease.

• In evaluating any patient with an animal bite, take an accurate history of the species involved and circumstances of the bite incident (see Figure 9 -105 dog, cat, or ferret that has bitten a human for signs of illness within 10 days from the time of a bite. If no illness occurs, the person has not been exposed to rabies from that animal. • Consider assisting public health officials by providing appropriate animal isolation and observation for clinical sign of rabies:

 If a currently vaccinated dog, cat, or ferret is exposed to a known or suspect rabid animal, it should be revaccinated, confined, and observed for 45 days.

If the dog, cat, or ferret is not currently vaccinated, it should be isolated and observed for clinical signs of rabies for 6 months (vaccinated 1 month before release). • Consider assisting public health officials by providing animal decapitation services for rabies testing. • Consider rabies in the differential diagnosis of any dog, cat, ferret, horse, or livestock with behavioral changes or exhibiting unexplained neurological signs. • Contact public health authorities immediately with suspected animal case of rabies. • Disinfect any cage and housing of a rabid animal with soap solutions, 1% sodium hypochlorite, 2% glutaraldehyde, iodine solutions, or quaternary ammonium compounds. 3 • Support the PEP of staff at high risk for rabies exposure.

Rabies is caused by a number of related rhabdoviruses, which are bullet-shaped RNA viruses belonging to the genus Lyssavirus. Lyssa viruses are unique among rhabdoviruses in their ability to replicate in a host animal's CNS. 4 Different strains of rabies virus are adapted to particular animal species and can have spillover to other species. Rabies viruses can affect any mammal.

Rabies viruses occur worldwide on all continents except Antarctica and Australia but in varying degrees of prevalence.

Reliable data on the prevalence in many countries are not available. Certain Pacific and Caribbean islands, including Hawaii, are considered to be free of the virus. 5 The WHO has estimated that 55,000 fatal cases occur in humans annually, with the greatest disease burden in Asia (31,000 deaths), followed by Africa (24,000 deaths). 6

The majority of human cases occur in countries where rabies is endemic in the dog population. Travelers to such areas are therefore one group at risk of exposure and infection. Occupational groups at risk include veterinarians, wildlife rehabilitators, wildlife management workers, zoologists, animal quarantine workers, animal control officers, and laboratory workers.

Children may be at increased risk because of their behavior of contacting wild and domestic animals. Once exposed, immunocompromised individuals may be at increased risk of contracting infection.

Unvaccinated dogs and cats with exposure to wild animals, particularly raccoons, bats, foxes, and skunks, are at increased risk of rabies exposure and infection.

Animals are the natural reservoir for rabies viruses. Although all mammals are considered susceptible to infection, only carnivores and bats are capable of maintaining the viral reservoir (Figure 9 -98). 4 Worldwide, domestic and wild canids and other carnivores are the principal reservoir species for rabies virus. In the United States, dog rabies strain has now been eliminated largely as a result of aggressive vaccination and animal control efforts. However, the disease is now most frequently reported among wild mammals with identifiable virus variants circulating in bats, raccoons, skunks, and foxes (Table 9 -51). These variants can affect other mammals including humans, cats, and dogs. 4, 7 The disease is generally not reported in small rodents (e.g., squirrels, hamsters, gerbils, mice, or rats), lagomorphs (rabbits), or marsupials (opossums).

Unlike many other zoonotic diseases, animals are not believed to be subclinical carriers. Bats, canines, and other animals that develop rabies and are capable of spreading infection to other animals typically die of the disease within a short time. 8 In the United States and Europe, oral rabies vaccine programs are used to contain and eliminate the virus from raccoon, skunk, fox, and coyote populations. 9 In parts of the developing world, especially Asia and Africa, the disease remains endemic in the domestic dog populations and constitutes a risk to travelers to rabies endemic countries (see Chapter 10) . In Latin America, vaccination campaigns have drastically reduced cases of rabies in domestic animals and humans, but canine and wildlife rabies (including vampire bats) remains a risk.

The rabies virus enters the body by a bite, an open wound, or by contact with mucous membranes and replicates near the site of exposure (Figures 9-99 and 9-100) . It then travels slowly through sensory and motor nerves to the CNS, where it causes encephalitis. Finally, it spreads centrifugally to the salivary glands and other organs through peripheral nerves. Blood, urine, and feces are not considered infectious.

Humans are usually exposed through a bite from a rabid animal. Not all humans bitten by rabid animals become infected, even in the absence of prophylactic immunization. The likelihood of transmission depends in part on the amount of virus in the saliva. Therefore very minor bites and bites through clothing may be less likely to transmit infection. 8 Transmission by contact of saliva with mucous membranes and conjunctiva is possible but less common than bite-related transmission. Both humoral and cellmediated immunity appear to play an important role in susceptibility to infection. Immunocompromised individuals are therefore at higher risk of infection from exposure to a rabid animal.

Aerosol transmission has been reported in humans entering caves frequented by bats and in laboratory settings, but this route of exposure is considered rare. Human infection through ingestion of infected meat or milk has not been reported. 8 Person-to-person transmission has rarely been reported through corneal or organ donation. 10 Transmission between animals results from direct contact such as bites. Dogs and other infected animals are infectious for several days (as long as 13 days has been reported with some rabies virus strains) before symptoms appear and then continue to shed virus in saliva until death; the total period of infectiousness may vary among species. 8

Worldwide, factors affecting the density of dog populations have been drivers of rabies infection risk. Increasing urbanization has brought migrants from rural areas to live closer together, often in extreme poverty, with accompanying dogs and other domestic animals that are inadequately immunized against rabies.

In countries such as the United States where wildlife populations are reservoirs, key factors include translocation of animals from a rabies-endemic area to one that has been free of rabies. For example, the epizootic of rabies in raccoons along the Eastern Seaboard of the United States occurred in part because of the transportation of rabid raccoons across state lines to be released for hunting purposes. Another factor is the increasing contact between wildlife such as bats, raccoons, skunks, and coyotes related to encroachment of suburban housing developments on wildlife habitat ( Figure  9-101) . Cats could play a potential role in increasing contact between rabid wildlife and human populations.

After exposure to rabies the disease has an incubation period that varies from weeks to months (usually 20 to 90 days), 8 but the incubation period has been reported to be as long as several years. 11 The distance from the exposure site to the head and neck helps determine the length of time until the onset of symptoms (Table 9-52) .

Early symptoms include anxiety, headache, fever, and malaise. There may be pain, irritation, and other sensory changes around the bite. The patient often becomes excitable with sensitivity to light and sound and demonstrates aerophobia (fear of flying) 12 as well as pupil dilation and increased salivation. Over a short period (2 to 6 days), the disease progresses inexorably to weakness; paralysis, including spasm of the swallowing muscles, leading to inability to swallow even liquids; and fear of water (hydrophobia). Delirium and seizures can follow, as well as generalized paralysis, with death usually to the result of respiratory arrest. In the United States, most autochthonous human rabies cases have been identified as bat rabies variants among people who did not recognize their exposure or who did not seek postexposure treatment.

The incubation period appears to vary among species (see Table 9 -52) but usually last weeks to months. Once clinical signs develop, there are two major manifestations of rabies infection in animals, termed furious rabies and dumb (paralytic) rabies. Either or both forms may occur during the course of infection in a single infected animal.

Furious rabies is characterized by agitation, aggression (including unprovoked biting attacks on other animals, humans, and itself), sexual stimulation and priapism, roaming behavior, excess salivation and drooling, and abnormal vocalizations (Figure 9-102) . Convulsions often develop.

Dumb rabies is marked by lethargy and paralysis. The muscle paralysis begins in the head and neck, with difficulty swallowing that may lead a dog owner to become exposed by trying to help the animal swallow. The paralysis spreads to the extremities, leading to generalized paralysis and death (Figures 9-103 and 9-104) .

Management of potential rabies exposure consists of three components: (1) wound first aid, (2) risk assessment, and (3) administration of PEP if indicated.

Any bite or scratch from a potentially infected animal should be cleaned immediately with soap and water and irrigated copiously with water and/or a dilute solution of povidoneiodine and water. A tetanus booster should be administered if more than 10 years have elapsed since the last vaccination (see Chapter 10).

Risk assessment and decisions regarding PEP are crucial steps in the management of rabies exposures. This requires the clinician to gather an accurate history of the exposure, including the following information that should be included in the clinical chart: • Current location of animal, and whether animal control or other authority is aware of incident and is going to quarantine/observe or euthanize the animal (in which case PEP can be reserved unless the test results for rabies are positive) • Type of exposure (e.g., bite to exposed skin, bite through clothing, scratch, lick, contact with intact skin only) • The exact location of all bites or scratches • When exposure occurred • Rabies immunization history of the individual • Whether the individual is immunocompromised • The species of animal involved, if known • Whether the animal showed any signs of illness (including the signs of rabies listed in Table 9-52) • Whether a bite or scratch occurred or whether the circumstances suggest an unrecognized exposure (such as a bat found in a room where someone was sleeping) • If the animals is a domestic animal, record of immunization and name/contact information of veterinarian caring for animal Using this information, the clinician can then assess the risk of rabies transmission and the need for PEP. Public health officials can be consulted to assist in determining the need for rabies PEP. Figure 9 -105 shows an algorithm for making this decision. The risk assessment process often requires close cooperation among the treating clinician, the public health department, animal control or veterinarian evaluating the animal, and the public health or other laboratory performing tests on the brain of the animal (if available).

If the biting animal is tested for rabies or is a dog, cat, or ferret that can be monitored for 10 days, PEP is not necessary unless the animal shows clinical signs and subsequent test results are positive for rabies. However, if it is determined that PEP is indicated, it should be initiated as soon as possible after rabies exposure. The CDC posts updated recommendations for PEP on its Web site. 14 PEP should be started even if a prolonged time has elapsed since exposure because the incubation of human rabies can be many months. Table 9 -53 lists the vaccines and antibody preparations available in the United States.

For persons who have never been vaccinated against rabies, PEP should include administration of both passive antibody (rabies immune globulin) and vaccine. For previously unvaccinated persons, the vaccine regimen consists of HDCV or PCECV, 1.0 mL IM (deltoid area), one each on days 0, 3, 7, and 14. The deltoid area should be used in adults and the anterior thigh can be used in children. The gluteal area should not be used for rabies immunization. Hema rabies immune globulin (HRIG, 20 international units/kg body weight) should be given just once, at the beginning of antirabies prophylaxis, and infiltrated directly around the wound site if possible. Do not administer HRIG to a person who previously received any of the rabies vaccinations from Table 9 -53 either for preexposure or postexposure purposes. Previously immunized individuals should receive only vaccine (HDCV or PCECV, 1.0 mL IM [deltoid area]), one each on days 0 and 3 after exposure.

Vaccinated dogs, cats, ferrets, and livestock that have been exposed to a known or suspected rabid animal should be revaccinated and observed in the home or farm for 45 days for signs of rabies. 15 If an unvaccinated dog, cat, ferret, or livestock animal is bitten by a rabid or potentially rabid animal, it should be euthanized or maintained in strict quarantine and monitored Figure 9 -104 n Dog with dumb rabies, manifested as depression, lethargy, and a seemingly overly tame disposition. Domesticated animals with dumb rabies may become increasingly depressed and try to hide in isolated places, whereas wild animals seem to lose their fear of humans, often appearing unusually friendly. (From Centers for Disease Control and Prevention Public Health Image Library, Atlanta, Ga.) closely for signs of rabies for 6 months. Quarantine should be under the supervision of local animal control or public health authorities at an approved boarding site. If the animal victim is a valuable specimen (e.g., zoo animal), contact public health professionals to determine possible management.

The diagnosis in humans can be made by biopsy of the skin at the nape of the neck (at the hairline) and by using DFA staining of frozen skin sections. Serology is also used to detect viral neutralizing antibody in serum and CSF, 12 and a PCR test is available to detect Lyssavirus RNA. Clinicians must work with their state public health officials to submit specimens to the CDC laboratory.

In animals, the brain of euthanized animals is examined using DFA staining (Color Plate 9-58). 2 A rapid immunohistochemical test has recently been developed and provides high sensitivity and specificity. 16 

Although a number of aggressive attempts to treat symptomatic rabies infection with antiviral therapy have reported survival success in an isolated case (see Milwaukee Protocol at http://www.chw.org/display/PPF/DocID/33223/router. asp), 17 clinical rabies infection in humans remains an almost invariably fatal disease, with the principal treatment supportive intensive care.

Therefore prevention of the development of clinical disease through the use of preexposure and postexposure vaccination strategies is the mainstay of preventing rabies deaths in humans. (See Human Rabies Prevention-United States, 2008 Recommendations of the Advisory Committee on Immunization Practices (ACIP) at http://www.cdc.gov/ mmwr/preview/mmwrhtml/rr57e507a1.htm.)

Treatment is not attempted in animals. Rabid animals are euthanized. Disinfection of the cage area should be accom-plished with disinfectants such as a 1% solution of household bleach. 2 3 In numerous instances, there have been temporal relationships between RMSF cases in dogs and human infection in members of the same households, demonstrating that dogs can serve as sentinels for human environmental infection risk. 4 Tragically, lack of communication between veterinarians and human health care providers has contributed to delays in diagnosis, sometimes with fatal consequences. In other cases, however, detection of RMSF in dogs has alerted human health care providers to initiate timely treatment of an infected person. 5 In addition to tick bites, a risk factor for human infection is exposure to infectious tick feces, tissues, or fluids when removing ticks from dogs. RMSF is therefore a grim reminder to human and animal health professionals of the importance of considering the diagnosis, sharing information about animal and human cases, and educating patients and clients about proper measures to prevent tickborne disease.

• Characterize the risk of rickettsial disease in the community. • Educate the public to prevent tick exposure through the following measures:  Avoid tick-infested areas, but if not possible, wear appropriate clothing (long sleeves, long pants, tuck pants legs into socks, and wear light-colored clothing to visualize ticks). Wash clothes with hot water. 6  Use CDC-recommended tick repellents such as DEET or permethrin (apply to clothes, not skin). Be sure to follow label instructions before using any repellent.

 Do frequent tick checks to remove even tiny immature-stage ticks. Inspect children at least once daily for ticks. When in heavily infested areas, inspect children every 3 to 4 hours.

Use appropriate technique to remove ticks, such as a tick removal "spoon," or wear gloves or grasp tick with tweezers as close to the skin as possible and pull gently. Applying matches, diesel fuel, nail polish, or petroleum jelly on the tick is not recommended and could lead to additional exposure to infectious material from the tick. 7  Disinfect tick bites with household 70% isopropyl alcohol or 2% iodine solution. Follow up by cleaning the area, applying antibiotic topical on the tick bite site, and washing hands.

 Implement integrated pest management techniques including landscape management (see Box 9-3) to reduce tick exposures. • Advocate for tick prevention in dogs to reduce human exposure of the infection.

• Instruct patients on tick exposure prevention (see above).

• Consider the diagnosis in all patients with animal contact and/or travel to endemic countries. • Report suspicion of disease immediately to public health authorities. See http://www.cdc.gov/ncidod/dvrd/rmsf/ Case_Rep_Fm.pdf for the CDC case report form.

• Recommend preventive acaricide treatment for pets.

• Notify health care professional if cases are diagnosed in dogs. Such cases could both pose a risk to humans and serve as a sentinel warning of environmental exposure risk.

The causative agent of RMSF, Rickettsia rickettsii, is a member of a family of closely related spotted fever Rickettsiae that are found worldwide. Rickettsiae are obligate intracellular coccobacilli with one of the smallest bacterial genomes. 8 Because of a history of laboratory-acquired infections, many of which have proven fatal, 9 handling of R. rickettsii cultures requires biosafety level 3 containment. Because this bacterium was added to the select agent list, only approved laboratories can maintain cultured R. rickettsii. Table 9 -54 shows diseases caused by Rickettsiae in the spotted fever group. Several of these agents in addition to R. rickettsii are found in the United States. Rickettsia akari causes rickettsialpox, a disease transmitted from mice to humans via mites that causes a vesicular skin rash, fever, and adenopathy and has been reported in urban dwellers in the eastern United States. 12 Rickettsia parkeri can cause a mild form of spotted fever with eschar formation at the site of a tick bite. 10, 13 Rickettsia felis is transmitted by cat fleas to other animals, including humans, and is one of the causes of flea-borne (murine) typhus, a mild rickettsial disease. 12

Despite its name, human cases of RMSF occur throughout the United States with higher incidence in the south Atlantic and western-central regions (Color Plate 9-59). 12 Even in endemic areas, infection rates of ticks with R. rickettsii are low. Outside the United States, RMSF occurs throughout the Western Hemisphere, with cases reported from Canada to Brazil and Argentina.

Since 1920, the disease has gone through three major cycles of emergence and has been increasing in incidence since 2000.The reasons for this are unclear. 14 The majority of reported cases in the United States occur in children younger than 15 years with a peak incidence between ages 5 and 9 years. This is believed to be due to behaviors that expose children to ticks. 15 Living near dogs carrying ticks is a reported risk factor. Laboratory workers are at risk and should use caution when handling infected material and cultures because infection can occur by accidental parenteral exposure or through aerosols.

Ixodid (hard) ticks are both a disease reservoir and the vectors for RMSF, although R. rickettsii appears to cause mortality in ticks. At present, the two principal tick species associated with RMSF in the United States are the American dog tick (Dermacentor variabilis) (Figure 9-106) found east of the Great Plains, and the Rocky Mountain wood tick (Dermacentor andersoni) (Figure 9 -107) found between the Cascade and Rocky Mountains of the west. Immature ticks of these two species feed predominantly on small rodents in rural and suburban environments, including the rice rat, golden mouse, white-footed mouse, and pine vole. 16 The brown dog tick (Rhipicephalus sanguineus), by contrast, feeds mainly on dogs and has been associated with recent human infections in the southwestern United States and is the principal vector of RMSF in Mexico (Figure 9 -108). 17 In South America, the major tick vector is Amblyomma cajennense.

In addition to ticks, dogs and rodents can also serve as disease reservoirs for RMSF as well as infected hosts that may develop clinical disease. 18

Once infected with R. rickettsii, many ticks die. 14 Those that survive remain infected for life, and female ticks can pass the infection to their offspring through transovarial transmission. The ticks have a three-stage life cycle from larva to nymph and adult (Figure 9-109) . To progress from one stage to another, the tick must have a blood meal; all three stages feed on vertebrates and can transmit infection. During blood meals, R. rickettsii in the salivary gland of an infected tick can be injected into the dermis of the host animal, resulting in transmission. If an uninfected tick feeds on an infected host animal, the tick can become infected with the organism. For tick-to-human transmission to occur, the tick must be attached for at least 6 hours and may remain attached for days to weeks.

In addition to tick bites, humans can become infected by exposure to tick feces, tissues, or fluids by removing and crushing an infected tick, allowing secretions to contact cuts or broken skin. 8 The rickettsial organism can also be spread human to human by blood transfusion. 19 

Environmental factors driving the emergence of RMSF are poorly understood and are thought to vary with the ecology of the different tick reservoir species. In areas where D. variabilis is the principal tick reservoir, the environmental risk of RMSF has been estimated based on the density of small mammals in a particular area that serve as hosts for the tick. 16 Seasonality and climate play a strong role in human infection risk, with most cases in the United States reported between April and December when the adult ticks are more active. 15 

In the early stage of RMSF, symptoms can be nonspecific, including fever, myalgias, and headache. Only 3% to 18% of patients present at their first medical visit with the classic triad of fever, rash, and a history of a tick bite. 20 Therefore the disease should be suspected even if one of these signs is absent. Abdominal pain, nausea, and vomiting can be prominent features. The rash of RMSF occurs eventually in most cases and is often a maculopapular eruption with central petechiae that typically begins in the extremities around the wrists and ankles and spreads centripetally toward the trunk (Figure 9 -110). In many, but not all, cases the rash involves the palms and soles (Color Plate 9-60). 8 Elderly and darkskinned patients may have no visible rash (Rocky Mountain spotless fever).

Thrombocytopenia, elevated liver function test results, and hyponatremia are often seen. Nearly half of patients experience hemorrhages from vasculitis rather than low platelets. In severe cases, renal failure, pulmonary edema, and respiratory distress develop. The development of neurological signs, including meningismus, neurological deficits, deafness, and photophobia, is associated with a poor prognosis. Death can occur between 8 and 15 days after the onset of symptoms if antibiotic treatment has not been started early enough in the course of the disease. 8 Survivors of severe cases may have deafness, other neurological deficits, and gangrene of the extremities. 2 Male gender, advanced age, chronic alcoholism, African American race, and glucose-6-phosphate dehydrogenase deficiency have been associated with a greater risk of fulminant disease. 1

Dogs are often infected in endemic areas, with reported seroprevalence rates ranging from 4% to 63%, some of which could be due to cross-reactivity with other Rickettsiae in the spotted fever group. 18 Infection causes a systemic vasculitis with signs resembling some of those in humans. Within several days of tick attachment, dogs may develop fever, lethargy, lameness, and anorexia. Other signs can include edema of the scrotum, face, ears, or extremities; epistaxis and other bleeding problems, including ecchymoses and petechiae; respiratory distress; ataxia, conjunctivitis; and eye pain (Figure 9 -111 and Color Plate 9-61). Neurological disease is seen in about a third of cases. 21 Cases can be mild or severe with fatality as a result of arrhythmias, shock, and disseminated intravascular coagulation. The vasculitis can result in gangrene of the extremities in severely affected dogs. The case fatality rate can be as high as 10%. In recovered animals, immunity appears to be lifelong. 19 RMSF has rarely been reported in cats, which are believed to be much less susceptible to infection than dogs. 19 The organisms have been isolated from opossums, rabbits, chipmunks, squirrels, rats, and mice, which seem to have inapparent infection. Table 9 -55 summarizes the clinical presentation of RMSF in humans and other animals.

The differential diagnosis of RMSF in humans includes a large number of other acute febrile illnesses, including viral respiratory tract infection, gastroenteritis, other tickborne diseases including ehrlichiosis (which causes fever but no rash), thrombocytopenic purpura, and mononucleosis. Clinicians must maintain a high level of suspicion for infection in endemic areas. Clues to the diagnosis include presence of fever and rash, exposure to ticks, and occurrence of RMSF in other humans or dogs in the household or area.

Findings of thrombocytopenia, hyponatremia, and elevated transaminase values support the diagnosis. Physicians should never delay treatment waiting for laboratory confirmation. Immunohistochemistry can offer timely diagnosis but is not widely available. A PCR test is available in some centers but is not 100% sensitive. Diagnostic serology can be done but is mostly useful for retrospective diagnosis of cases. Therefore the burden falls on clinicians to suspect the diagnosis and initiate antibiotics often on clinical grounds.

In dogs, the disease can be confused with canine ehrlichiosis, which responds to the same treatment. The scrotal edema may resemble that seen in brucellosis. Helpful laboratory diagnostic findings in dogs include thrombocytopenia and serology using immunofluorescence (micro-IF or direct), ELISA, or latex agglutination. PCR is available in some centers. 19

The treatment of choice for RMSF in adults and children is doxycycline (Table 9 -56). 1 In pregnant women, the benefit may also outweigh the risk, but an infectious disease specialist and/or the patient's obstetrician should be consulted. Antibiotic treatment should never be delayed while awaiting results of diagnostic testing, because delay in treatment can lead to fatal outcomes. 20 Patients may require supportive care in intensive care settings if necessary if complications develop. Treatment in dogs usually involves inpatient care with early administration of antibiotics and supportive treatment with intravenous fluids and blood transfusion if necessary. riFT vALLeY Fever*

Other names in humans: none

Rift Valley fever (RVF) is a zoonotic arboviral disease that primarily affects ruminant livestock (cattle, sheep, and goats) and camels, but the disease can also occur in humans. Cattle, sheep, and goats appear to be particularly susceptible to infection. Animal infection is characterized by acute hepatic necrosis; increased abortions among pregnant animals; and high mortality rates in young, neonatal livestock populations. Most human infections are asymptomatic or may present as an uncomplicated influenza-like illness. However, a small percentage of human infections may result in significant neurological illness, retinitis, hepatitis, or hemorrhage progressing to death. RVF virus could potentially be introduced into the United States by an infected person or animal, especially during their viremic phase, or by an infected vector. Although RVF is currently found in Africa and the Arabian Peninsula, the virus has the potential to become established in other geographical areas owing to the abundant range of competent vectors capable of transmitting infection, the high level of viremia that develops in both infected animals and humans that allows sustainability of the virus, and the ability of the virus to adapt to different ecological conditions. However, for the virus to become established in the United States, climatic conditions must be favorable to ensure survivability of the mosquito vector, and appropriate numbers of livestock are necessary for adequate amplification of the virus. A recent publication evaluated potential pathways of RVF introduction into the United States and concluded that air transportation of a viremic civilian or mechanical transportation via aircraft or ship of an RVF-infected vector were likely pathways for introduction of RVF virus into the United States. 1 Therefore it is essential that communication among animal and human health officials be coordinated to detect this potentially devastating zoonotic infectious disease. Fortunately, a multiagency working group has been formed to discuss a research agenda, modeling efforts, and surveillance and response capabilities, among other activities, to develop a comprehensive national RVF prevention and response plan. 2

• Be alert to the possibility of RVF introduction into the Western hemisphere and the subsequent spread by mosquito vectors. • The irregular interval between RVF epizootics/epidemics adds to the challenge of preventing and controlling this virus. Consider increased use of techniques such as satellite remote sensing to predict global outbreaks of RVF. Environmental criteria in west and south Africa may require further evaluation to determine the validity and applicability of remote sensing imagery in these areas. • Ensure that populations that work with livestock in endemic areas use proper precautions when butchering and processing meat. • Use of mosquito control techniques may be highly effective in either preventing the introduction of the virus in domestic animal populations by killing immature stages of vectors 3 or control of adults during epizootic/epidemic conditions.

• Generally, the risk of infection in travelers is low. However, travelers to RVF-affected areas during an epizootic or epidemic should take appropriate precautions, such as using bed nets during sleep periods, using mosquito repellents, and avoiding contact with infected livestock. • Due to the zoonotic nature of this virus, it is critical that individuals take appropriate precautions when (1) performing necropsies on suspect animals, (2) performing laboratory procedures, (3) assisting with livestock parturitions, (4) butchering possibly infected animals, or (5) performing other procedures that may place them at high risk of exposure to RVF virus. • Report any suspected case of RVF to the appropriate local and state public health authorities. RVF cases suspected or confirmed in active duty U.S. military personnel are reportable to their respective services per the Tri-Service Reportable Events guidelines. 4 • Use appropriate precautions especially when handling acute-phase blood products from suspect patients. • No commercially available preventive vaccine exists for use in humans. An experimental inactivated vaccine has been used to protect laboratory and veterinary workers at high risk of RVF infection.

• Consider RVF infection with increased abortions in ruminants; high mortality rates in neonatal and young *The opinions and assertions contained in this chapter are the private views of the author and are not to be construed as official or reflecting true views of the Department of the Army or the Department of Defense, to whom the author was contracted during the writing of this chapter. The author is grateful for the contributions of Dr. Kenneth Linthicum to this section. lambs, kids, and calves; and human illness particularly after heavy rains. • In the United States, RVF is a foreign animal disease; therefore for any suspected case of RVF, it is critical to promptly notify the appropriate state and federal veterinary regulatory authorities. • Ensure that appropriate PPE is worn when performing a necropsy on a suspect animal, when treating an ill suspect case, or when assisting with reproductive procedures. At a minimum, consider wearing a mask (to help avoid aerosols), gloves, and goggles. • Before submitting any specimens for diagnostic purposes, contact the appropriate reference laboratory 5 to inquire about shipping requirements, diagnostic capabilities, and required specimens for submission. • Animal disease prevention in enzootic areas may be accomplished by vaccination of susceptible livestock. The administration to small ruminants of one dose of a live attenuated virus vaccine (Smithburn strain) may confer long-term immunity and will minimize animal disease before the onset of an epizootic. However, live vaccine use may induce abortions or fetal abnormalities in pregnant animals. For disease prevention in pregnant ruminants in nonzoonotic areas, an initial dose and booster dose of a formalin-inactivated vaccine may be administered to cattle, sheep, and goats; annual revaccination is required. In addition, animal movement control is essential to prevent introduction of infected animals into new geographical locations that can support maintenance of the virus.

RVF is a mosquito-borne virus of the genus Phlebovirus in the family Bunyaviridae 6 (Figure 9-112) . Vector transmission may occur by mechanical or biological means. It is a single-stranded enveloped RNA virus with three segments-S (small), M (medium), and L (large)-that is readily inactivated by a pH below 6.8, lipid solvents, or strong solutions of sodium hypochlorite. 7 There is only one serotype of RVF virus. However, there are three distinct lineages: Egyptian, West African, and Central East-African. 8

RVF is a disease that occurs primarily in Africa and the Arabian Peninsula. RVF was first identified in 1930 in Merino sheep along the shores of Lake Naivasha in the Rift Valley of Kenya 9 when a total of 3500 lambs and 1200 ewes died of acute hepatic necrosis after a period of excessive rainfall.

Herdsmen who managed the flocks on the farm also complained of fever and arthralgia. 9 Animal epizootics, along with human epidemics, have occurred periodically since then, primarily in sub-Saharan Africa. 10 During the past three decades, human and animal disease has also been confirmed in western Africa and Egypt, associated with the construction of dams and subsequent flooding or irrigation projects that favor mosquito production. In 1977-1978 an outbreak that affected both humans and animals was confirmed in Egypt, the first time the virus had been identified outside sub-Saharan Africa. 11 A second occurrence of RVF occurred in Egypt in 1993. In 2000, RVF infection was reported in southern Saudi Arabia and northern Yemen along the Red Sea, the first time this virus was confirmed outside the African continent. The appearance of the virus in this new geographical location was likely due to the importation of viremic livestock from eastern Africa into the Arabian Peninsula. 12 In Saudi Arabia, 882 human cases were reported that resulted in 124 deaths, 13 and Yemen reported 1087 suspected case patients and 121 deaths. 14 Abortions in small ruminants and increased mortality in young susceptible livestock were reported concurrent with human illness.

Human groups at increased risk of RVF infection include veterinarians, abattoir workers, livestock herdsmen, and virology laboratorians as a result of occupational exposures. During epidemics, the general human population is at risk as a result of direct contact with infected livestock or animal products (including unpasteurized milk) or exposure to mosquito vectors. During epidemics, the risk of infection to travelers, soldiers, relief workers, or other individuals may be high if exposed to infected mosquitoes or to infected animals, their blood, or infected tissues. Within animal populations, newborn ruminants (sheep, goats, and cattle) are particularly susceptible to RVF virus, resulting in a fatal infection; followed by pregnant ruminants; and then young sheep and cattle. Adult ruminants are less susceptible to infection; however, exotic breeds are more susceptible and exhibit more pathology. Horses and swine are even less susceptible. 

Many different species of mosquitoes are involved in the transmission of RVF; the virus has been isolated from more than 30 species among six genera of mosquitoes (Figure 9-113) . 15 Additionally, RVF virus has been isolated from flies and Culicoides, biting midges. However, a few arthropod species play key roles in the transmission during epidemics/epizootics and during the period between these disease-occurring events. The reservoir of RVF in sub-Saharan Africa is thought to be Aedes mosquitoes (Ae. vexans, Ae. mcintoshi, and Ae. dalzieli primarily) that can transovarially transmit RVF virus to their drought-resistant eggs, 16 thereby allowing the virus to remain dormant and survive for long periods in soil depressions pending significant rainfall. 17 This vertical transmission is critical in maintaining RVF in endemic/enzootic areas.

The natural reservoir of RVF virus is currently unknown. The role of wildlife in the perpetuation, maintenance, and circulation of virus during the interepizootic period is also not clearly understood. 18 Experimentally, rhesus macaques 19 and inbred laboratory mice 20 have been shown to demonstrate clinical signs of disease once infected with RVF virus.

Once appropriate levels of rainfall occur and land depressions fill with water, dormant RVF-infected Aedes mosquito eggs hatch and adults emerge (Figure 9-114) and, acting as primary vectors, feed on susceptible livestock (Figure 9-115) . Infected livestock amplify the virus, developing significant viremias-up to 10 8.0 plaque-forming units (PFUs)/mL 1and contribute to epizootic maintenance, circulation, and spread of the virus via secondary vectors (Culex mosquitoes) that feed on livestock and perpetuate the infection. Intense virus activity may last for 6 to 12 weeks. 21 Human infection can occur after a bite from an infected mosquito or by mechanical transmission from other insects. However, most infections occur as a result of direct or indirect exposure to infected blood, tissues, or body fluids of infected animals; by the butchering or slaughtering of infected animals; or by performing veterinary or obstetrical procedures on infected animals. In this way, RVF can be considered an occupational disease of individuals who work with livestock (see Chapter 12) . Infection occurs by way of inoculation or aerosolization and inhalation of virus. Infection may also occur subsequent to consuming unpasteurized milk from infected animals. Direct human-to-human horizontal transmission has not been documented; however, two recent articles describe case reports of vertical transmission of RVF infection from pregnant mother to fetus. 22, 23 Direct animalto-animal transmission has not been reported.

Epizootics and epidemics occur at irregular internals (ranging from 3 to 15 years) 21, 24 and typically follow significant rainfall that floods areas of sub-Saharan eastern and southern Africa, subsequently hatching dormant floodwater Aedes mosquito eggs. 25 However, in more arid areas of Africa, the interval may approach every 15 to 35 years. The frequency depends on rainfall and other climatic conditions that favor large vector populations, susceptible animal species populations, and the existence or introduction of virus in the geographical area. For these reasons, satellite imagery may offer an early warning of environmental conditions that favor disease occurrence, allowing a few months' lead time to mitigate disease impacts in both animals and humans. The National Aeronautical and Space Agency (NASA) and other agencies have used satellite imagery remote sensing to create predictive risk maps for RVF outbreaks. This remote sensing approach incorporates measures such as the normalized difference vegetation index (an indicator of recent rainfall and green vegetation), sea surface temperature, and rainfall. 26 In October 2006, this technology assessed such environmental conditions and accurately forecasted an outbreak of RVF in Kenya before an actual confirmed outbreak in December 2006. Figure 9-116 shows an example of an environmental risk map for RVF produced by NASA.

The outbreak in Egypt along the Nile Delta in 1977-1978 was a concern because the virus had not been previously identified north of the Sahara Desert. However, conditions that favored an outbreak included construction of the Aswan High Dam and flooding of the Nile River delta 24 and a concurrent large outbreak in East Africa. Another incident following a change to the environment occurred in western Africa in Mauritania and Senegal in 1987. One year after the construction of the Diama Dam and subsequent flooding of the Senegal River basin, an outbreak of RVF affected both humans and other animals. 24, 27 Despite the linkages between recent flooding and rainfall to many RVF outbreaks, not all follow this pattern because some outbreaks appear to be related to the trade and movement of infected viremic domestic animals across borders. 11, 12, 24 

In humans, the incubation period of RVF is 2 to 6 days; RVF produces an influenza-like illness with fever, headache, arthralgia, and myalgia. 28 Viremic titers are high after infection and can persist for more than 1 week. Recovery is usually complete; however, complications or a more serious form of the disease can manifest as three different syndromes.

Between 0.5% and 2% of human RVF infections result in retinitis; onset occurs 1 to 3 weeks after the initial symptoms. The disease may resolve within 10 to 12 weeks; however, permanent vision loss may occur in 1% to 10% of those with this syndrome. Death is uncommon in those infected with the ocular form of RVF.

Meningoencephalitis occurs in 1% of those infected with RVF, generally 1 to 4 weeks subsequent to the initial symptoms. Patients may report an intense headache, photophobia, memory loss, and confusion; convulsions and coma may ensue. The death rate is low; however, neurological sequelae are common in individuals with this form of RFV infection.

Fewer than 1% of those infected have hemorrhagic fever, which typically develops 2 to 4 days after illness onset; jaundice is generally observed first. Additional hepatic involvement manifests as hemorrhage, hematemesis, melena, ecchymoses, and persistent bleeding from other sites. Death occurs 3 to 6 days after onset of these symptoms; the case fatality rate may approach 50%. The overall case fatality rate of RVF infection in humans typically ranges from 0.5% to 1.0%. However, during a recent outbreak in Kenya, the case fatality rate was 29% among 404 confirmed or probable cases during a 3-month period from November 30, 2006 , to January 25, 2007 The high case fatality rate was likely due to severe illness and the hemorrhagic fever presentation of many of those infected.

RVF causes morbidity and mortality in many different livestock species. In Africa, exotic livestock breeds are more susceptible to infection than indigenous breeds such as Bos indicus. 21 In pregnant ungulates, abortion is the most common clinical sign. Abortion may occur at any time during the gestation period and the rate may approach 100% in infected pregnant ewes. In newborn lambs, kids, and calves after an incubation period as short as 12 hours, the most prevalent clinical sign is death, preceded by fever. Mortality rates can approach close to 100% in some species. Older animals may demonstrate weakness, anorexia, listlessness, and a nasal discharge. Infection in adult cattle and small ruminants is often subclinical; however, some animals may develop fever, anorexia, bloody diarrhea, and a mucopurulent nasal discharge. Adult camels do not demonstrate clinical signs of illness; however, they do abort. The mortality rate in adult livestock may range from 10% in cattle to 20% in sheep. Infection and disease in domestic animals causes considerable economic losses because of the significant number of abortions, the high rate of mortality in young ruminants, and the disruption in trade and exports that are associated with epizootics.

Although some species of wildlife have detectable antibody levels against RVF, such infections are generally subclinical. One recent publication reported that of 16 different wildlife species sampled during 1999-2006 in Kenya, seven had detectable neutralizing antibodies against RVF. These data suggest that native wildlife are indeed infected with RVF 30 ; however, additional studies are needed to determine their role as reservoirs or amplifiers of the virus. Table 9 -57 shows the comparative presentation of disease in humans and other animals.

In humans, RVF should be suspected in the differential diagnosis when the following conditions are observed: influenza-like illness, retinitis, and/or meningoencephalitis and hemorrhagic fever in individuals with livestock contact, especially in the setting of high mosquito vectors associated with recent flooding or after significant rainfall. Cases of abortion in ruminants also support the diagnosis in humans. Recent human infection is determined by serology to detect IgM antibodies by ELISA; by virus isolation during the acute, viremic phase; or by RT-PCR to detect viral antigen. 28 In animals, the differential diagnoses for a "storm" of abortions in pregnant ruminants and a high mortality rate among young/neonatal ruminants includes a number of diseases such as brucellosis, ovine enzootic abortion, Nairobi sheep disease, rinderpest, peste de petit ruminants, vibriosis, ephemeral fever, Wesselsbron disease, trichomonas, and heartwater. To detect RVF infection in animals, heparinized blood may be analyzed for virus isolation, especially during the acute phase when virus levels are elevated. Acute and convalescent sera can be used to detect a rise in antibody levels by ELISA or hemagglutination inhibition; antibody is present within 6 to 7 days after infection. 31 Tissue specimens may also be submitted for virus isolation as long as they are not formalinized. Electron microscopy may be used to detect viral particles in tissue specimens or RT-PCR can be used to detect viral antigen. For histopathological review, the best necropsy samples to submit in 10% buffered formalin include the spleen, liver, and brain (particularly from aborted fetuses).

Asymptomatic human infections typically do not warrant treatment. For individuals with more significant illness, treatment is supportive. Although there are no specific antivirals that are effective once symptoms occur, antivirals such as ribavirin and interferon-alpha have shown some promise in treatment trials involving nonhuman primates. There is no treatment available for infected animals. 

Other names in humans: Salmonella infection

The genus Salmonella was named after Dr. Daniel Salmon, a noted veterinary pathologist. As an infectious disease challenge, it epitomizes the importance of human health and animal health clinicians working collaboratively. It is one of the most common causes of infectious diarrhea and gastroenteritis. At the same time, its true importance is probably underestimated; it is thought that fewer than 1% of cases in industrialized countries, and even fewer in developing countries, are reported.

• Educate clinicians that Salmonella infection is reportable to public health authorities. • Educate the public about the risk to children and others of Salmonella poisoning from food. • Use good kitchen hygiene; be particularly careful with foods prepared for children, the elderly, or immunocompromized individuals. • Thoroughly wash raw vegetables and fruits. • Do not eat foods made with raw eggs or unpasteurized milk products. • Cook poultry, ground beef, and eggs thoroughly. • Breastfeeding prevents salmonellosis and many other health problems in infants. 1 • Educate the public, veterinarians, and human health clinicians on CDC guidelines for prevention of reptile and other animal associated salmonellosis; such educational messages have proven effective 2 (Box 9-6; see also http://www.cdc.gov/healthypets/spotlight_an_ turtles.htm). 3 • Ensure that local petting zoos and other areas where the public has contact with animals have policies and procedures for reduction of infection risk such as handwashing stations. • Ensure that local pet stores are not selling small turtles. • Disinfect with 1% sodium hypochlorite, 70% ethanol, 2% glutaraldehyde, or iodine solutions.

• The disease is reportable to public health authorities.

• Ask about a history of pet and other animal contact in all patients presenting with gastroenteritis and other Salmonella infections.

• Counsel pregnant women to remove any reptiles kept as pets in the house. 4 • Counsel immunocompromised patients, young children, older adults, and patients with sickle cell anemia to avoid contact with puppies and kittens that have diarrhea and with any reptiles, baby chicks, or ducklings.

• Counsel pet owners not to feed dogs and cats raw meat diets and to wash hands after handling animals, feces, and animal food treats. • Counsel owners to practice good sanitation of cages, runs, feed and water dishes; proper storage of feed and feed utensils; reduce overcrowding situations; isolate and screen for illness in new animals. • Ensure that appropriate infection control procedures are being followed by staff in veterinary care facilities. • Counsel clients that immunocompromised individuals, infants, and older adults should avoid contact with reptiles, baby chicks, and ducklings.

• Pet store owners, health care providers, and veterinarians should provide information to owners and potential purchasers of reptiles and amphibians about the risks for and prevention of salmonellosis from these pets. • Persons at increased risk for infection or serious complications from salmonellosis (e.g., children younger than 5 years and immunocompromised persons) should avoid contact with reptiles and amphibians and any items that have been in contact with reptiles and amphibians. • Reptiles and amphibians should not be allowed in households that include children younger than 5 years or immunocompromised persons. A family expecting a child should remove any pet reptile from the home before the infant arrives. • Reptiles and amphibians should not be allowed in child care centers. • Persons always should wash their hands thoroughly with soap and water after handling reptiles and amphibians or their cages. • Reptiles and amphibians should not be allowed to roam freely throughout a home or living area. • Pet reptiles and amphibians should be kept out of kitchens and other food-preparation areas. Kitchen sinks should not be used to bathe reptiles and amphibians or to wash their dishes, cages, or aquariums. If bathtubs are used for these purposes, they should be cleaned thoroughly and disinfected with bleach. • Reptiles and amphibians in public settings (e.g., zoos and exhibits) should be kept from direct or indirect contact with patrons except in designated animal-contact areas equipped with adequate handwashing facilities. Food and drink should not be allowed in animal contact areas.

From Centers for Disease Control and Prevention: Diseases from reptiles. http://www. cdc.gov/healthypets/animals/reptiles.htm. Accessed January 16, 2009. • Counsel owners who want to give antibiotics prophylactically to their pets that that practice is ill advised due to the possibility of selecting for antibiotic-resistant strains. • Be aware of CDC recommendations about reptiles and pets; see http://www.cdc.gov/healthypets/spotlight_ an_turtles.htm. • Counsel reptile owners on proper handwashing after pet handling and not bathing reptiles in bathtubs or sinks (Figure 9 -117). 5

Salmonella are gram-negative, facultative anaerobic rodshaped bacteria belonging to the family Enterobacteriaceae that colonize the small intestine. There are thousands of distinct serovars, many adapted to particular animal species. In humans, the most common agents are S. typhimurium and S. Enteritidis. Salmonella Typhi, the causative agent of typhoid fever, and S. Enteritidis serotype Paratyphi are found only in humans. Most Salmonella serovars have animal reservoirs and are potentially zoonotic. β-Lactamase-mediated antimicrobial resistance is common. Antibiotic resistance in Salmonella species has been linked to the use of antibiotics in animal agriculture. 6

Salmonella occur commonly worldwide in both animals and humans. S. Enteritidis is the most common species, followed by S. typhimurium.

Young children appear to be at increased risk of significant infection. Playing in sandboxes has been linked to risk in children. 7 Older adults and immunocompromised individuals are also considered high-risk groups. Individuals with HIV infection are at risk of recurrent septicemia. Patients with sickle cell disease can develop focal infections such as osteomyelitis. Other risk factors include achlorhydria, antacid treatment, antibiotic therapy, and malnutrition. Ownership of reptiles and other pets (including rodents) is a risk factor for infection (Figures 9-118 and 9-119 ). An estimated 4% of the U.S. population owns reptiles, and a FoodNet study estimated that 6% of reported salmonellosis cases in the United States were attributable to reptile and amphibian ownership. 8 Salmonellosis can also be an occupational disease. An outbreak occurred among 45 workers in companion animal veterinary medical facilities, and lack of proper biosafety precautions was considered the cause. 9 Other cases have occurred among veterinary pathologists performing necropsies, 10 workers producing poultry vaccines, 11 and workers exposed to raw meat. 7 Newborns and debilitated animals are at risk of more severe disease. Crowding, boarding, mixing, and malnutrition are stressors that predispose many animals to infection. Group housing is associated with higher rates of infection in cats. Feeding dogs and cats raw meat has been found to increase the risk of infection. 12 Dry pet food and pig ear dog treats have been found to be contaminated and pose a risk to pets and their owners.

Animals are the natural reservoir for all Salmonella species except S. Typhi and S. Paratyphi. A wide range of species may be asymptomatic carriers of Salmonella, including dogs, cats, birds (including poultry), cattle, swine, horses, reptiles and amphibians, wildlife (including rodents), carnivores, and even crustaceans. Poultry are considered one of the principal reservoirs for Salmonella organisms and have harbored hundreds of different serovars.

Prevalence rates of subclinical infection in dogs is between 1% and 35%. 13 A recent survey found infection rates as high as 50% in group-housed cats. 14 Infected migrating songbirds can result in epidemics in bird-hunting cats.

Reptiles have rates of subclinical infection as high as 90% and pose a significant risk of transmission to pet owners and animal handlers in zoos and pet stores. The sale or distribution of small turtles has been illegal in the United States since 1975 because children were more likely to treat smaller turtles as toys and put them in their mouths. 15 However, pet turtles continue to be sold illegally and have caused recent outbreaks of salmonella infection.

Salmonella is considered primarily a foodborne disease, usually of animal origin. Food or water that is contaminated with feces from an infected animal is then ingested by a susceptible human host (Figure 9-120) . Person-to-person spread can occur by the fecal-oral route or by food handlers who are shedding organisms and contaminate ready-to-eat food items.

Infection can occur sporadically or in large outbreaks involving thousands of individuals with a common exposure. 16 Contaminated peanut butter and peanut paste was the source of a multistate outbreak of S. Typhimurium infection for people and pets through contamination of processed foods and pet treats. 17 An outbreak in humans and dogs in the United States and Canada was linked to contaminated raw food pet treats; presumably the owners did not wash their hands adequately after handling the treats. 18 Coprophagia and scavenging spreads the bacteria. Zoonotic transmission can also occur by direct contact with the feces of an infected animal. Animals with acute illness shed copious numbers of Salmonella in feces. 

Salmonella can persist for months in food, feces, soil, and water given appropriate environmental conditions. The bacteria are resistant to dehydration and salinity. Survival in composted manure is as short as a week, and pasteurization kills Salmonella organisms. 19 Seasonality appears to affect the occurrence of disease, with more cases reported in the spring and summer. 20

Human infection with non-typhi Salmonella can take a number of forms, including gastroenteritis, bacteremia and vascular infection, localized infection, and chronic carrier state (Figure 9-121) . 21 Gastroenteritis in an immunocompetent adult often manifests as self-limited diarrhea. The incubation period is 6 to 72 hours. The principal symptoms are acute onset of diarrhea, often accompanied by nausea, abdominal pain, headache, fever, myalgias, vomiting, and malaise. Dehydration, sometimes severe, may occur, especially among the young and elderly. In most cases, symptoms resolve within 3 to 7 days. Diarrhea lasting longer than 10 days should suggest another diagnosis. However, convalescent patients may shed bacteria for weeks or months, and a chronic carrier state can occur in adults. 21 Certain strains of Salmonella are particularly pathogenic in humans, such as S. choleraesuis and S. dublin, which can cause prolonged bacteremia, invasive disease, and death. 6, 22 However, other Salmonella serotypes can also cause bacteremia, which can be accompanied by endovascular infection.

Localized infection can occur in 5% to 10% of cases of bacteremia. Specific infections include osteomyelitis, septic arthritis, endocarditis, meningitis, and pneumonia. Patients with sickle cell anemia are more susceptible to some of these conditions. 21 In patients with AIDS and other immunocompromised individuals, bacteremia is common and often includes severe complications including localized infections, fulminant diarrhea, and death.

In adult cattle, sheep, pigs, and horses the disease takes three forms: subclinical carriage, mild clinical disease, or acute onset of fever and diarrhea, often with dehydration, abdominal pain, and sometimes bacteremia and death (Color Plates 9-62 to 9-64). Abortion may be the presenting sign of infection. Malabsorption and pneumonia may be part of the clinical syndrome. Newborn calves, lambs, piglets, and foals are more likely to develop septicemia (Figure 9-122) . Outbreaks occur on farms, often precipitated by crowding, stress, calving, and mixing in feedlots. 19 Outbreaks also occur in equine hospitals. 19 In dogs and cats, the disease is often subclinical. In puppies, kittens, or adults stressed by hospitalization, boarding, or concurrent disease, acute diarrhea with fever and septicemia can occur. Complications can include development of chronic infection and recurrence of disease under stressful conditions.

In caged birds, clinical salmonellosis is rare but may be seen in immunocompromised or stressed animals (songbird fever) (Color Plate 9-65). Although poultry often do not manifest disease, two serovars adapted to poultry, S. Pullorum and S. Gallinarum, cause serious losses on farms worldwide. Pullorum disease causes anorexia and diarrhea in chicks and has a high mortality rate. Fowl typhoid due to S. Gallinarum is a disease of adult birds (Figure 9-123) .

Reptiles can shed Salmonella without clinical signs; however they may develop abscesses (Figure 9-124) . Infection in wildlife is common, and clinical cases have been seen even in manatees and beluga whales. 19 Table 9 -58 provides clinical presentations of salmonellosis in humans and other animals. 

Gastroenteritis in humans due to Salmonella can resemble other bacterial, viral, and protozoal forms of diarrhea. The incubation period and the presence of fever and often bloody stools can help narrow the differential diagnosis, and definitive diagnosis is made by bacterial culture In animals, fecal analysis and culture are used to diagnose infection. In poultry, serology is used to identify and eliminate flocks that have carriers of S. pullorum and S. gallinarum.

The mainstay of treatment for enteritis caused by Salmonella in immunocompetent adults is fluid and electrolyte replacement. Mild and asymptomatic infection does not require antibiotic treatment. Indications for the use of antibiotics include age younger than 1 year or older than 50 years, compromised immune status, and presence of vascular grafts or prosthetic joints.

When antibiotics are used, their use should be guided by the culture and sensitivity results because some Salmonella organisms are resistant to ciprofloxacin and other antibiotics. Evidence of localized infection is an indication for longer courses of treatment. Antimicrobial treatment may also prolong the carrier state, which may affect the ability of some food workers to return to work.

Subclinical carriage in animals is not treated with antibiotics. If an adult dog or cat has uncomplicated gastroenteritis, it also can be treated without antibiotics with isolation, supportive care, and gastrointestinal protectants. Infected neonates, aged, and immunocompromised animals are candidates for isolation, possible plasma transfusions, supportive care, and glucocorticoid (for endotoxic shock) and antibiotic therapy. Fecal cultures should be monitored on a monthly basis to determine whether an animal is a carrier. Table 9 -59 shows recommend antibiotics for treatment of Salmonella infection in humans and other animals when antibiotic treatment is appropriate. 

Scabies is a skin infestation caused by the mite Sarcoptes scabiei. Reports of scabies in humans date back to antiquity, and it was the first infectious disease linked to a specific etiology with the use of a microscope. In 1834 the mite was conclusively demonstrated on a young female patient in a Paris clinic, establishing the association between the mite and its dermatological manifestations. 1 This little-appreciated historical event represented the first etiological diagnosis in medicine. In human medicine, scabies continues to cause both sporadic cases and outbreaks in industrial countries, and immunocompromised persons can experience severe infection. Dogs and many other animals also experience significant infections with variants of S. scabiei that are adapted to particular host species. With close contact such as occupational exposure, transmission of animal scabies variants from animals to humans can occur. Although such zoonotic infestations (pseudoscabies) are usually self-limited, they underscore the importance of communication between human and animal health professionals about cases of skin rashes occurring concurrently in humans and animals. This section focuses on scabies, but there are a number of other mite species that infest animals and are capable of causing self-limited skin infections in humans that may be misdiagnosed or missed by medical providers.

• Be alert for outbreaks of skin disease caused by scabies in situations of human crowding. • Consider zoonotic mite infestation as a cause of outbreaks of skin rashes in the community; consult with local veterinarians.

• Educate veterinarians about the zoonotic potential of scabies and other mites and encourage voluntary reporting of cases of sarcoptic mange in animals.

• Disease usually not reportable but public health authorities should be notified in outbreak settings such as among institutionalized persons and day care centers. • In evaluating cases of pruritic skin rash, consider possibility of zoonotic transmission of scabies or other mites (pseudoscabies); ask about contact with animals or fomites that could contain mites. Consider consulting a veterinarian. • Immunocompromised patients may present with heavier scabies mite burdens, requiring extended treatment regimens. • Delusions of parasitosis can be an underlying condition in the absence of scabies or following diagnosis and treatment of actual infestations.

• Counsel owners of a pet with scabies about the risk of human transmission and that it could be self-limiting or persistent, requiring treatment after the pet has been treated. • Advise health care providers and public health professionals about the risk to humans of animal scabies and other mite infestations. • Companion animals should be carefully screened for scabies and other mite infestations. • Animal scabies may be reportable to agriculture/public health authorities if history is linked with a pet store or facility that permits contact with animals in public settings (e.g., petting zoo). • Some states require reporting of sarcoptic mange in sheep and cattle.

Sarcoptes scabiei is a species of mite in the family Sarcoptidae that lives parasitically on or in the skin of mammals. Adult mites are 0.3 to 0.5 mm long and roughly circular with four pairs of legs (Figure 9-125) . Variants of S. scabiei are found in a variety of animal species but are taxonomically indistinguishable between human and animal species. For example, scabies in dogs is caused by S. scabiei var canis. 2 In addition to S. scabiei, a number of other mites that infest animals are able to also cause skin rashes in humans. Table 9 -60 lists some of these mite species with zoonotic potential. Dermanyssus gallinae, the red poultry mite, is a nocturnal blood-sucking mite that is the most common mite found in pigeons. Close contact with poultry, wild birds, or nesting material can lead to human infection, which presents as a nonspecific dermatitis that is intensely pruritic and often misdiagnosed. 3, 4 Cheyletiella species, the walking dandruff mite, may be present as a subclinical infection in dogs and cats but can cause an erythematous, papular rash in humans in contact with infected animals. The papules are usually on the arms, trunk, and buttocks and develop into yellow crusted lesions that can be intensely pruritic. Rarely, bullous eruptions and systemic reactions have been reported. 5, 6 Otodectes cynotis is a common mite found in the ears of dogs and cats, where it causes local irritation. It can migrate to other parts of the pet's body, and because it is not host specific, it is capable of infecting humans as well, causing a papular skin rash or an external otitis. 6 Notoedres cati (feline scabies) is a rare but highly contagious disease of cats that can also infect humans, 7 causing a pruritic rash within hours without visible skin burrows (Figure 9 -126 and Color Plate 9-66).

Scabies is a global problem with widespread distribution in human populations of all ages. It is also found in animal populations worldwide. Outbreaks of often fatal sarcoptic mange in animals have occurred in wildlife populations such as foxes, leading to fluctuations in population size.

Human scabies can occur in outbreaks among institutionalized patients 8 or in other situations of crowding such as refugee camps. The presence of immunocompromised patients in such settings may facilitate transmission, and immunocompromised individuals are at risk of more severe infection. Sexual contact is another major risk factor for disease transmission.

Persons at risk for zoonotic transmission of scabies include farmers, veterinarians, wildlife rehabilitators, and pet owners who have close contact with potentially infected animals.

In industrialized nations, scabies often presents as a sexually transmitted parasitic infection with secondary transmission to household members, especially children, who are easily infected when parents or caretakers are infested. 9 Patients with HIV-AIDS and other immunocompromising states are easily infected and sustain heavy mite burdens leading to crusted or hyperkeratotic scabies. 10 In animal populations, contact with infected animals is the major risk factor for scabies infection. Puppies, especially those from a pound or animal shelter or whelped in a large breeding kennel, may be at increased risk. Dogs that are allowed to roam freely and contact wildlife or other dogs, including at dog parks, may be at higher risk of infestation. 6 Debilitated animals may be at increased risk of severe cases of sarcoptic mange. Wildlife also can sustain scabies; foxes are particularly susceptible to heavy mite infestations (Figure 9 -127). In one case report, a wild red fox (Vulpes vulpes) infected a wildlife rehabilitator and a veterinarian who were treating the animal, as well as several dogs residing near a golf course where the affected fox was originally found. 11

Only one distinct genus and species of S. scabiei exists but variants are somewhat host adapted to humans and various specific animal populations. Species affected include dogs, cattle, sheep, pigs, horses, and foxes. Variants adapted to one species may infect another species, but in such instances sustained transmission does not occur.

The S. scabiei mite is not considered a vector for other infectious agents, although cases of infestation may become superinfected with Staphylococcus, Streptococcus, or other bacteria.

Scabies is transmitted through sustained direct skin-toskin contact 12 during activities such as sexual contact, holding infants and animals, or while performing handson care. Casual contact such as handshaking is unlikely to lead to transmission. Sustained person-to-person and other intraspecies transmission requires adult female mites. After impregnation, the female burrows quickly into the epidermis of the host animal, forming a tunnel in the stratum corneum at the boundary with the stratum granulosum ( Figure  9 -128). Two to three large eggs are laid daily and these hatch in 4-6 days, giving rise to nymphal mites that molt to adult forms. Eggs develop into adult mites within 10 to 14 days.

Because many variants of the scabies mite cannot live long outside the body, indirect transmission via fomites is generally less important than direct transmission. However, in the case of crusted (hyperkeratotic) scabies, infected individuals have enormous quantities of mites on their person and shed mites on clothing, bed linen, and even furniture. 13 These mites can persist for days on particles of sloughed epidermis. In such situations, contact with fomites can easily lead to further disease transmission.

When an animal strain of S. scabiei infects a human, the mite is able to penetrate the skin and rapidly cause a pruritic rash but is unable to successfully reproduce and persist. The result is the self-limited condition termed pseudoscabies. Reverse zoonotic transmission can also occur.

Mites in the environment are highly susceptible to temperature and humidity conditions and rarely survive beyond 2 to 3 days. Higher ambient temperatures lead to lower survival times. 7 Environmental conditions that predispose human to scabies transmission include crowding and institutionalization. Similarly, environments with animal crowding and extensive animal-to-animal contact, such as animal shelters, breeding colonies, dog parks, and crowded kennels, may encourage animal-to-animal transmission of scabies. Areas where wildlife such as foxes contact domestic animals also represent environmental risks.

Scabies in humans is manifested about 20 to 35 days after transmission and results in pruritus that is particularly evident in the evening hours while the affected person is trying to sleep. This hypersensitivity is incompletely understood and results from some metabolite of the mites. Skin lesions commonly appear on the webbing of the fingers, genitalia, breasts, flexor surface of the wrists, elbows, and later the abdomen. The burrow or track is diagnostic (Color Plate 9-67) but is not always visible. More commonly papules and vesicles are the most typical skin lesions. Feet and legs are commonly affected areas in children. Rarely do lesions appear on the face and neck except in infants and immunocompromised patients, in whom face and neck lesions are more common.

Elderly patients such as residents of long-term care facilities frequently have extensive lesions on the shoulders and upper back as well as the usual areas noted. Secondary eczematization or thickening of the skin is common in this population, as well as low-grade bacterial infections such as Staphylococus aureus and Streptococcus pyogenes. Although these cases are fairly easy to diagnose, they also are more challenging to treat.

Crusted or hyperkeratotic (Norwegian) scabies occurs usually in immunocompromised patients and has a distinctive appearance of grey-green crustiness on the hands and feet, occasionally elbows and arms. Pruritus may be absent. This condition is also easy to diagnose but very difficult to treat. Color Plate 9-68 shows a patient with crusted scabies. In cases of pseudoscabies, intense pruritus and an erythematous rash are often present, but burrows may be absent.

The presentation of disease in animals is variable as shown in Table 9 -61. The hallmark of animal scabies is pruritus that may not represent location of mites; this is also true for humans (Figures 9-129 and 9-130) . Generally longer duration infestations result in thickening of skin with secondary bacterial infections. 7 In clinical veterinary practice, sarcoptic mange is a common presentation in dogs. The infestation has no age, breed, or sex predilection, occurs with no seasonality, and presents as an intensely pruritic, papular crusting dermatosis affecting the periocular skin, pinnal margins, elbows, and hocks, which may later progress to more generalized involvement, especially of the ventral areas (Figure 9-131 ). There may be very little to moderate hair loss in contradistinction to demodicosis (eyelash mites) or red mange, which shows little pruritus and extensive alopecia.

In horses, sarcoptic mange is the most severe type of mange, with intensely pruritic lesions on the head, neck, and shoulders. Swine historically have suffered extensive involvement, calling for routine mass treatment of most herds. Modern antihelmintic treatment of swine with broad-spectrum parasiticides has successfully eliminated this problem. Foxes may develop severe sarcoptic mange that can be fatal.

Skin scrapings are the most common and reliable method to demonstrate the presence of mites, eggs, and scybala (discrete fecal pellets) in both humans and other animals. This procedure is as simple as it is essential and could be performed by technicians, nursing staff, physicians, and veterinarians. Standard references 14 call for applying mineral oil (some clinicians prefer to use type B microscopic immersion oil because it is more viscous and easier to work with) to a lesion or placing oil on a sterile scalpel blade (disposable #10 or #20), which is held at a right angle to the skin surface and used to scrape the area in a manner to remove visible skin debris until the superficial skin or stratum corneum is removed, leaving the scraped area pink but not necessarily hemorrhaging. The material adhering to the blade from two to three postage stamp-sized areas is then transferred to a microscope slide, diluted with more oil if necessary, with a cover slip applied after using it to scrape excess oil adhering to the scalpel blade, and the wet mount specimen is examined under ×4 and ×10 low power. The slide should be methodically examined as follows: Sweep left to right, move down one field, and right to left until the entire slide area is examined for mites (adults, nymphs, or larval mites) or distinctive eggs and the smaller scybala (fecal pellets that are numerous and distinct brown-gold/orange in color). Occasionally some skin lesions may be due to the Demodex folliculorum mite (eyelash mite) that has widespread distribution in human populations. These distinctive cigar-shaped mites have an elongated tail structure, whereas Sarcoptes mites have a distinctive turtle-like shape with four pairs of legs (Figure 9-132) .

The scraping procedure not only enables diagnosis within minutes, but also helps to classify patients for mite load. A human patient's scraping with only a mite or two prob- ably is not highly infectious for others (average of 10 adult female mites on a patient) and needs only minimal treatment and simple contact precautions for a brief period of a day or two. However, patients with crusted or hyperkeratotic scabies demonstrate an extraordinary number of mites on each slide. Patients, especially the elderly with a history of extensive home care or long-term care residency, may have a large number of mites from skin with red, raised, pruritic lesions and evidence of secondary eczematization. Although these lesions are not specifically crusted scabies, these cases are classified as "atypical crusted scabies" or "aggressive scabies" and require more intense treatment and oversight. 15 In dogs and humans, skin scrapings may not always produce mites or their effects but call for thorough attempts at recovery nonetheless. After scraping and in the absence of mites, a diagnosis can be made based on exclusion of other diseases, epidemiological links, clinical impression (degree of pruritus, history, distribution pattern), and response to treatment.

Other techniques for diagnosis include epidermal shave biopsy, needle biopsy, and burrow ink test. In the latter technique, a blue or black felt-tip pen is rubbed over the lesions and then ink is removed with an alcohol pledget and the blue or black ink dye is pulled into the burrow by capillary action and is diagnostic. A solution of tetracycline can also be applied and examined under a Wood's light. Table 9 -62 outlines treatment guidelines with various scabicides. Treatment is preceded with a bath or shower in water 

Ivermectin 200 mcg/kg PO or SC, for 2 treatments 2 weeks apart of tepid temperature. Patients should clip fingernails and toenails, remove rings and bracelets, and wash the area under nails with a hand brush or toothbrush. Apply the scabicide according to directions behind the ears and from the neck down, paying particular attention to the hands (especially between fingers), the umbilical area, groin, the buttocks, and feet (especially between the toes). The medication should be left on for the prescribed number of hours and then thoroughly rinsed off with tepid soapy water (bath or shower). At the conclusion of therapy, intimate articles of clothing and bed linens should be laundered in hot water and dried on the hot cycle. Patients should be counseled that 24 hours after therapy, they no longer are infectious but may still experience itching for a few weeks afterward. Family members should be treated even if asymptomatic. The majority of patients respond to one treatment, and although there is a lack of well-controlled studies documenting that two applications are better than one, treatment is usually repeated, especially if there is microscopic and/or morphologic evidence of treatment failure. Patients in institutional settings may have a higher mite burden and require one to two additional treatments. Scabies in immunocompromised individuals (crusted or Norwegian scabies) generally requires much more intense scabicidal treatment. Keratolytic agents (salicylic acid or alpha-hydroxy acid products) can be used to soften tissue, permitting better penetration of topicals, coupled with frequent reassessment and longer periods of contact isolation. Bedding and personal effects initially need special handling. Such patients have heavy mite burdens and need multiple applications of topical treatments.

Treatment of pseudoscabies due to zoonotic mite transmission often relies on treatment of the infected animal and disinfection of the environment. Consultation with a veterinarian is recommended if zoonotic transmission is suspected.

Treatments for animals are summarized in Table 9 -62. Requirements vary with species and age of the animal. It is wise to follow label directions owing to risk of toxicity. It is important to counsel animal handlers about risk of human transmission.

Treatment may be approached topically or systemically. Topical treatments include a 2.5% lime sulfur dip (Lym Dip; DVM Pharmaceutical, Inc.) that is licensed for weekly use with a wide margin of safety. Disadvantages include foul odor and staining of light-colored coats. Amitraz (Mitaban; Pharmacia & Upjohn Animal Health) is an alternative and is applied as a 0.025% sponge-on solution at 2-week intervals. Amitraz should not be used on Chihuahuas, in pregnant bitches, or puppies younger than 3 months. Clipping hair of dogs with long coats and/or dense hair coats is recommended. Amitraz vapors can induce hyperglycemia; it should not be handled by individuals with diabetes or applied to patients with diabetes.

Systemic therapy is an attractive alternative and includes extralabel use of macrocyclic lactones-for example, ivermectin (Ivomec; Merial Animal Health), milbemycin (Interceptor; Novartis Animal Health), moxidectin (Cydectin; Fort Dodge Animal Health), and selamectin (Revolution; Pfizer Animal Health) that are licensed for treatment of canine sarcoptic mange. Ivermectin should not be used in Collies or sheep dogs and their crosses. Consult product literature for safe and proper administration. 16 It would be prudent to also treat all dogs known to have contact with an affected animal. Concurrent environmental treatment of bedding, grooming equipment, and the general areas of habitation with an ascaricidal spray (e.g., one containing permethrin) is recommended to prevent possible reinfestation.

Infection with roundworms of the genus Toxocara is probably one of the most common infections associated with ownership of cats and dogs. Puppies and kittens often have symptomatic infections. Visceral or ocular larval migrans can occur in people. Seroprevalence studies suggest 5% to 30% of children may be infected. 1 

• Ensure pet owners bring animals for strategic deworming and prompt parasite treatment.

• Counsel pet owners about the proper disposal of animal feces and handwashing. • See the CDC manual about toxocariasis for veterinarians that reviews specific prevention and treatment measures 4 ; available online at http://www.cdc.gov/ncidod/ dpd/parasites/ascaris/prevention.htm. • Recommend keeping cats indoors.

Toxocara canis and T. cati are ascarid roundworms (nematodes) that are large (10 to 12 cm long) and live in the small intestine of carnivorous mammals but also migrate into tissues and cause extraintestinal pathology (Figure 9-133) . T. canis is recognized more widely in both animals and humans than T. cati and causes more serious infections in dogs. 5 Toxascaris leonina is seen in adult dogs and cats and is less well recognized as a zoonotic agent. The raccoon roundworm, Baylisascaris procyonis, results in rare but serious disease in humans.

Toxocara infections occur worldwide, with human seroprevalence rates varying widely (from 0 to more than 80%) among populations. 3 A recent CDC study estimated the seroprevalence rate in the United States at 14%. 6 In one study, more than 30% of dogs younger than 6 months sampled across the United States were shedding T. canis eggs, whereas rates of feline infection with T. cati have been reported to exceed 25%.

Although roundworms can occur in adults, disease in children is most frequently reported. A recent CDC seroprevalence study found increased risk among children and youth younger than 20 years. Children are believed to have the highest attack rates as a result of direct contact with dogs and cats and/or soil contaminated by infective eggs. Children with pica (inappropriate ingestion of soil and other substances related to nutritional deficiencies) are considered at increased risk.

Humans, dogs, cats, and wild carnivores can develop clinical manifestations. Humans are a terminal host, meaning that the roundworms cannot reproduce and carry on their life cycle. Rodents are paratenic hosts. 7

In both animals and humans, infection often begins by swallowing of infective, embryonated eggs. Because the eggs take up to two weeks to embryonate, the source of eggs is usually contaminated soil or food rather than direct contact with an infected animal. 8 These eggs then hatch, the larvae penetrate the intestinal mucosa, and then migrate through the liver and bloodstream to the lungs (Figure 9 -134). In humans, they may then pass to other tissues as well, causing granulomatous lesions in the lungs and abdominal organs (visceral larva migrans) or the eye (ocular larva migrans). 3 If infective eggs are swallowed by a puppy, the larvae hatch and migrate as above; but once in the lungs, the larvae are often coughed up and swallowed to then mature into adult worms in the animal's small intestine. These adult worms then produce eggs, which are shed in the puppy's feces, and also can cause abdominal distention and obstruction.

Transplacental transmission occurs when a pregnant bitch transmits infective larvae directly to the developing fetus. Larvae that migrate to the mammary gland can also be passed to puppies during nursing. 5 Cats are thought to be infected by eating tissue containing larvae of other infected animals, especially rodents. 7 Transplacental passage of T. canis is not thought to occur in cats, but transmammary transmission has been reported. 4

Because the eggs of Toxocara species can survive for years in soils, 7 the degree of environmental contamination of playgrounds, sandboxes, and other locations frequented by children is a significant environmental risk factor. In surveys in the United States, the United Kingdom, and Japan, 30% of playground soil samples and 75% of sampled sandboxes contained potentially infectious eggs. 3

Toxocara infection in humans is usually asymptomatic. When disease develops, it is often chronic and mild and related to hypersensitivity response to larval invasion of tissues. The two main forms of disease are visceral larva migrans and ocular larva migrans.

Visceral larva migrans is seen particularly among preschool children. Signs and symptoms include fever, weight loss, wheezing, cough, abdominal pain, skin rashes, and hepatosplenomegaly. Laboratory findings include leukocytosis and eosinophilia.

Ocular larva migrans may develop as long as 10 years after infection with T. canis and is usually seen among older children who present with unilateral vision loss. Findings on examination can include a subretinal mass, leukocoria, cataracts, and retinal scarring (Color Plate 9-69). 8 When motile larvae are trapped in the eye, a diffuse unilateral subacute neuroretinitis can occur. 9

T. canis infection in dogs usually produces more severe signs in puppies than in older dogs. In puppies infected in utero, a parasitic pneumonia may develop with a resultant high mortality rate. Development of a large parasitic load in the intestine may lead to abdominal distention, colic, anorexia, vomiting, rough hair coat, diarrhea, cachexia, coughing, and sometimes death. Neurological involvement may occur including twitching and seizures. Eosinophilia is often seen.

Cats generally have less severe disease than dogs. A potbellied appearance, diarrhea, and vomiting may develop. Eosinophilia is common. 7 Table 9 -63 compares the clinical presentations of toxocariasis in humans and other animals.

In humans, clues to the diagnosis of visceral larva migrans include a history of exposure to contaminated soils or foods, the appearance of typical signs and symptoms, eosinophilia, and antibodies to Toxocara. Enzyme immunoassay with Toxocara excretory-secretory antigens is the preferred serological test. 8 However, it may lead to underdiagnosis if a person is infected with an unusual serovar not well covered by the standard test. Serial serology titers are required to document seroconversion; a fourfold increase in titer is considered evidence of recent infection. 10 Ocular migrans is diagnosed clinically. Antibody titers to Toxocara species may be elevated in aqueous and vitreous fluid compared with serum levels, which may aid in diagnosis. The differential diagnosis includes other causes of retinal masses, including retinoblastoma. 9 In animals, the detection of eggs in feces through a fecal flotation test is diagnostic (Figure 9-135) . The spherical, pitted eggs of T. canis and T. cati can be distinguished from the smooth, ovoid eggs of T. leonine, which has less zoonotic potential. 5

Antihelmintic treatment is directed toward relief of symptoms. Because infection is generally asymptomatic in humans, treatment is sometimes withheld. In cases of severe organ involvement, steroids may be indicated in addition to antihelmintics. Table 9 -64 outlines treatment guidelines in humans and other animals.

In dogs and cats, infection is usually treated aggressively with a number of antihelmintic agents. Because transplacental infection does not occur with T. cati, cats are usually treated as kittens.

Strategic deworming against roundworms (and hookworms) includes deworming the pregnant dog; treating puppies and kittens beginning at 2 weeks of age, then every 2 weeks through weaning (6 to 8 weeks); and then treating monthly until the pet is 6 months old. Nursing dogs and queens should be treated with their litters. Older animals can be monitored through at least annual fecal examinations. Many pups and kittens are not brought to the veterinarian until they are 6 to 8 weeks, so owners of pregnant animals need to work with their veterinarians to ensure earlier deworming. • Counsel owners that healthy seropositive cats are little danger to owners. Seronegative cats that have the potential to become infected and shed oocysts are more of a human risk. • A modified live vaccine is available in Europe and New Zealand for sheep.

Toxoplasma gondii is a protozoan that has three infectious stages: oocysts (shed in the feces, containing sporozoites), tachyzoites (rapidly multiplying form found in tissues), and bradyzoites (slowly multiplying form found in tissues; Figure  9 -138). 2 In addition, tissue cysts (found in muscle or CNS tissue) contain dormant bradyzoites.

The disease is found worldwide. The U.S. National Health and Nutrition Examination Survey (NHANES 1999 (NHANES -2004 found an age-adjusted T. gondii seroprevalence among persons 6 to 49 years old of 10.8% (95% confidence limits [CL] 9.6%, 11.9%), and a rate among women of childbearing age (15 to 44 years) of 11.0% (95% CL 9.5%, 12.4%). 3 Higher rates have been reported in other parts of the world, including European countries where undercooked meat consumption is common, and sub-Saharan Africa where extensive contact with cats can occur. 1

Analysis of NHANES data has suggested that individuals in occupations with soil contact, lower educational level, living in crowded conditions, and foreign-born individuals are at increased risk. 1 Other studies have reported increased risk with cat ownership, soil contact, eating unwashed vegetables, and eating undercooked or raw meat. In a number of studies, however, current ownership of a cat has not been associated with increased risk of seropositivity. 1 Fetuses and immunocompromised persons are particularly vulnerable to severe sequelae from infection.

Cats and other felids are the only hosts in which T. gondii can reproduce sexually. Infection is most commonly seen in intermediate hosts such as humans, sheep, goats, swine, dogs, and horses, although most mammals and some birds are infected. Game animals such as deer can be infected with tissue cysts, posing a risk for human consumption. Mechanical vectors include contaminated vegetables and other food products, soil, and sand.

When naïve cats ingest viable Toxoplasma organisms, the parasite is able to reproduce in the cat's intestinal lining and results in the shedding of immature oocysts in the feces. After a period of 2 to 3 weeks, the cat develops immunity and no longer sheds oocysts. The immature oocysts shed in cat feces are not immediately infectious but take 1 to 5 days to sporulate into mature oocysts with viable sporozoites (Figure 9-139) . These infectious oocysts can persist in the environment for several months. If they are ingested by an intermediate host either directly or through contaminated soil, they begin to asexually multiply in the host's intestinal epithelium and produce tachyzoites. The tachyzoites disseminate in the intermediate host's bloodstream and lymph system both freely and intracellularly within monocytes and macrophages. 4 After several weeks of rapid multiplication, the intermediate host may develop immunity. Once the host is immune, the life cycle shifts to the production of bradyzoites, which multiply less rapidly and tend to form tissue cysts in brain, myocardial, and nervous tissue where they may persist for life.

If an intermediate host ingests raw or undercooked meat containing these cysts, the bradyzoites may be released and develop into tachyzoites. The first time cats are infected, the parasite's life cycle is completed when some of the bradyzoites initiate a sexual cycle to produce unsporulated oocysts that are shed in the feces for 1 to 2 weeks. Cats are typically resistant to reinfection. 5 The primary routes of toxoplasmosis transmission to humans are the ingestion of raw or undercooked meat that contains viable cysts, the ingestion of infectious oocysts due to contact with cat feces or contaminated soil or fomites, and congenital infection. The relative importance of these different routes of transmission is poorly understood and probably varies by geographical region. A survey of more than 6000 commercial samples of beef, chicken, and pork from retail stores in the United States found a low incidence of infectious cysts, with viable T. gondii detected only in samples of pork. 6 Transplacental transmission occurs during active infection of the mother with the tachyzoite phase. The risk of transmission from an infected pregnant woman to her fetus is considered lower in early pregnancy (although the consequences to the fetus are greater) than in subsequent weeks. 7 Other transmission pathways include organ transplants and blood transfusions.

A number of factors, such as humidity and temperature, determine how long it takes for immature oocysts to develop into mature infectious oocysts and how long such oocysts can persist in soil and water and on environmental surfaces. 

Most cases of toxoplasmosis in immunocompetent children and adults are asymptomatic. Symptoms, when they occur, are usually self-limited and can include significant cervical or other lymphadenopathy and fever with atypical lymphocytosis. Rarer complications can include toxoplasmic chorioretinitis, myocarditis, and myositis. The incidence of ocular toxoplasmosis in immunocompetent persons is believed to be more common than previously thought, and toxoplasmosis is one of the most common causes of uveitis in the general population, leading to vision loss in some cases. 8, 9 Encephalitis and even death can occur but are rare in immunocompetent hosts. 9 In immunocompromised patients, toxoplasmosis often produces severe disease, including encephalitis and cerebral abscesses (Figure 9-140) , pneumonitis, chorioretinitis (Color Plate 9-70), and myocarditis with a high mortality rate if the disease is not treated in a timely fashion. Symptoms of encephalitis can include confusion, seizures, sensorimotor deficits, and ataxia. 10 Infection in immunocompromised humans may be the result of reactivation of latent infection but can also result from acute infection. Organ transplants can be a source of infection in immunocompromised persons. 9 One of the most significant complications of human toxoplasmosis infection occurs when a pregnant woman is in the acute phase of the illness (tachyzoite phase) and the organism passes to a fetus, resulting in congenital infection. Congenital toxoplasmosis can present as mild to severe disease, with complications including hydrops fetalis, perinatal death, prematurity, decreased birth weight, retinal scarring, and a classical triad of chorioretinitis, hydrocephalus, and cerebral calcifications (Figure 9-141) . Although more than half of infected newborns are considered normal shortly after birth, most will develop ocular and/or other complications if not treated. 11

Evidence of past infections in cats and many other animal species is common, but clinical cases are rarely recognized because most infections are subclinical (Figure 9-142) . In cats, the disease is most commonly seen in congenitally infected kittens, leading to stillbirth, neonatal fever, respiratory distress, uveitis, and neurological involvement (Color Plate 9-71). 12 It is also seen in immunocompromised animals with lethargy, fever, neurological signs, or generalized retinitis (Color Plate 9-72).

Dogs, especially puppies, may develop acute signs of infection including fever, respiratory signs (Color Plate 9-73), and diarrhea. Immunosuppressed older dogs may manifest neurological involvement (Figure 9-143) .

In sheep, goats, and swine, toxoplasmosis can cause abortion and neonatal mortality (Figure 9-144) . Birds, including poultry, are commonly infected but generally do not manifest clinical signs. Table 9 -65 compares clinical presentations of toxoplasmosis in humans and other animals. 

In humans, the cornerstone of diagnosis is serology. 13 High titer of anti-Toxoplasma IgM suggests an acute infection (IgM titers can persist for 18 months), whereas IgG antibodies may indicate past infection. Elevated IgM titers can be verified at a Toxoplasma reference laboratory such as the CDC or Toxoplasmosis Serology Lab (Palo Alto Medical Foundation Research Institute). 5 When congenital toxoplasmosis is suspected, diagnostic studies include maternal seroconversion detected via the immunosorbent agglutination assay (ISAGA), fetal ultrasound findings, and amniocentesis with PCR detection of T. gondii.

In animals, the serological testing for IgG, IgM, and antigen with follow-up tests in 3 weeks helps differentiate acute from chronic infection. The IgM antibodies rise 2 weeks after infection and may persist for a maximum of 3 months. A fourfold increase in IgG titers between samples is also suggestive of a recent infection. 12

Treatment in immunocompetent humans is usually not indicated because of the mild and self-limited nature of the disease. If significant organ involvement occurs or in particular clinical situations such as immunocompromise, pregnancy, and congenital infection, antimicrobial treatment is necessary (Table 9 -66). In addition to antimicrobials, prednisone is added to the treatment regimens for congenital toxoplasmosis, chorioretinitis, and toxoplasma meningitis. The recommended treatment regimens are complex, and consultation with an infectious disease specialist is advisable.

Antibiotics can be used in animals but they may not clear infection. 

• Consider the diagnosis of a TSE in cattle, sheep, cats, and other animals with abnormal behavior and progressive neurological deterioration consistent with prion disease. • Counsel owners and farmers about federal feed restrictions and proper feeding practices to reduce risk of disease transmission.

TSEs are believed to be caused by abnormal forms (PrP sc ) of naturally occurring (PrP C ) cellular prion proteins. 6 These misshapen prion proteins are capable of self-replication and transmissibility and form protease-resistant deposits in the brains of infected animals. For many years, TSEs were referred to as slow virus infections because of their transmissibility, resistance to filtration, and long latent periods. Most pathologic features of prion diseases involve the CNS. TSE agents, such as the agent of scrapie, are remarkably resistant to disinfection and inactivation by heat, radiation, or chemicals, 7 although more robust disinfection strategies are effective. 8 Strains differ between abnormal prions infecting different species, possibly related to variations in the threedimensional protein structure or length and sequence of the amino acid chain. The BSE agent has been transmitted experimentally, using a variety of techniques and doses, to other species, including cats, mice, pigs, sheep, goats, cattle, mink, macaque monkeys, and marmosets. 9

vCJD has been reported mostly in the United Kingdom, with smaller numbers of cases reported elsewhere in Europe and in Japan. Three cases reported in the United States and one case reported in Canada are believed to be the result of exposure to the BSE agent overseas. In addition to the United Kingdom, BSE has been reported in smaller numbers in most other European countries and in Japan, Israel, Canada, and the United States.

Cases of feline spongiform encephalopathy (FSE) were reported in captive felids in zoos in the United Kingdom and domestic cats in the United Kingdom and Europe. Cases have declined greatly since a ban on bovine spleen and CNS tissue in cat foods. 2 CWD of deer and elk occurs primarily in an endemic area of Colorado and Wyoming. In recent years, CWD has been detected in neighboring states, as well as in Wisconsin, Illinois, West Virginia, New York, and in the provinces of Alberta and Saskatchewan in Canada.

The prevalence of scrapie among sheep in the United States has been estimated at approximately 0.2%, based on voluntary surveillance. 10 Scrapie is considered eradicated from Australia and New Zealand.

Transmissible mink encephalopathy (TME), first described in 1947, has occurred sporadically in the United States, Canada, Finland, Germany, and Russia.

Groups at increased risk for vCJD include those who resided in the United Kingdom during the BSE epidemic and consumed beef products. Hunters are at risk of exposure to CWD in deer and elk through dressing carcasses and meat consumption. Similarly, persons working with sheep and goat carcasses may have some exposure to the scrapie agent, and mink farmers may have exposure to TME. To date, no cases of TSEs related to CWD, FSE, or TME exposure have been described in humans. 11

BSE is a disease of cattle, but concurrent with the BSE outbreak in the United Kingdom, a similar disease tied to BSEcontaminated feed consumption appeared in other bovids kept in zoos, including kudu, eland, oryx, gemsbok, bison, nyala, and Ankole (exotic ungulate encephalopathy).

FSE has been found in fewer than 100 domestic cats and captive felids, including cheetahs, pumas, ocelots, and a tiger. 9 CWD occurs in captive and free-ranging Cervidae, including mule deer, white-tailed deer, and elk, and has been detected in a moose.

Scrapie occurs in sheep and goats.

Transmission of BSE, vCJD, FSE, and TME is believed to be due to ingestion of contaminated animal products ( Figure  9 -145). Scrapie can be transmitted horizontally in flocks.

In addition, maternal transmission appears to play a role in scrapie infection. 12 Person-to-person transmission of vCJD has been reported through contaminated blood products, possibly due to the persistence of the agent in lymphocytes. CWD transmission appears related to both direct contact between animals and indirect contact with contaminated environments.

Transmission of iatrogenic CJD involves contaminated articles such as surgical instruments. For other TSEs, the role of environmental contamination is less clear. CWD is spread horizontally between deer and elk, and such transmission is believed to be due in part to environmental contamination, leading to ingestion of the agent. 3 Research is focusing on the role of saliva in the environmental spread of disease. Scrapie may also be transmitted through pastures contaminated with birth products from an infected animal. 3

At least four different prion-related diseases have been reported in humans, all chronic and invariably fatal neurodegenerative conditions. These include CJD, Gerstmann-Sträussler-Sheinker syndrome (GSS), fatal familial insomnia (FFI), and kuru. Of these, CJD is the most common. 2 GSS and FFI are genetically mediated diseases, whereas kuru transmission has been linked to cannibalism among islanders in the South Pacific. CJD has three main variants: sporadic CJD (sCJD), iatrogenic CJD, and variant CJD (vCJD). vCJD is associated with BSE. Recently a new type of CJD has been described, known as proteinase-sensitive prionopathy (PSPr). 13 Iatrogenic CJD is a rare form of CJD that has been linked to corneal transplants, growth hormone derived from pituitary extracts, dura matter grafts, and contaminated neurosurgical instruments. 7 sCJD is characterized by a rapidly progressive dementia with confusion and often associated movement disorders such as ataxia and myoclonus. It is typically a disease of older individuals (median age, 68 years). In sCJD the electroencephalogram (EEG) may show periodic high-voltage complexes. Samples of CSF are acellular with normal glucose but may show elevation of protein including a protein known as 14-3-3. 14 vCJD differs from sCJD in a number of ways, including the younger age of patients (median age, 28 years), the prominent symptoms of paresthesias, the lack of specific EEG findings, specific MRI findings of an increased signal in the posterior thalamus, and the ready detection of the agent in lymphoid tissue. Patients with vCJD also have a prolonged clinical course compared with patients with sCJD (median illness duration of 13 to 14 months vs. 4 to 5 months for sCJD). 7

BSE initially presents with subtle locomotive and behavioral abnormalities that progress over a period of months. Cattle spend decreased time ruminating and demonstrate increased nose licking, sneezing, nose wrinkling, head tossing, and teeth grinding. An increased startle response can develop, but undisturbed animals may develop paresis, ataxia, and falling episodes. Weight loss and decreased lactation can occur. Recumbency (downer cow), coma, and death occur weeks to months later (Figure 9-146 ).

An atypical form of BSE has been reported to be due to a variant prion causing a disease termed bovine amyloidal spongiform encephalopathy (BASE). The molecular form of this new bovine PrPsc resembles that found in a particular form of human sporadic CJD. 6 CWD of elk and deer produces subtle changes in behavior and weight loss (Figure 9-147) . A spectrum of symptoms including loss of fear of humans, somnolence, and hyperexcitability may occur. Late disease manifests with increased water consumption, increased salivation, low head carriage, a fixed stare, and chronic weight loss despite continued feed intake. 3 FSE produces an increase in aggressive or shy behavior, ataxia, and increased sensitivity to sound or touch. On biopsy of cases, spongiform degeneration of the neuropil of the brain and spinal cord have been described (Color Plate 9-74). 9 Death occurs within 6 to 8 weeks of onset of signs.

Scrapie also has an insidious onset, with behavioral changes including increased excitability. Tremors of the head and neck (tremblante du mouton) may occur, as can seizures. Intense pruritus develops, leading to loss of fleece over body areas (Figure 9-148) . TME produces abnormal behavior, including increased excitability, tremors, circling, and biting. The disease progresses to death within weeks or months. 

The differential diagnosis of CJD in humans includes other causes of dementia, such as Alzheimer's disease, Lewy body dementia, normal-pressure hydrocephalus, neurosyphilis, hypothyroidism, HIV-associated dementia, and senile dementia. The diagnosis of vCJD should be suspected in any person who has resided in a BSE area who presents with behavioral abnormalities and sensory complaints accompanied by signs of dementia. Suspected cases should be referred to a qualified neurologist for definitive diagnosis. 15 MRI findings of ribbons of cortical hyperintensity or basal ganglia or thalamic hyperintensity can help suggest the diagnosis. 17 The disease can be diagnosed by brain biopsy showing spongiform changes and the presence of the prion protein PRP sc (Figure 9-149) . Other tests include tonsillar biopsy for PRP sc as well as CSF testing for the stress protein 14-3-3, which is elevated in some patients with CJD, although it occurs in other conditions as well. 18 In cattle, BSE is often diagnosed by ELISA or Western blot analysis on brain tissue with confirmation by immunohistochemistry.

CWD can be diagnosed by immunohistochemistry, Western blot, or ELISA on brain and/or lymph nodes. Scrapie diagnosis is usually by ELISA or Western blot analysis of brain tissue postmortem, or by biopsy of lymphoid tissue (retropharyngeal, third eyelid, or rectal mucosa).

At present, CJD and other prion diseases in humans are fatal neurological diseases without proven effective therapies. There is ongoing research for development of vaccines and for potential compounds with anti-prion activity. 14, 19, 20, 21 ) . Current treatment of affected humans is limited to alleviating symptoms and patient comfort. Affected animals should be euthanized and removed from the food supply. 

Other names in humans: TB; atypical mycobacterial infection, MAI, MAC, Mycobacterium marinum, leprosy

Tuberculosis (TB), an infectious, granulomatous disease, is one of the oldest recognized diseases in humans and animals and exemplifies the close parallels between human and animal health. Mycobacterium tuberculosis complex (MTBC), which includes M. tuberculosis and M. bovis, has been found in Egyptian and New World mummies 1,2 and recovered from spinal and bone lesions of Iron Age human remains in Britain and South Siberia. 3, 4 In animals, there is documentation of TB in buffalo in China more than 500,000 years ago. 5 TB is believed to have been a key factor in the extinction of mammoths and mastodons around 10,000 years ago. 5 Approximately one third of the world's human population, or about 2 billion people, are infected with TB; active cases of TB in 2006 were reported to exceed 9 million. 6 Coinfection with HIV disease accounts for more than 15 million cases of TB infection, and TB is an important cause of HIV-related deaths throughout the world. TB has now become the leading cause of death from any infectious disease worldwide, with mortality from tuberculosis in 2006 of 1.7 million. 6 TB in livestock and wildlife is a worldwide problem and has serious socioeconomic ramifications, especially in developing nations. In the United States, recent surveillance has shown a resurgence of TB in animals among diverse species such as white-tailed deer, 7 bobcats, coyotes, opossums, raccoons, and red foxes. 8, 9 Although the public health linkage between TB in humans and other animals has been recognized for more than a century, the key issue was believed to be human infection with bovine TB through the ingestion of unpasteurized dairy products. However, recent advances in molecular diagnosis have shed light on additional human-animal TB issues including occupational and reverse zoonotic infection. This section discusses TB in humans and other animals. Infection with non-tuberculous mycobacteria (NTM) is covered in an accompanying summary.

The control of TB in both humans and other animals relies on similar basic practices and principles:

• Identify, test, and treat/manage high-risk populations.

• Physically isolate or separate cases from other people or animals. • Ensure appropriate medical treatment and management of the case and/or livestock and herd management. • Provide case investigation.  Identify probable routes of transmission, mainly respiratory and gastrointestinal.  Identify close contacts of cases to prevent or control secondary cases, including companion animals and those at high risk of infection; evaluate close contacts for active TB, perform tuberculin skin testing of contacts, treat close contacts if indicated, and work with agriculture officials to cull livestock if indicated.  Address issues of ongoing transmission; identify potential human or animal sources of infection, shared common sources (human or animal congregate living facilities, congregate areas of potential exposure, such as waiting rooms, holding pens), and infected food or water supply (unpasteurized dairy products, especially from endemic countries).

• Encourage communication and consultation between human and veterinary public health programs and awareness of the national and local incidence and prevalence of TB in human, domestic animal, and wildlife populations. • Encourage coordination and consultation between veterinary and human public health programs for contact investigation and recommendations for companion or household animals of active human TB cases and human contacts of veterinary TB. 

Mycobacteria are nonmotile, rod-shaped, obligate aerobic bacteria classified as acid-fast because of the impermeability of their thick, waxy coats to certain dyes and stains. There are more than 120 species of mycobacteria, which are generally divided into rapidly growing (visible on culture within 7 days) and slow growing (those requiring longer periods of growth). Most mycobacteria are not considered pathogenic. The species of greatest pathogenicity to humans and other animals are those classified as Mycobacterium tuberculosis complex (MTBC), the etiologic agents of TB. Of all the mycobacteria, only MTBC and M. leprae (the agent of leprosy) are obligate intracellular organisms; the others live freely in the environment. Because of the importance of MTBC as a pathogen to humans and other animals, other mycobacteria are generally referred to as nontuberculous mycobacteria (NTM) or mycobacteria other than tuberculosis (MOTT). However, as they are found throughout the environment, they may also be referred to as environmental mycobacteria (EM). These NTM are discussed below in a separate section. TB was traditionally thought to be a zoonotic disease transferred to humans during the neolithic ages through contact between humans and animals domesticated for livestock. It was therefore believed that M. tuberculosis had evolved from M. bovis. There is now evidence that all members of the MTBC evolved from a TB progenitor, M. prototuberculosis, estimated to be as old as 3 million years (Color Plate 9-75). In addition, researchers have shown that tubercle bacilli are able to exchange parts of their genome with other strains, a process that is crucial to the adaptation of pathogens to different host species. 10, 11 

Mycobacteria of the MTBC group are found worldwide. Zoonotic TB due to foodborne and occupational exposures occurs more commonly in developing countries.

Certain occupational groups are at an increased risk of exposure to TB, including health care workers, exposure livestock workers, workers in zoos and animal parks, and animal care workers in primate facilities (see Chapter 12) . For example, there has been zoonotic transmission of M. bovis from a diseased white rhinoceros to seven zookeepers. 12 Along with zoo workers, zoo animals appear to be at an increased risk of potential infection. A multispecies epizootic transmission of M. tuberculosis occurred in a metropolitan zoo among Asian elephants, Rocky Mountain goats, a black rhinoceros, and humans. 13 There has also been documented transmission in an exotic animal farm among four elephants with M. tuberculosis and 11 of 22 handlers, one of whom subsequently had active disease. The isolates for all active cases were identical. 14

As Table 9 -68 shows, different members of the MTBC group are adapted to different host species, although interspecies transmission can occur. TB in wildlife has become a major problem in many parts of the world, and transmission of disease is increasingly bidirectional at the livestock-wildlife interface in industrialized and developing countries. Wildlife reservoirs such as badgers, opossums, ferrets, deer and other cervids, feral pigs, African buffalo, and bison serve as sylvatic reservoirs and ongoing sources of infection to pastured animals primarily through contamination of water and food sources within their shared environment. The presence of multiple maintenance hosts favors the long-term persistence of infection and disease among differing populations. 15, 16 Conversely, infection in wildlife species such as kudu, baboons, lions, and hyenas may represent a sporadic spillover from a livestock reservoir. Therefore TB in livestock and pastured animals will no longer be able to be eradicated or controlled by traditional livestock control programs that do not take into account the wildlife disease reservoirs. In addition to the risks of transmission between wildlife and livestock, wildlife TB can pose a zoonotic threat to game hunters who butcher carcasses (respiratory and cutaneous exposure) and who consume undercooked meat. 17, 18 In addition, TB in peridomestic wildlife such as nonhuman primate populations in Asia may pose a risk of direct zoonotic transmission to humans via close contact.

Infection with TB begins when the organism is introduced into the body, usually by inhaled droplet nuclei containing tubercle bacilli, which when <5 microns reach the pulmonary alveoli (Figure 9-151) . The bacilli are then phagocytized by the pulmonary alveolar macrophages and destroyed or contained. The alveolar macrophages are an important part in the initiation of the host's immune response to the mycobacteria. Antigen of the tubercle bacilli then stimulates the host's cellular immune response and the immune cascade is triggered. Immunologic control or containment of the infection is achieved through a potent cell-mediated immune response beginning with helper T-lymphocytes and, later, a delayed hypersensitivity response. This immune response also involves the production of proinflammatory cytokines, especially interferon-gamma (IFN-γ), tumor necrosis factor (TNF), and interleukin-1.

The spread of the infection may be halted by the immune system at the local lymph node level. However, because cellular immune response usually takes between 4 and 12 weeks to be elicited, it may not, or only partially, be stopped there. The MTBC bacillus may then spread systemically via the regional lymph nodes and lymphatic system and enter the bloodstream (primary disease). Hematogenous circulation of the tubercle bacilli is generalized but may affect mainly organs and tissues that are more densely vascularized, such as bone, liver, spleen, central nervous system, kidneys, and genital tract, where the bacilli are then targeted by local mononuclear phagocytes. These organs, along with lymph nodes, are therefore the most common sites of extrapulmonary disease. Studies of tissue from infected asymptomatic individuals have shown viable M. tuberculosis in primary lesions in the lung and in lesionfree areas of lung and lymph nodes. Although primary lesions can occur anywhere in the lung, postprimary disease most commonly develops in the apical regions. 19 The immune system continues to attempt to isolate the bacillus, forming granulomas or tubercles (Color Plate 9-76) The granuloma may become thick walled and dense, effectively encapsulating the organism and preventing further spread. The bacilli then become latent within the granulomas. These granulomas may eventually calcify. The major route of transmission for humans (and one of the main routes for animals) is through respiratory aerosolization. When there is active TB in the lungs, the bacillus is expelled and aerosolized in the form of droplet nuclei through coughing (or any explosive respiratory action such as singing, shouting, sneezing, or talking). For these droplet nuclei to be inhaled and reach the alveoli in humans, they must be 3 to 5 microns or less in size. In animals, the exact sizes of infecting droplet nuclei may vary depending on the species.

Other risk of exposure to infectious aerosols includes opening an infected chest cavity such as during autopsy, necropsy, or slaughter of livestock, as well as hosing down an area where an infected animal has been housed. The efficiency of transmission of TB depends on a number of factors, as shown in Box 9-7. 20 The second most common route of transmission is through the gastrointestinal tract by the ingestion of infected material. Drinking or eating unpasteurized milk products traditionally has been the principal means by which humans have acquired zoonotic TB. 21 In industrialized countries pasteurization and strict herd testing and management have made such gastrointestinal transmission rare, but zoonotic TB caused by M. bovis acquired through ingestion may be seen in immigrants from countries with a continuing prevalence of M. bovis infection in cattle or livestock. 22, 23 Of note are the recent documented human-to-human transmissions of M. bovis, including an epidemiologically linked cluster of six cases identified in the United Kingdom. Five of the patients had pulmonary TB disease and one had TB meningitis 24 ; only one was known to be HIV infected. The index case had a history of occupational exposure and consumption of unpasteurized milk and cheese both as a young adult and recently in a country not free from bovine TB. In another cluster, human nosocomial transmission of M. bovis among HIV-infected individuals occurred in a Spanish hospital, resulting in 30 deaths. 25 Humans may also serve as a source of TB infection for animals, including nonhuman primates, cattle, dogs, and macaws. [26] [27] [28] [29] [30] [31] Animal-to-animal transmission of TB occurs through respiratory and gastrointestinal routes. 32 Respiratory infection can occur in herds or closely quartered animals through pulmonary disease or draining lymphadenopathy. Infection is also acquired by ingestion of infected meat, sharing of infected water and food sources, grooming, and exposure to secretions.

Because a major influence on the aerosol transmission of TB in humans and other animals is the closeness and duration of contact with the infected individual, population density can be a key environmental factor driving TB transmission. Although being outdoors significantly decreases the risk of transmission, the close or sheltered outdoor housing of animals and humans may decrease that advantage. Contaminated water can be another environmental risk for disease transmission in animals.

During primary and latent infection, the person does not exhibit signs of disease and is not considered infectious. Immunocompetent individuals will develop a balance between host and mycobacteria, and the infection will remain latent. However, if there is a breakdown of the host's immune function and the infection is no longer able to be effectively contained, active disease may develop (Figure 9-150) .

More than 90% of humans infected with MTBC maintain control of the infection through immune mechanisms during their lifetime. These individuals have an approximately 10% chance of developing active TB disease during their lifetime: 5% within the first few years of infection (progressive primary TB disease) and 5% at a later stage in their lives (reactivation TB disease). However, that probability of progressing to active disease is significantly increased in the presence of comorbid conditions that compromise immune function. Factors associated with this increased risk are outlined in Box 9-8.

HIV exerts a significant adverse affect on the pathogenesis of TB. With a suppressed or poorly functioning immune system, the host will release an immature response to the tubercle bacillus. The decrease in the number and function of T-cell lymphocytes as a result of HIV disease weakens the immune reaction and the host cannot, or only poorly, contain the TB organisms that are present. There is a greater chance of rapid progression from infection to disease after recent TB infection. There is also a question of whether an individual with HIV has an increased chance of infection with TB from the loss of innate resistance. People with HIV have an 8% to

Characteristics of the Source Case 10% chance per year to progress from infection to active TB. The 1-year mortality rate for treated, HIV related TB is 4 times the rate of non-HIV related TB, around 35%. TB also worsens HIV disease by inducing stimulation and replication of T-cell lymphocytes. These T cells are then targeted by the virus, resulting in increased HIV replication. If the tuberculous infection is initially contained by the immune system, which then subsequently experiences a significant deterioration in the quantity and function of T-helper cells, the bacillus may no longer be contained and the TB reactivates. In addition, the cytokines produced in response to TB infection stimulate the production of HIV in vitro. 33 Active TB is usually a slowly progressive disease characterized by systemic symptoms of weight loss, fatigue, anorexia, fevers, chills, night sweats, and wasting. The severe weight loss and wasting associated with the disease led to its former name of consumption. When the disease is pulmonary, presenting symptoms may also include a persistent cough (with or without sputum production), chest pain, and hemoptysis. Although TB is generally a chronic, debilitating disease, it may present with an acute, rapidly progressing course. Disease is generally pulmonary, followed by lymphatic drainage and local lymphadenopathy, or disseminated (especially in immunocompromised hosts; Color Plate 9-77). Manifestations may vary depending on the extrapulmonary site of disseminated disease. Central nervous system involvement may present as either meningeal or parenchymal disease. Meningitis more commonly affects the basilar meninges, and the cranial nerves may also be involved. Parenchymal lesions may be single or multiple and present as solid tuberculomas or TB abscesses. Symptoms will depend on the location of the lesion and/or mass effect from surrounding edema (Figure 9-151) . TB may also present in the spinal vertebrae (Pott's disease) (Figure 9-152) . 

As in humans, TB can be either a chronic or rapidly progressive disease, with the clinical signs varying greatly according to the species involved. As with humans, it is believed that many animals infected with MTBC remain in a latent phase, although the natural history is less well understood. In cattle, TB is often not apparent, and therefore not diagnosed, until terminal stages of the disease; it is often found only at necropsy or in abattoirs (Color Plate 9-78). This, unfortunately, allows for a prolonged period of transmission. The initial presentation, besides cachexia, progressive weakness, and anorexia, may also include cough, lymphadenitis, and draining sinus tracts, especially around the neck, face, and chest. In later stages, lymph nodes may be enlarged to the point of impingement on airways, gastrointestinal (GI) tract, or blood vessels. 34 GI tract involvement may be manifested by diarrhea or constipation. The female genital tract may be involved. At necropsy, both tuberculous granulomas and abscesses may be present.

In Cervidae, which include deer, antelope, moose, elk, and reindeer, TB has been found in both farmed and freeliving animals. The course may be chronic and progressive or acute. The presentation is similar to that found in cattle with granulomas, but thin-walled abscesses are also common.

In nonhuman primates, as in humans, there is a broad clinical spectrum of disease, including latent TB, chronic primary TB, rapidly progressing and fulminant disease, and reactivation TB. 35 Old World species appear to be more susceptible than New World species.

Culture-confirmed cases of TB have been diagnosed in at least 36 elephants in the United States from 1994 to 2006. 36 It has been reported in captive elephants, primarily Asian, although the potential for transmission to wild elephants is increasing. Clinical disease in elephants usually has a chronic, debilitating presentation. Signs may not be present until the disease is advanced and include weakness, weight loss, and coughing, although they may also be specific to the organ system involved, such as chronic vaginal discharge or conjunctivitis.

TB also occurs in domestic and companion animals. Dogs and cats may present with a typical clinical picture of wasting, anorexia, and progressive decline. If the MTBC was acquired through the respiratory tract, signs may also include cough and shortness of breath; if acquired through the ingestion of infected meat or milk, GI signs may be present.

The key factor in the diagnosis of active TB is that of clinical suspicion based on the presenting history, signs or symptoms, chest radiograph, and/or laboratory testing. Microscopy looks for the presence of acid-fast bacilli (AFB) on direct smears of clinical specimens. The finding of AFB indicates the presence of mycobacteria but not the specific species.

Identification of the mycobacterial species is through culture or molecular testing such as polymerase chain reaction. A tissue biopsy specimen may show characteristic histological findings, such as granuloma, caseation, necrosis, calcification, and typical cellular immune response. The presumptive diagnosis of TB (mycobacteriosis) may be made on this basis, especially in animals.

Cultures may use liquid media, such as the mycobacteria growth indicator tube (MGIT, BBL Becton Dickinson Microbiology Systems, Cockeysville, Md.) and/or solid agar media, such as Bactec (Becton-Dickinson Diagnostic Instrument Systems, Sparks, Md.) Lowenstein-Jensen, or Middlebrook 7H10. MTBC is a slow-growing organism that replicates approximately every 24 hours. Growth in liquid media usually occurs within 1 to 3 weeks, whereas growth on solid media may be 6 to 8 weeks. Drug susceptibility testing is performed on isolates of MTBC routinely for isoniazid, rifampin, pyrazinamide, and ethambutol.

Since the genetic mapping of MTBC, molecular testing has been used in the diagnosis of TB. Nucleic acid amplification (NAA) tests, such as the Mycobacterium tuberculosis Direct (MTD) test (Gen-Probe, Inc., San Diego, Calif.) are performed on direct specimen smears based on the presence of MTBC RNA. The sensitivity and specificity of the NAA test on a positive AFB smear are greater than 95% and 99.6%, respectively. PCR is a species-specific DNA-based test used to identify MTBC. Further genotyping on positive TB cultures often may be done, usually by one of two methods: mycobacterial interspersed repetitive units (MIRU) or spoligotyping. Genotyping is used to assist TB control programs in identifying outbreaks and recent transmission in a more real-time manner so that appropriate secondary testing and management can be performed sooner. Molecular testing of the TB isolate for genetic resistance mutations is beginning to be used.

Thoracic radiographs may be part, or the initial finding, of the clinical presentation of TB in humans and other animals (Figures 9-153 and 9-154) . Classically, TB is an upper lobe disease, either unilateral or bilateral. Abnormalities typically are seen in the apical and posterior segments of the upper lobe or the superior segments of the lower lobe; however, lesions may appear in any part of the lungs. Radiographic abnormalities may present as infiltrates, nodules, cavitary lesions, pleural thickening, or a diffuse miliary pattern. Hilar and mediastinal lymphadenopathy may be present, with or without accompanying infiltrates or cavities. Immunosuppressed individuals may present with only hilar or mediastinal adenopathy, or the chest radiograph may appear normal. 

The tuberculin skin test (TST) has been the standard screening tool for TB infection in humans and other animals (Figure 9-155) . It produces a delayed-type hypersensitivity reaction in those with tuberculous infection. It is useful for determining how many individuals in a group are infected (e.g., contact investigation) and in the evaluation of those with signs or symptoms or those who are suspected of having TB.

The TST is administered by subcutaneously injecting a preparation of (inactive) mycobacterial antigens. In humans, 0.1 mL of purified protein derivative (PPD) is placed on the inner surface of the forearm. More complete information on TB skin test placement, reading, and interpretation is available at http://www.cdc.gov/TB/pubs/slidesets/ core/html/trans4_slides.htm. The TST is usually read after 48 to 72 hours. The induration (not the erythema) is measured and should be recorded in millimeters, not simply as negative or positive. In humans, a positive TST reaction may be measured for up to 7 days, although a negative reaction can only be read until 72 hours. The TST, however, has limited sensitivity and specificity. In humans, there is an overall false-positive rate of 20% and a false-negative rate of 20%. False-positive results may be seen in NTM infection, recent Bacillus Calmette-Guérin (BCG) vaccination, or incorrect administration. False-negative results may occur in overwhelming TB disease, anergy, recent TB infection, newborns, recent live-virus vaccinations, some viral illnesses, incorrect administration, or waning immune response (usually due to age or prolonged time since infection). Because of the possibility of a waning immune response, in some instances a two-step TST is performed. In those situations, an initial TST may serve to stimulate, or boost, subsequent TSTs. A two-step TST is therefore currently recommended for baseline testing in those who will undergo periodic testing, such as health care workers. 37 This helps to differentiate between a boosted reaction and one due to recent infection. The criteria for determining whether a human TST is positive depends on the risk group of the individual. Table 9 -69 defines the size of the induration per risk group. Figure 9 -155 n This technician is in the process of correctly placing a tuberculin skin test in this recipient's forearm, which will cause a 6-mm to 10-mm wheal (i.e., a raised area of skin surface) to form at the injection site. The tuberculin skin test is used to evaluate people for latent tuberculosis infection. In the United States, this skin test consists of an intradermal injection of exactly one tenth of a milliliter of tuberculin, which contains 5 tuberculin units. Correct placement of this intradermal injection involves inserting the needle bevel slowly at a 5-to 15-degree angle. The needle bevel is advanced through the epidermis, the superficial layer of skin, approximately 3 mm so that the entire bevel is covered and lies just under the skin surface. A tense, pale wheal that is 6 mm to 10 mm in diameter appears over the needle bevel. (From Centers for Disease Control and Prevention Public Health Image Library, Atlanta, Ga. Courtesy Gabrielle Benenson.) Table 9 -69 n Criteria for Tuberculin Positivity, by risk Group reaction ≥5 mm of induration reaction ≥10 mm of induration reaction ≥15 mm of induration HIV positive status Recent immigrants (i.e., within the past 5 years) from high-prevalence countries Injection drug users Residents and employees † of the following highrisk congregate settings: prisons and jails, nursing homes, and other long-term facilities for the elderly; hospitals and other health care facilities; residential facilities for patients with acquired AIDS; and homeless shelters Mycobacteriology laboratory personnel Persons with the following clinical conditions that place them at high risk: diabetes mellitus, chronic renal failure, some hematological disorders (e.g., leukemias and lymphomas), and other specific malignancies (e.g., carcinoma of the head or neck and lung), weight loss of ≥10% of ideal body weight, gastrectomy, and jejunoileal bypass Children younger than 4 years or infants, children, and adolescents exposed to adults at high risk Recently IFN-γ-releasing assays (IGRAs) are being used to detect latent TB infection. Generally these are whole blood assays that measure and compare the amount of IFN-γ released by white blood cells in response to antigens of MTBC. In humans, QuantiFERON-Gold (Cellestic, Inc., Valencia, Calif.) and T-SPOT.TB (Oxford Immunotec, Oxford, U.K.) are examples of assays used. 38 In other animals, the TST is the only skin test for use in cattle prescribed by the World Organisation for Animal Health. 39 However, there is no standardization of TST testing in animals, as individual protocols are established by each country. In cattle, testing may use M. bovis antigen alone (caudal fold test [CFT], cervical test [CT]) or along with M. avium (comparative cervical test [CCT]). 8 Test results are read at 72 hours ± 6 hours. The preferred TST placement sites in animals differs by species and include the caudal fold in bovids, ear in pigs, and eyelid in primates.

Skin testing in animals produces high rates of false-positive and false-negative results. These are often from the same interference: mycobacterial species, such as M. avium or M. avium subsp. paratuberculosis, overwhelming or advanced disease, in the face of comorbidity that prevents an appropriate immune response, early infection, or improper test administration.

In cattle, buffalo, bison, and other bovids, several serological tests based on M. bovis have been developed and are in use, such as SeraLyte-Mbv (PriTest, Redmond, Wash.) and Chembio Bovid TB STAT-PAK (Chembio Diagnostic Systems, Inc., Medford, NY). 36 There are also assays for use in cervids, primates, badgers, camelids, elephants, and other exotic wildlife, among others. 40 

Primary prevention remains the optimum course of disease control. It has proven extremely difficult, if not impossible, to eradicate any public health disease such as TB without an effective vaccine. Currently numerous studies are assessing vaccines for human and differing veterinary populations to prevent infection.

Treatment of active TB uses a combination of antibiotics for a prolonged period of time. The exact regimen is based on or modified according to the organism's susceptibilities. For drug-susceptible isolates, treatment usually is with three or four drugs (isoniazid [INH] , rifampin [RIF], pyrazinamide [PZA] with or without ethambutol [EMB]) for the first 2 months, then INH and RIF to complete 6 months' total treatment. Table 9 -70 shows drug treatment regimens for pan-susceptible TB. 42 Multidrug-resistant tuberculosis (MDR-TB) is resistant to at least INH and RIF, the two best first-line TB medications. Extensively drug-resistant tuberculosis (XDR-TB) in addition to INH and RIF is also resistant to the best second-line drugs, the fluoroquinolones and an injectable such as kanamycin or capreomycin. The treatment of TB with drug-resistant organisms is more complicated and difficult and should be done by or in consultation with experts. Regimens for resistant TB Table 9 -70 n Drug regimens for Culture-Positive Pulmonary Tuberculosis Caused by Drug-Susceptible Organisms generally use a combination of first-and/or second-line drugs for an extended period of time-between 9 and 24 months depending on the resistance pattern. Treatment of latent TB infection (LTBI) in humans, previously referred to as prophylaxis, is based on the TST risk groups previously discussed. Because current skin test recommendations target high-risk groups, the intent to test is generally the intent to treat. The first-line medication for the treatment of LTBI remains INH, currently recommended for 9 months. An alternative treatment is INH for 6 months. INH regimens may be daily or intermittent. Table 9 -71 shows recommended regimens for the treatment of LTBI.

Until recently, the approach to treatment of TB in animals has not included the use of medications to treat until cure, and it is still the rare exception. The overwhelming majority of animals with suspected or confirmed TB are culled or euthanized, such as with cattle. This has been done for several reasons: an effort to halt the spread of the disease to other animals or herds and mitigate the economic loss of herd and trade; the lack of practical alternatives; the difficulty of testing methods to distinguish MTBC disease from infection or from nontuberculous mycobacterial disease; the cost of TB medication regimens; problems with drug administration and monitoring; and the inability or unreliability of monitoring response to disease or LTBI treatment. In non-herd situations or where the animal is of significant economic or species value, such as zoo animals and rare or endangered species, pharmacotherapy has been used. Treatment of elephants with multidrug regimens has been documented, including for MDR-TB.

Due to a paucity of data, the medication dosing for TB in animals has been based loosely on data from human pharmacokinetic studies and dosages. However, the increased use of pharmacotherapy for veterinary TB may result in more species-specific recommendations. For example, a number of pharmacokinetic studies have been done on TB drug levels in elephants. [41] [42] [43] [44] [45] Expert consultation is suggested in the treatment of veterinary TB.

The first-line TB medications used in animals are the same as humans: INH, RIF, EMB, and PZA (which is not used in the treatment of M. bovis as this organism is usually resistant). Other antituberculous medications also include quinolones and systemic aminoglycosides. Veterinary quinolones used for TB include enrofloxacin and marbofloxacin, and aminoglycosides include amikacin and streptomycin. Nevertheless, much more investigation is needed in the area of veterinary antituberculous pharmacotherapy.

Companion animals rarely are treated for TB, either because of the advanced condition of the animal, belief that TB cannot be treated, or concerns regarding public health. It is probable that many, if not most, cases of TB in these animals have gone undiagnosed as a result of a combination of lack of awareness of the disease, lack of information regarding diagnostics and testing, and the impression that, regardless, treatment is not feasible. That TB in companion animals is an issue of public health concern has been cited as another reason for not considering pharmacotherapy. However, it may be possible in these situations to consider some of the same principles of TB disease control as used in other human and veterinary settings, such as housing the animal separately and/or outdoors while awaiting test results or a response to therapy. Nonetheless, the logistics and feasibility †Definitions of evidence ratings: I = randomized clinical trial; II = data from clinical trials that were not randomized or were conducted in other populations; III = expert opinion. ‡When directly observed therapy (DOT) is used, drugs may be given 5 days/wk and the necessary number of doses adjusted accordingly. Although there are no studies that compare 5 with 7 daily doses, extensive experience indicates this would be an effective practice. §Patients with cavitation on initial chest radiograph and positive cultures at completion of 2 months of therapy should receive a 7-month (31-week; either 217 doses [daily] or 62 doses [twice weekly]) continuation phase. ¶Five-day-a-week administration is always given by DOT. Rating for 5 day/wk regimens is AIII. ¶Not recommended for patients with HIV infection with CD4 + cell counts <100 cells/mL. #Options 1c and 2b should be used only in HIV negative patients who have negative sputum smears at the time of completion of 2 months of therapy and who do not have cavitation on the initial chest radiograph. For patients who start this regimen and are found to have a positive culture from the 2-month specimen, treatment should be extended an extra 3 months. of this approach depend on each individual situation, and discussion with TB experts is advisable.

NTM are environmental opportunistic pathogens that differ from the members of MTBC (and M. leprae) in that they are not obligate pathogens but rather are found in the environment and environmental reservoirs that serve as the source of infection. 46 Although most NTM do not cause human or animal disease, some may be pathogenic with potential for interspecies and zoonotic transmission. Table 9 -72 shows common potentially pathogenic mycobacteria, classified according to growth rate as either rapid growing (less than 1 week) or slow growing (more than 1 week). Transmission of NTM is achieved through inhalation or ingestion of water, particulate matter or aerosols, or through trauma. 47 NTMs are not generally considered communicable between humans and animals or as zoonotic infections and as such are not reportable diseases. Consequently, epidemiological data on the prevalence of NTM disease are not well established and surveillance information is limited. The clinical and epidemiological presentation of NTM infection has changed dramatically in recent years. This is thought to be due, in part, to the ability of these organisms to survive and flourish in habitats shared with humans and other animals, such as drinking water. In addition, an increase in the proportion of HIV-infected and other immunosuppressed hosts suggest a continuing and increasing prevalence of NTM infections in the future. Human risk factors associated with NTM disease include comorbid lung conditions such as prior TB disease, silicosis, and bronchiectasis, and host immunosuppression such as HIV infection. With the rise of HIV infection in the 1980s came increasing reports of disseminated human NTM infections, such as M. avium complex (MAC).

The most common sites of NTM disease in humans are pulmonary, lymphatic, skin, and soft tissue and disseminated disease. Pulmonary disease, commonly from M. avium, M. intracellulare, M. kansasii, or M. abscessus, generally presents as a chronic condition with a persistent or varying cough; additionally, there may be fatigue, malaise, sputum production, fever, weight loss, dyspnea, and hemoptysis. †Strength of recommendation: A = Both strong evidence of efficacy and substantial clinical benefit support recommendation for use. Should always be offered. B = Moderate evidence for efficacy or strong evidence for efficacy but only limited clinical benefit supports recommendation for use. Should generally be offered. C = Evidence for efficacy is insufficient to support a recommendation for or against use, or evidence for efficacy might not outweigh adverse consequences (e.g., drug toxicity, drug interactions) or cost of the treatment or alternative approaches. Optional. D = Moderate evidence for lack of efficacy or for adverse outcome supports a recommendation against use. Should generally not be offered. E = Good evidence for lack of efficacy or for adverse outcome support a recommendation against use. Should never be offered. ‡Quality of evidence supporting the recommendation: I = Evidence from at least one properly randomized controlled trial. II = Evidence from at least one well-designed clinical trial without randomization from cohort or case-controlled analytic studies (preferably from more than one center), from multiple time-series studies, or from dramatic results from uncontrolled experiments. III. = Evidence from opinions of respected authorities based on clinical experience, descriptive studies, or reports of expert committees. §Recommended regimen for persons aged <18 years. ||Recommended regimens for pregnant women. ¶The substitution of rifapentine for rifampin is not recommended because rifapentine's safety and effectiveness have not been established for patients with latent tuberculosis infection. NRTIs, Nucleoside reverse-transcriptase inhibitors; NNRTIs, non-nucleoside reverse-transcriptase inhibitors; DOT, directly observed therapy; RZ, rifampin plus pyrazinamide.

In HIV unaffected individuals, pulmonary infections with NTM traditionally had been found in older males. However, it has been found that bronchiectatic MAC disease may also present in older, thin females without prior pulmonary disease (Lady Windermere syndrome), sometimes in the presence of pectus excavatum, mitral valve prolapse, or scoliosis. 48 In HIV-infected individuals, NTM disease usually manifests when the host's CD4/T-lymphocyte cell counts are less than 50 cells/mL and often presents as a disseminated, multiorgan infection, commonly from M. avium. Acquisition of the NTM is usually through the GI or respiratory tracts; symptoms are nonspecific and include fever, night sweats, weight loss, anorexia, and diarrhea. Disseminated disease has also been reported with M. intracellulare, M. simiae, M. marinum, M. xenopi, and M. abscessus.

The diagnosis of pulmonary NTM disease is based on a combination of clinical and laboratory criteria 48 :

1. Symptoms and findings on imaging studies (chest radiograph or high-resolution CT scan) consistent with the diagnosis, 2. Exclusion of other conditions with a similar presentation, such as TB, and 3. Either multiple positive sputum cultures of the NTM species, a positive culture from a bronchial wash or lavage, or a biopsy specimen with typical histological features and a positive culture result from either the biopsy specimen or sputum. Lymphatic disease is the most common NTM presentation in children and rarely affects immunocompetent adults. The majority of cases are due to MAC, and sites are usually unilateral in cervical, submandibular, submaxillary, or preauricular lymph nodes. The diagnosis may be made by lymph node biopsy and specimen culture. A negative skin test response (<10 mm) may be helpful. Treatment may depend on the particular species of NTM, but localized disease in immunocompetent individuals may include surgical excision of the lymph node.

Skin, soft tissue, and bone disease, most commonly caused by M. fortuitum, M. abscessus, M. chelonae, M. marinum, or M. ulcerans, usually occurs through penetration, such as in puncture wounds, traumatic injuries, surgical wounds or injection, or skin trauma. For example, tenosynovitis of the hand, commonly from M. marinum, may occur in those cleaning aquariums (Color Plate 9-79). Chronic infections may occur in tendons, joints, and bones. In addition to antibiotics, surgical intervention may be indicated.

M. ulcerans is the agent causing Buruli's ulcer, which is an increasing cause of morbidity and disability in many parts of the world, especially West Africa. 49 In animals, natural infections with M. ulcerans have been observed in koalas, ringtail possums, and an alpaca. 50 In animals, M. paratuberculosis is the causative agent of Johne's disease (Figure 9-156 ). This is a progressive infection affecting ruminants, causing GI symptoms such as diarrhea and wasting, and is an important cause of economic losses in cattle. M. paratuberculosis also has been postulated as a cause of Crohn's disease in humans.

Avian mycobacteriosis (avian TB) in birds may be caused by several species of NTM, usually of the MAC or M. genavense, which are environmentally ubiquitous. These organisms may infect any bird (though uncommon in greycheeked parakeets), but is more common in older or immunosuppressed birds (Color Plate 9-80 and Figure 9 -157).

Avian TB usually presents as a chronic disease involving the GI tract and liver; signs include wasting despite a good appetite and loose droppings. Primary respiratory signs are uncommon. Rarely, tubercles may be seen on the face and oral cavity of infected birds. 51 The diagnosis of avian TB usually has been made by culture of the organism, although adequate culture specimens may be difficult to obtain. The finding of mycobacterial organisms in histology associated with inflammatory cells and the clinical presentation have been used to make a presumptive diagnosis. PCR testing is available, although the results must be interpreted carefully. 52 A positive result means that there are mycobacteria present but does not necessarily mean that it is the cause of disease. Most birds with avian TB either succumb to the disease or are euthanized. In some areas it is a reportable avian disease. Other than in birds, MAC infection in mammals is sporadic and not considered transmissible. However, disseminated disease has been reported in captive, nondomestic hoofed animals and in immunosuppressed dogs and cats. 53 M. marinum may commonly be found in marine animals and water. It can be transmitted directly from fish or marine animals to humans; it may indirectly be transmitted through water or contaminated equipment, such as aquariums (see above). Infection in ecothermic fish may present as a systemic disease with internal tuberculomas, anorexia, weight loss, skin defects, spinal deformities, abdominal distention, and exophthalmia. The prognosis in fish is poor; those affected are usually killed and removed from the environment, as infection may be transmitted if the fish are cannibalized.

M. leprae is the causative agent of leprosy (Hansen's disease) in humans, a chronic, granulomatous disease primarily affecting the skin and peripheral nerves. Leprosy has also been reported in wild armadillos and nonhuman primates. M. lepraemurium is the etiologic agent of murine leprosy, a disease primarily affecting the skin and viscera of rats and mice. 54 A B Figure procedures involving tularemia should be performed in at least biosafety level 2 conditions. Examining suspected cultures should be done in a biological safety cabinet. Procedures that could produce aerosols or droplets require biosafety level 3 conditions. 2 • Disinfect with 1% sodium hypochlorite, 70% ethanol, and glutaraldehyde. • Consider the possibility of bioterrorism in the event of a cluster of unexplained cases.

• Report disease to public health authorities using the case definition; see http://www.cdc.gov/ncphi/disss/ nndss/casedef/tularemia_current.htm. • Consider the diagnosis in persons presenting with acute onset of fever and exposure to ticks or animals. • Inquire about occupational risk factors for infection and ensure that workers at risk take precautions. • Ensure that any laboratory workers handling strains of tularemia virulent to humans are using biosafety level 3 precautions. 3 • Provide PEP following aerosol exposure. • A vaccine for tularemia is under review by the FDA but is not currently available in the United States. 4

• In many states tularemia in horses is a reportable disease to the state veterinarian. Disease in cats and dogs may be reportable to public health authorities. • In endemic areas, counsel owners to neuter cats to prevent roaming and keep cats indoors. • Treat dogs, cats, and horses for ectoparasites. • Ensure policies are in place to isolate suspected cases and for veterinary staff to use protective equipment and extreme care in handling infected animals, carcasses, or tissues. • Treat early if tularemia is suspected; otherwise, prognosis is poor.

Francisella tularensis is a small, gram-negative intracellular coccobacillus. Two major subspecies are recognized with different biochemical and pathological characteristics: F. tularensis tularensis and F. tularensis holarctica. F. tularensis subspecies tularensis (Jellison type A) is considered to have higher virulence, with human case fatality rates between 5% and 15% without treatment and a median lethal dose (LD 50 ) in rabbits of 1 to 10 organisms. F. tularensis subspecies holarctica (Jellison type B) has a lower infectivity (LD 50 >10 6 organisms in rabbits) and rarely causes human fatalities. 5 Recently type A isolates in the United States have been further divided, using molecular techniques, into type A-East and type A-West, with type A-West less virulent than either type A-East or type B. 6 Viable organisms can be found for months in fomites or the carcasses or hides of infected animals and years in frozen infected meat. The organism can be disinfected with 1% hypochlorite, 70% ethanol, glutaraldehyde, or formaldehyde or inactivated by moist heat (121° C for at least 15 minutes) and dry heat (160-170° C for at least 1 hour). 7

Tularemia is a disease of the Northern Hemisphere. Historically, the highest prevalence has been recorded in the United States and Russia. However, in both countries the prevalence has declined significantly since World War II. In the United States, the incidence peaked in 1939 with 2291 reported cases; in recent decades the average number of U.S. cases has been less than 200 annually. 1 Most cases occur in the south-central and western states, including Missouri, Alaska, Oklahoma, South Dakota, Tennessee, Kansas, Colorado, Illinois, Utah, and Montana. 8 The two major pathogenic strains vary in their geographical distribution. F. subspecies tularensis is primarily confined to North America, although isolation of strains resembling F. tularensis subspecies tularensis has recently been reported in Europe. 9 F. tularensis holarctica is also found in North America but to a lesser extent. By contrast, it is the predominant strain in Europe and Northern Asia. A third strain, F. tularensis subspecies mediasiatica, is found in central Asia.

In the United States, higher attack rates occur in children aged 5 to 9 years and individuals 75 years or older. Native Americans/Alaskan natives have an incidence of 0.5 per 100,000, 10 times the rate in whites (0.04/100,000). It is thought that the higher rates in children reflect exposure risk due to tick and other insect bites, whereas the increased risk in Native Americans may be related to increased exposure. High rates of infection in ticks and dogs have been found in reservations reporting human outbreaks. 1 Other risk groups include farmers, landscapers (especially those engaged in mowing lawns 10 ) , and hunters who may encounter carcasses of infected rabbits or other animals. Cat ownership has been reported as a risk factor for infection in areas experiencing outbreaks. 11 Veterinarians and wildlife rehabilitators may be at risk through handling sick animals. Laboratory workers are also at risk because of the infectiousness of the organism.

Tularemia is found in more than 250 species of mammal, birds, reptiles, and fish. 8 Aquatic animals have developed tularemia after being immersed in contaminated water Different species vary in their susceptibility to the disease. In the United States, cottontail rabbits (Sylvilagus species) as well as jackrabbits, beaver, moles, squirrels, muskrat, meadow voles, and sheep are prone to the disease, which is often fatal.

Cats are at increased risk because of their predatory habits. A serological survey found evidence of past infection in 24% of cats tested in Connecticut and New York, suggesting that the disease in cats may be more common than often recognized. 12 Tularemia is found in a number of vector species, including several species of tick, deer flies, mites, lice, midges, fleas, bedbugs, and mosquitoes. Vector-transmitted infections are believed to account for the majority of human and other animal cases in the United States. Recognized vectors in the United States include the wood tick (Dermacentor andersoni), dog tick (D. variabilis), lone star tick (Amblystoma americanum), and the deer fly (Chrysops discalis). 8 Flies can carry Francisella for 2 weeks and ticks may be infected throughout their lifespan.

Animal-to-animal and animal-to-human transmission of tularemia appears to take place through a variety of mechanisms, including direct inoculation through a bite from an infected arthropod vector, a bite or scratch or conjunctival contact from an infected animal, inhalation of aerosols containing organisms, and ingestion of contaminated food or water (Figure 9 -158). Human-to-human transmission has not been reported. The mode of transmission helps determine the clinical form of the disease.

In the United States, the most common form of the disease is the ulceroglandular type, which develops after a vector bite (usually a tick or fly) and consists of an ulcer at the site of the bite with associated lymphadenopathy and fever. Direct handling of infected carcasses (especially rabbits) can also result in this form of infection. Less commonly, the inhalation of organisms results in primary pneumonic tularemia. Contact with mucous membranes of a susceptible host causes the oculoglandular form of the disease. Ingestion of contaminated meat or water can cause a typhoidal form of the disease characterized by fever and nonspecific GI symptoms, including diarrhea. 13 Although rare, there are cases of humans developing infection from contact with infected cats and dogs. Exposure risk factors include cat bites 14 and being licked by an infected dog. 15

F. tularensis can survive for months in water and sediment. A number of human outbreaks have occurred next to bodies of water, including one associated with crayfish fishing. 16 In an outbreak of pneumonic tularemia in Martha's Vineyard, skunks and raccoons were found to frequently be seroreactive, raising the possibility of peridomestic environmental contamination by feces; however, this has not been confirmed as the source of illness. 17 Another environmental factor is the changing conditions that can lead to increases in rodent populations; outbreaks have been associated with increases in populations of rodents. Intentional introduction of game animals such as hares into new geographical areas for hunting has lead to outbreaks in Spain, where it had not been previously reported. 18

Tularemia causes an acute febrile disease that usually begins 3 to 5 days after exposure. Although most cases are charac- terized by the abrupt onset of fever, chills, fatigue, myalgia, headache, and nausea, several distinct forms of the disease are related to the mode of transmission and the virulence of the organism. Infection caused F. tularensis subspecies tularensis may progress to septicemia, with disseminated intravascular coagulation, acute respiratory distress syndrome, CNS involvement, and multiorgan failure. Disease related to F. tularensis subspecies holarctica is more likely to produce mild symptoms with a low case fatality rate. Most cases (87%) 19 present as ulceroglandular tularemia, resulting from insect bites or direct contact with an infected carcass (Figure 9 -159 and Color Plate 9-81). One of the first symptoms is lymphadenopathy localized in the area where the bite or scratch occurred. A painful papule develops either simultaneously or within several days at the site of the initial skin entry. This papule then ulcerates, taking several weeks to heal. 5 The lymphadenopathy may also suppurate and become ulcerative (Color Plate 9-82). Rarely, if there is contact with conjunctival membranes, oculoglandular tularemia develops, with purulent conjunctivitis and lymphadenopathy. Glandular tularemia resembles the ulceroglandular form but without skin lesions. 19 Primary pneumonic tularemia results from inhalation of infected aerosols and manifests as pneumonitis and bronchiolitis, which may lead to respiratory failure. Pneumonic tularemia may also develop as a complication of other forms and is associated with a higher mortality rate. 19 The typhoidal form of tularemia is considered rare, is caused by ingestion of contaminated food or water, and may be difficult to diagnose. Symptoms can include fever, gastroenteritis, septicemia, and pneumonia. Ingestion may also lead to oropharyngeal tularemia with throat pain, prominent pharyngitis, oral ulcers, and enlargement of cervical lymph nodes.

Susceptibility to F. tularensis infection varies among animal species. Rabbits and many rodents develop fatal disease. Sheep also have high mortality rates.

Cats can develop an acute febrile syndrome caused by tularemia that can be fatal (Color Plate 9-83). Ulceroglandular disease in cats has also been reported. 20 Dogs appear to be more resistant and likely to develop asymptomatic infection. However, fever, anorexia, and lethargy have been reported in a dog that ate an infected rabbit. 21 Horses can develop a febrile infection associated with impaired coordination and depression. 22 Cattle appear to be resistant. Table 9 -73 compares clinical presentations of tularemia in humans and other animals.

Diagnosis in humans is usually based on clinical signs and confirmed by serological studies showing at least a fourfold rise in titer that occurs 2 weeks after the onset of illness. A direct immunofluorescence test and/or PCR test may be available for rapid diagnosis.

Culture of body fluids should be performed only in reference laboratories because of risk of infection to laboratory personnel. Lymph nodes should not be biopsied unless antibiotics have already been started because of the risk of inducing bacteremia. 5 In other animals, a direct antibody or IFA assay (Color Plate 9-84) is considered the most rapid and accurate means of diagnosis 15 ; an immunohistochemical analysis for formalin-fixed tissue has also been developed. Serology is used if the animal survives, with a fourfold titer difference between acute and convalescent titers confirming infection. Culture of the bacterium can be performed but poses a health risk for laboratory personnel.

Antibiotics are the mainstay of therapy. Isolation of patients and prophylactic treatment of contacts of human patient are not necessary because human-to-human transmission has not been observed. For individuals who have had high-risk exposures to infected animals or other sources of the organism, prophylactic antibiotics are indicated as shown in Table 9 -74. (Note: tetracycline and chloramphenicol are bacteriostatic and have been associated with relapses in humans).

Little is known about effective treatment regimens in animals because the disease is often fatal before treatment begins. However, recommended antibiotic regimens are shown in Table 9 -74. An important part of animal treatment is isolation of the animal and protection of veterinary staff, including wearing of gowns, gloves, and face masks, including eye protection, when handling a suspected case. 15 

Carina Blackmore

West Nile virus (WNV) was first isolated from a febrile woman in Uganda in 1937. 1 The first human disease outbreak occurred 20 years later in Israel. The virus was first detected in the Americas in 1999 by a veterinary pathologist when a flavivirus was identified as the cause of an apparent zoonotic encephalitis outbreak in humans and corvid birds (e.g., crows and jays) in Queens, New York. WNV has since become the most important cause of mosquito-borne disease in North America. It spread across the 48 continental United States in 6 years, and more than 27,000 human cases and 25,000 horse cases of WNV disease were reported during the period 1999 to 2007. Outbreaks of human or equine WNV encephalitis have also occurred in southern Europe, Israel, the Democratic Republic of the Congo, and Russia. WNV is an example of a disease where tracking sentinel cases in birds, 2 horses, dogs, 3 and other animals, as well as WNV positive pools of mosquitoes, has proved useful for efforts aimed at early detection and prevention of human cases. Several zoonotic arthropod-borne (arboviral) diseases are known to circulate within the United States, including St. Louis encephalitis (SLE), Eastern equine encephalitis (EEE), La Crosse encephalitis (LAC) and Western equine encephalitis (WEE). These arboviruses may have different vector and vertebrate hosts than WNV but many of the guidances discussed below are relevant for prevention of and control of them all. They are also relevant for potentially emerging zoonotic arboviruses such as Rift Valley Fever virus.

• Recommend to the public:  Do not go outdoors at dusk and dawn when mosquitoes are most active. Protect bare skin and clothing with a mosquito repellent. Make certain the repellent is used according to its label. Do not use repellents over cuts, wounds, or irritated skin. Do not use repellent under clothing. • DEET (N,N-diethyl-3-methylbenzamide) 4 and picaridin 5 are effective repellents registered for skin application by the EPA. Depending on the duration of protection desired, products containing 4.75% DEET provide roughly 90 minutes' effectiveness; products containing 23.8% DEET provide an average of 5 hours of protection. 6 • Among plant-based repellents registered with the EPA, oil of lemon eucalyptus provides longer-lasting protection than others, with an efficacy similar to a repellent with low concentrations of DEET. Repellents can be reapplied according to the manufacturer's instructions. • Sunscreen and insect repellent can be applied simultaneously. However, it is not recommended to use a product combining sunscreen and repellents as sunscreen often needs to be applied more frequently and repeated application may increase the toxic effects of the repellent. • Permethrin, a pyrethroid product, is an effective repellent registered for application on clothing, camping gear, or mosquito nets. • Safety precautions when using repellents on children:

 Keep repellents out of the reach of children.

Do not allow young children to apply insect repellent to themselves; have an adult do it for them.

Apply the repellent to your own hands and then rub them on the child. Avoid children's eyes and mouth and use it sparingly around their ears.  Do not apply repellent to children's hands as children may tend to put their hands in their mouths.  Wash treated skin with soap and water after returning indoors and wash treated clothing.

The American Academy of Pediatrics does not recommend repellents be used on children younger than 2 months. Instead, they recommend the use of mosquito netting over infant carriers. Oil of lemon eucalyptus products should not be used on children younger than 3 years. • Determine and implement the most appropriate surveillance methods for WNV risk in your region, considering possible use of mosquito, bird, or mammal sentinel information, as well as climate tracking (Color Plates 9-85 and 9-86).

• In suspected cases, submit serum and/or CSF for WNV antibody testing. • Monitor public health surveillance on human WNV disease in the local area, including surveillance of sentinel animals, to estimate current human health risk. • Counsel all patients, especially adults older than 50 years and families with infants, to avoid being bitten by mosquitoes, including the appropriate use of repellents and mosquito netting. • Report cases to the health department if required in the state per recommended case definition.

• Advise horse owners on how to prevent equine WNV disease. Horses should be protected from mosquito bites. This can be done by eliminating mosquito breeding sites, providing screened housing, and applying insect repellents. • Vaccinate horses against WNV disease. There are three licensed WNV vaccines currently available: an inactivated whole virus vaccine, a live recombinant canary pox vector vaccine, and a modified live chimera vaccine. The American Association of Equine Practitioners provides the following guidance on WNV vaccination of horses 7 : Primary vaccination of previously unvaccinated horses with either the inactivated or canary pox vector vaccine involves administration of 2 doses of vaccine 4 to 6 weeks apart followed by revaccination at a 12-month interval. Label instructions for the modified live chimera vaccine recommend a single injection followed by a 12-month revaccination interval. More frequent boosters may be warranted for juvenile (<5 years) or geriatric (>15 years) horses. Although the licensed WNV vaccines are currently not labeled for administration to pregnant mares, many veterinary practitioners do administer them to pregnant mares. Booster vaccination of pregnant mares 4 to 6 weeks before foaling provides passive, colostral protection to their foals. To avoid interference from colostral antibodies, primary vaccination of foals from vaccinated mares should be started at 4 to 6 months of age. Foals should receive a third dose in the spring of the year following their birth. Foals of unvaccinated mares should ideally receive two doses of vaccine before the mosquito-borne disease season starting at 3 months of age. The modified live flavivirus chimera vaccine is labeled for foals 5 months or older. A single dose should be administered followed by a second dose at 10 to 12 months of age (before the next WNV season). • Prevent dogs and cats from eating birds and other wildlife. Japanese encephalitis antigenic serocomplex. 1 More distantly related mosquito-borne flaviviruses in the Americas include yellow fever and Dengue virus.

WNV was first identified in Uganda in 1937. It is now endemic in parts of Africa, Europe, Australia, and Asia as well as North, Central, and South America. 9, 10 Groups at Risk WNV is transmitted by mosquito bite, and persons in all age groups are at risk of infection. In areas where WNV is hyperendemic, it is a mild, common childhood illness. 11 In industrialized temperate areas the incidence of neuroinvasive WNV disease and death increases in those who are immunosuppressed or 50 years and older. 11, 12 The risk for WNV meningitis and encephalitis is also slightly higher among males than females.

WNV is a mosquito-borne virus. The enzootic cycle involves transmission of the virus among infected Culex mosquitoes and wild birds (Figure 9 -161). Many bird species can become infected by WNV, although only a small proportion are likely to be important reservoir hosts. Passerine birds (crows, jays, finches, grackles, sparrows) are thought to play a role in the WNV transmission cycle. They are common, widespread, and develop a high and prolonged viremia, 13 all important features for a vertebrate reservoir host. Humans, horses, and other mammals are incidental hosts of the virus.

WNV is maintained in nature by mosquitoes and wild birds (Figure 9 -162). The overwintering mechanisms of the virus are not fully understood; however, overwintering adult mosquitoes are thought to play a role. 14 Human and other mammals are incidental hosts of the virus. Non-mosquitoborne transmission such as transplacental infection, breastfeeding, blood transfusion, and organ transplantation have also been documented. 15 Fecal-oral transmission has been reported among animals including alligators, cats, some raptors, hamsters, and golden crows. 16

Virus amplification and transmission are favored by warm temperatures, and the peak virus activity occurs in the late summer months. Different vectors prefer different breeding habitats. The Culex pipiens species breed in stagnant pools of groundwater, artificial containers, catch basins, or sewage seepage. They prefer to breed in highly organic (polluted) water. Culex tarsalis, the most important WNV vector in the western United States, tolerates a wide range of habitats but prefers permanent or semipermanent seepage areas and surface pools associated with irrigated pastures. Culex nigripalpus, a principle WNV vector in the Southeast, is a floodwater mosquito.

Most individuals infected with WNV (80%) remain asymptomatic. 17 The clinical presentation ranges from a mild nonneuroinvasive fever illness to encephalitis, coma, and death (Table 9 -75). It is estimated that fewer than 1% of infected persons develop severe neurological disease. Typical symptoms of West Nile fever include fatigue, fever, headache, and muscle weakness. Half of the persons interviewed in a survey among West Nile fever patients in Chicago also had difficulty concentrating. 18 More severe clinical syndromes include aseptic meningitis, myelitis, polyradiculitis, and encephalitis. Patients often present with a prodrome of fever, headache, and other nonspecific symptoms. Many develop movement disorders such as severe tremors and parkinsonism. 19

Horses infected with WNV may develop fever, depression or apprehension, stupor, behavioral changes, intermittent lameness, ataxia, caudal paralysis, droopy lip, teeth grinding, muscle twitching, tremors, difficulty rising, recumbency, convulsions, and death. 20 inapparent infections, whereas others become severely ill and succumb to the virus. Signs of WNV neurological disease include sudden onset of mild ataxia, abnormal head posture, circling, reclination, quadriparesis, and tremors. Nystagmus, seizures, disorientation, signs of depression, weight loss, impaired vision, and sudden death may also be present. 9, 23 Birds shed virus orally and in their feces, and bird-to-bird transmission has been reported. 9, 24 Gross pathology often includes an enlarged, necrotic, and hem-orrhaging liver and spleen, myocardial degeneration and inflammation, pericardial lesions, pancreatitis, and chronic adrenalitis. Dogs and cats appear to be relatively resistant to WNV and generally develop subclinical disease after exposure. Acute encephalitis, polyarthritis, and myocarditis have been reported in dogs. 22 Fever and lethargy have been reported in cats. In addition, WNV has been isolated from the brain of a cat with neurological disease. 25 Outbreaks of WNV disease with high mortality rates have been seen among farm-raised alligators. The virus appears to spread via fecal-oral transmission in the alligator pens (Color Plates 9-87 and 9-88).

WNV infection has also been documented in bats, a skunk, and a few rodent species.

Serological tests used to diagnose WNV infection include ELISA and antigen (IgM and IgG) capture ELISA, hemagglutination inhibition, plaque reduction neutralization, and virus neutralization. Virus can also be identified in the CNS and other tissues using virus isolation, PCR, and immunohistochemistry.

For surveillance of WNV in dead birds, public health and partner agencies have used the VecTest antigen-capture assay (Medical Analysis Systems, Camarillo, Calif.), 29 Rapid Analyte Measurement Platform (RAMP) assay (Response Biomedical Corp, Burnaby, British Columbia, Canada), 30 and real-time RT-PCR.

There is no specific treatment for WNV infection in either humans or animals. In more severe human cases, intensive supportive care is indicated, such as hospitalization, intravenous fluids, airway management, respiratory support (ventilator), prevention of secondary infections (pneumonia, urinary tract, etc.), and good nursing care. Research trials are under way to identify effective antiviral treatment and vaccines.

Nonspecific immunoglobulin and plasmapheresis should be considered for patients with Guillain-Barré syndrome. The treatment is not indicated for patients with paralysis due to damage of anterior horn cells. 28 

Anthropogenic environmental change and the emergence of infectious diseases in wildlife

From "us vs. them" to "shared risk": can animals help link environmental factors to human health?

5-minute veterinary consult clinical companion canine and feline infectious disease and parasitology

Public health aspects of dirofilariasis in the United States

The Merck veterinary manual

Pasteurella multocida urinary tract infection with molecular evidence of zoonotic transmission

Handbook for zoonotic diseases of companion animals

Zoonosis update: Anthrax

Cutaneous anthrax associated with drum making using goat hides from west Africa-Connecticut

Responding to detection of aerosolized Bacillus anthracis by autonomous detection systems in the workplace

Case records of the Massachusetts General Hospital. Case 30-2005. A 56-year-old man with fever and axillary lymphadenopathy

Human benefits of animal interventions for zoonosis control

Guidelines for coordinated human and animal brucellosis surveillance

Handbook for zoonotic diseases of companion animals. Ames, IA: The Center for food security and public health

The Merck veterinary manual

Safety of Brucella abortus strain RB51 vaccine in non-target ungulates and coyotes

Zoonoses and communicable diseases common to man and animals

From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis

Endemic, notifiable bioterrorismrelated diseases, United States, 1992-1999

Campylobacter jejuni-an emerging foodborne pathogen

Handbook for zoonotic diseases of companion animals

The Merck veterinary manual

Control of communicable diseases manual

Fatal prosthetic valve endocarditis due to Campylobacter fetus

The need to differentiate Campylobacter fetus subspecies isolated from humans

Zoonoses and communicable diseases common to man and animals

Sanford guide to antimicrobial therapy

Risk factors for sporadic Campylobacter jejuni infections in rural Michigan: a prospective case-control study

Risk factors for sporadic Campylobacter infection in the United States: a case-control study in FoodNet sites

Occurrence of Campylobacter jejuni in pets living with human patients infected with C. jejuni

Campylobacter fetus bacteraemia in a healthy individual: clinical and therapeutical implications

Campylobacter spp. in dogs and cats in Switzerland: risk factor analysis and molecular characterization with AFLP

Salmonellae and campylobacters in household and stray dogs in northern Taiwan

Broilers do not play a dominant role in the Campylobacter fetus contamination of humans

Species diversity of campylobacteria in a wild bird community in Sweden

Campylobacter, from obscurity to celebrity

Association between Campylobacter infection and Guillain-Barré syndrome

5-Minute veterinary consult clinical companion canine and feline infectious disease and parasitology

Handbook of zoonoses: identification and prevention

Sanford guide to antimicrobial therapy

References 1. Centers for Disease Control and Prevention

Handbook for zoonotic diseases of companion animals

Control of communicable diseases manual

Zoonotic cryptosporidiosis

Zoonoses and communicable diseases common to man and animals

The infectivity of Cryptosporidium parvum in healthy volunteers

A massive outbreak in Milwaukee of Cryptosporidium infection transmitted through the public water supply

Evidence supporting zoonotic transmission of Cryptosporidium spp. in Wisconsin

Case-control study of environmental and social factors influencing cryptosporidiosis

5-minute veterinary consult clinical companion canine and feline infectious disease and parasitology

References 1. Stehr-Green JK, Schantz PM. The impact of zoonotic diseases transmitted by pets on human health and the economy

Control of communicable diseases manual

Zoonoses and communicable diseases common to man and animals

Infectious diseases of the dog and cat

Principles and practice of infectious diseases

Hazardous hedgehogs

Physician's guide to arthropods of medical importance

The first case of dipylidium caninum found and identified in a human being in Guatemala

The Merck veterinary manual

Handbook of zoonoses: identification and prevention

Zoonoses and communicable diseases common to man and animals

Dipylidium caninum mimicking recurrent Enterobius vermicularis (pinworm) infection

Unusual neurological presentation of dipylidiasis in a child

5-minute veterinary consult clinical companion canine and feline infectious disease and parasitology

Zoonoses and communicable diseases common to man and animals

Cystic echinococcosis in the Americas

CRC handbook series in zoonoses, Section C: Parasitic zoonoses

Echinococcosis-an emerging parasite in the immigrant population

Risk factors for alveolar echinococcosis in humans

Wilderness in the city: the urbanization of Echinococcus multilocularis

Infectious and tropical diseases: a handbook for primary care

Control of communicable diseases manual

Influence of environmental factors on the infectivity of Echinococcus multilocularis eggs

WHO classification of alveolar echinococcosis: principles and application

The Merck veterinary manual

Handbook for zoonotic diseases of companion animals. The Center for Food Security & Public Health

Prevention and control of cystic echinococcosis

Percutaneous needle aspiration, injection, and reaspiration with or without benzimidazole coverage for uncomplicated hepatic hydatid cysts

Sanford guide to antimicrobial therapy

5-minute veterinary consult clinical companion canine and feline infectious disease and parasitology

Control of communicable diseases manual

Concurrent infection in a dog and colonization in a child with a human enteropathogenic Escherichia coli clone

Extraintestinal pathogenic Escherichia coli-induced acute necrotizing pneumonia in cats. Zoonoses Pub Health

Virulence and fitness gene patterns of Shiga toxin-encoding Escherichia coli isolated from pigs with edema disease or diarrhea in Germany

Imported chicken meat as a potential source of quinolone-resistant Escherichia coli producing extended-spectrum β-lactamases in the UK

Extraintestinal pathogenic Escherichia coli

Handbook for zoonotic diseases of companion animals

Zoonoses and communicable diseases common to man and animals

Handbook of zoonoses: identification and prevention

Occurrence of Escherichia coli O157:H7 in diverse farm environments

Enterohemorrhagic Escherichia coli excretion by child and her cat

Modelling the vector pathway and infection of humans in an environmental outbreak of Escherichia coli O157

H7 outbreaks

National Association of State Public Health Veterinarians et al. Compendium of measures to prevent disease associated with animals in public settings

An outbreak of Escherichia coli O157 infection following exposure to a contaminated building

Sanford guide to antimicrobial therapy

Centers for Disease Control and Prevention. Disease listing: Escherichia coli general information: CDC DFBMD

Infectious and tropical diseases: a handbook for primary care

Longitudinal prevalence study of diarrheagenic Escherichia coli in dairy calves

Principles and practice of infectious diseases

Handbook for zoonotic diseases of companion animals

Prevalence and genotypes of Giardia duodenalis in post-weaned dairy calves

Prevalence of species and genotypes of Cryptosporidium found in 1-2 year old dairy cattle in the eastern United States

Clustering of giardiasis among AIDS patients in Los Angeles County

Passive immunity and serological immune response in dairy calves associated with natural Giardia duodenalis infections

Infectious diseases of the dog and cat

Giardia infection in farm animals

Zoonoses and communicable diseases common to man and animals: vol. III: chlamydioses, parasitoses

Genotyping of Giardia duodenalis from human and animal samples from Brazil using betagiardin gene: a phylogenetic analysis

Canine zoonoses in Bangkok temples

Zoonotic transmission of giardiasis: a case control study

The Merck veterinary manual

Occurrence of Giardia sp. cysts and Cryptosporidium sp. oocysts in faeces from public parks in the west of Scotland

Giardia sp. cysts and infectious Cryptosporidium parvum oocysts in the feces of migratory Canada geese (Branta canadensis)

The potential for marine bivalve shellfish to act as transmission vehicles for outbreaks of protozoan infections in humans: a review

Infectious and tropical diseases: a handbook for primary care

Control of communicable diseases manual

Principles and practice of infectious diseases

The 5-minute veterinary consult clinical companion canine and feline infectious disease and parasitology

Comparison of direct immunofluorescence, immunoassays, and fecal flotation for detection of Cryptosporidium spp. and Giardia spp

Northern California animal shelters

Sanford guide to antimicrobial therapy

Blackwell's five-minute veterinary consult: canine and feline

Center for Disease Control and Prevention. Prevent rodents: index: CDC rodent control

Hantavirus and arenavirus antibodies in persons with occupational rodent exposure

Regulation of rodent-borne viruses in the natural host: implications for human disease

Hantavirus pulmonary syndrome-United States: updated recommendations for risk reduction

Genetic reassortment among viruses causing hantavirus pulmonary syndrome

Genetic diversity and distribution of Peromyscus-borne hantaviruses in North America

An unusual hantavirus outbreak in southern Argentina: person-to-person transmission? Hantavirus Pulmonary Syndrome Study Group for Patagonia

Person-to-person transmission of Andes virus

Pan American Health Organization

Phylogenetically distinct hantaviruses in the masked shrew (Sorex cinereus) and dusky shrew (Sorex monticulus) in the United States

Control of communicable diseases manual

Risk factors for hantavirus infection in Germany

Hantavirus RNA in saliva from patients with hemorrhagic fever with renal syndrome

Hantaviruses: underestimated respiratory viruses?

Community-acquired pneumonia: new facets of an old disease-hantavirus pulmonary syndrome

A spatial model of shared risk for plague and hantavirus pulmonary syndrome in the southwestern United States

Infectious and tropical diseases: a handbook for primary care

Serologic survey for hantavirus infection in domestic animals and coyotes from New Mexico and northeastern Arizona

Hantavirus pulmonary syndrome-five states

References 1. Georgiev VS. Parasitic infections. Treatment and developmental therapeutics. 1. Necatoriasis. Curr Pharma Des

Zoonoses and communicable diseases common to man and animals

The Merck veterinary manual

Control of communicable diseases manual

Cutaneous larva migrans associated with Loffler's syndrome

5-Minute veterinary consult clinical companion canine and feline infectious disease and parasitology

Principles and practice of infectious diseases

Sanford guide to antimicrobial therapy

Influenza Virus

Swine influenza virus: zoonotic potential and vaccination strategies for the control of avian and swine influenza

Influenza H1N1

Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on lummunization Practices (ACIP) 2009. MMWR

The importance of including swine and poultry workers in influenza vaccination programs

Compendium of veterinary standard precautions for zoonotic disease prevention in veterinary personnel

American Association of Equine Practitioners Influenza virus vaccination guidelines

Control of avian influenza in poultry

The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host

Evolution and adaptation of H5N1 influenza virus in avian and human hosts in Indonesia and Vietnam

Influenza vaccines of the future. SpringerLink

Influenza vaccine: a summary for clinicians

Risk factors for human infection with avian influenza A H5N1

Swine workers and swine influenza virus infections

Contact variables for exposure to avian influenza H5N1 virus at the human-animal interface

Avian influenza

Transmission of avian influenza virus (H3N2) to dogs

Influenza A virus (H3N8) in dogs with respiratory disease

Emergence of a novel swine-origin influenza A (H1N1) virus in humans

Swine influenza

Avian influenza: introduction

Centers for Disease Control and Prevention. Influenza symptoms and laboratory diagnostic procedures

Centers for Disease Control and Prevention. Avian influenza A virus infections of humans

World Organization for Animal Health

Diseases of poultry

H3N2 influenza virus transmission from swine to turkeys, United States

Interspecies transmission and reassortment of influenza A viruses in pigs and turkeys in the United States

References 1. World Health Organization. Leishmaniais and HIV coinfection

Control of communicable diseases manual

Autochthonous visceral leishmaniasis in dogs in North America

Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial

Leishmaniasis: current situation and new perspectives

Cutaneous leishmaniasis in Texas: a northern spread of endemic areas

Canine leishmaniasis-new concepts and insights on an expanding zoonosis: part two

Canine visceral leishmaniasis, United States and Canada

Principles and practice of infectious diseases

The 5-minute veterinary consult clinical companion canine and feline infectious disease and parasitology

PCR-based diagnosis of acute and chronic cutaneous leishmaniasis caused by Leishmania (Viannia)

North Carolina State College of Veterinary Medicine Veterinary Teaching Hospital. Tick borne diagnostic laboratory

Oral miltefosine for Indian visceral leishmaniasis

Sanford guide to antimicrobial therapy

Infectious diseases of the dog and cat

Leptospirosis: a zoonotic disease of global importance

Handbook for zoonotic diseases of companion animals

Antibiotics for preventing leptospirosis

The Merck veterinary manual

Principles and practice of infectious diseases

Zoonoses and communicable diseases common to man and animals

Disease listing, leptospirosis, technical information

Leptospirosis on Oahu: an outbreak associated with flooding of a university campus

Leptospirosis in a caver returned from Sarawak, Malaysia

Case of Weil's disease in an innercity hospital in the USA

Leptospirosis Working Group, Outbreak of leptospirosis among triathlon participants and community residents in

Fulminant leptospirosis in a patient with human immunodeficiency virus infection: case report and review of the literature

Prevalence of and risk factors for leptospirosis among dogs in the United States and Canada: 677 cases (1970-1998)

Prevalence of leptospiral infection in Texas cattle: implications for transmission to humans

Cyclical changes in seroprevalence of leptospirosis in California sea lions: endemic and epidemic disease in one host species

Suburban leptospirosis: atypical lymphocytosis and gamma-delta T cell response

Leptospirosis-can it be a sexually transmitted disease?

Evaluation of environmental risk factors for leptospirosis in dogs: 36 cases

Risk factors associated with antibodies to leptospires in inner-city residents of Baltimore: a protective role for cats

5-Minute veterinary consult clinical companion canine and feline infectious disease and parasitology

Leptospirosis: a re-emerging zoonotic disease

Control of communicable diseases manual

Severe course of rat biteassociated Weil's disease in a patient diagnosed with a new Leptospiraspecific real-time quantitative LUX-PCR

Randomized controlled trial of doxycycline prophylaxis against leptospirosis in an endemic area

Treatment and outcome of dogs with leptospirosis: 36 cases

Antimicrobial therapy in veterinary medicine

The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America

The dog as a sentinel for human infection: prevalence of Borrelia burgdorferi C6 antibodies in dogs from southeastern and mid-Atlantic states

Infectious diseases of the dog and cat

Centers for Disease Control and Prevention. Lyme disease prevention and control: protect yourself from tick bites

Placerville Veterinary Clinic. Tick removal tools

ACVIM small animal consensus statement on Lyme disease in dogs: diagnosis, treatment, and prevention

Sequence typing reveals extensive strain diversity of the Lyme borreliosis agents Borrelia burgdorferi in North America and Borrelia afzelii in

Control of communicable diseases manual

Canine borreliosis

Spirochete associated arthritis (Lyme disease) in a dog

Arthritis caused by Borrelia burgdorferi in dogs

Assessing peridomestic entomological factors as predictors for Lyme disease

Lyme disease-United States

The role of lizards in the ecology of Lyme disease in two endemic zones of the Northeastern United States

Seroprevalence of antibodies against Borrelia burgdorferi and Anaplasma phagocytophilum in cats

Centers for Disease Control and Prevention. Lyme disease transmission

Temporal regulations of the outer surface proteins of the Lyme-disease spirochaete Borrelia burgdorferi

Forest fragmentation predicts local scale heterogeneity of Lyme disease risk

Increased incidence of Lyme borreliosis in southern Sweden following mild winters and during warm, humid summers

Lymphocytic choriomeningitis virus. A neglected pathogen of man

Lymphocytic choriomeningitis virus-an old enemy up to new tricks

Arenoviruses: proposed name for a newly defined virus group

Lymphocytic chiromeningitis virus

Control of communicable diseases manual

Minnesota: lymphocytic choriomeningitis virus (LCMV). www.cvm.umn

Tropical infectious diseases: principles, pathogens, and practice

Transmission of lymphocytic choriomeningitis virus by organ transplantation

A new arenavirus in a cluster of fatal transplant-associated diseases

Lymphocytic choriomeningitis virus transmitted through solid organ transplantation-Massachusetts

Interim guidance for minimizing risk for human lymphocytic choriomeningitis virus infection associated with rodents

Lymphocytic choriomeningitis virus infection and house mouse (Mus musculus) distribution in urban Baltimore

Lymphocytic choriomeningitis infection of the central nervous system

Post-translational processing of the glycoproteins of lymphocytic choriomeningitis virus

The mouse in biomedical research, vol I: history, genetics, and wild mice

Report of two cases, with recovery of the virus from gray mice (Mus musculus) trapped in the two infected households

Distribution of the lymphocytic choriomeningitis virus in an endemic area

Human-rodent contact and infection with lymphocytic choriomeningitis and Seoul viruses in an innercity population

Rodent sightings and contacts in an inner-city population of

Pet rodents and fatal lymphocytic choriomeningitis in transplant patients

Lymphocytic choriomeningitis virus, Virology monographs. 10

Syrian hamsters as vectors of lymphocytic choriomeningitis

Lymphocytic choriomeningitis outbreak associated with pet hamsters. Fifty-seven cases from New York State

Lymphocytic choriomeningitis virus in man. Serologic evidence of association with pet hamsters

Lymphocytic-choriomeningitisvirus infection traced to a pet hamster

Congenital lymphocytic choriomeningitis virus syndrome: a disease that mimics congenital toxoplasmosis or cytomegalovirus infection

Lymphocytic choriomeningitis in the newborn. Probable transplacental infection

Congenital lymphocytic choriomeningitis virus infection in twins

Hydrocephalus complicating lymphocytic choriomeningitis virus infection

Lymphocytic choriomeningitis virus: emerging fetal teratogen

Lymphocytic choriomeningitis virus: an unrecognized teratogenic pathogen

Congenital lymphocytic choriomeningitis virus infection: an underdiagnosed disease

Lymphocytic choriomeningitis virus: an underdiagnosed cause of congenital chorioretinitis

Congenital viral infections of the brain: lessons learned from lymphocytic choriomeningitis virus in the neonatal rat

Zoonoses and communicable diseases common to man and animals

Sanford guide to antimicrobial therapy

Community-associated MRSA: superbug at our doorstep

Characterisation of methicillinresistant Staphylococcus aureus isolates from dogs and their owners

Methicillin-resistant Staphylococcus aureus isolated from a veterinary surgeon and five dogs in one practice

Prevalence of methicillin-resistant Staphylococcus aureus among staff and pets in a small animal referral hospital in the UK

Surveillance of Staphylococcus aureus in veterinary teaching hospitals

Methicillin-resistant Staphylococcus aureus (MRSA) isolated from animals and veterinary personnel in Ireland

Panton Valentine leukocidin (PVL) toxin positive MRSA strains isolated from companion animals

Suspected transmission of methicillinresistant Staphylococcus aureus between domestic pets and humans in veterinary clinics and in the household

Cluster of methicillin-resistant Staphylococcus aureus colonization in a small animal intensive care unit

Methicillin-resistant staphylococci in companion animals

Methicillin-resistant Staphylococcus aureus outbreak in a veterinary teaching hospital: potential human-to-animal transmission

Methicillin-resistant Staphylococcus aureus in horses and horse personnel

Community-associated methicillin-resistant Staphylococcus aureus in horses and humans who work with horses

High prevalence of methicillin resistant Staphylococcus aureus in pigs

Community-acquired MRSA and pig-farming

Methicillin resistant Staphylococcus aureus colonization in pigs and pig farmers

Transmission of methicillin-resistant Staphylococcus aureus strains between different kinds of pig farms

An outbreak of methicillin-resistant Staphylococcus aureus skin infections resulting from horse to human transmission in a veterinary hospital

Prevalence of methicillin-resistant Staphylococcus aureus among veterinarians: an international study

Methicillin-resistant Staphylococcus aureus colonization in veterinary personnel

MRSA transmission between cows and humans

Asymptomatic nasal carriage of mupirocin-resistant, methicillin-resistant Staphylococcus aureus (MRSA) in a pet dog associated with MRSA infection in household contacts

High risk for nasal carriage of methicillin-resistant Staphylococcus aureus among Danish veterinary practitioners

Transmission of a Panton-Valentine leukocidin-positive, methicillin-resistant Staphylococcus aureus strain between humans and a dog

Increase in a Dutch hospital of methicillin-resistant Staphylococcus aureus related to animal farming

Methicillinresistant Staphylococcus aureus in veterinary doctors and students, the Netherlands

Environmental management of Staph and MRSA in community settings

Handbook for zoonotic diseases of companion animals. Ames, IA: The Center for food security and public health

Centers for Disease Control and Prevention. Healthcare-associated methicillin resistant Staphylococcus aureus

Guidelines for the prevention and management of community-associated methicillin-resistant Staphylococcus aureus: a perspective for Canadian health care practitioners

Management of multidrugresistant organisms in healthcare settings

Methicillin-resistant Staphylococcus aureus in animals: a review

The molecular evolution of methicillin-resistant Staphylococcus aureus

Community-associated MRSA-resistance and virulence converge

Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks

Antimicrobial resistance in developing countries

The changing epidemiology of Staphylococcus aureus

Active bacterial core surveillance (ABCs) MRSA investigators. Invasive methicillinresistant Staphylococcus aureus infections in the United States

Nasal carriage of methicillin-resistant Staphylococcus aureus among hospital staff and outpatients

Prevalence of Staphylococcus aureus nasal colonization in the United States

Screening of Staphylococcus aureus, Staphylococcus intermedius, and Staphylococcus schleiferi isolates obtained from small companion animals for antimicrobial resistance: a retrospective review of 749 isolates (2003-04)

Methicillin-resistant Staphylococcus aureus in pigs with exudative epidermitis

Methicillin-resistant Staphylococcus aureus (MRSA) isolated from small and exotic animals at a university hospital during routine microbiological examinations

Characteristics of orf in a farming community in mid-Wales

Unusual presentation of human giant orf (ecthyma contagiosum)

Human orf (ecthyma contagiosum)

National Association of State Public Health Veterinarians. Compendium of measures to prevent disease associated with animals in public settings

Orf virus infection in children: clinical characteristics, transmission, diagnostic methods, and future therapeutics

Orf virus infection in humans

Zoonoses and communicable diseases common to man and animals

Centers for Disease Control and Prevention. Frequently asked questions about sore mouth (orf virus

Parapoxviruses: from the lesion to the viral genome

Animal and Plant Health Inspection Service, Veterinary Services, National Animal Monitoring System. Sheep 2001, part II: reference of sheep health in the United States

The Merck veterinary manual

Immunity and counter-immunity during infection with the parapoxvirus orf virus

Almila Tuncel A. Rapid improvement of human orf (ecthyma contagiosum) with topical imiquimod cream: report of four complicated cases

Characterization of sealpox, a separate member of the parapoxviruses

Principles and practice of infectious diseases

Giant orf on the nose

Ecthyma contagiosum (orf)-report of a human case from the United Arab Emirates and review of the literature

A case of human orf contracted from a deer

Severe persistent orf in young goats

A severe outbreak of contagious ecthyma (orf) in a free-ranging musk ox (Ovibos moschatus) population in Norway

The development of oral lesions in lambs naturally infected with orf virus

Control of communicable diseases manual

Orf-induced immunobullous disease: a distinct autoimmune blistering disorder

A case of human orf in an immunocompromised patient treated successfully with cidofovir cream

Control of communicable diseases manual

Residence-linked human plague in New Mexico: a habitat-suitability model

Centers for Disease Control and Prevention. Emergency preparedness and response: plague: veterinary issues: dogs and ungulates

Recombinant F1-V fusion protein protects black-footed ferrets (Mustelae nigripes) against virulent Yersinia pestis infection

Principles and practice of infec tious diseases

ical terrorism: strategic plan for preparedness and response. Recommendations of the CDC Strategic Planning Workgroup

A spatial model of shared risk for plague and hantavirus pulmonary syndrome in the southwestern United States

Cases of human plague associated with exposure to infected domestic cats

Dynamics of plague in a Gunnison's prairie dog colony complex from New Mexico

Zoonoses and communicable diseases common to man and animals

Classic flea-borne transmission does not drive plague epizootics in prairie dogs

Oropsylla hirsuta (Siphonaptera: Ceratophyllidae) can support plague epizootics in black-tailed prairie dogs (Cynomys ludovicianus) by early-phase transmission of Yersinia pestis. Vector Borne Zoonotic Dis

Handbook of zoonoses: identification and prevention

Clinical, clinicopathologic, and pathologic features of plague in cats: 119 cases (1977-1988)

Yersinia pestis infection in three dogs

The 5-minute veterinary consult clinical companion: canine and feline infectious diseases and parasitology

Bioterrorism agent fact sheet: plague/Yersinia pestis

Gentamicin and tetracyclines for the treatment of human plague: a review of 75 cases in New Mexico

Sanford guide to antimicrobial therapy

Blackwell's five-minute veterinary consult: canine and feline

Zoonoses and communicable diseases common to man and animals

Handbook for zoonotic diseases of companion animals

National Institutes of Health. Biosafety in microbiological and biomedical laboratories

Control of communicable diseases manual

Q fever in children: an emerging public health issue in Queensland

An outbreak of cat-associated Q fever in the United States

The Merck veterinary manual

Seroprevalence of Coxiella burnetii infections among cats in different living environments

Cat or dog ownership and seroprevalence of ehrlichiosis, Q fever, and cat-scratch disease

Coxiella burnetii in bulk tank milk samples, United States

A pedagogical farm as a source of Q fever in a French city

Suburban transmission of Q fever in French Guiana: evidence of a wild reservoir

Acute Q fever in children presenting with encephalitis

Pseudoepidemic of Q fever at an animal research facility. Vector Borne Zoonotic Dis

The 5-minute veterinary consult clinical companion: canine and feline infectious diseases and parasitology

Sanford guide to antimicrobial therapy

References 1. Alliance for Rabies Control

The 5-minute veterinary consult clinical companion: canine and feline infectious disease and parasitology

Handbook for zoonotic diseases of companion animals

Rabies serology and animal transport to rabies-free areas

World Health Organization

Clinical practice. Prophylaxis against rabies

Pan American Health Organization

Status of oral rabies vaccination in wild carnivores in the United States

Rabies in transplant recipients investigation team. Transmission of rabies virus from an organ donor to four transplant recipients

Unexplained rabies in three immigrants in the United States: a virologic investigation

Control of communicable diseases manual

The Merck veterinary manual

Centers for Disease Control and Prevention. Human Rabies Prevention-United States

Evaluation of a direct, rapid immunohistochemical test for rabies diagnosis

Survival after treatment of rabies

Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis-United States: a practical guide for physicians and other health-care and public health professionals

Long-term sequelae of Rocky Mountain spotted fever

Assessing the magnitude of fatal Rocky Mountain spotted fever in the United States: comparison of two national data sources

Implications of presumptive fatal Rocky Mountain spotted fever in two dogs and their owner

Short report: concurrent Rocky Mountain spotted fever in a dog and its owner

Centers for Disease Control and Prevention. Lyme disease prevention: protect yourself from tick bites

Evaluation of five popular methods for tick removal

Principles and practice of infectious diseases

Laboratory-associated infections: summary and analysis of 3921 cases

Rickettsia parkeri: a newly recognized cause of spotted fever rickettsiosis in the United States

American boutonneuse fever: a new spotted fever rickettsiosis

Control of communicable diseases manual

Rickettsia parkeri infection after tick bite, Virginia. Emerg Infect Dis

Rocky Mountain spotted fever-changing ecology and persisting virulence

Interspecific differences between small mammals as hosts of immature Dermacentor variabilis (Acari: Ixodidae) and a model for detection of high risk areas of Rocky Mountain spotted fever

Rocky Mountain spotted fever from an unexpected tick vector in Arizona

The Merck veterinary manual

The 5-minute veterinary consult clinical companion: canine and feline infectious diseases and parasitology

Consequences of delayed diagnosis of Rocky Mountain spotted fever in children-West Virginia

Handbook for zoonotic diseases of companion animals

Sanford guide to antimicrobial therapy

Postexposure management and treatment of anthrax in dogs-Executive Councils of the American Academy of Veterinary Pharmacology and Therapeutics and the American College of Veterinary Clinical Pharmacology

Evaluation of pathways for release of Rift Valley fever virus into domestic ruminant livestock, ruminant wildlife, and human populations in the continental United States

Rift Valley Fever Working Group: Developing a research agenda and a comprehensive national prevention and response plan for Rift Valley fever in the United States

Efficacy of a sustained release methoprene formulation on vectors of Rift Valley fever in field studies in Kenya

Tri-Service reportable events: guidelines and case definitions

Recognizing Rift Valley fever (FAO Animal Health Manual 17). Rome: Food and Agriculture Organization of the United Nations

Wilson's microbiology and microbial infections

Rift Valley fever

Origin of 1997-98 Rift Valley fever outbreak in East Africa

Enzootic hepatitis or Rift Valley fever: an undescribed virus disease of sheep, cattle and man from East Africa

A possible route for the introduction of Rift Valley fever virus into Egypt during 1977

Genetic analysis of viruses associated with emergence of Rift Valley fever in Saudi Arabia and Yemen

Centers for Disease Control and Prevention. Outbreak of Rift Valley fever-Yemen

Rift Valley fever: present status and risk to the Western hemisphere

Rift Valley Fever

Rift Valley fever virus (family Bunyaviridae, genus Phlebovirus). Isolations from Diptera collected during an inter-epizootic period in Kenya

Interepidemic Rift Valley fever virus seropositivity, northeastern Kenya

Experimental Rift Valley fever in rhesus macaques

Resistance to Rift Valley fever virus in Rattus norvegicus: genetic variability within certain "inbred" strains

Preparation of Rift Valley fever contingency plans (FAO Animal Health Manual 15). Rome: Food and Agriculture Organization of the United Nations

Case report: Rift Valley fever with vertical transmission in a pregnant Sudanese woman

Vertical transmission of fatal Rift Valley fever in a newborn

Rift Valley fever

Rainfall and epizootic Rift Valley fever. B World Health Org

Climate and satellite indicators to forecast Rift Valley fever epidemics in Kenya

Rift Valley fever virus

World Health Organization. Rift Valley fever fact sheet

Rift Valley fever outbreak-Kenya

Prevalence of antibodies against Rift Valley fever in Kenyan wildlife

World Organisation for Animal Health. Manual of diagnostic tests and vaccines for terrestrial animals (OIE terrestrial manual). 6th ed. Paris: World Organisation for Animal Health

Centers for Disease Control and Prevention. Division of Foodborne, Bacterial and Mycotic Diseases: Salmonellosis: general information

Effect of regulation and education on reptile-associated salmonellosis

Reptile-associated salmonellosis-selected states

Alerting pregnant women to the risk of reptile-associated salmonellosis

Diseases pets and people share

Zoonoses and communicable diseases common to man and animals

Risk factors for Salmonella enteritidis and typhimurium (DT104 and non-DT104) infections in The Netherlands: predominant roles for raw eggs in Enteritidis and sandboxes in typhimurium infections

Reptiles, amphibians, and human Salmonella infection: a population-based, case-control study

Multidrug-resistant Salmonella typhimurium in four animal facilities

Salmonella transmission through splash exposure during a bovine necropsy

Salmonella serotype enteritidis infections among workers producing poultry vaccine-Maine

Septicemic salmonellosis in two cats fed a raw-meat diet

The risk of salmonellae shedding by dogs fed Salmonella-contaminated commercial raw food diets

Cats as a risk for transmission of antimicrobial drug-resistant Salmonella

Multistate outbreak of Salmonella infections associated with peanut butter and peanut butter-containing products-United States

Human salmonellosis associated with animal-derived pet treats-United States and Canada

The Merck veterinary manual

Evaluation of Salmonella occurrence in domestic animals and humans in North Dakota

Principles and practice of infectious diseases

Salmonellosis outcomes differ substantially by serotype

Sanford guide to antimicrobial therapy

Blackwell's five-minute veterinary consult: canine and feline

The 5-minute veterinary consult clinical companion: canine and feline infectious diseases and parasitology

The story of scabies

Pseudoscabies caused by Dermanyssus gallinae in Italian city dwellers: a new setting for an old dermatitis

Dermatitis in humans associated with the mites Pyemotes tritici, Dermanyssus gallinae, Ornithonyssus bacoti and Androlaelaps casalis in Israel

Systemic manifestations of Cheyletiella infestation in man

Zoonotic skin diseases of dogs and cats

The Merck veterinary manual

Biology, host relations, and epidemiology of Sarcoptes scabiei

Epidemiology of scabies

Crusted (Norwegian) scabies: treatment of nail involvement

Outfoxing a rash: clinical example of human-wildlife interaction

Scabies in 1976

Mites in the environment of Norwegian scabies

Scraping for human scabies: a better method for positive preparations

):637. 16. van den Hoek JA, et al. A persistent problem with scabies in and outside a nursing home in Amsterdam: indications for resistance to lindane and ivermectin

Sanford guide to antimicrobial therapy

Control of communicable diseases manual

Toxocara canis infestation. Clinical and epidemiological associations with seropositivity in kindergarten children

Toxocara canis infection of children: epidemiological and neuropsychologic findings

Control of communicable diseases manual

CDC guidelines for veterinarians: prevention of zoonotic transmission of hookworm and ascarid infection of dogs and cats

The Merck veterinary manual

National seroprevalence and risk factors for zoonotic Toxocara spp. infection

The 5-minute veterinary consult clinical companion: canine and feline infectious diseases and parasitology

Infectious and tropical diseases: a handbook for primary care

Principles and practice of infectious diseases

Zoonoses and communicable diseases common to man and animals

Sanford guide to antimicrobial therapy

Toxoplasma gondii infection in the United States: seroprevalence and risk factors

The Merck veterinary manual

Toxoplasma gondii infection in the United States, 1999-2004, decline from the prior decade

Zoonoses and communicable diseases common to man and animals: vol. III: chlamydioses, parasitoses

Handbook for zoonotic diseases of companion animals

Prevalence of viable Toxoplasma gondii in beef, chicken, and pork from retail meat stores in the United States: risk assessment to consumers

Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counseling

Reconsidering the pathogenesis of ocular toxoplasmosis

Principles and practice of infectious diseases

Nelson textbook of pediatrics

The 5-minute veterinary consult clinical companion: canine and feline infectious diseases and parasitology

Recent developments for diagnosis of toxoplasmosis

Sanford guide to antimicrobial therapy

Antimicrobial therapy in veterinary medicine

On the question of sporadic or atypical bovine spongiform encephalopathy and Creutzfeldt-Jakob disease

Control of communicable diseases manual

The Merck veterinary manual

CJD Incidents Panel, Engineering and Scientific Advisory Committee et al: The impact of Cruetzfeldt-Jacob disease on surgical practice

Implications of prion disease for dentistry: an update. Oral Surg Oral Med Oral Pathol Oral Radiol Endod

Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease

The public health impact of prion diseases

Novel methods for disinfection of prion-contaminated medical devices

Other animal prion diseases

An evaluation of scrapie surveillance in the United States

Human prion disease and relative risk associated with chronic wasting disease

Evidence of scrapie transmission via milk

A new prionopathy

Principles and practice of infectious diseases

Variant Creutzfeldt-Jakob disease and the acquired and transmissible spongiform encephalopathies

Risk of scrapie in British sheep of different prion protein genotype

Prion infections of the brain

Harrison's principles of internal medicine

Vaccine approaches to prevent and treat prion infections: progress and challenges

Systematic review of therapeutic interventions in human prion disease

A systematic review of prion therapeutics in experimental models

Characterization of Mycobacterium tuberculosis complex DNAs from Egyptian mummies by spoligotyping

Detection of mycobacterial DNA in Andean mummies

First report of Mycobacterium bovis DNA in human remains from the Iron Age

Genotyping analysis of the earliest known prehistoric case of tuberculosis in Britain

Did ice-age bovids spread tuberculosis?

Global tuberculosis control 2008: surveillance, planning, financing

Bovine tuberculosis in free-ranging white-tailed deer from Michigan

The sensitivity of gross necropsy, caudal fold and comparative cervical tests for the diagnosis of bovine tuberculosis

Bovine tuberculosis in free-ranging carnivores from Michigan

The evolution of mycobacterial pathogenicity: clues from comparative genomics

Comparative and functional genomics of the Mycobacterium tuberculosis complex

Human exposure following Mycobacterium tuberculosis infection of multiple animal species in a metropolitan zoo

Rhinoceros' rhinorrhea: cause of an outbreak of infection due to airborne Mycobacterium bovis in zookeepers

Mycobacterium tuberculosis infection as a zoonotic disease: transmission between humans and elephants

Implications of tuberculosis in African wildlife and livestock

Tuberculosis: a reemerging disease at the interface of domestic animals and wildlife

Mycobacterium bovis (bovine TB) exposure as a recreational risk for hunters: results of a Michigan hunter survey

Human Mycobacterium bovis infection and bovine tuberculosis outbreak

Tuberculosis: a problem with persistence

Controlling tuberculosis in the United States: Recommendations from the

Milk as a vector of transmission of bovine tuberculosis to humans in Spain: a historical perspective

Human tuberculosis due to Mycobacterium bovis in the United States

The epidemiology of Mycobacterium bovis infections in animals and man: a review

Cluster of human tuberculosis caused by Mycobacterium bovis: evidence for person-to-person transmission in the UK

High rate of tuberculosis reinfection during a nosocomial outbreak of multidrug-resistant tuberculosis caused by Mycobacterium bovis strain B

The zoonotic importance of Mycobacterium tuberculosis: transmission from human to monkey

Transmission of Mycobacterium tuberculosis from human to cattle

Putative transmission of Mycobacterium tuberculosis infection from a human to a dog

Mycobacterium tuberculosis transmission from human to canine

Possible human-avian transmission of Mycobacterium tuberculosis in a green-winged macaw (Ara chloroptera)

Mycobacterium tuberculosis infection in a green-winged macaw (Ara chloroptera): report with public health implications

Cattle-to-cattle transmission of bovine tuberculosis

Immunity: the immune response to infectious and inflammatory disease

Manual of diagnostic tests and vaccines for terrestrial animals (OIE terrestrial manual). 6th ed. Paris: World Organisation for Animal Health

Immunological concepts in tuberculosis diagnostics for non-human primates: a review

United States Animal Health Association

Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings

Guidelines for using the QuantiFERON-TB Gold Test for detecting Mycobacterium tuberculosis infection

A review of tests available for use in the diagnosis of tuberculosis in non-bovine species

Update on the treatment of tuberculosis and latent tuberculosis infection

Population pharmacokinetics of isoniazid in the treatment of Mycobacterium tuberculosis among Asian and African elephants (Elephas maximus and Loxodonta africana)

Pharmacokinetics of ethambutol (EMB) in elephants

Population pharmacokinetics of pyrazinamide in elephants

Dose selection and pharmacokinetics of rifampin in elephants for the treatment of tuberculosis

Falkinham 3rd JO. Health impacts of environmental mycobacteria

The changing pattern of nontuberculous mycobacterial disease

An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases

Infections due to non-tuberculous mycobacteria (NTM)

Mycobacterium ulcerans in wild animals

Aspergillus and mycobacteria diagnostics

Diagnosis of avian mycobacteriosis: comparison of culture, acid-fast stains, and polymerase chain reaction for the identification of Mycobacterium avium in experimentally inoculated Japanese quail (Coturnix coturnix japonica)

Mycobacterium avium and Mycobacterium intracellulare infection in mammals

Mycobacterium leprae and Mycobacterium lepraemurium infections in domestic and wild animals

References 1

Consensus statement: tularemia as a biological weapon: medical and public health management

Biosafety and selectable markers

Figure 9-159 n This Vermont muskrat trapper contracted tularemia, which manifested as a cutaneous lesion on his left lateral forehead. (From Centers for Disease Control and Prevention Public Health Image Library

Control of communicable diseases manual

Epidemiologic and molecular analysis of human tularemia

The Merck veterinary manual

First isolation of Francisella tularensis subsp. tularensis in Europe

Tularemia on Martha's Vineyard: seroprevalence and occupational risk

The 2000 tularemia outbreak: a case-control study of risk factors in disease-endemic and emergent areas

Detection of antibodies to Francisella tularensis in cats

A waterborne tularemia outbreak

Cat-bite tularemia in a seventeen-year-old girl treated with ciprofloxacin

The 5-minute veterinary consult clinical companion: canine and feline infectious diseases and parasitology

Waterborne outbreak of tularemia associated with crayfish fishing

Pneumonic tularemia on Martha's Vineyard: clinical, epidemiologic, and ecological characteristics

Epidemic outbreak of tularemia in Palencia

Principles and practice of infectious diseases

Localized cutaneous infection with Francisella tularensis resembling ulceroglandular tularemia in a cat

Naturally occurring tularemia in a dog

Zoonoses and communicable diseases common to man and animals: vol. I: bacterioses and mycoses

Infectious and tropical diseases: a handbook for primary care

Sanford guide to antimicrobial therapy

West Nile virus: Uganda

West Nile virus surveillance using sentinel birds

Juvenile dogs as potential sentinels for West Nile virus surveillance

The insect repellent DEET

New pesticide fact sheet: picaridin

Centers for Disease Control and Prevention. West Nile virus: questions and answers: insect repellent use and safety

American Association of Equine Practitioners

Handbook for zoonotic diseases of companion animals

West Nile virus: a primer for the clinician

West Nile virus in birds

West Nile virus

West Nile virus: clinical description

Experimental infection of North American birds with the New York 1999 strain of West Nile virus

West Nile virus in overwintering Culex mosquitoes

Epidemiology and transmission dynamics of West Nile virus disease

West Nile virus

1999: results of a household-based seroepidemiological survey

Clinical characteristics and functional outcomes of West Nile fever

Virology, pathology and clinical manifestations of West Nile virus disease

Evaluation of an outbreak of West Nile virus infection in horses: 569 cases

Investigation of an outbreak of encephalomyelitis caused by West Nile virus in 136 horses

Experimental infection of dogs and cats with West Nile virus

Clinical signs and results of specific diagnostic testing among captive birds housed at zoological institutions and infected with West Nile virus

Arboviruses in birds

West Nile virus: epidemiology and ecology in North America

Variations in biological features of West Nile viruses

Neurologic manifestations and outcome of West Nile virus infection

Acute flaccid paralysis and West Nile virus infection

VecTest as diagnostic and surveillance tool for West Nile virus in dead birds

Assays to detect West Nile virus in dead birds

In 1986, an outbreak of bovine spongiform encephalopathy (BSE) occurred in the United Kingdom that was eventually linked to the use of livestock feed containing meat and bone from animals infected with a prion disease (prion is short for proteinaceous infectious particle). Shortly afterward, outbreaks of transmissible spongiform encephalopathies (TSEs) were reported in zoo animals and domestic cats that had consumed BSE-contaminated meat products. In retrospect, this unusual occurrence of prion diseases in animals was a sentinel event for human health risk. In 1996, the emergence in humans of a variant form of Creutzfeldt-Jakob disease (vCJD), a progressive dementia, was attributed to consumption of contaminated beef from BSE-infected cattle. As a result of the implementation of a number of feed bans, such as a prohibition against feeding mammalian protein to any farmed animals in the United Kingdom, the incidence of reported cases of both BSE and vCJD has dropped dramatically in recent years. Outbreaks in cats and other animals also declined related to similar feed bans. Despite the success in controlling BSE and vCJD, prion diseases continue to be a public health concern. Sporadic Creutzfeldt-Jakob disease (CJD), which has no known link to animal prion diseases, occurs worldwide at a case rate of approximately 1 case per 1 million persons. 1 Other variations of human prion disease are reported worldwide at lower rates (see "Disease in Humans" section on the following page). Chronic wasting disease (CWD), a prion disease of wildlife such as deer and elk, is extending its range in the United States and Canada. Scrapie, a prion disease of sheep, continues to affect sheep and goat populations in some parts of the world. The origin, transmissibility, and ability for cross-species infection of these diseases remain poorly understood. Therefore ongoing vigilance for the emergence of TSE-related disease in humans and other animals by human and veterinary clinicians and public health authorities is warranted. Francisella tularensis causes an acute febrile illness in humans and other animals that can be fatal. The incidence of tularemia has decreased in the United States since the first half of the twentieth century. 1 However, sporadic outbreaks continue to occur, and the disease has emerged in regions where it previously had not been recognized. Moreover, its widespread occurrence in wildlife and arthropod vectors, its ability to persist in water and soils, and its high infectiousness for both humans and domestic animals make it both a high-priority biological terrorism agent as well as a zoonotic pathogen with potential to cause significant health effects in human and animal populations.

• Provide epidemiological analysis of this reportable disease. • Educate the public to avoid tick, fly, and mosquito bites by using appropriate clothing and repellents. • Educate hunters to use puncture-resistant gloves when skinning or handling game, especially rabbits, and to cook wild meat thoroughly. • The CDC recommends that laboratory personnel be alerted when tularemia is suspected. Diagnostic